26.12.2013 Views

Group Annual Report 2012 - ERGO Versicherungsgruppe AG

Group Annual Report 2012 - ERGO Versicherungsgruppe AG

Group Annual Report 2012 - ERGO Versicherungsgruppe AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>2012</strong><br />

<strong>Group</strong> <strong>Annual</strong> <strong>Report</strong>


Management <strong>Report</strong><br />

Overview of <strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>2012</strong> 2011 Change previous<br />

year (%)<br />

Total premium income € million 18,562 20,270 − 8.4<br />

Gross premiums written € million 17,091 18,519 − 7.7<br />

Expenses for claims and benefits (gross) € million 17,556 17,369 1.1<br />

Investment result € million 5,262 4,116 27.8<br />

Operating result € million 951 806 17.9<br />

Consolidated result € million 289 349 − 17.2<br />

Investments € million 125,390 117,309 6.9<br />

Technical provisions (net) € million 120,859 113,977 6.0<br />

Equity € million 4,587 3,827 19.9<br />

Full-time representatives 17,862 19,087 − 6.4<br />

Salaried employees 29,768 31,311 − 4.9<br />

<strong>ERGO</strong> is one of the major insurance groups in Germany<br />

and Europe. We have a presence in more than 30 countries<br />

worldwide, but the focus of our activities is on the European<br />

and Asian regions. <strong>ERGO</strong> offers a broad range in<br />

insurance, pension provision and services, and is one<br />

of the leading insurers across all segments in its home<br />

market of Germany. Around 48,000 people work for our<br />

<strong>Group</strong>, either as salaried employees or as full-time selfemployed<br />

sales partners. In <strong>2012</strong>, premiums amounted to<br />

over € 18 billion and insurance benefits for our customers<br />

accounted for more than € 17 billion.<br />

Our customers determine the way we operate. <strong>ERGO</strong> is strictly<br />

geared towards the wishes and needs of its customers,<br />

and intends to improve this still further by pursuing a<br />

close dialogue with them. We are implementing our claim<br />

“To insure is to understand” by providing advice and<br />

products which meet the needs of our customers as well<br />

as understanding and picking up on customers’ personal<br />

concerns. This is enhanced by a clear and understandable<br />

communication, innovative services and swift support in<br />

the event of damage or loss.<br />

Our customers can choose which form of contact with<br />

<strong>ERGO</strong> suits them best, as we have the right sales channel<br />

for every customer: Self-employed insurance sales<br />

partners, staff working in direct sales, as well as insurance<br />

brokers and strong cooperation partners – both in Germany<br />

and abroad – respond to the needs of private and corporate<br />

customers alike. We maintain partnerships with the<br />

major European bank UniCredit <strong>Group</strong> and other banks,<br />

both in Germany as well as in various European countries.<br />

<strong>ERGO</strong> is part of Munich Re, one of the leading global reinsurers<br />

and risk carriers. Within Munich Re, <strong>ERGO</strong> is the<br />

specialist for primary insurance, i. e. for insuring private and<br />

corporate customers directly, both in Germany and abroad.<br />

The group’s investments of € 214 billion, of which € 125 billion<br />

is accounted for by <strong>ERGO</strong>, are managed primarily by the<br />

joint asset management and fund company ME<strong>AG</strong>.


<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Group</strong> <strong>Annual</strong> <strong>Report</strong>


Contents<br />

3 Letter by the Chairman of the Board of Management<br />

6 <strong>Report</strong> of the Supervisory Board on the <strong>2012</strong> financial year<br />

Management <strong>Report</strong><br />

10 The <strong>ERGO</strong> Insurance <strong>Group</strong><br />

14 The <strong>ERGO</strong> Insurance <strong>Group</strong> – Governing bodies<br />

16 Business environment<br />

19 Business performance<br />

23 Assets and financial position<br />

27 Other success factors<br />

31 Risk report<br />

42 Opportunities report<br />

44 Prospects<br />

Consolidated<br />

Financial Statements 48 Consolidated balance sheet as at 31 December <strong>2012</strong><br />

50 Consolidated income statement for the financial year <strong>2012</strong><br />

51 Statement of recognised income and expense<br />

52 <strong>Group</strong> statement of changes in equity<br />

54 Consolidated cash flow statement for the financial year <strong>2012</strong><br />

55 Principles of presentation and consolidation<br />

74 Notes to the consolidated balance sheet – assets<br />

95 Notes to the consolidated balance sheet – equity and liabilities<br />

110 Notes to the consolidated income statement<br />

118 Disclosures on risks from insurance contracts and financial<br />

instruments<br />

130 Other information<br />

136 List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

148 Auditor’s report


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

3<br />

Letter by the Chairman of<br />

the Board of Management<br />

Dear Readers,<br />

“Rescue routine” was the German word of the year <strong>2012</strong>. This means that the top spot has<br />

been claimed for the third time in five years by a term reflecting the turbulence on the<br />

capital markets, following “financial crisis” in 2008 and “stress test” in 2011. This shows<br />

how much the unpredictability of the markets continues to affect our everyday lives. The<br />

effects of the financial and national debt crises for companies and citizens are becoming<br />

ever clearer. This makes special demands on us not only in the management of our investments<br />

but also increasingly in our core business as an insurer.<br />

Our major investment portfolio still features investments that yield higher rates of return<br />

than can currently be achieved. In addition, we took early action to hedge against the risk<br />

of falling interest rates which will enable us to hold out for a long time in a climate where<br />

low interest rates prevail. After all, we make promises of benefits to customers that often<br />

last a lifetime, so we have to be able to make good on our promises even if interest rates<br />

remain extremely low.<br />

Dr. Torsten Oletzky<br />

Chairman of the Board of Management<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

As a result, sustainable security takes precedence over returns on investment. This is<br />

why we have continued to lower policyholders’ bonuses for new German life insurance<br />

contracts. And our new unisex tariffs for health insurance feature lower technical interest<br />

rates. As lower capital yields are already taken into account during the calculation process,<br />

premium rates are higher as a result.<br />

For many customers, life insurance remains the best route to pursue in terms of private<br />

old-age provision. However, due to low interest rates, they are no longer able to fulfil<br />

customer expectations as they once did. <strong>Annual</strong> guarantees are expensive and have an<br />

adverse impact on the rate of return. This is why we will provide new product concepts in<br />

the future. Our guarantees have the main task to fulfil our customers’ demands in terms<br />

of planning security for their old age. At the same time, we will make our new products<br />

more flexible so that they adapt more successfully to the different stages in a person’s life.<br />

The new product generation will be launched this year.<br />

The fact that we have lowered the conditions of single-premium life insurance policies<br />

out of prudence already for <strong>2012</strong> has affected our new business. A lower life insurance<br />

business and sales of daughter companies in the previous year led to a decrease of 8.4%<br />

in total premium income, down to € 18.6 billion (20.3 bn). By contrast, the operating result<br />

was up significantly by 17.9% to € 951 million (806 m). The investment result recorded a


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Letter by the Chairman of 4<br />

the Board of Management<br />

major increase to € 5.3 billion (4.1 bn), while net returns rose from 3.4% to 4.1%. One of the<br />

major reasons for this increase was the cessation of the adverse effects of the previous<br />

year. The combined ratio of 95.8 (94.4)% in the German non-life segment did not live up<br />

to our high demands. However, at 100.5 (105.1)%, the combined ratio for international<br />

business developed favourably. Overall, the operating performance corresponded to our<br />

expectations.<br />

At € 417 million, the consolidated result before provisions for restructuring costs was<br />

slightly above our target. Taking these provisions into account, we achieved a result of<br />

€ 289 million (349 m). The provisions were set up in order to provide for the restructuring<br />

of our sales organisations. In order to introduce a consistent advisory process, reduce<br />

complexity and save on overheads, we started to streamline structures in our sales<br />

department in <strong>2012</strong>.<br />

We intend to merge five German sales organisations into two units under the umbrella<br />

of an <strong>ERGO</strong> sales company which will enable us to manage and support our sales teams<br />

consistently, bundle recruitment and will ensure a more homogeneous brand appearance.<br />

All these are important requirements for the proper use of resources and for efficient<br />

workflows. However, the related cut of up to 700 salaried sales posts and 650 in-house<br />

posts has been a hard decision to make. In cooperation with our co-determination bodies,<br />

we are attempting to find fair, socially responsible solutions for those affected. I sincerely<br />

hope that we are able to find appropriate solutions.<br />

In <strong>2012</strong>, our sales representatives were also the focus in terms of implementing our brand<br />

promise “To insure is to understand”. The mutual development of a consistent advisory<br />

process means that customer requirements are taken into account in every respect. If our<br />

sales partners are able to provide advice and conduct sales at the same high level, our<br />

customers will obtain the best possible insurance for all situations in life. In my opinion,<br />

you do not need to be an independent advisor in order to provide excellent insurance<br />

advice.<br />

This year’s Customer <strong>Report</strong> will also focus on how our sales partners advise and support<br />

our customers. The report describes how we implement our brand promise in terms of<br />

sales and other areas, and puts the focus on customers and their queries. The positive<br />

feedback that followed the first <strong>ERGO</strong> Customer <strong>Report</strong> in May <strong>2012</strong> gave us the reassurance<br />

that we are on the right track with this approach.<br />

In <strong>2012</strong>, we continued to improve the clarity of our customer communication with further<br />

revisions to customer letters as well as to terms and conditions of insurance policies.<br />

We have a special committee to ensure that our communication remains clear. It is now<br />

easier than ever to understand what we cover and what we do not – so that our customers<br />

always know what to expect from us. This is only fair and also prevents misunderstandings<br />

from arising. We are particularly proud of our TÜV certification for “Clear Communication”.<br />

In order to attain this certification, all of our customer communication was subject to<br />

external auditing by the technical inspection agency TÜV Saarland.<br />

Our understanding of “To insure is to understand” also includes being ready to respond<br />

to criticism. In summer <strong>2012</strong>, we were subject to allegations that we did not fully report<br />

on instances of misconduct in our sales organisations. Even if not all allegations were<br />

substantiated, we learnt that we did not fulfil our own demands on transparency in every<br />

respect. As a consequence, we published the results of our internal audit into claims of<br />

misconduct on incentive trips and other sales events on our website in October <strong>2012</strong>.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Letter by the Chairman of 5<br />

the Board of Management<br />

We also listed the actions we have taken so that everyone can form an opinion on these<br />

events. We will continue to maintain this transparency and openness.<br />

When it comes to products, we are increasingly gearing them towards the expectations<br />

and requirements of our customers. Our new accident insurance package offers complete<br />

support with lots of assistance services and one-to-one advice. When developing the<br />

product, our colleagues listened closely to people who had experienced accidents to guide<br />

them. This approach has met with approval: the product has gone down well with our<br />

customers. And when we notice that a product no longer conforms to the expectations of<br />

our customers, we adapt it or discontinue it.<br />

As far as our international business is concerned, we are continuing to pursue our<br />

expansion in Asia and are increasingly benefiting from our years of preparation and local<br />

presence. After a five‐year preparatory period, a team has been working in the Chinese<br />

province of Shandong since spring <strong>2012</strong> to set up the <strong>ERGO</strong> China Life Insurance. The joint<br />

venture with the Shandong State-owned Assets Investment Holding Company as a strong<br />

local partner is intended to go into business this year as soon as the final approval has<br />

been obtained from the local authorities.<br />

In India, we agreed on a joint venture in life insurance in November <strong>2012</strong> with the wellpositioned<br />

Avantha <strong>Group</strong> conglomerate – an excellent addition to our successful market<br />

presence in non‐life insurance with the joint venture HDFC <strong>ERGO</strong>. By contrast, we have sold<br />

<strong>ERGO</strong> Daum Direct in the difficult South Korean market.<br />

These are the main topics that shaped <strong>2012</strong> for us, and we will continue to work on many<br />

of them this year too. Our employees and management alike have driven the Company<br />

onwards with their conscientious work, commitment and excellent ideas. Our expert sales<br />

partners are fully dedicated to our customers. I would like to thank each and every one of<br />

them for their hard work. I am sure that we have created a solid foundation for success<br />

both for this year and the years to come.<br />

As an insurer, we depend heavily on the trust our customers have in us. If people ask why<br />

we deserve this trust, I say to them: because customers are always our focus, and they<br />

sense how much we value them. Because we take on challenges and are prepared to<br />

change with the times. Because we think ahead, try to take action in good time, and learn<br />

from our mistakes.<br />

And we will do everything we can to earn and merit this trust in the future.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

6<br />

<strong>Report</strong> of the Supervisory Board<br />

on the <strong>2012</strong> financial year<br />

The Supervisory Board reviewed the Company’s situation in detail during the reporting<br />

period. It monitored the management’s activities in accordance with legislation and<br />

the Company’s Articles of Association and advised the Board of Management regarding<br />

management of the Company. We were also involved in all major decisions. The Board of<br />

Management informed us regularly and in detail about important topics such as corporate<br />

planning, business development and the Company’s current situation. We were also<br />

consulted concerning corporate strategy.<br />

Dr. Nikolaus von Bomhard<br />

Chairman of the Supervisory Board<br />

of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

In the year under review, the Supervisory Board convened for three scheduled and two<br />

extraordinary meetings, which were attended by almost all members. In addition, the<br />

various committees (Standing Committee, Audit Committee and Board Committee) met,<br />

and the respective Chairpersons regularly reported in detail on their work. They were<br />

also available to answer any questions. The Nomination Committee and the Conference<br />

Committee as decreed by Section 27, para. 3, of the German Co-Determination Act<br />

( MitbestG) did not have to meet.<br />

The Board of Management also informed us in between sessions about important issues<br />

and significant upcoming decisions. Furthermore, as Chairman of the Supervisory Board,<br />

I was in regular contact with the Chairman of the Board of Management and discussed<br />

with him <strong>ERGO</strong>’s strategy, risk and capital management as well as current business<br />

develop ments. The subject of these discussions included the allegations made against<br />

<strong>ERGO</strong> by the press again in summer <strong>2012</strong>. These allegations were made known in 2011<br />

and subsequently clarified in detail.<br />

Main issues<br />

During the balance sheet meeting held on 20 March <strong>2012</strong>, the Supervisory Board was<br />

given a detailed review of the 2011 financial statement as well as being informed of<br />

<strong>ERGO</strong>’s business development. The Chief Risk Officer also informed us in detail of <strong>ERGO</strong>’s<br />

risk strategy and risk situation. In addition, the Board of Management reported on<br />

preparations for the introduction of the new Solvency II regulatory system. During the<br />

session held on 3 August <strong>2012</strong> we debated the profitability of classic life insurance in the<br />

context of the current economic and political environment in Germany.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Supervisory Board report 7<br />

on the <strong>2012</strong> financial year<br />

We were told about the plans for a new <strong>ERGO</strong> life insurance product line, which is due to<br />

be launched in 2013. Finally, in its meeting on 4 December <strong>2012</strong>, the Supervisory Board<br />

discussed the reports by the Board of Management regarding the development and risk<br />

exposure of <strong>ERGO</strong>’s investments. Other topics included developments in the non‐life and<br />

international segments. We also discussed the Labour Director’s HR <strong>Report</strong>.<br />

In two extraordinary meetings held on 4 June and 30 October <strong>2012</strong>, the Supervisory Board<br />

discussed the results of the audits investigating allegations made against <strong>ERGO</strong> by the<br />

press as well as the measures adopted by the Board of Management in response to these<br />

allegations. The Board of Management presented the measures implemented so far and<br />

those to be adopted, along with more information about the topic of transparency on the<br />

<strong>ERGO</strong> website.<br />

In addition, during its meetings on 3 August and 4 December <strong>2012</strong>, the Supervisory Board<br />

discussed the “Future of Sales” Initiative, including the planned strategic realignment of<br />

<strong>ERGO</strong>’s sales organisations. In its meeting on 4 December <strong>2012</strong>, the Standing Committee<br />

approved and passed the transactions and measures concerning the <strong>Group</strong>’s organisation.<br />

Furthermore, the Board of Management informed us about a joint venture set up in China<br />

between <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> and life insurer <strong>ERGO</strong> Lebensversicherung <strong>AG</strong><br />

with a state investment company as a local partner, as well as a joint venture in the Life<br />

segment in India with the Avantha <strong>Group</strong>. It also outlined the sale of shares in <strong>ERGO</strong> Daum<br />

Direct in South Korea. In addition, we were told about the conclusion of a domination<br />

agreement between MunichFinancial<strong>Group</strong> GmbH – a 100% subsidiary of Münchener<br />

Rückversicherungs-Gesellschaft <strong>AG</strong> – and <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>. The contract was<br />

entered in the commercial register on 20 November and came into force on that date.<br />

Besides decisions regarding the extension of appointments to the Board of Management<br />

that were due to expire, we also addressed the topic of remuneration for the members<br />

of the Board of Management. The plenum made a decision on the amount of variable<br />

remuneration based on the annual performance in the 2011 financial year and for the<br />

2009 mid-term incentive plan. Furthermore, the assessment base and targets for variable<br />

remuneration were stipulated for the <strong>2012</strong> financial year. We also discussed changes to<br />

the remuneration system as of 1 January 2013 and passed the resolution accordingly.<br />

On this basis, we were able to establish the assessment base and targets for variable<br />

remuneration for the 2013 financial year.<br />

Corporate governance<br />

The <strong>ERGO</strong> Supervisory Board attaches great importance to good corporate governance.<br />

We took a close look at the efficiency of our operations by means of a questionnaire in the<br />

reporting year and discussed the various suggestions for improving the efficiency of the<br />

Supervisory Board.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Supervisory Board report 8<br />

on the <strong>2012</strong> financial year<br />

Company and <strong>Group</strong> financial statements<br />

KPMG Bayerische Treuhandgesellschaft Aktiengesellschaft Wirtschaftsprüfungs gesellschaft<br />

Steuerberatungsgesellschaft, Munich, audited the annual financial statements prepared<br />

by the Board of Management, including the management report and the consolidated<br />

financial statements, including the <strong>Group</strong> management report for the <strong>2012</strong> financial year,<br />

and awarded them an unqualified auditor’s opinion.<br />

At a meeting held on 11 March 2013, the Supervisory Board’s Audit Committee discussed<br />

these documents at length, having examined them in advance. We then discussed<br />

in detail the annual financial statements and the consolidated financial statements,<br />

the management report and the <strong>Group</strong> management report, along with the reports<br />

by the external auditor at the balance sheet meeting, which was also attended by<br />

representatives of the auditing company, who made a statement. We had no objections.<br />

We approved the annual financial statements and consolidated financial statements for<br />

<strong>2012</strong>, which have now been endorsed. We reviewed the Board of Management’s proposal<br />

for the appropriation of profits and have approved it.<br />

Changes to the Supervisory Board<br />

Ms Ira Gloe-Semler, Mr Hans-Peter Claußen and Mr Ralph Eisenhauer stepped down from<br />

the Supervisory Board either during the year under review or at the end of the year. We<br />

wish to thank them for their dedication and in some cases many years of service on<br />

our Board. Ms Martina Scholze, Dr. Anne Horstmann and Mr Volker Kallé have joined the<br />

Supervisory Board as their replacements or as legally appointed members.<br />

Our gratitude to the Board of Management and staff<br />

The Supervisory Board would like to thank the members of the Board of Management and<br />

all Company employees as well as the staff of all companies within the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> for their huge personal commitment in a reporting year that was shaped by many<br />

changes and challenges.<br />

Düsseldorf, 19 March 2013<br />

On behalf of the Supervisory Board<br />

Dr. Nikolaus von Bomhard<br />

Chairman of the Supervisory Board<br />

of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

10<br />

Management <strong>Report</strong><br />

The <strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>ERGO</strong> is one of the major insurance groups in Germany<br />

and Europe. We have a presence in more than 30 countries<br />

worldwide, but the focus of our activities is on European<br />

and Asian regions. <strong>ERGO</strong> offers a broad range of insurance,<br />

pension provisions and services. In its home market<br />

of Germany, <strong>ERGO</strong> ranks among the leading providers<br />

across all segments. Around 48,000 people work for our<br />

<strong>Group</strong>, either as salaried employees or as full-time selfemployed<br />

sales partners. In <strong>2012</strong>, premiums amounted to<br />

over € 18 billion and insurance benefits for our customers<br />

accounted for more than € 17 billion.<br />

Our customers can choose which form of contact with<br />

<strong>ERGO</strong> suits them best, as we have the right sales channel<br />

for every customer: self-employed insurance sales partners,<br />

staff working in direct sales, insurance brokers and strong<br />

cooperation partners – both in Germany and abroad –<br />

respond to the needs of private and corporate customers<br />

alike. We maintain sales partnerships with the major<br />

European bank UniCredit <strong>Group</strong> and other banks, both in<br />

Germany and other European countries.<br />

<strong>ERGO</strong> is part of Munich Re, one of the leading global<br />

reinsurers and risk carriers. Within Munich Re, <strong>ERGO</strong> is the<br />

specialist for primary insurance, i. e. for insuring private and<br />

corporate customers directly, both in Germany and abroad.<br />

The group’s investments of € 214 billion, of which € 125 billion<br />

is accounted for by <strong>ERGO</strong>, are managed primarily by the<br />

joint asset management and fund company ME<strong>AG</strong>.<br />

As an integral part of Munich Re, <strong>ERGO</strong> is integrated into<br />

the core processes of Munich Re in terms of regulatory and<br />

corporate law, e. g. group strategy and corporate policy,<br />

capital and financial planning, risk management, controlling,<br />

reporting and accounting, or in general regarding significant<br />

legal transactions and measures. In <strong>2012</strong>, a domination<br />

agreement was concluded between MunichReFinancial<strong>Group</strong><br />

GmbH – which is wholly owned by Münchener Rückversicherung<br />

<strong>AG</strong> – and <strong>ERGO</strong> Versicherungs gruppe <strong>AG</strong>. A group<br />

directive regulates the responsibilities and competences<br />

between the group executive management of Munich Re and<br />

<strong>ERGO</strong> in decisions of primary importance.<br />

This consolidated management report summarises the<br />

business activities of our <strong>Group</strong>. There is a general overview<br />

of <strong>ERGO</strong>’s performance on pages 19–22, which includes<br />

information on the following divisions: Life Germany,<br />

Health, Property-Casualty Germany, Direct Insurance,<br />

Travel Insurance and International.<br />

Our brand strategy<br />

In our domestic market of Germany, we offer life and<br />

property-casualty products under the <strong>ERGO</strong> brand. This<br />

product range is supplemented by our specialist insurers –<br />

DKV for health insurance, D.A.S. for legal protection and<br />

ERV for travel insurance.<br />

We are primarily represented on the international market<br />

by the <strong>ERGO</strong> brand and are actively giving the brand a<br />

higher profile. In line with this strategy, we renamed<br />

companies in Austria, Slovenia, Croatia and the Czech<br />

Republic during the reporting period. Over the course of<br />

the current year, we merged companies in Hungary and<br />

Slovakia; the merged companies now operate under the<br />

<strong>ERGO</strong> brand.<br />

Our brand communicates a clear promise to our customers:<br />

“To insure is to understand.” This promise represents a<br />

consistent approach that takes customers’ requirements<br />

into account in all areas of business. It consists of needsbased<br />

advice which understands and picks up on the<br />

customers’ concerns along with clear and easy-to-understand<br />

communication, innovative services and prompt<br />

support in the event of loss or damage.<br />

At the same time we are working towards further fulfilling<br />

our customers’ expectations and invite them and others<br />

to give us feedback which we analyse self-critically. Using<br />

the online <strong>ERGO</strong> Customer Workshop or as a member of<br />

the <strong>ERGO</strong> Customer Advisory Board, consumers can help<br />

to shape our products and services by contributing their<br />

suggestions and wishes.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>11<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong><br />

During the reporting period we published the first <strong>ERGO</strong><br />

Customer <strong>Report</strong>. We have received numerous suggestions,<br />

ideas and criticism from consumers in the form of letters,<br />

conversations, e-mails,online feedback forms and via<br />

Facebook. These comments were condensed into 179<br />

questions, which we then answered.<br />

The <strong>ERGO</strong> Customer Advocate represents the interests of<br />

our customers within the Company. He takes on the role of<br />

mediator in cases where a customer feels that he has not<br />

been treated fairly and is not getting anywhere. Together<br />

with the <strong>Group</strong>’s size and financial strength, <strong>ERGO</strong>’s strong<br />

customer orientation makes it a long-term reliable partner<br />

for customers.<br />

Our management style and objectives<br />

Our Company is managed strictly with the customer, service<br />

and profitability in mind. The focus here is on integrated<br />

management of the divisions and their administrative<br />

processes, modern risk management comprising asset<br />

liability management, and value and risk-based management<br />

of all business activities.<br />

Our activities include various business models, providing<br />

all types of life, annuity and health cover and virtually all<br />

aspects of property-casualty insurance as well as legal<br />

protection cover.<br />

Value-based management<br />

Our objective is to analyse risks from every conceivable angle<br />

and to assess and diversify them, thereby creating lasting<br />

value for shareholders, customers and staff. The guiding<br />

principle of our entrepreneurial thinking and activity is to<br />

increase the value of our Company on a lasting basis, which<br />

also includes our active capital manage ment. We pursue this<br />

goal primarily by consistently applying value-based management<br />

systems which we constantly refine. Economic earnings<br />

are instrumental to answering the uestion of whether or<br />

not we have created value over a given period. They consider,<br />

for example, the costs of the relevant risk capital and the<br />

long-term nature of the business, and correspond to the<br />

change to the economic equity over a specified period of<br />

time.<br />

The framework for any business activity is our risk strategy,<br />

derived from the business strategy, from which we extract<br />

a detailed network of limitations and reporting thresholds.<br />

Besides value-based parameters, we observe a range of<br />

important additional conditions in managing our business.<br />

They include rules of local accounting systems, tax<br />

aspects, liquidity requirements and regulatory parameters.<br />

Our value-based management is characterised by the<br />

following aspects:<br />

• We assess business activities not only according to their<br />

earnings potential but also relative to the extent of the<br />

risks assumed, which is decisive in measuring added<br />

value as well. This is why we have implemented high<br />

quality standards for underwriting, pricing, cumulative<br />

controls and claims management. Only the risk–return<br />

relationship reveals how beneficial an activity is from<br />

the shareholder point of view.<br />

• With value-based performance indicators we ensure<br />

the economic view and the necessary comparability of<br />

alternative initiatives and prioritise these.<br />

• We closely link strategy and operative planning.<br />

Property-casualty insurance:<br />

combined ratio and economic earnings<br />

Across property-casualty insurance and other segments,<br />

which are by and large distinguished by their short-term<br />

business nature, we largely consider two factors: combined<br />

ratio and economic earnings.<br />

The combined ratio describes the percentage ratio<br />

between the sum of expenses for claims and benefits to<br />

customers (net) plus operating expenses (net) to earned<br />

premiums (net).<br />

When interpreting the combined ratio, the particular<br />

circumstances of the class of business in question have<br />

to be taken into account. The composition of the portfolio<br />

is of great significance, as is the degree to which the<br />

claims burden fluctuates over time. The time lag between<br />

premiums being received and claims being paid is of key<br />

significance. The more extended this period is, the longer<br />

the premiums received can be invested in the capital<br />

markets.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>12<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong><br />

Higher combined ratios in classes of business with comparatively<br />

late claims notifications and long claims settlement<br />

processes (e. g. liability insurance) regularly go hand<br />

in hand with higher results from investments, which in<br />

turn cover the provisions for outstanding claims. These<br />

returns are not reflected in the combined ratio. For this<br />

reason, while we aim to keep the combined ratio as low<br />

as possible, it is not a sufficiently significant variable when<br />

considered on its own.<br />

The economic value creation is of decisive importance,<br />

which cannot be described properly with the combined<br />

ratio alone. The economic value added is determined<br />

internally – in compliance with the prospective regulatory<br />

system “Solvency II” – using economic earnings. Value<br />

added is characterised by the fact that value creation is<br />

not evaluated on the basis of current and forecast profits<br />

alone, but also by taking into account the amount of<br />

risks taken.<br />

The starting point for calculating economic earnings is<br />

the change in economic equity within a period of time.<br />

Determining factors are primarily the IFRS result, the<br />

change to the balance sheet and off-balance sheet<br />

reserves on the assets and liability side, as well as risk<br />

capital costs for the risks insured. The change in economic<br />

equity is adjusted according to capital measures, such as<br />

dividends. Additional adjustments concern the change<br />

of items, which are not included in the economic capital,<br />

yet still bear influence on the economic value added.<br />

An example of this is the construction of goodwill value<br />

following an acquisition.<br />

Life and Health:<br />

market-consistent embedded value<br />

Life and health insurance products are characterised<br />

by their long-term nature and the distribution of results<br />

over the duration of the policies. For valuing such longterm<br />

portfolios whose performance cannot be reasonably<br />

measured on the basis of a single year, we follow<br />

the Principles of Market Consistent Embedded Value<br />

(MCEV) © , the current version of which was published by<br />

the European Insurance CFO Forum in October 2009.<br />

MCEV comprises a company’s equity and the value of<br />

in-force covered business. The latter is the present value of<br />

future net profits from the insurance portfolio and related<br />

investments calculated using financial and actuarial<br />

methods, taking into consideration the time value of<br />

the financial options and guarantees and the explicitly<br />

determined costs of capital.<br />

MCEV relates to the portfolio as at the valuation date. It<br />

encompasses more than 97% of our life insurance and<br />

long-term health insurance business. By contrast, MCEV<br />

does not include the value of future new business. However,<br />

the valuation is made under the assumption of<br />

continued operations. Options and guarantees – especially<br />

for the policyholders – are explicitly valued using stochastic<br />

simulations. MCEV reflects the present value of all cash<br />

flows for all important currency regions on the basis of the<br />

swap rates and the implicit volatilities at the valuation date<br />

of 31 December <strong>2012</strong>. Assets that are traded on the capital<br />

markets are valued on the basis of the market values<br />

observed at the valuation date.<br />

The development of the insurance portfolio is modelled<br />

by applying the current expectations for biometrics (e. g.<br />

mortality and morbidity), lapses and costs. The participation<br />

of policyholders in surplus is modelled according to the<br />

current planning and in line with the statutory regulations,<br />

and these are included in the valuation. For the individual<br />

companies, we use tax rates and calculations based on<br />

national regulations; tax loss carry-forwards are also<br />

included in the calculation. The cost of capital essentially<br />

includes costs for the not explicitly modelled risks of the<br />

business.<br />

The change in MCEV within one year – excluding effects<br />

of exchange-rate fluctuations, acquisition and sale of<br />

companies, dividends and capital injections – is shown<br />

as the total embedded value earnings. These are used<br />

under the term Economic Earnings to manage life and<br />

health insurance. If the total embedded value earnings<br />

are adjusted by also including the influences of changes<br />

in capital market parameters, such as changes to the rate<br />

of interest, the term is known as the operating embedded<br />

value earnings, which are a measure of the operative<br />

business performance for one year.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>13<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong><br />

Managing investments<br />

The main focus of our investment strategy is assetliability<br />

management, in which we take into account key<br />

characteristics of underwriting and other liabilities in<br />

structuring our investment portfolio and measure investment<br />

risks not only in absolute terms, but also in relation<br />

to changes of value in our liabilities. Changes in economic<br />

factors are likely to influence the value of our capital<br />

investments, just as they will have an impact on the value<br />

of technical provisions and liabilities. This reduces our<br />

vulnerability to the effect of capital market fluctuations<br />

and stabilises our own equity. For this purpose, we mirror<br />

important features of the liabilities, such as maturity<br />

patterns, currency structures, and inflation sensitivities, on<br />

the assets side of the balance sheet by acquiring investments<br />

with similar characteristics if possible. In terms<br />

of currency positioning, exchange-rate fluctuations thus<br />

affect assets and liabilities in equal measure. Currency<br />

conversion losses on assets are largely offset economically<br />

by gains made by converting technical liabilities. In<br />

this approach, any deviations from the structure of our<br />

liabilities are made consciously taking due account of our<br />

risk-bearing capacity and the risk spreads achievable. To<br />

a limited extent, we also align our investment portfolio<br />

in such a way that it increases in value in line with rising<br />

inflation rates. To achieve this, we invest in inflationsensitive<br />

asset classes such as inflation-linked bonds and<br />

inflation-linked swaps, as well as real assets.<br />

Non-financial performance measures<br />

In addition to these purely financial performance factors,<br />

non-financial performance measures such as innovation,<br />

speed of processes, staff-training level as well as customer<br />

satisfaction, sales service and productivity also play a<br />

part. A company can only be successful over the long<br />

term if it operates sustainably and takes account of such<br />

future- oriented qualitative factors. This is why our strategic<br />

management focuses on the five target groups, namely<br />

customers, sales partners, staff, society and investors.<br />

We promote an entrepreneurial culture among our staff<br />

through the clear allocation of responsibility and accountability,<br />

making clear how much the individual, unit and<br />

field of business contribute to increasing value. Our incentive<br />

systems for executives and the Board of Management<br />

therefore also encourage value creation: the higher a staff<br />

member or executive is positioned in the management<br />

hierarchy, the more dependent their remuneration is on<br />

performance. <strong>ERGO</strong> Insurance <strong>Group</strong> Board members and<br />

executives have targets according to economic earnings.<br />

Furthermore, the customer satisfaction index, Net Promotor<br />

Score, is a key controlling variable for <strong>ERGO</strong> which extends<br />

into the targets and awarding of bonuses to members of<br />

the Board of Management.<br />

To configure our economic asset-liability management<br />

as effectively as possible, we also use derivative financial<br />

instruments to hedge against fluctuations in the interest<br />

rate, equity and currency markets. Under IFRS accounting,<br />

we recognise these in profit or loss, i. e. as income or<br />

expense in the income statement. This type of recording<br />

is not done with related underlying trans actions. Despite<br />

our economically well-balanced insurance and investment<br />

portfolios, accounting inconsistencies of this kind and other<br />

differences between the economic and balance sheet<br />

perspectives can give rise to considerable fluctuations in<br />

our IFRS investment, currency and consolidated results,<br />

particularly in times of greater volatility on the capital<br />

markets. Financial derivatives are explained in further detail<br />

in the notes on the consolidated financial statements [6l].


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

14<br />

Management <strong>Report</strong><br />

The <strong>ERGO</strong> Insurance <strong>Group</strong> – Governing bodies<br />

Supervisory Board<br />

Dr. Nikolaus von Bomhard, Chairman<br />

Chairman of the Board of Management of<br />

Münchener Rückversicherungs-Gesellschaft <strong>AG</strong><br />

Michael David, Deputy Chairman<br />

Insurance employee<br />

Dr. Christine Bortenlänger<br />

Managing Director of<br />

Deutsches Aktieninstitut in Frankfurt<br />

Hans-Peter Claußen, until 31 August <strong>2012</strong><br />

Insurance employee<br />

Ralph Eisenhauer, until 31 December <strong>2012</strong><br />

Executive employee<br />

Frank Fassin<br />

District Chairman Financial Services ver.di NRW<br />

Prof. Dr. Nadine Gatzert<br />

Professor for Insurance Economics at the<br />

Friedrich-Alexander University in Erlangen-Nuremberg<br />

Ira Gloe-Semler, until 20 March <strong>2012</strong><br />

Associated Union of Workers Secretary ver.di<br />

Dr. Heiner Hasford<br />

Member of the Board of Management of<br />

Münchener Rückversicherungs-Gesellschaft <strong>AG</strong> (retired)<br />

Dieter Herzog<br />

Insurance employee<br />

Dr. Anne Horstmann, since 1 September <strong>2012</strong><br />

Insurance employee<br />

Dr. Lothar Meyer<br />

Chairman of the Board of Management of<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> (retired)<br />

Dr. Markus Miele<br />

Managing Partner of Miele & Cie. KG<br />

Silvia Müller<br />

Insurance employee<br />

Marco Nörenberg<br />

Insurance employee<br />

Bernd Otten<br />

Head of Corporate Office Münchener Rückversicherungs-<br />

Gesellschaft <strong>AG</strong><br />

Prof. Dr. Bernd Raffelhüschen<br />

Director of the Institute of Public Finance of the<br />

Albert-Ludwigs-University of Freiburg<br />

Martina Scholze, since 27 April <strong>2012</strong><br />

Trade Union Secretary of Financial Services <strong>Group</strong> of ver.di<br />

Richard Sommer<br />

Former Head of the Federal <strong>Group</strong> Insurance of ver.di<br />

Dr. Theodor Weimer<br />

Spokesman of the Board of Management<br />

of Unicredit Bank <strong>AG</strong><br />

Heinz Wink<br />

IT employee<br />

Prof. Dr. Klaus L. Wübbenhorst<br />

Managing Director of WB Consult GmbH<br />

Volker Kallé, since 1 January 2013<br />

Executive employee


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>15<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong><br />

Governing bodies<br />

Audit Committee<br />

Dr. Heiner Hasford<br />

Dr. Theodor Weimer<br />

Heinz Wink<br />

Board Committee<br />

Dr. Nikolaus von Bomhard<br />

Hans-Peter Claußen, until 30 April <strong>2012</strong><br />

Dieter Herzog, since 1 May <strong>2012</strong><br />

Dr. Markus Miele<br />

Nomination Committee<br />

Dr. Nikolaus von Bomhard<br />

Dr. Lothar Meyer<br />

Dr. Markus Miele<br />

Standing Committee<br />

Dr. Nikolaus von Bomhard<br />

Michael David<br />

Dr. Lothar Meyer<br />

Dr. Markus Miele<br />

Marco Nörenberg<br />

Conference Committee<br />

Dr. Nikolaus von Bomhard<br />

Michael David<br />

Dr. Heiner Hasford<br />

Richard Sommer<br />

Board of Management<br />

Dr. Torsten Oletzky, Chairman<br />

<strong>Group</strong> Development<br />

Communications<br />

<strong>ERGO</strong> Customer Advocate<br />

Legal Affairs, Compliance<br />

Internal Auditing<br />

Dr. Bettina Anders<br />

IT Germany as well as Comprehensive Questions<br />

of Principle, Customer Service, Company Organisation<br />

Dr. Daniel von Borries<br />

Finances and Investments<br />

Life Insurance Germany<br />

ME<strong>AG</strong>/<strong>ERGO</strong>-Interface<br />

Christian Diedrich<br />

Non-Life Insurance<br />

(Property-Casualty, Legal Protection) Germany<br />

Dr. Ulf Mainzer, Labour Director<br />

Domestic Human Resources as well as<br />

Comprehensive Questions of Principle,<br />

General Services, Facility and Materials<br />

Management/Purchasing and Logistics<br />

Germany<br />

Dr. Jochen Messemer<br />

International Operations<br />

(except for Travel Insurance)<br />

Dr. Clemens Muth<br />

Health Insurance (including Travel Insurance)<br />

Dr. Rolf Wiswesser<br />

Sales Germany, Competence Centre Bank Sales Germany,<br />

Marketing, Brand Management<br />

Dr. Christoph Jurecka<br />

Accounting, Taxes, Planning and Controlling,<br />

Risk Management


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

16<br />

Management <strong>Report</strong><br />

Business environment<br />

Our business environment is being shaped by a number of<br />

global trends with a long-term impact. Demographic shifts<br />

are giving rise to fundamental developments and posing<br />

enormous challenges for social security and healthcare<br />

systems, particularly in industrialised countries. Increasing<br />

life expectancy is placing a burden on pay-as-you-go social<br />

security systems, a situation aggravated further by falling<br />

birth rates. Europeans will therefore only be able to maintain<br />

their old-age provision and first-class medical care in<br />

the medium term if they take out additional private cover.<br />

This presents a great opportunity for the private insurance<br />

industry. However, consistently low interest rates are<br />

threatening the success of long-term savings.<br />

Developing and emerging countries are experiencing rapid<br />

population growth and, at the same time, a swift rise in<br />

prosperity among large sections of the population. As a<br />

result, the emerging Asian economies in particular are gaining<br />

in global importance. Correspondingly, the economic and<br />

geopolitical weight of industrialised countries is declining.<br />

Worldwide economic integration, technological progress and<br />

digitalisation are accelerating the globalisation of capital<br />

flows and supply chains, and increasing the complexity of<br />

the world economy.<br />

In this environment, we are seeing a rising number of<br />

major events which impact on the insurance industry.<br />

Insured losses are rising disproportionately to economic<br />

activity. We believe that climate change is responsible,<br />

alongside advancing urbanisation and a concentration<br />

of assets in exposed regions. This is producing new risk<br />

potentials and accumulation risks that make it imperative<br />

to constantly refine our underwriting.<br />

Companies like <strong>ERGO</strong>, which are among the leaders in<br />

terms of risk management, are able to take advantage of<br />

the opportunities arising from this global trend. With our<br />

sound risk awareness, we are able to hold our ground even<br />

in a complex and volatile environment.<br />

General economic trend<br />

Global economic growth weakened for a further consecutive<br />

year in <strong>2012</strong>, due in large part to the still-smouldering<br />

state debt and banking crisis in the Eurozone. The eurozone<br />

as a whole had already slid into a recession in late 2011<br />

from which it was unable to free itself during the period of<br />

review. Budget consolidation measures curbed growth, and<br />

at the same time the rate of unemployment continued to<br />

rise, reaching a record level.<br />

Chinese economic growth slowed down considerably, due<br />

in part to receding global demand for export. The performance<br />

of the Japanese economy also weakened over the<br />

course of the year. Meanwhile, the moderate economic<br />

growth of the USA buttressed the global economy.<br />

At the beginning of the year, the Euvrozone crisis appeared<br />

to have very little impact on the German economy, though<br />

the economy faltered in the second half of the year.<br />

German price-adjusted GDP rose by just 0.7% in <strong>2012</strong><br />

( provisional estimate from the Federal Bureau of Statistics<br />

of 15 January 2013). The trend on the German employment<br />

market, however, remained positive. The average unemployment<br />

rate for the year was 6.8%. Average inflation on<br />

consumer prices in Germany was 2.0% in <strong>2012</strong>.<br />

Capital market trends<br />

Political events, particularly within the European Economic<br />

and Monetary Union, and measures adopted by the central<br />

banks were the driving forces behind capital market<br />

develop ments, including large fluctuations. Periods of high<br />

demand for high-risk securities alternated with periods of<br />

risk aversion. Overall, for most of the asset classes trends<br />

were positive.<br />

Over the past year, the overall positive development for<br />

virtually all types of securities belied the major fluctuations<br />

of <strong>2012</strong>. The main driving force behind these fluctuations<br />

in the international markets was the ongoing state debt


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>17<br />

Business environment<br />

crisis in the Eurozone. At the beginning of the year, some<br />

government bonds in countries on the European periphery<br />

recorded considerable gains. We attribute this development<br />

to the generous provision of liquidity from the<br />

European Central Bank (ECB), which also greatly benefited<br />

high-risk securities such as shares. However, the crisis<br />

intensified in the second quarter due to uncertainty about<br />

the outcome of the Greek elections, the adjustment of the<br />

goals to reduce Spain’s budget deficit and debates on the<br />

possibility of certain countries leaving the euro. As a result,<br />

the returns on most “safe haven” bonds reached new lows.<br />

Plans to set up a Eurozone banking union and the ECB’s<br />

announcement of its intention to possibly buy up all shortterm<br />

government bonds from countries on the European<br />

periphery led to lower returns on peripheral bonds and a<br />

marked recovery on the stock market in the second half of<br />

the year. All in all, <strong>2012</strong> was a positive year for shares. The<br />

Euro Stoxx 50 price index was up by 13.8% and the DAX<br />

performance index increased by 29.1%.<br />

Yet demand remained high for safe-haven securities, such<br />

as German government bonds. The already low return on<br />

ten-year German government bonds fell a further 50 basis<br />

points to 1.3% by the end of the year. This change in<br />

interest rates made some considerable gains possible on<br />

the bond markets.<br />

Central banks outside the Eurozone also relaxed their<br />

monetary policy due to weak economic growth on a<br />

global scale. The US Federal Reserve announced a further<br />

bond-purchasing programme, which will be maintained<br />

until the situation on the employment market improves<br />

substantially.<br />

The trend in the insurance industry<br />

At the end of <strong>2012</strong>, insurers in several EU countries introduced<br />

the new unisex tariffs, meaning that gender is no<br />

longer a factor in the calculation of premiums and benefits<br />

in terms of risk differentiation, following a verdict passed<br />

by the European Court of Justice in 2011. The court viewed<br />

different premiums for men and women as undue discrimination.<br />

For example, life insurance companies may<br />

no longer take into account the observed difference in life<br />

expectancies of men and women. This ruling is valid for all<br />

policies signed since 21 December <strong>2012</strong>.<br />

The overall economic trend has a strong effect on the<br />

development of premiums in the insurance industry, especially<br />

for property-casualty insurance. In the case of life<br />

and health insurance, additional important factors are the<br />

influence of capital markets and changes to the legal and<br />

tax frameworks. This means that the European insurance<br />

markets operate according to very different parameters.<br />

In line with the focal point of our business, the following<br />

sections take a closer look at trends in our domestic market<br />

of Germany.<br />

On the whole, insurance premiums in Germany rose by 1.5%<br />

in <strong>2012</strong>. The figures here and below are based on provisional<br />

estimates provided by the German Insurance Association<br />

and the German Association of Private Health Insurers.<br />

The market figures are based on gross figures established<br />

in accordance with the German Commercial Code (HGB),<br />

meaning they are not necessarily comparable with figures<br />

calculated according to IFRS or net of reinsurance.<br />

Life insurance in <strong>2012</strong><br />

Life insurance in Germany (including pension and retirement<br />

funds) continued to suffer from the adverse conditions<br />

experienced on the capital markets in <strong>2012</strong>. Persistently<br />

low interest rates have led to a reduction of bonus rates<br />

across the industry. This particularly influenced the market<br />

for single-premium products. New business with regular<br />

premiums was also down on last year. Widespread economic<br />

uncertainty has prompted customers to be cautious<br />

of long-term commitments. New business was down by 2%<br />

across the market. The top priority for customers is the security<br />

of their private old-age provision, making guaranteed<br />

components very important to them. Insurance against the<br />

financial impact of occupational disability and the need for<br />

nursing care also recorded a marked increase in business.<br />

Total premium income was up slightly by 0.8% to € 83.8 billion<br />

(83.2 bn) across the industry, due to a lower number of<br />

policies expiring. The previous year saw a large amount of<br />

scheduled maturities. Many of these policies were taken out<br />

in 1999 because of the planned tax reforms at that time.<br />

The amount paid out to life insurance customers therefore<br />

dropped to € 75 billion 85 bn).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>18<br />

Business environment<br />

The German Federal Court of Justice ruled against various<br />

life insurers, rendering certain terms of insurance invalid<br />

in several verdicts during the period covered by this report.<br />

These included terms governing the surrender value,<br />

cancellation fee and the calculation of acquisition costs<br />

applied to new policies from 2002 to 2007. The cancellation<br />

fee clause may also affect tariffs from 2008 onwards.<br />

Private health insurance in <strong>2012</strong><br />

The share of private health insurance in the wider health<br />

insurance market stabilised in <strong>2012</strong> despite difficult market<br />

conditions. According to initial provisional forecasts, private<br />

health insurance achieved growth of 3.4% in premium<br />

income, amounting to € 35.9 billion (34.7 bn). Private health<br />

insurers’ benefits, including settlement expenses, rose by<br />

around 4.8% to € 23.9 billion (22.8 bn).<br />

The new amendments to the law governing financial<br />

services mediation and property include a limit on commission<br />

amounts paid to agents and an extension of the<br />

cancellation liability periods, both of which have been in<br />

force since 1 April <strong>2012</strong>. In addition, the state has been<br />

paying the premiums on behalf of the disadvantaged<br />

directly to the respective private health insurer since this<br />

date. In return, the insurance companies have agreed in<br />

recognition of regulatory admissibility to forego premiums<br />

payable by 31 January <strong>2012</strong> due to the extent of the gap in<br />

statutory cover.<br />

Property-casualty insurance in <strong>2012</strong><br />

Since the economic situation of private households and<br />

businesses continues to improve, property-casualty insurance<br />

recorded a healthy rise of 3.7% in premium income<br />

in <strong>2012</strong> to € 58.7 billion (56.6 bn). Once again, all lines of<br />

business made a contribution. However, this was mainly<br />

due to rises in premium rates and adjustments to clauses<br />

rather than an increase in the number of insured risks.<br />

Motor insurance grew by an impressive 5.1%, although it<br />

still has a way to go before producing a technical profit.<br />

The rates of growth of liability insurance (+ 2.0%), legal<br />

protection insurance (+ 1.5%) and accident insurance<br />

(+ 1.0%) were all below average. Premium income recorded<br />

for transport and aviation insurance was up by 3.5%,<br />

property insurance lines of business rose by 4.3%.<br />

Claims expenditure rose proportionately to the increase in<br />

premiums. On the one hand, damages related to natural<br />

hazards in <strong>2012</strong> were down on the previous year. On the<br />

other, extreme frost in February and a number of other<br />

major damaging events caused a great deal of destruction.<br />

An explosion in a chemical factory has been the largest<br />

single insurance claim in Germany to date. The combined<br />

ratio across the market is expected to remain virtually<br />

unchanged at 98%.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

19<br />

Management <strong>Report</strong><br />

Business performance<br />

<strong>2012</strong> was a year dominated by challenging economic<br />

conditions and good progress in major projects for <strong>ERGO</strong><br />

Insurance <strong>Group</strong>. The state debt crisis in the Eurozone has<br />

continued, leading to shrinking economies in certain countries,<br />

including some where we are active, such as Greece.<br />

Interest rates fell yet further for government bonds which<br />

have been considered safe by market participants.<br />

In our home market of Germany, we have begun an<br />

extensive reorganisation of our sales forces. We aim to<br />

introduce a uniform advisory procedure, reducing complexity<br />

and therefore cutting costs. This major project is set<br />

to be completed during the course of the next two years.<br />

This will result in savings from as early as 2014; from 2015<br />

these should amount to over € 160 million gross per year.<br />

The project, however, has placed the current year’s result<br />

under considerable strain. In the fourth quarter of <strong>2012</strong>,<br />

we booked the provisions for the restructuring costs which<br />

impacted our net result by an amount of €− 128 million.<br />

We have considerably increased profits in our international<br />

business. Our operating result abroad has more than<br />

doubled, leading to a considerable net result. Our restructuring<br />

measures of the past few years are now yielding<br />

results.<br />

The consolidated result for <strong>ERGO</strong> Insurance <strong>Group</strong><br />

amounted to € 289 million (349 m). We had aimed for<br />

around € 400 million and would have achieved this figure,<br />

but for the one-off costs of restructuring. This is clearly<br />

shown in the stark increase in operating profit, up by 17.9%<br />

to € 951 million (806 m).<br />

We determine figures for long-term business in the<br />

life and health insurance segments according to strict<br />

market-consistent methods. We still do not apply interest<br />

surcharges or liquidity premiums. The market-consistent<br />

embedded value (MCEV) determined in this way, rose to<br />

€ 2.7 billion (0.9 bn). Contributing to this was the fact that<br />

risk premiums recorded on fixed interest-bearing securities,<br />

especially those for government bonds in peripheral Eurozone<br />

countries, had fallen at the end of <strong>2012</strong>. An additional<br />

factor was the first-time inclusion of <strong>ERGO</strong> Direkt Krankenversicherung<br />

in the MCEV calculation. The total embedded<br />

value earnings came to € 1.5 billion (− 3.0 bn). The value of<br />

new business climbed to € 146 million (37 m).<br />

Premium income<br />

<strong>ERGO</strong> Insurance <strong>Group</strong>’s total premium income was 8.4%<br />

lower in the reporting year than the preceding year, at<br />

€ 18.6 billion (€ 20.3 bn). This significant drop is as much<br />

a result of disposals as it is due to organic effects. By the<br />

end of 2011 we had sold our international health insurer to<br />

Munich Health Holding <strong>AG</strong>. We had also sold our Portuguese<br />

subsidiaries by the end of 2011, and in October <strong>2012</strong>, we sold<br />

<strong>ERGO</strong> Daum Direct in South Korea. This divestment explains<br />

6.1% percentage points of the drop. Furthermore, we sold<br />

considerably less single-premium life insurance policies in<br />

Germany and Austria and underwrote a significantly lower<br />

volume of the single-premium MaxiZins product in direct<br />

insurance. This is due to low interest rates and fiscal changes<br />

in Austria. Gross premiums written – in contrast to total<br />

premiums they do not include the savings premiums from<br />

unit-linked life insurance and capitalisation products – was<br />

€ 17.1 billion (€ 18.5 bn), a drop of 7.7%.<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Change<br />

%<br />

Total premium income 18,562 20,270 − 8.4<br />

Gross premiums written 17,091 18,519 − 7.7<br />

Investment result 5,262 4,116 27.8<br />

Net insurance benefits 1 16,744 16,703 0.2<br />

Net operating expenses 3,512 3,814 − 7.9<br />

Consolidated result 289 349 − 17.2<br />

1 Incl. policyholders’ profit participation


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>20<br />

Business performance<br />

Total premium income <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Change<br />

%<br />

Life Germany 4,754 4,955 − 4.1<br />

Health 4,932 5,975 − 17.4<br />

Property-casualty Germany 3,138 3,087 1.6<br />

Direct insurance 1,212 1,422 − 14.8<br />

Travel insurance 460 485 − 5.2<br />

International 4,066 4,346 − 6.4<br />

Total premiums 18,562 20,270 − 8.4<br />

For business within Germany, total premium income reached<br />

€ 14.2 billion (€ 14.6 bn) (− 2.3%), while gross premiums<br />

written in accordance with IFRS were € 13.2 billion (€ 13.3 bn)<br />

(− 0.9%). For international business, total premium income<br />

stood at € 4.3 billion (€ 5.7 bn) (− 24.1%), while gross premiums<br />

written in accordance with IFRS were € 3.9 billion (5.2 bn)<br />

(− 24.9%).<br />

The German life insurance business saw gross premiums<br />

written fall by 5.6% to € 3.9 billion (€ 4.2 bn). Both this and<br />

the 4.1% drop in total premiums can be largely traced<br />

back to less single-premium business. Due to the low rate<br />

of interest, we are very cautious about the conditions we<br />

offer our customers. Overall, single-premium business was<br />

down by 11.5% to € 939 million (1,061 m). The continuing<br />

economic uncertainty and the drop in the technical interest<br />

rate to 1.75% as of 1 January <strong>2012</strong> was also reflected<br />

in new business based on regular premiums: reaching only<br />

€ 307 million (€ 314 m), it was 2.0% down on last year’s<br />

figures. When measured in terms of APE (annual premium<br />

equivalent, i. e. regular premiums plus a tenth of single<br />

premiums), new business fell by 4.4%.<br />

As a result of the aforementioned divestment of international<br />

health subsidiaries, gross premiums written in the<br />

health segment were 17.4% lower. The remaining domestic<br />

business grew slightly by 0.5% to € 4.93 billion (€ 4.91 bn).<br />

Premium rate adjustments in <strong>2012</strong> were very low – something<br />

our customers were very pleased about. At € 176 million<br />

(225 m), the new business was significantly lower<br />

than last year’s figures (− 21.6%). In 2011, the abolition<br />

of the three-year waiting period when taking out health<br />

insurance has had a positive impact on the number of<br />

new intakes in comprehensive health insurance at the<br />

beginning of the year.<br />

In Germany, gross premiums written for property- casualty<br />

insurance increased by 1.6%. At 6.0%, commercial/<br />

industrial insurance business once again recorded the<br />

highest rise. In the area of private property insurance,<br />

we registered a 1.9% increase in premiums and a 0.4%<br />

increase in motor insurance. Despite a slight decrease of<br />

1.2% in the number of insured vehicles, the profitability of<br />

the portfolio has improved overall. There were also slight<br />

decreases in premium income in the areas of legal protection<br />

insurance (− 0.4%) and in personal accident insurance<br />

(− 1.6%). The latter was primarily due to lower premiums<br />

in personal accident insurance with premium refunds<br />

(ROP). We discontinued this product in late <strong>2012</strong> because<br />

we wanted our accident insurance products to focus more<br />

on ensuring quality of life with their extensive assistance<br />

services. This is no longer possible for ROP products as a<br />

result of the low interest-rate income currently achievable<br />

on investments.<br />

Total premium income for the direct insurance business was<br />

down by 14.8%. This is due to the MaxiZins capitalisation<br />

product: to reflect the low interest rates on the capital<br />

markets, we also lowered interest, which alone resulted in a<br />

decrease in premium income of € 242 million as compared to<br />

the previous year. By contrast, gross premiums written were<br />

up by 3.5% to € 957 million (€ 924 m). Total premium income<br />

from life insurance fell by 25.9%. The only health insurance<br />

we offer as direct insurance is supplementary, an area<br />

which registered solid growth of 15.7%, primarily as a result<br />

of premium rate adjustments. Property-casualty insurance<br />

increased by 1.0%.<br />

Gross premiums written for travel insurance were 5.2% less<br />

than the previous year, also because unprofitable contracts<br />

were not extended. In Germany, a decline of 1.2% was<br />

recorded, while international business fell by 8.1%.<br />

The fact that total premium income in the International<br />

business was lower than the previous year (− 6.4%) is due<br />

to the effects described above, namely, sale of daughter


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>21<br />

Business performance<br />

Investment result <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Change<br />

%<br />

Regular income 4,813 5,042 − 4.5<br />

Write-ups/write-downs 109 − 1,041 110.4<br />

Realised gains/losses 35 708 − 95.1<br />

Other income/expenses 305 − 594 151.3<br />

Total 5,262 4,116 27.8<br />

companies, lower single-premium business and strictly<br />

profit-oriented underwriting. Total premium income was<br />

therefore 8.5% down on the previous year for life insurance<br />

and 4.8% lower for property-casualty insurance.<br />

Benefits and costs<br />

Benefits for our clients in the reporting year amounted<br />

to € 17.6 billion (€ 17.4 bn). For our own account, i. e. after<br />

the deduction of the reinsurers’ share, the figure stood<br />

at € 16.74 billion (€ 16.70 bn), up by 0.2%. The fact that<br />

these developments differ from the premium income is<br />

primarily due to the net investment income. As a result of<br />

lower write-downs, this figure was much higher than in<br />

the previous year. The net value of unrealised gains and<br />

losses in unit-linked life insurance was particularly positive<br />

in the year under review, following negative performance<br />

the previous year. As a result, total transfers to provisions<br />

for future policy benefits were higher overall. Expenditure<br />

on premium refunds was significantly higher than for<br />

the previous year; this was also due to an increase in the<br />

expected share for policyholders entitled to bonuses in the<br />

German life insurance business in the future.<br />

Net claims expenditure was 10.5% below last year’s<br />

total. Even when adjusted for the sale of daughter companies,<br />

net claims would have been below the previous<br />

year’s figure. This was primarily due to German life insurance<br />

(− 14.6%). In the health segment, there was a slight<br />

decrease (− 1.6%), while German property-casualty insurance<br />

(including legal protection) recorded an increase of<br />

3.4%. The combined ratio there was 95.8% (94.4%) for the<br />

year under review. Improvements in motor insurance were<br />

up against high levels of frost damage from the late cold<br />

snap in February and some coincidental cases of major<br />

damage in the summer. In the year under review, we also<br />

restructured our reinsurance relations with Munich Re concerning<br />

property-casualty insurance, and quite a number<br />

of contracts were commuted. In addition, we made risk<br />

provisions within the range of actuarial estimates and have<br />

also made higher provisions for claims in specific lines of<br />

business.<br />

In <strong>2012</strong>, the German Federal Court of Justice ruled against<br />

various life insurers, rendering their terms of insurance<br />

invalid in several verdicts (see chapter ‘Business environment’).<br />

<strong>ERGO</strong> Lebensversicherung <strong>AG</strong> was one of the<br />

companies directly affected from a ruling. Since the rulings<br />

were decisions in principle, the other companies of the<br />

<strong>ERGO</strong> <strong>Group</strong> will also not continue to apply the terms of<br />

insurance in question. We adjusted provisions set up before<br />

<strong>2012</strong> accordingly.<br />

The developments in our international business have been<br />

very positive; here, we were able to improve our combined<br />

ratio significantly. At 100.5% (105.1%), we were almost<br />

able to achieve the level required for technical profit. The<br />

range of measures implemented over the past few years to<br />

improve earnings are starting to take effect. We achieved<br />

exceptional technical profit in both Poland and Greece in<br />

<strong>2012</strong>. Results are also starting to improve notably in Turkey,<br />

though there is still a good amount of progress to be made<br />

in the current year.<br />

At € 3.5 billion (€ 3.8 bn), net operating expenditure was<br />

7.9% down on the previous year. This is roughly equivalent<br />

to the net premium income earned (− 7.5%). Gross acquisition<br />

costs also fell by 7.9%, with gross administrative<br />

expenses down by 3.0%. Once again we were forced to<br />

amortise deferred acquisition costs because of continually<br />

low interest rates.<br />

Investment result<br />

The investment result increased by a healthy 27.8% during<br />

the <strong>2012</strong> financial year to € 5.3 billion (€ 4.1 bn). Returns<br />

based on the average amount of investments at market<br />

value stood at 4.1% (3.4%). The improvement is largely<br />

due to the fact that there were no longer similar negative<br />

effects as in the previous year, notably the write-downs<br />

on Greek government bonds or the negative net value of<br />

unrealised gains and losses in unit-linked life insurance.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>22<br />

Business performance<br />

The situation on the capital markets became somewhat<br />

better in the second half of <strong>2012</strong>. However, this applied<br />

more to stock markets. At the end of the year the yield<br />

curve for German government bonds lay above the previous<br />

year’s value only for very short durations. The return<br />

on ten-year German government bonds lost 51 basis points<br />

over the course of the year, bringing it to 1.32%. Once<br />

again, negative nominal returns were recorded in single<br />

cases. These low interest rates are causing us major problems<br />

as an institutional investor, since guarantees and<br />

interest rates on our investments are extremely important<br />

when it comes to old-age provision and health insurance.<br />

These demand a high degree of security and return. We<br />

therefore placed the bulk of our investments, amounting to<br />

€ 125 billion (€ 117 bn), into a broad range of fixed-interest<br />

securities and loans. A breakdown of our investment<br />

portfolio and major developments is detailed in the next<br />

chapter of this report.<br />

With this in mind, an assessment of our investment results<br />

is a double-edged sword. Regular income was 4.5% down<br />

on last year’s figure at € 4.8 billion (€ 5.0 bn). This is the<br />

result of the falling average interest rate for our portfolio.<br />

However, the extraordinary result, the net value of writeups<br />

and write-downs on capital investments as well as<br />

gains and losses from divestments, developed positively.<br />

It came to € 798 million (€− 538 m), once again a clearly<br />

positive figure. At € 603 million (€− 263 m), the net figure<br />

for unrealised gains and losses from unit-linked life insurance<br />

had a significant impact. The portfolio of interest-rate<br />

derivatives we hold to hedge the risk of sustained low<br />

interest rates increased in value too. This led to earnings<br />

of € 166 million (€ 368 m). The impact on the consolidated<br />

result was € 42 million (€ 83 m).<br />

appropriated to the technical result. For further details<br />

on calculating the technical interest income in particular<br />

business segments, please refer to [25] in the Notes.<br />

After the technical interest income has been deducted,<br />

the non-technical result essentially comprises that part of<br />

the investment result which does not constitute benefits<br />

to customers. This rose to € 295 million (€ 84 m) alongside<br />

the improved investment result. By contrast, the technical<br />

result dropped by 9.2% to € 656 million (€ 723 m). One<br />

of the reasons for this was the sale of companies in the<br />

previous year.<br />

The consolidated result was € 289 million (€ 349 m). It is<br />

important to note that provisions for restructuring costs for<br />

the reorganisation of our German sales forces reduced the<br />

result by € 128 million. If our results were adjusted for this<br />

effect, we would have achieved our goal of € 400 million.<br />

The cost of restructuring is spread over the following<br />

domestic business fields: Life insurance Germany, Health<br />

insurance, Property-casualty insurance Germany and<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> as the parent company. As<br />

a result, and due to the strain incurred by continually low<br />

interest rates, the result for the Life insurance Germany<br />

was slightly negative. The fall in profits in Health insurance<br />

can be largely attributed to major gains from divestments<br />

in the previous year from the sale of international companies,<br />

an event which was not repeated during the year<br />

under review. There were partially sharp rises in profits<br />

recorded for Property-casualty insurance Germany, International<br />

business, Direct insurance and Travel insurance.<br />

The developments in our international business have been<br />

particularly positive.<br />

Results<br />

The operating result was up by an impressive 17.9% to<br />

€ 951 million (€ 806 m). This is made up of the technical<br />

and non-technical results. A technical interest income is<br />

Events after the balance sheet cut-off date<br />

No events have occurred since the balance sheet cut-off<br />

date which require separate disclosure.<br />

Investment result by type of investment <strong>2012</strong> 2011 Change<br />

€ million € million %<br />

Land and buildings, including buildings on third-party land 183 170 7.6<br />

Investments in affiliated companies and associates 45 475 − 90.5<br />

Loans 2,303 2,202 4.6<br />

Other securities 2,390 1,816 31.6<br />

Other investments 341 − 547 162.3<br />

Total 5,262 4,116 27.8


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

23<br />

Management <strong>Report</strong><br />

Assets and financial position<br />

Our capital structure is essentially determined by our insurance<br />

activities: the liabilities side of the balance sheet is<br />

dominated by technical provisions (85.2% of the balance<br />

sheet total including unit-linked business), i. e. future payout<br />

commitments to our clients. Equity (3.1% of the balance<br />

sheet total) and strategic debt capital items (0.8% of the<br />

balance sheet total) are the most important sources of funds<br />

on the liabilities side. The assets side of the balance sheet is<br />

dominated by capital investments, which essentially serve to<br />

cover technical provisions.<br />

Equity and capital management<br />

Debt capital<br />

Subordinated capital and strategic debt complete our<br />

financial resources. They reduce our capital costs and<br />

ensure that sufficient liquidity is available at all times.<br />

The subordinated capital recorded on our balance sheet<br />

primarily comes from Munich Re (see also [14] in the<br />

Notes).<br />

Our liabilities are mainly deposits from business ceded<br />

to reinsurance (40.8%) and for direct insurance business<br />

(35.5%).<br />

Equity rose sharply to € 4.6 billion (3.8 bn) by the end of<br />

the reporting year. As well as retained earnings, “other<br />

reserves” in particular increased in value. The latter<br />

includes gains and losses recorded on the balance sheet<br />

and attributable to our shareholders, which rose considerably<br />

due to declining interest rates and increasing share<br />

prices. We report on the developments of our valuation<br />

reserves – on- and off-balance-sheet – later on in this<br />

chapter.<br />

We practise active capital management, which ensures<br />

that <strong>ERGO</strong>’s equity base is maintained at an appropriate<br />

level. We determine our capital requirements using our risk<br />

models and the requirements laid out by the regulatory<br />

bodies. Subordinated capital is also taking on an increasingly<br />

important role in our capital management and is<br />

partially classified as equity. Overall, our equity should<br />

not exceed the level required to run the business. This is<br />

because, through our incorporation into Munich Re’s groupwide<br />

capital management, we benefit from the group’s<br />

overall financial strength.<br />

There is no supervision at <strong>ERGO</strong> <strong>Group</strong> level because this<br />

takes place at the level of Munich Re. <strong>ERGO</strong>’s financial<br />

strength and that of its major subsidiaries are assessed<br />

by leading rating agencies. These ratings are high and are<br />

published on the <strong>ERGO</strong> website: www.ergo.com.<br />

Technical provisions<br />

Technical provisions are largely attributable to personal<br />

lines business, in particular from Life insurance Germany<br />

(51%) and Health insurance (28%) business. Detailed<br />

information on provisions can be found on pages 97 et<br />

seq. of the Notes to these financial statements.<br />

In the case of obligations arising from insurance business,<br />

we are unable to predict the time and amount of payment<br />

with certainty. The pattern of pay-outs of technical<br />

provisions over time varies enormously from one line of<br />

business to another. As regards travel insurance, business<br />

is extremely short-term. On average, final settlement<br />

of claims takes just a few days. In the area of propertycasualty<br />

insurance, a large portion of the reserves put<br />

aside is paid out within a year. For liability insurance, however,<br />

substantial amounts may accrue decades after the<br />

policy was taken out. In life and health insurance we use<br />

premiums to set up actuarial and ageing provisions, which<br />

make up the lion’s share of technical provisions.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>24<br />

Assets and financial position<br />

Investments<br />

As far as our investment strategy is concerned, our principle<br />

is to focus on the structure of our liabilities – essentially<br />

our technical obligations. On this basis, we develop an<br />

optimal investment strategy for each company, taking<br />

particular account of the capital strength of the company<br />

in question or its risk-bearing capacity.<br />

With our asset liability management (for more information,<br />

see the risk report) we strive to stabilise our balance sheet<br />

against fluctuations on the capital markets. We therefore<br />

focus on important liability characteristics such as maturity<br />

and currency structures or sensitivities to inflation when<br />

acquiring specific investments. We limit currency risks by<br />

covering expected liabilities wherever possible with investments<br />

in the corresponding currency. In order to make<br />

investment management as effective as possible, we also<br />

employ financial derivatives in order to hedge against<br />

fluctuations in interest rates and share prices.<br />

When applying this approach, we are aware of differences<br />

to the structure of our commitments and take account of<br />

the risk-bearing capacity and risk premium. At the same<br />

time, we of course comply with regulatory, accounting<br />

and tax requirements. Our aim is to guarantee maximum<br />

security, profitability and constant liquidity through appropriate<br />

mixing and spreading of investments.<br />

Taking account of the strategies developed in the strategic<br />

asset allocation department, the operating companies<br />

formulate mandates defining our investment categories,<br />

quality and limits. We also include key figures and threshold<br />

values for controlling purposes in these mandates.<br />

When investing, we consider social, ethical and ecological<br />

principles. Both our existing and new investments in shares<br />

and corporate, bank and government bonds must fulfil<br />

certain sustainability criteria. As such, we have primarily<br />

invested in the companies which are named on the Dow<br />

Jones Sustainability, FTSE 4 Good, ASPI and ESI lists, or<br />

which fulfil the criteria of rating agencies specialising in<br />

sustainability (e. g. oekom research). This continuous process<br />

is systematically applied and carried out by ME<strong>AG</strong>. We<br />

are of the firm opinion that for the long term, it is effective<br />

in terms of risk and profitability to consider sustainability<br />

criteria when making investments.<br />

Major developments and structure of<br />

investment categories<br />

At the end of the reporting year, our investments totalled<br />

€ 125 billion (117 bn) which is equivalent to a 6.9% rise. This<br />

amount includes € 6.0 billion (5.1 bn) (+ 17.0%) in investments<br />

for the account and at the risk of life insurance<br />

policyholders. The following information on the make-up of<br />

our investments relates to the investment portfolio, i. e. not<br />

including investments for the account or at the risk of life<br />

insurance policyholders.<br />

The vast majority of our investments is made up of fixedinterest<br />

securities, loans and short-term fixed-interest<br />

investments. We pay particular attention to the security<br />

of these investments. During the year under review, we<br />

sought to selectively reduce the number of government<br />

bonds in peripheral Eurozone countries. In an effort to<br />

spread our investment portfolio, we are increasingly investing<br />

outside the Eurozone. We add corporate bonds to<br />

increase the return.<br />

The duration until maturity of our bond portfolios increased<br />

slightly once again in <strong>2012</strong>. It reflects the average duration<br />

of our capital commitments and stood at 7.8 (7.1) on the<br />

balance sheet cut-off date.<br />

Our entire portfolio of interest-bearing investments is still<br />

characterised by its good rating structure. This is described<br />

in more detail in the Notes to the consolidated financial<br />

statements from page 80 onwards.<br />

We use special hedging instruments for life insurance in<br />

order to reach the level of interest guaranteed to our customers<br />

in the face of persistently low interest rates. In so<br />

doing, we regularly adapt the maturities of our hedges to<br />

coincide with changes in cash flows from our insurance<br />

business. We include changes in the value of such derivatives<br />

in profit or loss in our IFRS accounting, i. e. as income<br />

or expenditure in our income statement.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>25<br />

Assets and financial position<br />

Type of investments <strong>2012</strong> 2011<br />

€ million € million<br />

Land and buildings, including buildings on third-party land 2,271 2,347<br />

Investments in affiliated companies and associates 528 544<br />

Loans 54,373 53,215<br />

Other securities 60,560 54,672<br />

Other investments 1,701 1,440<br />

Total 119,433 112,217<br />

Investments for the benefit of life insurance policyholders who bear the investment risk 5,957 5,092<br />

The focus of our stock portfolio remains on shares in the<br />

Euro Stoxx 50 index. As our investment policy is geared<br />

towards secure investments, only a small proportion,<br />

€ 3.8 billion (2.9 bn), of our investments is to be found<br />

in shares. This figure includes shares in associated and<br />

affiliated companies. The value of our property portfolio<br />

amounted to an unchanged € 2.8 billion on the balance<br />

sheet cut-off date.<br />

Valuation reserves<br />

Capital market trends have a direct effect on our unrealised<br />

gains and losses as well as off-balance-sheet valuation<br />

reserves. <strong>2012</strong> saw interest rates continue to fall on the<br />

most creditworthy investments and share prices rise which<br />

led to increases in both our balance-sheet and off-balancesheet<br />

valuation reserves.<br />

The net value of unrealised gains and losses on non-fixedinterest<br />

securities calculated at market value rose in the<br />

year under review to € 0.3 billion (€ 0.1 bn). The main contributors<br />

to this are shares and investment funds. Risk-free<br />

interest rates at the end of <strong>2012</strong> were well down on those<br />

at the end of the previous year. At the same time, risk surcharges<br />

on government bonds from some Eurozone countries<br />

fell. As a result, the net value of unrealised gains and<br />

losses from our fixed-interest securities in the “available<br />

for sale” category rose sharply to € 4.8 billion (€ 0.9 bn).<br />

We record loans at amortised cost. The valuation reserves<br />

on these items rose to € 8.8 billion (€ 3.6 bn). Overall, our<br />

off-balance-sheet valuation reserves increased to € 10.0 billion<br />

(€ 4.9 bn).<br />

Investments<br />

Our investment in the expansion of our business in Asia<br />

continued in <strong>2012</strong>. We are actively pursuing the set-up of<br />

our joint venture in China; the life insurer is likely to commence<br />

operations in 2013 once the final licence has been<br />

received from the public authorities. And we signed a contract<br />

in India with the business conglomerate Avantha to<br />

set up a joint venture in the life insurance segment too.<br />

These investments have been funded using capital from<br />

normal operations.<br />

Analysis of the cash flow statement<br />

The cash flow of the <strong>ERGO</strong> <strong>Group</strong> is highly dependent on<br />

our business as a primary insurer: we generally receive the<br />

premiums for taking on the risk first, and then make payments<br />

at a later date in the event of benefits or claims.<br />

The significance of the capital flow statement is therefore<br />

somewhat limited.<br />

The cash flow statement (see page 54) was prepared in<br />

line with the indirect method and has been adjusted for<br />

changes in the consolidated group as well as exchange<br />

rate effects.<br />

The inflow of funds from operating business stood at<br />

€ 3.7 billion (1.9 bn). The calculation is based on the consolidated<br />

result of € 289 million (349 m). The major changes<br />

to the items Change in technical provisions (€+ 1.5 bn),<br />

Gains/losses on the disposal of investments (€+ 0.7 bn) and<br />

Other non-cash income and expenses (€− 2.3 bn) mainly


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>26<br />

Assets and financial position<br />

stem from factors of influence on the investment side.<br />

Consequently, the improved investment income and the<br />

increase in valuation reserves had a corresponding impact<br />

on the provision for premium refunds and provisions for<br />

unit-linked life insurance. The cash flow from operating<br />

activities was dramatically affected by gains from the<br />

disposal of affiliated companies last year. It is mainly<br />

write-downs and write-ups on investments which are<br />

reflected in other non-cash income and expenses; there<br />

were high write-downs last year whereas the year under<br />

review was particularly dominated by higher unrealised<br />

gains in unit-linked life insurance.<br />

The other two items worthy of mention are the change in<br />

other receivables and liabilities (€+ 1.3 bn) and the change<br />

in other balance sheet items (€+ 0.7 bn). The former was<br />

dominated by the previous year’s effect: in 2011 short-term<br />

loans from Munich Re expired which formed part of the<br />

restructuring of our debt capital. Factors which resulted in<br />

the change in other balance sheet items include reserves<br />

for the reorganisation of our sales forces as well as the<br />

increase in pension provisions because we had reduced the<br />

technical rate of interest.<br />

The cash outflow from investing activities of € 3.5 billion<br />

(€ 2.7 bn) is generally determined by payments for<br />

the acquisition of other investments or investments in<br />

unit-linked life insurance; they amounted to € 3.15 billion<br />

(3.14 bn) and € 362 million (489 m) respectively. In addition,<br />

last year saw cash inflows of € 951 million following<br />

the sale of affiliated companies; this item only accounted<br />

for € 12 million in the reporting period.<br />

Last year the cash flow stemming from financing activities<br />

was dominated by the restructuring of subordinated<br />

loans from Munich Re and high dividend payments during<br />

the 2010 financial year. Overall, there was a cash outflow<br />

stemming from financing activities of € 80 million (cash<br />

inflow of € 297 m).<br />

Overall, the level of cash and cash equivalents, which<br />

covers operating balances with banks, cheques and cash<br />

in hand, rose in <strong>2012</strong> to € 1.1 billion (0.9 bn).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

27<br />

Management <strong>Report</strong><br />

Other success factors<br />

We also intend to secure long-term economic success for<br />

our <strong>Group</strong> with factors which cannot always be measured<br />

using financial variables. We take corporate responsibility<br />

very seriously in regard to our customers, staff and sales<br />

partners, as well as the environment and the society we<br />

live and work in.<br />

We therefore conduct business sustainably, seeking to<br />

reconcile economic, environmental and social factors. This<br />

corresponds with the long-term nature of our business.<br />

As part of Munich Re, we were among the first companies<br />

to sign the United Nations Environment Programme<br />

Finance Initiative’s Principles for Sustainable Insurance.<br />

These principles were presented at the UN Conference on<br />

Sustain able Development in Rio de Janeiro in June <strong>2012</strong><br />

and provide us with guidance on how to take sustainability<br />

criteria into account in our core business.<br />

In <strong>2012</strong>, we significantly expanded our reporting on<br />

corporate responsibility at <strong>ERGO</strong>. Having introduced our<br />

comprehensive web pages at the beginning of the year,<br />

we then published our first Sustainability <strong>Report</strong> in autumn.<br />

The report describes how we understand our responsibility<br />

to our customers, staff, the environment and society.<br />

A comprehensive facts and figures section shows the<br />

current progress of our activities. Our Sustainability <strong>Report</strong><br />

was audited in accordance with the Global <strong>Report</strong>ing<br />

Initiative (GRI) and will appear annually in future.<br />

Responsible management<br />

Clear rules on the conduct of staff and sales partners<br />

are essential to strengthening public trust in <strong>ERGO</strong> and<br />

preventing damage to our reputation. After serious cases<br />

of misconduct were brought to light in 2011, we set up a<br />

separate Compliance Unit at the beginning of <strong>2012</strong>, directly<br />

answerable to the Chairman of the Board, and expanded<br />

it step by step throughout the year. Our Chief Compliance<br />

Officer leads the team in developing guidelines and advising<br />

staff and sales partners on how to implement them<br />

properly. If an employee or sales partner suspects abuse<br />

or serious breaches of the guidelines, he or she may also<br />

inform an external ombudsman.<br />

Negative reporting took its toll on <strong>ERGO</strong>’s reputation once<br />

more in <strong>2012</strong>. The media made agents’ misconduct on<br />

incentive trips a topic of discussion. We had to face the<br />

accusation that we had not addressed the issue openly<br />

enough in 2011 and therefore lacked credibility. In order to<br />

regain this lost trust, we provided transparency in September<br />

<strong>2012</strong> by publishing all known cases of misconduct on<br />

incentive trips on the Internet alongside the consequences<br />

drawn and the disciplinary measures <strong>ERGO</strong> had taken. We<br />

also updated the results of published investigations of<br />

allegations concerning the insurance business.<br />

We hope to regain lost trust with our openness. We also<br />

aim to convince both our customers and the general public<br />

of our quality through consistent implementation of our<br />

brand promise, “To insure is to understand”, and through<br />

first-class service.<br />

Customers and customer relationships<br />

Our products and services are geared towards all customer<br />

groups – private customers as well as small and mediumsized<br />

businesses and industrial clients. <strong>ERGO</strong> offers them<br />

products and services for old-age provision and saving<br />

schemes as well as protection of property, health, legal<br />

cover and travel insurance. In addition, our sales partners<br />

sell fund products supplied by ME<strong>AG</strong>, which is the asset<br />

manager of Munich Re and <strong>ERGO</strong>. We also offer bank products<br />

from our cooperation partner UniCredit <strong>Group</strong> and<br />

other banks. Other partners’ products and our comprehensive<br />

services and advice complete our portfolio.<br />

Our brand promise, “To insure is to understand”, means we<br />

make our customers and their needs the focal point of our<br />

business. We highly value clear and easy-to-understand<br />

language and constant dialogue with our customers. We<br />

have clear-language criteria which have been verified by<br />

external experts in communication. Based on these criteria,


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>28<br />

Other success factors<br />

we are reviewing our entire communication with our<br />

customers and are training our staff accordingly. Our<br />

Company is pursuing easy-to-understand, clear communication<br />

and its full integration into all our processes at<br />

all times. We successfully submitted all of our customer<br />

communication to an external audit: The inspection<br />

agency TÜV Saarland awarded us their seal of “Comprehensible<br />

communication” in February 2013.<br />

Our customers’ opinions are important to us. By expressing<br />

their wishes regarding our products and services, our<br />

customers help us continually improve what we offer.<br />

For example, we launched our new accident insurance in<br />

<strong>2012</strong>, developed according to our customers’ requests and<br />

expectations, and included assistance services in certain<br />

products. These services vary according to the customer’s<br />

individual situation and how serious their injury is. Our<br />

continuous advice service helps and guides victims of<br />

accidents. We also carried out comprehensive studies on<br />

our customers’ expectations in terms of security, flexibility<br />

and earnings in order to develop <strong>ERGO</strong>’s latest generation<br />

of life insurance products, which will be launched in 2013.<br />

As members of our Customer Advisory Board, participants<br />

in our Customer Workshop or on the Internet, consumers<br />

can provide us with extensive feedback. In the case of<br />

conflicts which the customer does not consider to have<br />

been solved by the Company, the <strong>ERGO</strong> Customer Advocate<br />

is available to clear up misunderstandings. He represents<br />

the interests of our customers within the Company.<br />

Our sales partners place great value on advice, support and<br />

service – and not just during their sales pitch. We set great<br />

store by the quality of our advice and see ourselves as an<br />

all-round problem solver for our customers long after the<br />

contract has been signed.<br />

Staff<br />

Our staff provide the basis for our success with their<br />

expertise, motivation and commitment, which is why we<br />

are dedicated to investing in developing their skills.<br />

The diversity of our staff is visible in their different mindsets,<br />

attitudes, experience, knowledge and skills. This is a<br />

great asset to our Company and an important foundation<br />

for our future success as a business. We laid down our<br />

common goal in Munich Re’s Diversity Policy in 2011: a<br />

working environment that values this diversity, promotes<br />

its various aspects and emphasises it for the good of the<br />

Company.<br />

We are always looking to develop our initiatives further.<br />

For example, in <strong>2012</strong> we reintroduced our development<br />

and mentoring programme for women and started a new<br />

HR process to guide employees through maternity/paternity<br />

leave. As part of our efforts to improve the balance<br />

between work and family life, we are currently running<br />

a pilot project to test the feasibility of managers working<br />

part time. Our diversity seminar for trainees won the<br />

InnoWard <strong>2012</strong>, the prize for education in the German<br />

insurance industry.<br />

Our management mission statement describes the<br />

conduct we expect of people with management<br />

responsibilities at <strong>ERGO</strong>. This includes valuing employees,<br />

using straightforward language, clearly defining goals,<br />

demonstrating enthusiasm and a willingness to participate<br />

in dialogue. This mission statement is a permanent<br />

feature of our training programme for managers. We have<br />

standardised the process of selecting, developing and<br />

supporting our top management staff across the <strong>Group</strong>.<br />

With cross-sector talent management and <strong>Group</strong>-wide<br />

succession planning, we wish to develop outstanding<br />

managers with a degree of loyalty that binds them to the<br />

Company.<br />

Ensuring that our staff and sales partners have qualifications<br />

which meet the needs of our industry still has a<br />

high priority in the context of our HR policy. Our goal is to<br />

extend our high level of quality and performance in order<br />

to reinforce our competitive position even further. This<br />

is why we are constantly adapting all of our training and<br />

further education opportunities to meet the Company’s<br />

current and future requirements for qualified and motivated<br />

long-term employees.<br />

In <strong>2012</strong>, members of the <strong>ERGO</strong> Insurance <strong>Group</strong> and its<br />

agencies in Germany trained 1,485 (1,551) school leavers,<br />

which is equivalent to a ratio of trainees to total working<br />

staff on par with the previous year at 6.5%. A special<br />

international trainee programme promotes the hiring and<br />

development of university graduates.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>29<br />

Other success factors<br />

<strong>ERGO</strong> launched a quality and efficiency programme in its<br />

German sales organisations in <strong>2012</strong>. We wish to standardise<br />

the different advisory and support processes and provide<br />

technical support, reduce complexity and cut costs. In<br />

order to achieve this goal, we shall merge – under a single<br />

<strong>ERGO</strong> sales company – five tied agents’ sales organisations<br />

into two units.<br />

As we have already announced, this restructuring will<br />

result in the loss of up to 700 salaried sales posts and up<br />

to 650 in-house posts in Germany. This is a consequence<br />

of streamlining the sales forces down to 120 regional head<br />

offices and of the realignment of the supporting in-house<br />

units. We plan to implement this by the beginning of 2014<br />

and do it in a socially acceptable way. The management<br />

and the works councils agreed on how to proceed and a<br />

contingency programme in February 2013.<br />

At the end of the reporting year there were 29,768 (31,311)<br />

salaried employees working for the <strong>ERGO</strong> Insurance <strong>Group</strong>,<br />

of which 24,166 (25,352) were employed in in-house<br />

positions and 5,602 (5,959) were salaried field sales staff.<br />

The average age of our employees is 41.3 (40.6), and the<br />

average length of service 12.2 (11.4) years. The percentage<br />

of women stood at 56.9% (56.4%).<br />

Social commitment<br />

<strong>ERGO</strong> and its subsidiaries have been committed to the<br />

communities we work in for years. Today, we focus on<br />

sponsoring all kinds of education and support social projects.<br />

Music, sport and health education all contribute to<br />

personal development and are therefore important components<br />

of a good education. We particularly want to open<br />

up opportunities and future prospects for children and<br />

teenagers, and allow them to take responsibility for their<br />

own lives.<br />

We want our social commitment to education to contribute<br />

to the future viability of our society. For example, the <strong>ERGO</strong><br />

“Jugend & Zukunft” (Youth and Future) foundation advises<br />

socially disadvantaged teenagers on the transition from<br />

school to training and work. <strong>ERGO</strong> Austria promotes learning<br />

and tutoring for children from disadvantaged families<br />

by donating to the “Wiener Lerntafel” (Vienna educational<br />

charity). We also support projects and initiatives which use<br />

innovative concepts to improve education for children and<br />

young people.<br />

We foster children’s musical skills as well as talented<br />

youngsters. For example, we support the local Düsseldorf<br />

project, “SingPause”, where trained singers regularly sing<br />

with primary school pupils. As part of the “Klasse in Sport”<br />

(Great at Sports) initiative, we sponsor daily qualified<br />

physical education at 26 primary schools across Germany<br />

because sport has been proven to aid children’s physical<br />

and cognitive development. The focus of our health projects<br />

is on prevention, education and exercise. For example,<br />

<strong>ERGO</strong> provides “mammobuses” in Estonia to provide<br />

women with information about breast cancer and free<br />

screening (mammography).<br />

As a large company, we are able to help others who need<br />

support, and we are happy to do so because it is a longstanding<br />

tradition within our Company. One example of<br />

social commitment is our integration of disabled employees,<br />

such as at <strong>ERGO</strong> Hestia in Poland, where employees<br />

with physical disabilities advise customers over the phone<br />

in the customer services department. In Germany, D.A.S.<br />

collaborates with a company specialising in the integration<br />

of disabled staff. This helps severely disabled employees to<br />

establish themselves in the business world with qualified<br />

administrative tasks. Our staff, too, are committed to helping<br />

others: for example, in Germany, the staff charitable<br />

association “ergo:wir helfen” (Ergo: we help) supports various<br />

social projects by donating the portion of salaries or<br />

commissions that comes after the decimal point.<br />

Environment<br />

Protecting the environment and natural sources of life has<br />

been an important concern for <strong>ERGO</strong> for many years, and<br />

we see it as being part and parcel of our social responsibility.<br />

In parts of the <strong>Group</strong>, we have been using an environment<br />

management system which complies with the globally<br />

accepted ISO 14001 standard for over ten years and<br />

we have it assessed by external experts on a regular basis.<br />

To ensure we use energy and resources as efficiently as<br />

possible, we are continually expanding this system: Munich<br />

was another large-scale German office to be certified in<br />

<strong>2012</strong>. <strong>ERGO</strong> uses the environment management system to<br />

consistently and systematically assess and minimise the<br />

use of energy and resources and the production of waste in<br />

its offices.<br />

We invest in the use of energy-efficient technologies such<br />

as gas-powered combined heat and power plants and<br />

cutting-edge cooling systems. We have been using carbonneutral<br />

electricity at all of our major German offices since<br />

2011.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>30<br />

Other success factors<br />

We also wish to reduce the emissions caused by our business<br />

travel. Train journeys within Germany have been carbon<br />

neutral since 2011. We are also gradually including more<br />

low-emission vehicles in our fleet and encourage our drivers<br />

to drive in an environmentally friendly manner: As of <strong>2012</strong>,<br />

ecological and safety training is obligatory for all drivers of<br />

fleet vehicles. We are working to improve our environmental<br />

record at our other offices in Germany and abroad. Our goal:<br />

by the end of 2015, operations across the entire <strong>ERGO</strong> <strong>Group</strong><br />

should be climate-neutral.<br />

As part of our duties imposed by the United Nations<br />

“Global Compact” environmental initiative, which <strong>ERGO</strong><br />

as part of Munich Re has signed, we regularly check our<br />

potential for improvement, including synergy effects.<br />

We continue to collect more and more data from our<br />

international companies, with the goal of providing ever<br />

more comprehensive environmental data. As part of the<br />

“Global Compact” initiative, Munich Re publishes an annual<br />

progress report on its website, which also covers developments<br />

at <strong>ERGO</strong>.<br />

Renewable energy is growing ever more significant due to<br />

the fact that fossil fuels are limited and the demand for<br />

environmental and climate protection is on the rise. <strong>ERGO</strong><br />

is doing its part by offering innovative insurance solutions,<br />

including those that cover loss of income from underperforming<br />

photovoltaic systems due to limited radiation<br />

or faulty components. We also support the environmental<br />

awareness of our customers with sustainable products<br />

and investment funds. When it comes to motor insurance,<br />

we promote vehicles with exceptionally low CO 2<br />

emissions<br />

through an eco tariff. We advise our corporate customers<br />

on how to avoid environmental damage, for which we also<br />

offer cover. As regards life insurance, our customers can<br />

invest in sustainable funds and a climate fund for their<br />

old-age provision and saving schemes.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

31<br />

Management <strong>Report</strong><br />

Risk report<br />

Objectives of risk management<br />

Risk management is an important element of corporate<br />

management. One part of risk management is the early<br />

recognition of developments which could endanger the<br />

Company’s existence (Section 91, para. 2 of the German<br />

Stock Companies Act, AktG). An additional aim is to retain<br />

the financial strength required to meet our obligations to<br />

customers and to create sustainable value for our shareholders.<br />

Another goal is to safeguard <strong>ERGO</strong>’s reputation<br />

and that of all the individual companies. This is achieved by<br />

means of risk management that encompasses all divisions.<br />

In this respect, we adhere to the German Control and<br />

Transparency Law (KonTraG) as well as to the requirements<br />

of Section 64a of the German Insurance Supervision Act<br />

(V<strong>AG</strong>).<br />

Organisational set-up of risk management<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> has developed specific systems and<br />

committees to ensure efficient risk management. The term<br />

‘risk governance’ is used to refer to all organisations and<br />

principles to do with risk. This is how we encourage the<br />

preservation and further development of a balanced riskand-control<br />

culture in respect to all categories of risk. Our<br />

Integrated Risk Management (IRM) unit is charged with<br />

securing risk management across the <strong>Group</strong>. There are<br />

decentralised risk management structures in place to help<br />

the IRM unit with this. The Chief Risk Officer (CRO) is at the<br />

top of the risk management hierarchy, with various decentralised<br />

risk officers reporting to him. The duties of the<br />

CRO include the identification, assessment and monitoring<br />

of risks, as well as reporting them to the Risk Committee,<br />

which is a standing committee of <strong>ERGO</strong> Insurance <strong>Group</strong>’s<br />

Board of Management. The committee is responsible for<br />

setting up and monitoring risk management strategies,<br />

systems and processes. It also ensures that the entire<br />

risk management system, consisting of risk criteria, limits<br />

and governance processes, complies with the regulatory<br />

requirements and the guidelines applicable throughout the<br />

<strong>Group</strong>. This structure enables us to recognise risks early<br />

and to manage them actively.<br />

Risk strategy<br />

Our risk strategy is derived from our business strategy and<br />

presents the risks arising from it. The Board of Management<br />

checks and approves the risk strategy annually and<br />

discusses it with the Supervisory Board. Our risk strategy<br />

defines <strong>ERGO</strong> Insurance <strong>Group</strong>’s upper risk threshold as<br />

it contains specifications and decisions on risk tolerance<br />

which are geared towards the capital and liquidity available<br />

and earnings volatility. Risk strategy is an important<br />

basis for our operative and strategic planning. Moreover,<br />

we derive limits from it, which we monitor carefully. In<br />

order to derive these limits, we take into consideration<br />

criteria relating to the whole Company and our entire<br />

insurance portfolio, as well as defining supplementary<br />

criteria to limit and managing peak risks, concentrations,<br />

loss accumulation and systematic risks.<br />

Risk management is important not only for limiting risks,<br />

but also for making use of business opportunities. Calibrating,<br />

or fine-tuning, the limits set out in our risk strategy<br />

takes into account the interests of both our customers and<br />

our shareholders. The most important part of this is ensuring<br />

the strength of our financial resources. Then there are<br />

supplementary limits for particular risks, such as concentration<br />

limits for natural catastrophes or pandemic risks,<br />

and criteria for market, credit and liquidity risks.<br />

In the event of capital bottlenecks or conflicts with the<br />

limit system, fixed escalation and decision-making processes<br />

are pursued which ensure that business interests<br />

and risk management aspects are brought into line. Where<br />

appropriate, we take action to reduce the risk, using<br />

reinsurance for example.<br />

Risk management cycle<br />

Risk management in an operational environment includes<br />

the identification, analysis, assessment and measurement<br />

of risks. Aspects of this include the reports on these areas<br />

of risk, limiting risk in the sense of reducing it to an acceptable<br />

amount, and monitoring risk.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>32<br />

Risk report<br />

Our risk management processes ensure we monitor all<br />

risks on an ongoing basis and actively manage them<br />

wherever necessary.<br />

Risk identification: Suitable systems and quantitative<br />

indicators are used to (quantitative component). Bottomup<br />

and top-down risk surveying are also used and supplemented<br />

by expert opinions (qualitative component). Our<br />

ad-hoc reporting process enables employees of the <strong>ERGO</strong><br />

Insurance <strong>Group</strong> to report risks to the central IRM unit at<br />

any time.<br />

Risk analysis and assessment at the highest level are<br />

the responsibility of the central IRM unit. They are carried<br />

out in close collaboration with many experts from different<br />

parts of the <strong>ERGO</strong> Insurance <strong>Group</strong>. This enables us to<br />

obtain an assessment that is both quantitative and qualitative,<br />

and which also takes into account possible interdependencies<br />

between the risks.<br />

In order to measure risk, we use specific instruments for<br />

each business segment, which we constantly continue to<br />

develop. Our primary risk measures are based on economic<br />

principles and therefore best reflect the risk in our portfolio.<br />

Our risk model results are regularly checked against<br />

those of the regulatory bodies and rating agencies. This<br />

takes place at various levels such as the different business<br />

segments, companies, types of risk, geographical locations<br />

and business lines.<br />

We regularly compare our risk model results to those of<br />

other businesses and take part in industry surveys to test<br />

our instruments and fine-tune them further. In addition,<br />

we also compare our model with the latest capital requirements<br />

of Solvency II and participate in industry-wide<br />

quantitative impact studies.<br />

Risk limitation is part of our risk strategy and included in<br />

the ‘limit and trigger manual’ used throughout the <strong>Group</strong>.<br />

Risk-reducing measures are decided and implemented on<br />

the basis of the defined upper risk threshold.<br />

We differentiate between quantitative and qualitative<br />

indicators when monitoring risk. Quantitative indicators<br />

are monitored centrally, whilst qualitative measures are<br />

monitored both centrally and locally according to the size<br />

and category of the risk.<br />

Control and monitoring systems<br />

In <strong>2012</strong>, we developed our internal risk control system<br />

(IKS) further with the particular aim of including more of<br />

our subsidiaries abroad. Our IKS is a uniform operational<br />

risk management system applicable throughout the <strong>Group</strong>.<br />

It includes <strong>Group</strong> management requirements as well local<br />

legal and regulatory requirements. The Board of Management<br />

is responsible for the IKS and, structurally, it falls into<br />

the responsibility of the IRM unit. Responsibility for individual<br />

risks and controls lie with the relevant experts and<br />

employees in the various units. By incorporating staff in<br />

this way, we have reinforced the basis for a uniform understanding<br />

of risk within the <strong>Group</strong> and have improved our<br />

awareness of risk and how to control it.<br />

The holistic management approach of the IKS means that<br />

we can achieve a rise in efficacy and efficiency in identifying,<br />

analysing, assessing and documenting major risks and<br />

key controlling aspects. The clear allocation of responsibilities<br />

for aspects of risk and its control and management<br />

creates transparency. By systematically linking major<br />

risks and processes, a risk map has been developed for<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> which indicates all the relevant<br />

risk checkpoints.<br />

The efficacy of the IKS in major processes and applications<br />

is regularly assessed by the <strong>Group</strong>’s internal auditors as<br />

part of audit planning over several years.<br />

Risk reporting<br />

We do not just fulfil current legal requirements with our<br />

risk reporting. We use it to create transparency within<br />

the <strong>Group</strong> for management and supervisory bodies, and<br />

to inform the public of our operations. The IRM unit is<br />

responsible for our risk reporting.<br />

Internal risk reporting informs management of the risk situation<br />

in terms of the individual risk categories quarterly.<br />

If a significant change in the risk situation occurs, or an<br />

exceptional event or case of damage, a report is written<br />

and delivered to the management immediately so that they<br />

can react to dangerous developments quickly. Our aim is to<br />

be able to recognise even weak signals and negative trends<br />

quickly and take appropriate countermeasures.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>33<br />

Risk report<br />

Our external risk reporting is aimed at providing a comprehensible<br />

insight into <strong>ERGO</strong>’s risk situation. This includes<br />

information on our risk management methods and processes,<br />

risk governance and specific risks affecting the<br />

Company.<br />

Major risks<br />

We deem major risks as those which can have a permanent<br />

negative impact on the whole of <strong>ERGO</strong> <strong>Group</strong>’s assets,<br />

financial situation or profitability. This definition has been<br />

strictly applied – taking individual risk tolerance into consideration<br />

– to individual business segments and legal<br />

entities. It is our IRM unit which makes the final decision<br />

on whether a risk be considered major for a particular<br />

entity. In order to do this, the team takes particular note<br />

of how the risks could affect our financial strength and<br />

earnings volatility, as these are our principal criteria.<br />

This risk report is then drawn up based on the calculations<br />

and accounting principles used by our Company. We are<br />

fully compliant with the German Accounting Standard<br />

DRS 5−20.<br />

As set out by the DRS 5−20, we divide our overall risk into<br />

five categories:<br />

• Technical risks<br />

• Risks from default on receivables<br />

from insurance business<br />

• Investment risks<br />

• Operational risks<br />

• Other risks<br />

Technical risks<br />

Management of technical risks takes a central role. The<br />

key elements of this include checking risk patterns and<br />

continually monitoring accounting principles for the<br />

purpose of calculating technical provisions. Premiums and<br />

reserves are calculated using carefully selected accounting<br />

principles.<br />

We underwrite insurance for private and corporate clients,<br />

which results in a heterogeneous portfolio of risks incurred.<br />

Each line of business and business division has its own<br />

general parameters for calculating tariffs and underwriting<br />

at individual company level in order to ensure a balanced<br />

portfolio among all those insured. Each actuarial office<br />

ensures that the calculation of tariffs is carried out properly<br />

and that sufficient provisions are set up to meet any<br />

obligation incurred.<br />

These measures and processes mean that the risks<br />

incurred in the business undertaken by our companies are<br />

managed adequately. We regularly use processes separate<br />

from those mentioned above in order to measure their<br />

suitability, and where appropriate, we adapt them further.<br />

However carefully we calculate our tariffs, and despite<br />

more-than-adequate reserves by current standards, further<br />

risks may arise. We monitor these new risks continually in<br />

order to limit them. This way, we are able to take appropriate<br />

countermeasures in good time when the level of risk<br />

increases. Further risks may include, for instance, the <strong>ERGO</strong><br />

Insurance <strong>Group</strong> in its entirety or individual operational<br />

insurance companies experiencing exceptionally high<br />

levels of claims or due to an accumulation of loss-entailing<br />

occurrences. The interaction of risks of change and risk<br />

concentrations may also lead to considerable potential for<br />

losses. This not only involves regional concentrations but<br />

can also occur either within a line of business or across<br />

several lines.<br />

The IRM unit is in charge of identifying, assessing, monitoring<br />

and coordinating cumulative risks and concentrations<br />

which occur across multiple business segments and balance<br />

sheets. In order to do this, the IRM unit operates in close<br />

collaboration with specialists in the various business segments.<br />

It informs the risk committee of the consequences<br />

of risk cumulations across the entire <strong>Group</strong>.<br />

These types of risk are observed using scenarios and<br />

model calculations which are there to provide information<br />

regarding the maximum total liability of the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> based on a corresponding extreme scenario.<br />

To protect the <strong>Group</strong> from disproportionate liability and<br />

fluctuations in revenue we take out reinsurance. We take<br />

both the situation within the particular legal entity and<br />

integration within the <strong>Group</strong> into account when making<br />

these decisions.<br />

Good creditworthiness is our prime criterion when choosing<br />

our reinsurer. This allows us to limit the contingency risk<br />

and risks concerning cash flow fluctuations. Our outwards<br />

reinsurance is mainly placed within the Munich Re <strong>Group</strong>.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>34<br />

Risk report<br />

Life insurance Health insurance Property-casualty insurance<br />

Biometric risk Biometric risk Premium risk<br />

Interest-rate risk Lapse risk Large loss and cumulative loss risk<br />

Other market risk Claims risk Reserve risk<br />

Lapse risk Technical interest-rate risk Interest-rate risk<br />

The table above depicts the specific features of the underwriting<br />

risks in our operational insurance companies<br />

depending on the particular area of business.<br />

A differentiated analysis of the technical risks and relevant<br />

factors specific to the business segment in question, as<br />

well as explanations of their management, can be found<br />

in the Notes to the Consolidated Financial Statements<br />

from page 118. This complies with the requirements of the<br />

German Accounting Standard IFRS 4.<br />

Risks from default on receivables from<br />

insurance business<br />

Receivables from reinsurers, agents and customers are<br />

always subject to risk from default. In the case of nonpayment<br />

of premiums, the insurer experiences a high<br />

level of liability. This is particularly problematic in the case<br />

of comprehensive health insurance, since the insurer no<br />

longer has the right to terminate the contract. The total<br />

amount of premium instalments which have not been paid<br />

is constantly monitored according to several criteria in<br />

order to be able to recognise at an early stage whether it<br />

could lead to a relevant impairment or put a strain on all<br />

policyholders.<br />

On the balance sheet cut-off date, accounts receivable,<br />

where payment had been due for more than 90 days,<br />

accounted for € 320 million (244 m). To hedge the risk, we<br />

have taken precautionary measures by making adjustments<br />

to the value of receivables. Over the past three<br />

years, value adjustments have been made, amounting to<br />

an average of 10.4% (9.7%) of the existing receivables on<br />

the cut-off date. This share is equivalent to an average of<br />

0.8% (0.7%) of premiums earned over a period of three<br />

years.<br />

Experience has shown our precautionary measures to be<br />

adequate.<br />

41.3% (50.9%) of our accounts receivable stem from<br />

Munich Re, which have been awarded the second highest<br />

rating by the international rating agency Standard &<br />

Poor’s. Overall, and based on the rating classification<br />

from Standard & Poor’s, the spread of receivables from<br />

reinsurers can be seen in the table below:<br />

Investment risks<br />

Investments undertaken by <strong>ERGO</strong> Insurance <strong>Group</strong> can be<br />

grouped into four investment categories: interest-bearing<br />

investments, shares, property and shareholdings. Besides<br />

the criteria of return, security and credit rating, aspects<br />

of liquidity, diversification and, above all, underwriting<br />

obligations are also taken into consideration. The assetliability<br />

teams (AL teams) are responsible for asset-liability<br />

manage ment. For every operational entity, members<br />

of these committees include representatives from the<br />

actuarial office, strategic asset allocation, investment<br />

control, the IRM unit and the asset management company<br />

ME<strong>AG</strong>, part of Munich Re. Basic investment decisions<br />

(strategic asset allocation) are taken at an individual<br />

company level. Mandates are then formulated by the<br />

<strong>ERGO</strong> investment management unit from these strategic<br />

directives, with ME<strong>AG</strong> acting in an advisory capacity.<br />

These mandates take into account tax, balance sheet and<br />

regulatory considerations and define investment categories,<br />

quality and thresholds. Moreover, key figures and<br />

threshold values for tax purposes are prescribed in the<br />

mandates. ME<strong>AG</strong> is responsible for putting these mandates<br />

into practice. The AL teams are in charge of monitoring<br />

the guidelines laid out in the mandates and advising on<br />

strategic investment decisions.<br />

Receivables from reinsurers according to rating classes <strong>2012</strong> 2011<br />

€ million € million<br />

Rating class 1 (AAA) − 2<br />

Rating class 2 (AA) 68 65<br />

Rating class 3 (A) 2 19<br />

Rating class 4 (BBB and less) − 1<br />

No rating 19 8<br />

Total 89 94


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>35<br />

Risk report<br />

We monitor investments which we manage ourselves<br />

based on projections and internal reporting. These include<br />

property loans, mortgages, remortgages, policy loans, staff<br />

loans, loans to officials, deposits retained, surpluses from<br />

unit-linked life insurance policies and some shareholdings<br />

and property investments. This is also true for investments<br />

managed by ME<strong>AG</strong>. Any deviations from the projections are<br />

looked into by the AL team where deemed necessary.<br />

ME<strong>AG</strong> monitors compliance with the guidelines set out in<br />

our mandates for specific parts of the business on a daily<br />

basis using our comprehensive early-warning system.<br />

We have implemented triggers for the various sources of<br />

risk, whose activation initiates a predefined process. The<br />

trigger landscape, which is in operation throughout the<br />

<strong>Group</strong>, differentiates between three danger levels involving<br />

different measures.<br />

The levels are derived from the risk tolerance of the company<br />

in question. The early-warning system is supplemented<br />

by analyses of long-term trends and scenarios,<br />

particularly as regards interest-rate and share markets.<br />

Proactive risk management has enabled a considerable<br />

reduction in the adverse effects of the financial and<br />

national debt crises on the <strong>ERGO</strong> Insurance <strong>Group</strong>. Over<br />

the last couple of years, we have significantly reduced the<br />

percentage of investments our companies hold in equities.<br />

In <strong>2012</strong>, these remained at the low levels recorded in previous<br />

years. Permanent monitoring of the risk of default by<br />

a contract partner is ensured by means of a <strong>Group</strong>-wide<br />

counterparty limit system.<br />

We continued to develop our risk management activities<br />

in the area of capital investments during <strong>2012</strong>. Improvements<br />

in the way liquidity, market and credit risks are<br />

taken into account by our early-warning systems are once<br />

again of particular note. The counterparty risk due to overthe-counter<br />

derivatives has, in the past, been reduced by<br />

implementing collateral management.<br />

The following account of our capital investment risks<br />

complies with the German Accounting Standard IFRS 7.<br />

Our main capital investment risks are market, credit and<br />

liquidity risks.<br />

Market risks<br />

A market risk is defined as the risk of losses or adverse<br />

effects on the financial strength of a company as a result<br />

of price amendments and fluctuations on the capital<br />

markets. Market risks form the lion’s share of capital<br />

investment risks. Market risks include, among other things,<br />

the risk of changes to the interest rate and their consequences,<br />

share price risk, the risk of changes in property<br />

prices, exchange rate risk, asset-liability mismatch risk and<br />

the credit spread risk resulting from worsening creditworthiness.<br />

Causes of possible reductions in market value vary<br />

from investment category to investment category.<br />

Fluctuations in market price not only affect our capital<br />

investments, they also influence our underwriting<br />

liabilities. This is particularly noticeable in the case of life<br />

insurance. The fact that the interest rate is sometimes<br />

guaranteed for a longer period, and the numerous options<br />

which policyholders have with traditional life insurance<br />

policies result in a major dependence on the value of<br />

liabilities on the capital markets.<br />

Market risks are handled by applying appropriate limiting<br />

and early-warning systems as well as our asset-liability<br />

management. This is done by limiting the divergences of<br />

current investments from those which are economically<br />

necessary to cover underwriting liabilities, a so-called<br />

replicating portfolio. In addition, risk-relevant restrictions<br />

for investments are taken into account, which stem from<br />

accounting in line with the German Commercial Code (HGB)<br />

or IFRS.<br />

At 94.1% (94.1%), the majority of our investments are<br />

interest-bearing. Consequently, the development of<br />

general interest-rate levels and the issuer-specific credit<br />

spreads have a considerable effect on the value of the<br />

investments and investment income. To secure investment<br />

returns in the long term, our activities in asset-liability<br />

management are regularly adjusted in line with current<br />

market conditions.<br />

We are pursuing a defensive investment strategy due to<br />

the expected continuance of volatile developments on the<br />

market. Financial derivatives are used to extend the investment<br />

horizon for interest-bearing investments and the<br />

risks run by investing in the stock markets.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>36<br />

Risk report<br />

Up-to-date market values for property are not always<br />

available. Consequently, surveys or other appropriate and<br />

generally recognised and verified assessment procedures<br />

are necessary. Adjustments are made to figures insofar<br />

as value impairments are deemed to be of a permanent<br />

nature.<br />

Currency risks are mainly hedged using forward exchange<br />

transactions. Additional risks stem mainly from long-term<br />

investments where there are no adequate or economically<br />

viable hedging mechanisms available. We monitor these<br />

risks on a permanent basis to enable us to take action<br />

against developments in good time. Exchange rate gains<br />

or losses recorded in accordance with IFRS are calculated<br />

by separating the change in market value in the original<br />

currency on the one hand and the effects of the exchange<br />

rate written against the income statement on the other.<br />

Potential risks due to fluctuations in the market value<br />

of investments are regularly assessed using so-called<br />

stress tests. These stress tests take into account blanket<br />

fluctuations in the market value of interest-bearing investments,<br />

shares and currencies. An example of a scenario<br />

analysis is in the Notes under “Market risks from financial<br />

instruments”.<br />

A host of other tools are also used to determine the<br />

potential market risk. In particular, a forecast is made<br />

of investment income on the next balance sheet cut-off<br />

date subject to changing capital market conditions. Based<br />

on the rating and quality of our investments, we do not<br />

see recognisable threats to the existence of the <strong>ERGO</strong><br />

Insurance <strong>Group</strong> or its obligations to its policyholders.<br />

Credit risk<br />

Credit risks stem from the danger that debtors are unable<br />

to keep up with their payment obligations or that deteriorations<br />

in creditworthiness lead to economic losses.<br />

As regards our fixed-interest investments, we keep the<br />

associated credit risk in check by choosing issuers of<br />

adequate quality and taking note of the contracting<br />

party’s limits. The rating undertaken by external rating<br />

agencies is only one of a number of risk criteria taken into<br />

account. We also conduct our own analyses, and issuers’<br />

ratings undergo an internal plausibility test. Both our own<br />

assessment and that of the external rating agency have<br />

to be positive for an investment to pass the risk appraisal<br />

procedure. The high demands we make of our issuers are<br />

reflected in our investment principles, which are applicable<br />

throughout the <strong>Group</strong>. Our securities portfolio is distinguished<br />

by the fact that most of the securities are from<br />

issuers of outstanding creditworthiness.<br />

88.3% (91.0%) of our interest-bearing investments received<br />

at least the third-highest rating available, “strong”, at the<br />

end of the financial year. See also sections [6g] to [6i] in<br />

the Notes. As a comparison, this is equivalent to an “A”<br />

rating from Standard & Poor’s. The table below shows how<br />

this is spread across the different types of securities.<br />

The diversification of <strong>ERGO</strong> Insurance <strong>Group</strong>’s investments<br />

is deemed adequate. The risk of default on fixed-interest<br />

investments increases in proportion to a decrease in the<br />

debtor’s creditworthiness. Debtors of low creditworthiness<br />

must therefore offer a higher coupon or level of interest<br />

to remain attractive despite the risk of default. Our risk<br />

manage ment strategy features appropriate trigger calculations<br />

to deal with the risk of a decrease in creditworthiness.<br />

The majority of our interest-bearing investments are<br />

securities not listed on the stock market. We determine<br />

the market value of these securities using yield curves and<br />

taking into account cautious credit spreads specific to the<br />

issuer. In the case of stock-listed interest-bearing investments,<br />

we use official rates.<br />

We have implemented a counterparty limit system throughout<br />

the <strong>Group</strong> in order to monitor and manage the risk<br />

Bonds portfolio according to individual categories Share in all Rating at least<br />

(31 December <strong>2012</strong>) interest-bearing investments % category “strong” % 1<br />

Bank bonds/loans against promissory notes 7.5 53.8<br />

Covered bonds/pfandbriefs 40.6 98.5<br />

Government bonds 40.0 88.7<br />

Corporate bonds 5.6 49.4<br />

Other 6.2 96.4<br />

1 This is equivalent to an “A” rating from Standard & Poor’s.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>37<br />

Risk report<br />

of default. The contracting party’s limits depend on their<br />

financial situation and the level of risk tolerance defined by<br />

the Board of Management. We coped with the critical situation<br />

of the banks and government bonds during the <strong>2012</strong><br />

financial year by continually checking the upper thresholds<br />

of our limits and reducing certain limits and implementing<br />

collateral management. In <strong>2012</strong>, we made further progress<br />

with the project we started in 2011 aiming at trading OTC<br />

derivatives via a central independent party. This project is<br />

based on a European Parliamentary regulation, the European<br />

Market Infrastructure Regulation (EMIR), and once<br />

the general regulatory conditions have been finalised, we<br />

expect to be able to start doing business in 2013. Our overall<br />

exposure in the financial sector – measured at market<br />

values – amounted to € 63.6 bn at the end of the financial<br />

year, of which € 54.9 bn (86.3%) is collateralised.<br />

We continually monitor the subordinate securities,<br />

dormant equity holdings and profit participation certificates<br />

in our portfolio for risk-control purposes.<br />

Our investments in peripheral Eurozone countries with<br />

high levels of national debt (Ireland, Italy, Spain) amount<br />

to 3.6% of our total investments. We reduced our involvement<br />

in the peripheral Eurozone countries further in <strong>2012</strong>,<br />

and totally withdrew from Greece and Portugal. The euro<br />

national debt crisis is expected to continue in 2013 even<br />

though the battery of political countermeasures has<br />

increased and the European Central Bank has introduced<br />

new instruments. Yet the critical situation in certain countries,<br />

particularly around the Mediterranean, continues to<br />

worsen. Budget consolidation, recession and high unemployment<br />

are testing the political will and the ability of<br />

nations to react to countermeasures.<br />

The following table shows the market and par value<br />

distribution of our exposure to government bonds in<br />

certain countries.<br />

We wrote down the value of our interest-bearing<br />

investments by € 14 m in the year under review, which is<br />

equivalent to 0.01% of total investments.<br />

Liquidity risks<br />

We must be in a position to meet our payment obligations<br />

at all times. This is ensured by our detailed liquidity<br />

planning. We use our asset-liability management to control<br />

cash flows from our investment portfolio and receipt of<br />

premiums in terms of time and quantity. This means they<br />

are sufficient to meet the liabilities incurred by our insurance<br />

contracts. In addition, we maintain a liquidity reserve.<br />

This protects us from unexpected liquidity bottlenecks,<br />

such as a sudden increase in cancellations. Liquidity risks<br />

are integrated into our control and limit system, which we<br />

update annually.<br />

Major hedging operations<br />

At <strong>ERGO</strong> Insurance <strong>Group</strong>, we mainly use financial derivatives<br />

to hedge market risks to our capital investments. The<br />

main risks in this area are interest-rate fluctuations and<br />

currency risks. We use our risk management system intensively<br />

to counter these, and, as already mentioned, use<br />

financial derivatives too.<br />

A permanently low interest rate brings with it the risk that<br />

outflows must be reinvested at a lower rate of interest. We<br />

cope with this reinvestment risk by continually developing<br />

our hedging strategies using derivatives. For companies<br />

offering personal insurance, we thus have a minimum<br />

reinvest ment interest rate in the case of falling interest<br />

rates. This is an important aspect of ensuring that we are<br />

able to fulfil our technical payment obligations in the long<br />

term. Since the low interest period is still ongoing, the interest<br />

yield on reinvestments made in <strong>2012</strong> benefited again<br />

from these hedging operations. According to the balance<br />

sheet requirements of the respective financial instruments,<br />

fluctuations in market values are either recorded in the<br />

revaluation reserve or the income statement.<br />

Government bonds and government-guaranteed securities -<br />

selected countries (31 December <strong>2012</strong>)<br />

Fair values<br />

€ million<br />

Carrying amounts<br />

€ million<br />

Portugal – –<br />

Republic of Ireland 1,084 1,025<br />

Italy 2,552 2,520<br />

Greece – –<br />

Spain 973 1,298


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>38<br />

Risk report<br />

We mainly hedge the risk of exchange rate fluctuations to<br />

capital investments in foreign currencies using derivatives.<br />

We monitor these financial derivatives using a trigger<br />

system on the one hand, and they also form part of the<br />

qualitative components of the risk controlling of the <strong>ERGO</strong><br />

Insurance <strong>Group</strong>’s investments and financial participations.<br />

This is the context in which we appraise the market, credit<br />

and liquidity risks. We use our counterparty limit system to<br />

monitor the issuer risk. The counterparty risk arising from<br />

the products is spread across several creditworthy issuers.<br />

We reduce this risk further by depositing covered bonds<br />

(pfandbriefs) as collateral. In addition, we reach agreements<br />

with the counterparties on collateral management,<br />

thus protecting claims from business based on derivatives.<br />

These hedging operations are fulfilling their role. We are<br />

not currently aware of any major risks posed by the hedging<br />

operations themselves.<br />

Operational risks<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong> considers operational risks as<br />

risks of losses associated with inappropriate procedures,<br />

technological breakdowns, human error or external events.<br />

We minimise these risks using systematic risk management<br />

aimed at their causes. It is one of the goals we as a<br />

Company have declared and consistently pursue to sensitise<br />

our staff to possible risks and therefore establish a<br />

certain risk culture.<br />

HR risks could include bottlenecking of staff. We reduce<br />

this risk using measures including HR advertising, tests to<br />

measure employees’ potential, human resources development<br />

and systematic succession planning. We use modern<br />

management tools and adequate monetary and nonmonetary<br />

incentives to motivate our staff.<br />

Companies are under increasing threat from white-collar<br />

crime (fraud). Our code of conduct sets out the rules and<br />

principles for correct and responsible behaviour. This code<br />

is valid for all legal representatives, managers and other<br />

staff.<br />

We have a separate code of conduct for our self-employed<br />

agents in Germany. In addition, all <strong>ERGO</strong> businesses<br />

in Germany and abroad have rules and principles for<br />

adequate and effective fraud prevention, detection and<br />

response. In cases of serious fraud, there is a special<br />

process to report this to the <strong>ERGO</strong> Fraud Prevention Officer.<br />

The number of reported cases of fraud in Germany and<br />

abroad shows our increasing sensitivity in this area as well<br />

as progress in our ever more consistent treatment and<br />

sanctioning of these occurrences. At least once a quarter,<br />

a report is submitted to the <strong>ERGO</strong> Board of Management<br />

and one to the <strong>ERGO</strong> Supervisory Board’s audit committee<br />

every six months.<br />

Due to the extent to which information technology (IT)<br />

systems have become vital to our work, we are also<br />

exposed to IT risks, particularly system failures and interruptions<br />

in service, the loss of data and external hacking.<br />

We combat these risks with a comprehensive system of<br />

precautionary measures, such as plans for emergencies,<br />

back-up solutions and controlled access. Management of<br />

our IT systems and the risks associated with them is the<br />

responsibility of IT<strong>ERGO</strong>, a member of the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong>.<br />

The implementation of crisis management as a major part<br />

of our business continuity management is practically complete.<br />

We are continuing to developing this by implementing<br />

training and practice measures. We are developing<br />

emergency and recovery plans for the processes necessary<br />

to <strong>ERGO</strong>’s business and integrating them into the local<br />

emergency plans.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>39<br />

Risk report<br />

Other risks<br />

Changes to law and regulations<br />

Changes to law and regulations can have a substantial<br />

impact on the Company. Over the course of time, these<br />

changes result in opportunities as well as risks, which is<br />

why we constantly monitor these developments. Furthermore,<br />

risks are addressed by being actively involved in<br />

industry bodies and committees.<br />

An example of a particularly significant change in law is<br />

the European Court of Justice’s (ECJ) verdict of 1 March<br />

2011 on the subject of price differences based on gender<br />

in insurance. On the basis of this, the court repealed the<br />

ruling permitting Member States to allow differentiated<br />

pricing of insurance products and premiums according to<br />

gender as of 21 December <strong>2012</strong>. This also applies if the<br />

differences come from a valid calculation of risk, based<br />

on accurate and relevant mathematical and statistical<br />

insurance data. The Member States’ laws on this, including<br />

Germany’s, must be altered to accommodate the new<br />

ruling. This verdict means considerable changes to how the<br />

prices of insurance products and premiums are calculated.<br />

The actuary in charge considers the risks arising from the<br />

changes to actuarial practice to have been sufficiently<br />

contained or eliminated through our actuarial analysis and<br />

application of the German Actuarial Association’s (DAV)<br />

advice. Even following the successful implementation of<br />

the gender verdict, a change in the gender make-up of our<br />

customer base could still change our technical risk. We<br />

limit this risk using conservative calculations and actuarial<br />

analyses. We reduce the technical interest rate risk in the<br />

long term by using a technical interest rate which stands at<br />

2.75% for the new unisex tariffs, meaning that <strong>ERGO</strong> is not<br />

exposed to any further risks from the unisex tariffs.<br />

One of the sociopolitical risks we face is national health<br />

insurance (“Bürgerversicherung”), which is a threat to<br />

private health insurance. By introducing compulsory public<br />

health insurance for all, such a national health insurance<br />

scheme would, at the very least, put an end to new business<br />

in comprehensive health insurance. Obstacles posed<br />

by the constitution are likely to prevent current holders<br />

of private health insurance from being required to join<br />

the public scheme. We have been monitoring this risk for<br />

several years and have publicly spoken out about the disadvantages<br />

of implementing such a system. Equivalent<br />

proposals have been made in the area of long-term<br />

nursing care insurance.<br />

Individual court verdicts may be legally binding for our<br />

companies and affect our reputation. We assess the possible<br />

outcomes of ongoing processes and their impact on<br />

our obligations in realtime. If potential monetary obligations<br />

are identified, we react to these immediately using<br />

appropriate provisions.<br />

The progress of the European Union’s Solvency II project<br />

was one of the reasons that future regulatory requirements<br />

became somewhat clearer in <strong>2012</strong>, although they still hold<br />

some major uncertainties, particularly in respect to the<br />

implementation timeframe. The developments laid out in<br />

Pillar 1 of Solvency II have already advanced a long way,<br />

with the exception of the central aspect of the assessment<br />

of technical liabilities. The issues which have not yet been<br />

decided upon are ones with far-reaching consequences for<br />

capitalisation under Solvency II, particularly on life insurance.<br />

This results in the risk that our life insurance businesses<br />

may not be able to fulfil their capital requirements.<br />

We expect further substantiation of transition deadlines<br />

from Solvency I to Solvency II and the future powers of the<br />

EIOPA when the Omnibus II Directive is adopted. Before<br />

this takes place, a European study of the effects of Omnibus<br />

II on policyholders, regulatory bodies and insurance<br />

companies (long-term guarantee assessment) is due to be<br />

carried out. The current plan is to integrate the Solvency II<br />

regime into national law by mid− 2013 and for it to come<br />

into force from 2014. However, further delays are to be<br />

expected, possibly several years beyond 2014.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>40<br />

Risk report<br />

The implementation of Solvency II on a national level will<br />

also alter German regulatory laws. We are continually<br />

monitoring the amendment process of the German Insurance<br />

Supervision Act (V<strong>AG</strong>) to incorporate the requirements<br />

of Solvency II, which began in the middle of the second<br />

quarter in 2011 and has been suspended at present. The<br />

reason for this is that the Solvency II project is still running<br />

and there are still decisions to be made at a European level.<br />

This means that the final integration into national law still<br />

poses some uncertainties.<br />

The German Parliamentary Finance Committee has however<br />

decided to integrate certain parts of the updates<br />

to the V<strong>AG</strong> into the Accompanying Act to the SEPA Bank<br />

Transfer Act (‘SEPA-Begleitgesetz’). These topics include:<br />

• Implementation of the ECJ’s ruling on unisex tariffs<br />

• Adjustment of the rules on participation in<br />

valuation reserves<br />

• Partial collectivisation of provisions for premium refunds<br />

• Extension of the time period allowed in which to transfer<br />

the undetermined provisions for premium refunds<br />

from free assets to tied assets<br />

The German Upper House (Bundesrat) has referred the<br />

Accompanying Act to the SEPA Bank Transfer Act to the<br />

Conciliation Committee. It is currently very doubtful as to<br />

whether this act will be implemented in its current form.<br />

The outcome of the conciliation process is not expected<br />

until spring 2013 at the earliest. We are continually<br />

monitoring these developments and are preparing an<br />

appropriate implementation process.<br />

On an international level, we are currently working on<br />

additional regulatory requirements for organisations<br />

declared to be systemically important financial institutions<br />

(SIFI). The scope of requirements specific to SIFIs<br />

can range from the duty to provide additional reports to<br />

increased equity requirements. Systemic relevance does<br />

not refer to the significance of a particular industry to the<br />

national economy in this instance, but rather to the potential<br />

impact of the insolvency of a particular company on<br />

the global real economy. The Financial Stability Board (FSB)<br />

is the primary body involved in these discussions, of which<br />

the banking industry is the current focus. The study of the<br />

insurance sector is to take place separately to that of the<br />

banks, and is to be led by the International Association of<br />

Insurance Supervisors (IAIS). The IAIS is currently working<br />

on a method of identifying G-SIIs (global systemically<br />

important insurers). A first overview of the companies identified<br />

as G-SIIs is expected to be published in April 2013.<br />

The insurance industry is of the understanding that its core<br />

business does not entail any systemic risks.<br />

Strategic risks<br />

We define strategic risks as those arising from bad business<br />

decisions, the poor implementation of decisions or a lack<br />

of ability to adapt to changes in our business environment.<br />

Strategic risks occur in the context of the Company’s and<br />

its business divisions’ existing and new earnings potentials.<br />

These risks generally arise early on and in conjunction<br />

with other risks and can lead to a significant long-term<br />

reduction in corporate value. We combat strategic risks by<br />

closely combining our strategic decision-making process<br />

with our risk management. This includes cultural and<br />

organisational aspects.<br />

Risks to our reputation<br />

We define a risk to our reputation as the risk of damage<br />

caused by the Company being perceived more negatively.<br />

How the public, customers, shareholders, employees and<br />

business partners perceive us is relevant, as is the case for<br />

other interested parties such as regulatory bodies.<br />

Reputation risks are monitored and managed using our<br />

internal risk control system (IKS). We further reinforced<br />

our compliance procedures in the Company in <strong>2012</strong>. Since<br />

then, we have had a separate Compliance Unit reporting<br />

directly to the Chairman of the Board. The unit reviews<br />

the Company’s guidelines on proper conduct of staff and<br />

provides advice on the implementation of these guidelines.<br />

We have introduced a uniform advice process for our sales<br />

organisations which takes the full breadth of customers’<br />

interests into account and aims to ensure a consistently<br />

high standard of advice.<br />

There are legal disputes between several former insurance<br />

intermediaries and <strong>ERGO</strong> Lebensversicherung <strong>AG</strong>, most<br />

of which have now been concluded. In connection with<br />

far-reaching claims by the former intermediaries, serious<br />

allegations have been levelled in the media since May<br />

2011, including reports of misconduct on incentive trips<br />

and errors in the sale of insurance products at <strong>ERGO</strong>. These<br />

cases have been extensively investigated by our internal


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>41<br />

Risk report<br />

audit function. <strong>ERGO</strong> has initiated the rectification of errors<br />

and has established reserves for any liabilities arising. In<br />

relation to all these events, additional claims for damages<br />

against <strong>ERGO</strong> and Munich Re have been announced.<br />

Financial burdens and reputational damage for <strong>Group</strong><br />

companies as a result of these allegations cannot be ruled<br />

out in future either.<br />

There are currently a number of lawsuits pending against<br />

various Ideenkapital companies. The plaintiffs are fund<br />

investors, who for the main part are asserting defects in<br />

prospectuses and products. The claims filed so far amount<br />

to a total of around € 6 m. Ideenkapital is defending itself<br />

against these claims. The possibility of further suits cannot<br />

be excluded.<br />

Emerging risks<br />

Our early risk warning system also covers emerging<br />

risks. These risks arise as a consequence of a change in<br />

conditions, be they legal, socio-political, geographical or<br />

technical. Such changes can affect our portfolio in ways<br />

we may not yet understand or recognise. By definition, the<br />

extent and likelihood of damages in relation to emerging<br />

risks bear a high degree of uncertainty. The Emerging Risk<br />

Think Tank, a group of experts at Munich Re, identifies,<br />

assesses and analyses new risks to the MR <strong>Group</strong>. <strong>ERGO</strong>’s<br />

IRM unit participates in the Emerging Risk Think Tank’s<br />

regular meetings. Topics which are particularly relevant to<br />

the <strong>ERGO</strong> Insurance <strong>Group</strong> or certain individual companies<br />

are analysed and assessed in more detail.<br />

Summary of the risk position<br />

All in all, we have come to the conclusion that neither the<br />

<strong>ERGO</strong> Insurance <strong>Group</strong>’s existence nor our policyholders’<br />

interests have been endangered at any point. Furthermore,<br />

we are not currently aware of any developments<br />

which could adversely affect the continued operations,<br />

net assets, financial or earnings situation of our Company<br />

in the long run. The individual insurance organisations<br />

belonging to the <strong>ERGO</strong> Insurance <strong>Group</strong> are subject to the<br />

regulatory requirements in the countries where they are<br />

active. The <strong>ERGO</strong> Insurance <strong>Group</strong>’s insurance companies<br />

all fulfilled the appropriate local solvency requirements<br />

in <strong>2012</strong> with the exception of one international company.<br />

For this company the increase in capital required will be<br />

undertaken in the current business year. All of the <strong>Group</strong>’s<br />

companies exhibit sufficient coverage of tied assets.<br />

We are able to guarantee the functionality of our risk<br />

management system to a high level. The structures and<br />

processes we have implemented allow us to recognise the<br />

development of risks early and instigate the appropriate<br />

management processes.<br />

We continually monitor our capital investments using a<br />

<strong>Group</strong>-wide early-warning system which encompasses<br />

various key figures for the risks and earnings of each company.<br />

This allows us to ensure that solvency requirements<br />

are met and that we have sufficient protection for our<br />

equity at both <strong>Group</strong> and individual company levels. It also<br />

helps us to manage our income. The <strong>Group</strong>’s risk management<br />

system is in essence the collaboration between<br />

central risk management and the risk management units<br />

in each company. We therefore judge the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong>’s risk position to be manageable, controlled and<br />

viable.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

42<br />

Management <strong>Report</strong><br />

Opportunities report<br />

As a major international insurance group, we offer an<br />

extensive array of insurance, provision and services, and<br />

the opportunities and risks for our business are just as<br />

diverse. In the chapter entitled ‘Prospects’, we offer an<br />

overview of how our business will probably develop under<br />

realistic parameters. We endeavour to address global<br />

trends with a long-term impact as extensively as possible.<br />

However, surprising and unforeseen events can never be<br />

ruled out completely. To protect ourselves against risks, we<br />

have established a sophisticated risk management system<br />

described in detail in our risk report. At the same time, we<br />

are also well prepared to seize unexpected opportunities to<br />

the benefit of our Company.<br />

It is clear, for example, that enhanced business opportunities<br />

will result for us if important macroeconomic parameters<br />

develop better than expected. Rapid stabilisation of the<br />

situation in the Eurozone could yield positive results and<br />

trigger an increase in premium income in most classes of<br />

insurance. Besides this, such a development could lead to<br />

a gradual normalisation of the bond markets and thus to<br />

a slow rise in yields on German government bonds. This<br />

would result in burdens on our investment result in the<br />

short term, but also bring higher returns in the long run,<br />

thus benefiting our long-term insurance business.<br />

Other trends and upheavals with an impact on our customers’<br />

demand for insurance or our portfolio include technological<br />

progress, demographic shifts and changes in the<br />

legal environment, in particular regulatory interventions.<br />

This not only leads to risks but also to opportunities, which<br />

we are keen to utilise.<br />

As a result of the need to provide for a rapidly ageing population,<br />

opportunities are arising within the life and health<br />

insurance sectors. The trend for annuity insurance, which<br />

has been apparent for a number of years now, looks likely<br />

to continue. Within the current climate of low interest rates<br />

and rapidly fluctuating capital markets, traditional life<br />

insurance products with annual guarantees are presenting<br />

a significant challenge to us. We are therefore developing<br />

a new generation of products that we will bring onto the<br />

market during the course of the year. Thanks to their intelligent<br />

combination of guarantees, return prospects and<br />

flexibility, we see a great deal of market potential.<br />

In health insurance, long-term nursing care is becoming<br />

the focus of attention. During the reporting period, the<br />

German legislature decided to begin funding private<br />

nursing care, something which could have a subsequent<br />

positive impact on the market. As the market leader for<br />

supplementary insurance, this is undoubtedly something<br />

we intend to participate in.<br />

Our accident insurance product, introduced in <strong>2012</strong>, offers<br />

a multitude of assistance services which aim to maintain<br />

quality of life for people involved in accidents. We are<br />

seizing opportunities which arise as a result of changes<br />

to family or household size. Alternative energy sources<br />

are resulting in an increased need for cover for property<br />

insurance – this includes both damage to equipment<br />

and loss of earnings. We are increasingly offering cover<br />

within the single European market, especially for industrial<br />

businesses.<br />

With our brand promise “To insure is to understand”, <strong>ERGO</strong><br />

stands out positively in the market and we expect to be<br />

able to strengthen and expand our position. In our industry<br />

which is quite complex for consumers, consumers often<br />

feel their wishes and concerns regarding insurance are not<br />

taken seriously. Surveys show that they bemoan the lack of<br />

transparency in products and services. Regulatory authorities<br />

strengthen consumer rights. Our aim is therefore to<br />

respond to customer calls for transparency, authenticity<br />

and simplicity in an accurate and timely fashion. With our<br />

clear and easy-to-understand communication, we will<br />

create the basis for a partnership-based approach.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>43<br />

Opportunities report<br />

Customers are increasingly purchasing insurance cover<br />

using a range of different channels. <strong>ERGO</strong>’s sales already<br />

cover a wide array of options and we have the right sales<br />

channel for everyone: self-employed insurance sales partners,<br />

staff working in direct sales, as well as insurance<br />

brokers and strong cooperation partners – both in Germany<br />

and abroad – respond to the needs of private and corporate<br />

customers alike. We maintain sales partnerships with<br />

the major European bank UniCredit and other banks, both<br />

in Germany as well as in various European countries. We<br />

believe that the prospects for growth lie primarily in bank<br />

sales and direct marketing.<br />

We also see indirect benefits from a rising level of regulations.<br />

When risks from long-term life and health insurance<br />

contracts are made easier to measure and thus more<br />

transparent, and have to be backed with the requisite<br />

capital, competitive discipline should improve and the<br />

products offered should be limited to those that generate<br />

value for customers and providers. As a result, life insurance,<br />

which is particularly challenging when market interest<br />

rates are low, could become more attractive for us<br />

again in the long term.<br />

The rapid development of emerging markets also presents<br />

opportunities for expanding profitably and further diversifying<br />

our business portfolio. We are already involved in<br />

promising joint ventures in selected emerging markets in<br />

Asia: in property insurance with HDFC <strong>ERGO</strong> in India and<br />

with the Global Insurance Company in Vietnam. Furthermore,<br />

in November <strong>2012</strong>, we formed a joint venture in<br />

India for life insurance with the well-positioned Avantha<br />

<strong>Group</strong> conglomerate. Since spring <strong>2012</strong>, we have been<br />

working intensively on setting up <strong>ERGO</strong> China Life Insurance,<br />

a joint venture with the Shandong state-owned<br />

Assets Investment Holding Company as a strong local<br />

partner. We are also using our expertise in products and<br />

sales channels within emerging European markets in order<br />

to launch the best business models on the respective<br />

market and therefore further expand our international<br />

business.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

44<br />

Management <strong>Report</strong><br />

Prospects<br />

The following assessment and comments on the likely<br />

development of our Company, including the main opportunities<br />

and risks, are made to the best of our knowledge<br />

and belief. They are based on a host of findings currently<br />

available relating to prospects for the industry, future<br />

economic and political parameters, as well as trends and<br />

the main factors influencing them. All of this may of course<br />

change in the future without this being foreseeable at the<br />

present time. The actual development of the Company and<br />

its results might therefore diverge considerably from the<br />

forecasts. This section also includes information on how<br />

the actual results for the year covered by this report differ<br />

from the predictions made last year.<br />

All in all, looking ahead at the next two financial years, we<br />

continue to anticipate a positive trend for the business of<br />

the <strong>ERGO</strong> Insurance <strong>Group</strong>. This assessment is based on a<br />

number of expectations which take into account the main<br />

opportunities and risks, our economic environment and our<br />

strategic alignment.<br />

Comparison of our predictions for <strong>2012</strong> with<br />

the results for <strong>ERGO</strong> from <strong>2012</strong><br />

Based on our predictions for last year, premium income<br />

did not quite reach the forecast amount, though we did<br />

meet expectations in profits, when adjusted to allow for<br />

restructuring costs.<br />

Total premium income amounted to € 18.6 billion, down on<br />

the expected € 19 billion. This is largely down to less singlepremium<br />

business in life insurance.<br />

In the area of health, growth was down on market figures<br />

as forecast (+ 3.4%). This was to be expected due to our low<br />

level of premium rate adjustments. Market growth, as well<br />

as our own, was lower than foreseen.<br />

expected a market growth of 1−2%. We also failed to meet<br />

our target in our combined ratio: we had hoped to bring it<br />

down to well under 95%, but it currently stands at 95.8%.<br />

In addition to a number of coincidental cases of major<br />

damage, we made risk provisions for outstanding claims<br />

within the range of actuarial estimates.<br />

Our gross premiums written in direct insurance grew, as<br />

expected. We forecast lower growth in travel insurance<br />

than in previous years. However, premium income fell by<br />

5.2% in the year under review.<br />

We projected that premiums would remain stable in international<br />

business, after making adjustments for disposals<br />

of affiliated companies; however, we did not achieve this.<br />

This was largely due to the conditions in the life insurance<br />

sector which developed worse than expected.<br />

We achieved our forecast for the consolidated result if the<br />

profit of € 289 million is adjusted by € 128 million for the<br />

effects stemming from the restructuring of our sales forces<br />

in Germany. This gives a result of € 417 million. We forecast<br />

a net profit of € 400 million in our last annual report.<br />

Economic environment<br />

Global economic growth is again likely to be only moderate<br />

in 2013. The consolidation of public finances and high<br />

unemployment will probably result in slower economic<br />

momentum in many industrialised countries. In the eurozone,<br />

we expect at most a slight recovery on an annual<br />

basis; for the USA we predict only modest growth. In the<br />

emerging economies, particularly China, India and Brazil,<br />

growth should be stronger than in <strong>2012</strong>. Inflation rates will<br />

consequently be moderate in most industrialised countries<br />

and will only reach a somewhat higher level in a few<br />

emerging countries.<br />

We had hoped that our property-casualty insurance in<br />

Germany would grow faster than the market. However, we<br />

did not achieve this goal with our 1.6% growth, compared<br />

to the assumed market growth of 3.7%; although we<br />

We forecast low economic growth and continued moderate<br />

inflation for Germany in 2013. In these circumstances,<br />

premium income can only be expected to grow modestly.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>45<br />

Prospects<br />

We expect that the world economy will expand more<br />

quickly after 2013. Nevertheless, the economic outlook is<br />

clouded by great uncertainty.<br />

A sharp downturn or even an extended period of stagnation<br />

cannot be completely excluded in a number of industrialised<br />

countries. A sustained low-interest-rate environment<br />

would substantially impair the situation of life insurance<br />

companies. The high levels of debt in many countries, an<br />

escalation of the US budgetary dispute, or upheavals in<br />

the eurozone could further destabilise the global financial<br />

system and the world economy to the detriment of the<br />

insurance industry.<br />

If there was a surprisingly strong economic recovery, the<br />

substantial interventions of the central banks and related<br />

expansion of the money supply might result in higher<br />

inflation, with corresponding inflation in claims costs for<br />

insurers.<br />

Capital markets<br />

A slow upturn in economic activity over the course of 2013 –<br />

driven by further expansive measures of the European<br />

Central Bank (ECB) in connection with a gradually receding<br />

credit crunch in the eurozone – should improve the position<br />

on the markets for risky assets. In turn, yields on German<br />

government bonds, which are currently extremely low,<br />

should rise again. Based on the very low volatility of the stock<br />

markets recently, greater fluctuations can be expected, as<br />

political uncertainty – e. g. through Italian elections – is still<br />

high. Moreover, some market participants now anticipate<br />

that Spain will submit an official application for assistance in<br />

2013 so as to qualify for unlimited bond-buying by the ECB.<br />

Further fiscal policy decisions which could induce major market<br />

movements are also due to be taken in the US. Given the<br />

continuing state debt crisis in the eurozone and the greater<br />

dynamism of the economy in the US, the US dollar should<br />

gain in attractiveness against the euro.<br />

Insurance industry<br />

The conditions in the individual European and Asian<br />

markets where we are active are very varied. Therefore,<br />

this section will concentrate on the detailed development<br />

of the part of our business which takes place in our home<br />

market of Germany, as this is the main focus of our<br />

Company.<br />

Life insurance in 2013 and 2014<br />

The life insurance market is likely to continue to be a difficult<br />

environment in which to work because of the European<br />

state debt crisis and the period of low interest rates on the<br />

financial markets. It is not only the customer who is struggling<br />

to find attractive investment opportunities for good,<br />

secure old-age provision, but simply that the possibilities<br />

are very limited, even for us insurers. For this reason, almost<br />

all life insurers have lowered the bonus rates for customers<br />

for 2013. This step, in combination with the large amount<br />

of additional interest reserves (‘Zins zusatzreserve’) set up in<br />

<strong>2012</strong>, increases the stability of the industry.<br />

We believe that over the next few years we will continue<br />

to see demand for products which pay out in the form of a<br />

pension, both in the traditional form and as more modern<br />

unit-linked products. Security is important to people, so the<br />

significance of the guaranteed amounts unit-linked products<br />

offer will increase. The industry will probably increase its<br />

use of innovative investment opportunities in order to provide<br />

the guaranteed amounts and returns that customers<br />

expect. In addition, insurance against the risks of disability<br />

or long-term nursing care is expected to remain important.<br />

The German Insurance Association (GDV) forecasts a stable<br />

development in premium income in 2013. There is some<br />

uncertainty as concerns the level of demand to be expected<br />

for the new unisex tariff products.<br />

Private health insurance in 2013 and 2014<br />

The introduction of the new unisex tariffs has changed the<br />

basic components of our calculations for new business in<br />

private health insurance. Many companies are using this<br />

changeover to revise their tariffs and update their product<br />

range. Various companies, including <strong>ERGO</strong>, are reducing their<br />

technical interest rates for new business. This is another<br />

area where only time will tell how customers will react to<br />

the new products.<br />

The German Bundestag passed the Restructuring of Care<br />

Act (PNG) on 29 June <strong>2012</strong> which includes the introduction<br />

of state-supported supplementary long-term nursing care<br />

insurance. This sets out a state contribution of € 60 per year


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Management <strong>Report</strong>46<br />

Prospects<br />

to independent care provision schemes starting in 2013.<br />

Such state-supported schemes are subject to obligation to<br />

contract and do not take risk assessment or the exclusion<br />

of benefits into account.<br />

Growth in private health insurance should remain on par<br />

with previous year’s level.<br />

Property-casualty insurance in 2013 and 2014<br />

We project further stable growth in property-casualty<br />

insurance premium income. This projection is based on the<br />

assumption that private households’ and businesses’ situations<br />

will continue to improve despite the weak economy.<br />

We foresee a rise in motor insurance premiums due to poor<br />

combined ratios across the industry. The migration of portfolios<br />

towards higher no-claims classes and cheaper tariff<br />

groups is not expected to have a large effect. We do not<br />

foresee any large changes to our private property business.<br />

Growth will only be possible through the adjustment of<br />

premiums for inflation. Growth in commercial segments<br />

could be similar to that in private property. We forecast<br />

little growth in legal protection insurance since premium<br />

adjustments here are hardly possible. The consequences of<br />

the adjustments to the Lawyers’ Remuneration Act remain<br />

to be seen.<br />

All in all, property-casualty insurers can expect growth in<br />

premium income of around 2.5%.<br />

Performance of the <strong>ERGO</strong> Insurance <strong>Group</strong><br />

in 2013 and 2014<br />

The German life insurance industry remains a difficult<br />

environment because of historically low interest rates, and<br />

further development will largely depend on the volatile<br />

single-premium business. It remains to be seen whether<br />

customers will understand that the reduction of profit<br />

participation was necessary in order to ensure long-term<br />

security. However, we expect our new products to be<br />

successful.<br />

The adjustments we will be making to our private health<br />

insurance premiums on 1 April 2013 will be more marked<br />

than those in the previous year. The prices for new business<br />

will also increase significantly compared to last year<br />

which is largely due to the adjustment in the technical<br />

interest rate and the introduction of the unisex tariffs. New<br />

business may be affected by the price increases and by<br />

political debates on private health insurance. We expect<br />

further growth in supplementary insurance, partly owing<br />

to the introduction of the new state-subsidised long-term<br />

care insurance. Therefore, we believe that there will be a<br />

slight growth in premiums in this business sector.<br />

We are looking to achieve stable premium income in the<br />

area of German property-casualty insurance. We continue<br />

to attach great importance to risk commensurate prices,<br />

which in our business with commercial and industrial<br />

clients are not always attainable in the current market<br />

environment. On the other hand, there is still potential for<br />

us to make up some ground in motor insurance. We are<br />

making our plans based on us achieving a combined ratio<br />

under 95%.<br />

Our direct insurer should be able to again increase its<br />

gross premiums written in 2013. The driving force for this<br />

should once again be health insurance. As concerns total<br />

premiums, it must be noted that due to the interest rate<br />

situation, the development of our MaxiZins product cannot<br />

be accurately predicted.<br />

We wish to continue our risk-based and profit-based<br />

underwriting policy in travel insurance. Based on this, and<br />

the difficult economic situation in Europe, we forecast a<br />

slight reduction in premiums.<br />

We should return to growth in our international business in<br />

2013 despite no longer recording premiums for the South<br />

Korean <strong>ERGO</strong> Daum Direct, which we sold in the year under<br />

review. Our combined ratio should fall below 100%.<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> forecasts total premium income<br />

of about € 18.5 billion. Even in 2014, the adverse market<br />

conditions for life insurance will impede significant growth.<br />

We expect a <strong>Group</strong> profit of between € 350–450 million in<br />

2013. For 2014, this figure should rise slightly.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

48<br />

Consolidated Financial Statements<br />

Consolidated balance sheet as at 31 December <strong>2012</strong><br />

Assets<br />

A. Intangible assets<br />

Notes to the<br />

consolidated<br />

financial<br />

statements<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

I. Goodwill [1] p. 74 205.7 205.6<br />

II. Other intangible assets [2] p. 76 519.0 551.7<br />

B. Investments<br />

724.7 757.4<br />

I. Land and buildings, including buildings on third-party land [3] p. 78 2,270.8 2,347.1<br />

Thereof: held for sale − 11.1<br />

II. Investments in affiliated companies and associates [4] p. 79 528.2 543.6<br />

Thereof: associates accounted for using the equity method 441.9 410.6<br />

III. Loans [5] p. 79 54,373.3 53,214.6<br />

IV. Other securities [6] p. 80<br />

1. Held to maturity 7.3 13.4<br />

2. Available for sale 59,200.3 53,589.9<br />

3. At fair value through profit or loss 1,352.1 1,068.2<br />

60,559.7 54,671.6<br />

V. Other investments [7] p. 89 1,701.0 1,440.1<br />

119,433.0 112,217.0<br />

C. Investments for the benefit of life insurance policyholders<br />

who bear the investment risk 5,957.0 5,092.0<br />

D. Reinsurers’ share in technical provisions [8] p. 89 4,560.6 4,775.7<br />

E. Receivables<br />

I. Current tax receivables 231.6 257.5<br />

II. Other receivables [9] p. 90 4,422.0 4,332.2<br />

4,653.6 4,589.7<br />

F. Cash at banks, cheques and cash in hand 1,102.7 920.8<br />

G. Deferred acquisition costs [10] p. 91<br />

– Gross 6,362.9 6,413.7<br />

– Reinsurers’ share 224.5 249.7<br />

– Net 6,138.4 6,164.0<br />

H. Deferred tax assets [11] p. 91 2,401.0 2,506.1<br />

I. Other assets [12] p. 93 2,237.0 2,323.5<br />

Total assets 147,208.0 139,346.2


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements49<br />

Consolidated balance sheet as at 31 December <strong>2012</strong><br />

Equity and liabilities<br />

Notes to the<br />

consolidated<br />

financial<br />

statements<br />

A. Equity [13] p. 95<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

I. Issued capital and capital reserve 841.4 841.4<br />

II. Retained earnings 2,257.2 2,270.9<br />

III. Other reserves 1,065.1 211.5<br />

IV. Consolidated result attributable to <strong>ERGO</strong> equity holders 276.0 334.2<br />

V. Non-controlling interests 146.9 168.9<br />

4,586.7 3,826.8<br />

B. Subordinated liabilities [14] p. 97 1,045.1 1,041.7<br />

C. Gross technical provisions<br />

I. Unearned premiums [15] p. 97 1,869.9 1,833.8<br />

II. Provision for future policy benefits [16] p. 98 95,544.2 94,012.3<br />

III. Provision for outstanding claims [17] p. 99 8,049.4 7,561.8<br />

IV. Provision for premium refunds and policyholders’ dividends [18] p. 102 13,602.9 9,853.9<br />

V. Other technical provisions [19] p. 103 95.5 119.0<br />

119,161.9 113,380.8<br />

D. Gross technical provisions for life insurance policies where<br />

the investment risk is borne by the policyholders [20] p. 103 6,257.2 5,371.9<br />

E. Other accrued liabilities<br />

I. Provisions for post-employment benefits [21] p. 104 1,780.7 1,190.9<br />

II. Other provisions [22] p. 107 1,509.2 1,306.7<br />

F. Liabilities<br />

3,289.9 2,497.5<br />

I. Current tax liabilities 683.1 766.9<br />

II. Other liabilities [23] p. 108 9,362.3 9,677.6<br />

10,045.4 10,444.5<br />

G. Deferred tax liabilities [11] p. 91 2,821.8 2,783.0<br />

Total equity and liabilities 147,208.0 139,346.2


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

50<br />

Consolidated Financial Statements<br />

Consolidated income statement for<br />

the financial year <strong>2012</strong><br />

Notes to the<br />

consolidated<br />

<strong>2012</strong><br />

€ million<br />

2011 1<br />

€ million<br />

financial<br />

statements<br />

1. Gross premiums written [24] p. 110 17,091.3 18,518.7<br />

2. Earned premiums<br />

– Gross 17,041.4 18,335.3<br />

– Ceded share 1,002.2 1,004.0<br />

– Net 16,039.1 17,331.3<br />

3. Income from technical interest [25] p. 112 4,873.9 3,908.1<br />

4. Expenses for claims and benefits [26] p. 113<br />

– Gross 17,556.0 17,369.2<br />

– Ceded share 811.5 666.1<br />

– Net 16,744.4 16,703.1<br />

5. Operating expenses [27] p. 113<br />

– Gross 3,800.2 4,058.6<br />

– Ceded share 287.8 244.9<br />

– Net 3,512.3 3,813.6<br />

6. Technical result (2.–5.) 656.2 722.8<br />

7. Investment result [28] p. 114<br />

– Investment income 6,819.4 7,674.5<br />

– Investment expenses 1,557.7 3,558.5<br />

– Total 5,261.7 4,116.0<br />

Thereof: income from associates accounted for using the equity method 66.2 47.0<br />

8. Other operating income [29] p. 116 352.4 359.6<br />

9. Other operating expenses [29] p. 116 445.5 484.0<br />

10. Deduction of income from technical interest − 4,873.9 − 3,908.1<br />

11. Non-technical result (7.–10.) 294.8 83.5<br />

12. Operating result 951.0 806.3<br />

13. Other non-operating result [30] p. 116 − 503.3 − 315.2<br />

14. Impairment losses of goodwill [31] p. 116 − 21.4<br />

15. Finance costs [32] p. 116 81.8 65.8<br />

16. Taxes on income [33] p. 117 76.6 54.5<br />

17. Consolidated result 289.3 349.4<br />

Thereof:<br />

– Attributable to <strong>ERGO</strong> equity holders 276.0 334.2<br />

– Attributable to non-controlling interests 13.3 15.3<br />

1 Previous year’s figures adjusted pursuant to IAS 8, see chapter “Principles of presentation and consolidation”


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

51<br />

Consolidated Financial Statements<br />

Statement of recognised income and expense<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Consolidated result 289.3 349.4<br />

Currency translation<br />

Gains (losses) recognised in equity 41.3 − 35.4<br />

Included in the income statement 1 − 7.1 − 8.2<br />

Unrealised gains and losses on investments<br />

Gains (losses) recognised in equity 886.3 54.1<br />

Included in the income statement 1 − 57.8 − 59.9<br />

Change resulting from valuation at equity<br />

Gains (losses) recognised in equity − 0.7 −<br />

Included in the income statement 1 − −<br />

Change resulting from cash flow hedges<br />

Gains (losses) recognised in equity − 0.3 1.5<br />

Included in the income statement 1 0.7 5.4<br />

Actuarial gains and losses on defined benefit plans − 348.1 31.5<br />

Other changes 5.6 − 8.4<br />

Income and expense recognised directly in equity 519.9 − 19.4<br />

Total recognised income and expense 809.2 330.1<br />

Thereof:<br />

− Attributable to <strong>ERGO</strong> equity holders 795.3 319.3<br />

− Attributable to non-controlling interests 13.9 10.8<br />

1 Consolidated income statement


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

52<br />

Consolidated Financial Statements<br />

<strong>Group</strong> statement of changes in equity<br />

Development of equity<br />

Issued capital and<br />

capital reserve<br />

Equity attributable<br />

to <strong>ERGO</strong> equity holders<br />

Retained earnings<br />

€ million € million<br />

Status at 31 December 2010 841.4 2,170.0<br />

Allocation to retained earnings − 343.8<br />

Consolidated result − −<br />

Income and expense recognised directly in equity − 28.9<br />

Currency translation − −<br />

Unrealised gains and losses on investments − −<br />

Change resulting from valuation at equity − −<br />

Change resulting from hedges − −<br />

Actuarial gains and losses on defined benefit plans − 29.4<br />

Other changes − − 0.5<br />

Total recognised income and expense − 28.9<br />

Change in shareholdings in subsidiaries − − 1.5<br />

Change in consolidated group − −<br />

Dividend − − 270.3<br />

Status at 31 December 2011 841.4 2,270.9<br />

Allocation to retained earnings − 334.2<br />

Consolidated result − −<br />

Income and expense recognised directly in equity − − 334.3<br />

Currency translation − −<br />

Unrealised gains and losses on investments − −<br />

Change resulting from valuation at equity − − 0.7<br />

Change resulting from hedges − −<br />

Actuarial gains and losses on defined benefit plans − − 340.2<br />

Other changes − 6.6<br />

Total recognised income and expense − − 334.3<br />

Change in shareholdings in subsidiaries − − 13.6<br />

Change in consolidated group − −<br />

Dividend − −<br />

Status at 31 December <strong>2012</strong> 841.4 2,257.2


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements53<br />

<strong>Group</strong> statement of changes in equity<br />

Equity attributable<br />

to <strong>ERGO</strong> equity holders<br />

Non-controlling<br />

interests<br />

Total equity<br />

Other reserves<br />

Consolidated<br />

Unrealised gains<br />

and losses<br />

Reserve from<br />

currency translation<br />

Valuation result<br />

from hedges<br />

result<br />

€ million € million € million € million € million € million<br />

323.2 − 65.9 − 2.1 343.8 175.0 3,785.4<br />

− − − − 343.8 − −<br />

− − − 334.2 15.3 349.4<br />

− 5.7 − 44.9 6.8 − − 4.5 − 19.4<br />

− − 44.9 − − 1.3 − 43.6<br />

− 5.7 − − − − 0.1 − 5.8<br />

− − − − − −<br />

− − 6.8 − 0.1 6.9<br />

− − − − 2.1 31.5<br />

− − − − − 7.9 − 8.4<br />

− 5.7 − 44.9 6.8 334.2 10.8 330.1<br />

− − − − − 0.6 − 2.1<br />

− − − − − 11.1 − 11.1<br />

− − − − − 5.2 − 275.4<br />

317.5 − 110.7 4.7 334.2 168.9 3,826.8<br />

− − − − 334.2 − −<br />

− − − 276.0 13.3 289.3<br />

818.9 34.2 0.5 − 0.6 519.9<br />

− 34.2 − − − 34.2<br />

818.9 − − − 9.6 828.5<br />

− − − − − − 0.7<br />

− − 0.5 − − 0.1 0.4<br />

− − − − − 7.9 − 348.1<br />

− − − − − 1.0 5.6<br />

818.9 34.2 0.5 276.0 13.9 809.2<br />

− − − − − 33.0 − 46.6<br />

− − − − − −<br />

− − − − − 2.8 − 2.8<br />

1,136.4 − 76.5 5.2 276.0 146.9 4,586.7


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

54<br />

Consolidated Financial Statements<br />

Consolidated cash flow statement<br />

for the financial year <strong>2012</strong><br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Consolidated result 289.3 349.4<br />

Net change in technical provisions 4,123.0 2,658.1<br />

Change in deferred acquisition costs 48.1 49.2<br />

Change in deposits retained and accounts receivable and payable − 77.4 − 153.0<br />

Change in other receivables and liabilities − 407.5 − 1,747.4<br />

Gains and losses on the disposal of investments − 34.9 − 708.1<br />

Change in securities held for trading − 99.6 − 44.2<br />

Change in other balance sheet items 684.3 23.1<br />

Other income/expenses without impact on cash flow − 806.0 1,462.8<br />

I. Cash flows from operating activities 3,719.2 1,890.0<br />

Inflows from losing control of consolidated subsidiaries 12.2 951.4<br />

Outflows from obtaining control of consolidated subsidiaries − − 24.0<br />

Change from the acquisition, sale and maturities of other investments − 3,148.6 − 3,138.0<br />

Change from the acquisition and sale of investments for unit-linked life insurance − 361.6 − 489.4<br />

Other 6.6 14.9<br />

II. Cash flows from investing activities − 3,491.4 − 2,685.1<br />

Inflows from increases in capital and from non-controlling interests − −<br />

Outflows to ownership interests and non-controlling interests − 42.6 − 35.1<br />

Dividend payments − 2.8 − 275.4<br />

Change from other financing activities − 34.8 607.0<br />

III. Cash flows from financing activities − 80.2 296.4<br />

Cash flows for the financial year (I. + II. + III.) 147.5 − 498.6<br />

Effect of exchange rate changes on cash 34.4 − 20.2<br />

Cash at the beginning of the financial year 920.8 1,439.5<br />

Cash at the end of the financial year 1,102.7 920.8<br />

Additional information:<br />

Income tax paid (net) − 225.6 − 139.4<br />

Interest paid 321.9 368.5<br />

Interest received 4,391.2 4,632.5<br />

Dividends received 157.8 195.6


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

55<br />

Consolidated
Financial Statements<br />

Principles of presentation and consolidation<br />

International accounting rules<br />

The consolidated financial statements of <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> were prepared on the basis of Section 315 a para. 3<br />

of the HGB (German Commercial Code) in conjunction with<br />

Section 315 a, para. 1 of the HGB as well as in conjunction<br />

with Article 4 of the Regulation (EC) no. 1606/2002 of the<br />

European Parliament and Council of 19 July 2002 concerning<br />

the application of international accounting standards.<br />

The international accounting standards stated in Articles 2,<br />

3 and 6 of the aforementioned Regulation were observed,<br />

as well as the rules designated in Section 315 a, para. 1<br />

of the HGB. The consolidated financial statements also<br />

comply with all requirements as laid down by the IFRS.<br />

The standards adopted by the International Accounting<br />

Standards Board (IASB) have been referred to as “International<br />

Financial <strong>Report</strong>ing Standards” (IFRS) since 2002;<br />

the standards from previous years continue to be referred to<br />

as “International Accounting Standards” (IAS).<br />

The underwriting items are recognised and measured in<br />

accordance with the regulations governing IFRS 4 (as it<br />

was initially applied on 1 January 2005) on the basis of<br />

US GAAP (United States Generally Accepted Accounting<br />

Principles).<br />

Consolidated group<br />

In accordance with IAS 27, the consolidated financial statements<br />

include <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> ( parent company)<br />

and all entities where <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

owns, directly or indirectly, the majority of the voting rights<br />

or where it has the actual ability to control ( subsidiaries).<br />

Special purpose entities, such as special funds, are included<br />

in the consolidated financial statements according to SIC 12<br />

if, from an economic point of view, they are controlled by<br />

<strong>ERGO</strong>.<br />

Following a licence issued by the relevant regulatory<br />

authorities in April <strong>2012</strong>, <strong>ERGO</strong> Insurance <strong>Group</strong>, together<br />

with the Shandong State-owned Assets Investment Holding<br />

Company (SSAIH), commenced the set-up of the company<br />

<strong>ERGO</strong> China Life Insurance Co., Ltd., Jinan, Shandong<br />

Province. This is intended primarily to provide life insurance<br />

to private customers in the Chinese province of Shandong.<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> and SSAIH both own half of the<br />

shares in the new company. Business operations are likely<br />

to commence in the first half of 2013, provided that further<br />

approval has been obtained by the authorities there.<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> signed an agreement with the<br />

Avantha <strong>Group</strong> in India on 1 November <strong>2012</strong> to set up a<br />

joint venture. The new company will provide life insurance<br />

for private customers. The registered offices of the<br />

future “Avantha <strong>ERGO</strong> Life Insurance Company” will be<br />

based in Mumbai. Business is due to start early in 2014<br />

provided that the authorities have issued the licence. <strong>ERGO</strong><br />

Insurance <strong>Group</strong> will initially have a 26% stake in the new<br />

company.<br />

In the first quarter of <strong>2012</strong> <strong>ERGO</strong> Insurance <strong>Group</strong> took the<br />

decision to sell its fully consolidated subsidiary San Marino<br />

Life Impresa sammarinese di assicurazione sulla vita<br />

S. p. A., San Marino. An agreement concerning the sale of<br />

the company with economic effect as of July <strong>2012</strong> was<br />

signed in the second quarter of <strong>2012</strong>; the sales price was<br />

€ 5 million.<br />

In the second quarter of <strong>2012</strong> <strong>ERGO</strong> Insurance <strong>Group</strong><br />

disposed of its shares, with economic effect as of October<br />

<strong>2012</strong>, in its fully consolidated subsidiary <strong>ERGO</strong> Daum Direct<br />

General Insurance Co. Ltd., Seoul. The disposal of the company<br />

resulted in a loss of € 25.2 million, which was recorded<br />

under investment results in the <strong>Group</strong>’s income statement.<br />

In addition, a loss of € 6.9 million, which was contained<br />

income and expense recognised directly in equity, was to<br />

be reclassified from other reserves to other non-operating<br />

result.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements56<br />

Principles of presentation and consolidation<br />

The following table shows the cash flows and net<br />

assets resulting from the takeover and loss of control of<br />

consolidated subsidiaries or other operations:<br />

Net assets obtained <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Goodwill − −<br />

Other intangible assets − −<br />

Investments − 33.0<br />

Cash − 1.7<br />

Other assets − 1.0<br />

Technical provisions (net) − −<br />

Other liabilities − − 0.1<br />

Total − 35.6<br />

Cash flows arising from obtaining control <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Total consideration for obtaining control − − 25.7<br />

Non-cash consideration for obtaining control − −<br />

Cash consideration for obtaining control − − 25.7<br />

Cash over which control was obtained − 1.7<br />

Total − − 24.0<br />

Net assets lost <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Goodwill − 49.5<br />

Other intangible assets 3.6 13.6<br />

Investments 216.3 1,955.2<br />

Cash 1.1 62.6<br />

Other assets 33.6 405.0<br />

Technical provisions (net) − 188.8 − 1,596.6<br />

Other liabilities − 27.3 − 521.8<br />

Total 38.6 367.4<br />

Cash flows arising from losing control <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Total consideration for losing control 13.4 1,045.7<br />

Non-cash consideration for losing control − −<br />

Cash consideration for losing control 13.4 1,045.7<br />

Cash over which control was lost − 1.1 − 94.2<br />

Total 12.2 951.4<br />

Number of consolidated subsidiaries 1 Germany International Total<br />

Development during the financial year<br />

31 December previous year 63 98 161<br />

Additions 3 3 6<br />

Reductions 2 − 10 10<br />

31 December financial year 66 91 157<br />

1 In addition, 36 German and 2 international special funds were included in the consolidated group.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements57<br />

Principles of presentation and consolidation<br />

Number of companies valued at equity Germany International Total<br />

Development during the financial year<br />

31 December previous year 19 13 32<br />

Additions 2 1 3<br />

Reductions − 1 1<br />

31 December financial year 21 13 34<br />

A list of the entire shareholdings is available in the Section<br />

entitled “List of shareholdings as at 31 December <strong>2012</strong> in<br />

accordance with Section 313, para. 2 of the German Commercial<br />

Code (HGB)”.<br />

Consolidation methods<br />

The annual financial statements of subsidiaries and special<br />

purpose entities incorporated into the <strong>Group</strong> are subject to<br />

standard accounting and valuation methods. As a general<br />

rule, the balance sheet cut-off date of companies included<br />

in the consolidated financial statements is 31 December.<br />

Some special funds have other balance sheet dates; these<br />

funds are consolidated on 31 December on the basis of<br />

interim financial statements.<br />

The consolidation of capital is done using the purchase<br />

method. In order to determine the equity capital at the<br />

time of acquisition, the assets and liabilities of the subsidiary<br />

or special fund are measured at fair value. The<br />

considera tion transferred in exchange for the acquired<br />

shares is netted against the equity capital apportionable to<br />

the <strong>Group</strong> at the time of acquisition; any residual positive<br />

amount is capitalised as goodwill.<br />

Profits earned by subsidiaries or special purpose entities<br />

after their first consolidation are included in <strong>Group</strong> equity.<br />

Receivables and liabilities as well as income and expenses<br />

relating to intra-<strong>Group</strong> transactions are eliminated insofar<br />

as they are not of minor importance.<br />

Pursuant to IAS 28, associates are generally all entities<br />

which are not subsidiaries or joint ventures and where<br />

there is the opportunity of exercising substantial influence<br />

on the business or financial policy.<br />

In case of participating interests of between 20% and 50%<br />

of the voting rights, the entities in question are deemed to<br />

be associated companies unless it can be clearly demonstrated<br />

that there is no significant influence.<br />

Recognition and measurement<br />

Use of judgement and estimates in recognition<br />

and measurement<br />

In the course of preparing the consolidated financial<br />

statements we have to use our judgement in applying<br />

accounting and valuation methods and to make estimates<br />

and assumptions. These affect the year-end items shown<br />

in the consolidated balance sheet, the consolidated<br />

income statement and disclosures of contingent assets<br />

and liabilities.<br />

The use of estimates is of utmost importance for technical<br />

provisions, since the valuation is based constantly on<br />

models and the trend in future cash flows of insurance<br />

policies is not entirely predictable. Nevertheless, arbitrary<br />

decisions and estimates also play an essential role with<br />

other items.<br />

Our internal processes are geared to determine amounts<br />

as accurately as possible, taking into account all the<br />

relevant information. Determination of these values is<br />

based on management’s best knowledge regarding the<br />

respective facts on the balance sheet date. Nevertheless, it<br />

is in the nature of these items that estimates may have to<br />

be adjusted over the course of time to take account of new<br />

knowledge.<br />

Owing to the uncertainties surrounding estimates any<br />

discretionary judgements also contain a subjective component.<br />

This may result in comparable items being measured<br />

differently by <strong>ERGO</strong> Insurance <strong>Group</strong> and another company,<br />

especially as the range of realistic assumptions can differ<br />

tremendously in individual cases. However, this does<br />

not mean that the valuation has not been done properly –<br />

merely that it reflects differing knowledge and assessments<br />

of future developments.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements58<br />

Principles of presentation and consolidation<br />

Discretionary judgements and estimates are of particular<br />

significance for the following items and are described in<br />

more detail in the respective explanatory notes:<br />

• Goodwill and other intangible assets<br />

• Fair values and impairments of financial instruments<br />

• Deferred acquisition costs<br />

• Technical provisions<br />

• Pension provisions<br />

• Deferred tax<br />

• Contingent liabilities<br />

Currency of the report<br />

The currency of the report is the euro (€). Figures are shown<br />

in millions of euros, and shown with figures after the decimal<br />

point. Figures in brackets refer to the previous year.<br />

Figures for previous year<br />

Changes in line with the provisions governing IAS 8 and<br />

the modification in calculating the technical interest made<br />

it necessary to make adjustments retrospectively to the<br />

consolidated income statement for the 2011 financial year<br />

and the corresponding items in the Notes to the consolidated<br />

financial statements, see section on “Changes in accounting<br />

policies”. Otherwise, last year’s figures were determined<br />

in the same way as for those in the <strong>2012</strong> financial year.<br />

Changes in accounting policies<br />

Application of the recognition, measurement and disclosure<br />

methods follows the principle of consistency. In the financial<br />

year <strong>2012</strong>, the following new IFRSs had to be applied for<br />

the first time:<br />

The amendments to IFRS 7 (rev. 10/2010), Financial Instruments:<br />

Disclosures, Improving Disclosures about Financial<br />

Instruments, contain more extensive disclosure requirements<br />

regarding the transfer of financial assets. The aim<br />

of these amendments is to make more transparent the<br />

influence of such transactions on the entity’s risk exposure<br />

and hence its financial situation. This change currently has<br />

no practical relevance for <strong>ERGO</strong>.<br />

The amendments to IAS 12 (rev. 12/2010), Taxes on Income,<br />

Deferred Tax: Recovery of Underlying Assets, address the<br />

issue that the measurement of deferred tax items depends<br />

on whether the carrying amount of an asset is expected<br />

to be recovered through use or through sale. In practice,<br />

the two are often difficult to distinguish. The amendments<br />

provide a solution through the introduction of a rebuttable<br />

presumption that recovery of the carrying amount will<br />

normally be through sale. These amendments are mandatory<br />

for financial years beginning on or after 1 January<br />

<strong>2012</strong>, and were adopted into EU law in December <strong>2012</strong>. As<br />

the clarification currently has no practical significance for<br />

<strong>ERGO</strong>, no consequences resulted from this delay.<br />

Our method of calculating technical interest has been<br />

modified in the primary insurance segments since <strong>2012</strong>.<br />

This particularly affects the life insurance business. In<br />

addition to the components used hitherto, the deposits<br />

retained on ceded business are now also taken into<br />

account as a basis for the technical interest. Thus the<br />

portion of investment income that corresponds to the<br />

deposit interest expense is included as a new component in<br />

the calculation of the technical interest and reallocated to<br />

the technical result. Pursuant to IAS 8.22, the modification<br />

has been applied with retroactive effect and the previous<br />

year’s figures have been adjusted accordingly. This change<br />

provides for a more accurate presentation of the technical<br />

result. As a result of the change, the income from technical<br />

interest in the financial year <strong>2012</strong> is higher than it would<br />

have been under the previous method. It is impracticable<br />

to determine the exact increase for the current period, but<br />

there was an increase of € 55.3 m for the same period last<br />

year, which includes the effect from the retroactive adjustment<br />

of a consolidated entry. In addition, the estimate<br />

for policyholders’ bonuses has been refined and has been<br />

used pursuant to IAS 8.32 as from <strong>2012</strong> for future periods.<br />

This adjustment has no effect on the consolidated balance<br />

sheet.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements59<br />

Principles of presentation and consolidation<br />

Consolidated income statement 2011<br />

as originally<br />

Changes from<br />

adjustments<br />

2011<br />

adjusted<br />

recognised pursuant to IAS 8<br />

1. Gross premiums written 18,639.2 − 120.4 18,518.7<br />

2. Earned premiums<br />

– Gross 18,455.7 − 120.4 18,335.3<br />

– Ceded share 1,004.0 − 1,004.0<br />

– Net 17,451.8 − 120.4 17,331.3<br />

3. Income from technical interest 3,852.8 55.3 3,908.1<br />

4. Expenses for claims and benefits<br />

– Gross 17,489.6 − 120.4 17,369.2<br />

– Ceded share 666.1 − 666.1<br />

– Net 16,823.5 − 120.4 16,703.1<br />

6. Technical result (2.–5.) 667.4 55.3 722.8<br />

10. Deduction of income from technical interest − 3,852.8 − 55.3 − 3,908.1<br />

11. Non-technical result (7.–10.) 138.9 − 55.3 83.5<br />

The net level premiums for the products of our foreign<br />

subsidiaries that fall under FAS 97 were previously shown<br />

in accordance with local accounting regulations. We have<br />

now recognised these net level premiums as a deposit,<br />

without impact on profit or loss, in accordance with the<br />

rules of FAS 97. Pursuant to IAS 8.41, the modification<br />

has been applied with retroactive effect and the previous<br />

year’s figures have been adjusted accordingly. This adjustment<br />

has no effect on the consolidated balance sheet. The<br />

adjustment made to insurance benefits mainly concerns<br />

the change within the provision for future policy benefits in<br />

addition to payments for insured incidents.<br />

The table lists the effects on the consolidated income<br />

statement for the 2011 financial year.<br />

Standards not yet in force and changes to standards<br />

All standards or changes in standards that have not yet<br />

entered into force will be applied by <strong>ERGO</strong> for the first time<br />

as from the mandatory effective date for entities domiciled<br />

in the European Union.<br />

Under the amendment to IAS 1 (rev. 06/2011), Presentation<br />

of Financial Statements, Presentation of Items of Other<br />

Comprehensive Income, “other comprehensive income”<br />

must now be divided into items that will be reclassified to<br />

profit or loss at a later date and items that will not. The<br />

purpose of this amendment is to improve the presentation<br />

of these items and align the approaches under IFRS and US<br />

GAAP. The amendments are mandatory for financial years<br />

beginning on or after 1 July <strong>2012</strong>, and were adopted into<br />

EU law in June <strong>2012</strong>.<br />

Unless mentioned separately below, the following standards<br />

are mandatory for financial years beginning on or<br />

after 1 January 2013. Only the amendments published<br />

as part of the IFRS <strong>Annual</strong> Improvement Process and the<br />

revised IFRS 9, Financial Instruments, as well as the related<br />

changes to the group-specific standards (IFRS 10, IFRS 11,<br />

IFRS 12 and IAS 27) have not yet been adopted into European<br />

law. The other standards were adopted in June or<br />

December <strong>2012</strong>.<br />

IFRS 9 (11/2009 and rev. 10/2010), Financial Instruments,<br />

replaces the current requirements of IAS 39 relating to recognition<br />

and measurement of financial instruments. Given<br />

its complexity, the overall project has been subdivided into<br />

three phases. The new rules in IFRS 9 that have thus far<br />

been adopted from the first phase of the project mainly<br />

concern the classification and measurement of financial<br />

instruments. Under these rules, financial assets will in<br />

future be divided into only two primary measurement categories:<br />

amortised cost and fair value through profit or loss.<br />

The distinction is to be made on the basis of the reporting<br />

entity’s business model and the contractual cash flows of<br />

the assets. In addition, for equity instruments there will be<br />

the option of measurement at fair value without affecting<br />

the income statement, although then it will not be permissible<br />

for value changes recognised in other comprehensive


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements60<br />

Principles of presentation and consolidation<br />

income to be subsequently transferred to profit or loss.<br />

There also remains the possibility of voluntary measurement<br />

at fair value (fair value option). For financial liabilities,<br />

there are no changes in the measurement rules except<br />

that if the fair value option is applied, value changes<br />

attribut able to a change in the entity’s credit risk must be<br />

recognised without impact on profit or loss in future.<br />

The two other phases of the project are concerned with<br />

rules for recognising impairments and for hedge accounting.<br />

While the discussion regarding hedge accounting has<br />

practically been concluded and the new rules are to be<br />

integrated into IFRS 9 in the short term, the IASB will first<br />

be publishing another exposure draft for the rules regarding<br />

recognition of impairments.<br />

Besides this, in November <strong>2012</strong>, the IASB published an<br />

exposure draft providing for a further change in the new<br />

measurement rules. This is designed to make it possible to<br />

continue measuring certain debt instruments at fair value<br />

without impact on profit or loss, depending on the contractual<br />

cash flows and an additionally defined business model<br />

that contains an intention to sell.<br />

Originally, IFRS 9 envisaged that the new provisions would<br />

be mandatorily effective as from 2013. Since discussions<br />

of the still outstanding project phases are taking longer<br />

than originally planned, the mandatory effective date<br />

of a standard amending IFRS 9 and IFRS 7 (rev. 12/2011)<br />

has been deferred to financial years beginning on or after<br />

1 January 2015.<br />

IFRS 10 (05/2011), Consolidated Financial Statements,<br />

supersedes the provisions of IAS 27 and SIC 12 and creates<br />

a uniform definition for control, irrespective of whether<br />

this control is based on company law or on contractual or<br />

economic circumstances. There are no longer independent<br />

provisions for structured entities (special purpose entities).<br />

A situation of control exists when an investor has the ability<br />

to direct an investee’s relevant activities and is exposed<br />

to the returns from those activities. Furthermore, IFRS 10<br />

addresses issues that have not been dealt with until now,<br />

including the regulation that a situation of control exists<br />

even if an investor holds less than a majority of the voting<br />

rights but regularly has a de facto majority of voting rights<br />

at the annual general meetings. The effects of the new<br />

standard on <strong>ERGO</strong>’s consolidated companies are currently<br />

being reviewed.<br />

IFRS 11 (05/2011), Joint Arrangements, defines joint operations<br />

and joint ventures and specifies how they are to be<br />

recognised in the balance sheet. The changes compared<br />

with IAS 31, Interest in Joint Ventures, mainly concern the<br />

elimination of the option of proportionate consolidation<br />

for joint ventures, the amended definition of joint control,<br />

and the extended scope of application of joint operations.<br />

These may now include arrangements structured through<br />

a separate vehicle. The elimination of the option of proportionate<br />

consolidation will have no impact on <strong>ERGO</strong>, as we<br />

do not avail ourselves of this option and already apply the<br />

equity method. The effects of the two other changes are<br />

currently being analysed.<br />

IFRS 12 (05/2011), Disclosure of Interests in Other Entities,<br />

combines the disclosures regarding facts and circumstances<br />

governed by IFRS 10, 11 and IAS 28. The objective<br />

of the standard is to provide information on the type and<br />

risk of interests in other entities and their implication for<br />

the consolidated financial statements. As a consequence,<br />

the information provided needs to be more comprehensive<br />

than hitherto. In particular, IFRS 12 requires disclosures<br />

relating to unconsolidated structured entities, non-controlling<br />

interests, discretionary judgements and assumptions<br />

in evaluating the nature of interests in other entities,<br />

as well as detailed information on each significant joint<br />

arrangement. The precise extent to which <strong>ERGO</strong> is affected<br />

by the extended disclosure requirements is currently being<br />

examined.<br />

IAS 27 (rev. 05/2011), Separate Financial Statements, now<br />

deals only with balance sheet recognition of investments<br />

in subsidiaries, joint ventures and associates in separate<br />

single-entity financial statements in accordance with IFRS,<br />

including the relevant disclosures in the notes. The definition<br />

of control, and balance sheet recognition of subsidiaries<br />

in consolidated financial statements is now regulated<br />

by IFRS 10. The standard has no effect on <strong>ERGO</strong>, as the provisions<br />

for single-entity financial statements in accordance<br />

with IFRS have remained unchanged.<br />

IAS 28 (rev. 05/2011), Investments in Associates and Joint<br />

Ventures, specifically includes amendments following<br />

from the publication of IFRS 11 and IFRS 12. Among other<br />

things, the standard integrates the balance sheet recognition<br />

of joint ventures and circumstances previously governed<br />

by SIC 13, Jointly Controlled Entities – Non-Monetary<br />

Contributions by Venturers. Furthermore, investments in


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements61<br />

Principles of presentation and consolidation<br />

associates or joint ventures held by open-ended investment<br />

funds or for unit-linked insurance, for example, are<br />

no longer excluded from the standard’s scope of application.<br />

Rather, there is now an option to measure these at<br />

fair value with impact on profit or loss. The amendments<br />

do not have any major implications for <strong>ERGO</strong>.<br />

As mandated by the IASB, application of IFRS 10, IFRS 11<br />

and IFRS 12 and the amendments to IAS 27 and IAS 28<br />

would be mandatory for financial years beginning on or<br />

after 1 January 2013. When the standards were adopted<br />

into European law, the mandatory effective date was<br />

deferred by one year, so that the standards concerned<br />

have to be applied for the first time by entities domiciled<br />

in the European Union for financial years beginning on or<br />

after 1 January 2014; voluntary application before that<br />

date is permitted.<br />

In June <strong>2012</strong>, the IASB adopted IFRS Consolidated Financial<br />

Statements, Joint Arrangements, and Disclosure of Interests<br />

in Other Entities – Transition Guidance (Amendments<br />

to IFRS 10, IFRS 11 and IFRS 12) (06/<strong>2012</strong>), which clarifies<br />

that the requirement to provide adjusted comparative<br />

information on first-time application is limited to the<br />

preceding comparative period only. Insofar as first-time<br />

application does not result in any change in the need to<br />

consolidate an entity at the date of first-time application,<br />

no adjusted comparative information for prior periods<br />

is necessary. In addition, the requirement to provide<br />

adjusted comparative information for prior periods is<br />

removed for unconsolidated structured entities. The effects<br />

of the changes on <strong>ERGO</strong> are currently being analysed.<br />

The amendments are generally mandatory for financial<br />

years beginning on or after 1 January 2013. However, we<br />

expect that when they are adopted into European law, the<br />

mandatory effective date in the European Union will be<br />

deferred by one year for these amendments as well.<br />

The IFRS Investment Entities (Amendments to IFRS 10,<br />

IFRS 12 and IAS 27) (10/<strong>2012</strong>) introduces a definition of the<br />

term “investment entities” and specifies that such entities<br />

are generally excepted from the requirement to consolidate<br />

their subsidiaries in future. Rather, they are required<br />

to measure them at fair value through profit or loss. The<br />

exception from the consolidation requirement does not<br />

apply to parents of investment entities that are not themselves<br />

investment entities. Besides this, additional disclosure<br />

requirements for investment entities are provided<br />

for. The amendments, whose application is mandatory for<br />

financial years beginning on or after 1 January 2014, are<br />

not relevant for <strong>ERGO</strong>.<br />

IFRS 13 (05/2011), Fair Value Measurement, provides guidance<br />

on measuring items at fair value if another standard<br />

prescribes fair value measurement or fair value disclosure<br />

in the notes to the financial statements. The standard thus<br />

does not determine what items need to be measured at<br />

fair value. IFRS 13 revises the definition of fair value, defining<br />

it as the price that would be received to sell an asset or<br />

paid to transfer a liability in an orderly transaction between<br />

market participants at the measurement date. The standard<br />

includes detailed information on how to determine<br />

the fair value for different types of assets and liabilities. In<br />

addition, the standard requires further disclosures in the<br />

notes – for instance, the fair value hierarchy thus far only<br />

required for financial instruments under IFRS 7 has now<br />

been extended to include all items measured at fair value.<br />

On the basis of IFRS 13, we have verified whether <strong>ERGO</strong>’s<br />

fair value measurement is in compliance with the new<br />

provisions, and we will make any adjustments in measurement<br />

necessary. The new disclosures in the notes also<br />

need to be implemented.<br />

The amendments published as part of the IFRS <strong>Annual</strong><br />

Improvement Process in May <strong>2012</strong> concern IFRS 1, Firsttime<br />

Adoption of International Financial <strong>Report</strong>ing Standards,<br />

which as such is not relevant for <strong>ERGO</strong>, as well as<br />

IAS 1, Presentation of Financial Statements, IAS 16, Property,<br />

Plant and Equipment, IAS 32, Financial Instruments:<br />

Presentation, and IAS 34, Interim Financial <strong>Report</strong>ing,<br />

and the knock-on change in the interpretation IFRIC 2,<br />

Members’ Shares in Co-operative Entities and Similar<br />

Instruments. Only the amendment to IAS 1, Presentation<br />

of Financial Statements, is of practical significance<br />

for <strong>ERGO</strong>, and this simplifies the rules currently in place.<br />

Where a retro spective change in accounting policies or a<br />

retrospective adjustment or reallocation of items under<br />

IAS 8 requires publication of a binding third comparative<br />

balance sheet, it is no longer necessary to make the<br />

relevant disclosures in the notes.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements62<br />

Principles of presentation and consolidation<br />

As a result of the amendments to IAS 19 (rev. 06/2011),<br />

Employee Benefits, the option for deferring the recognition<br />

of actuarial gains and losses, in particular the “corridor<br />

approach”, has been eliminated. These gains and losses<br />

must now be recognised in equity with no effect on profit<br />

or loss. Furthermore, the past service cost for retroactive<br />

changes in a defined benefit plan is to be immediately<br />

recognised in the income statement. The return on plan<br />

assets is now to be determined on the basis of the rate<br />

used to discount the present value of defined benefit obligations.<br />

The administrative costs and taxes payable by<br />

the plan are to be deducted from the return. The requirements<br />

regarding the asset ceiling have been integrated<br />

and further specified. Moreover, additional disclosures in<br />

the notes are required, e. g. analysing pension obligations<br />

in terms of their risks and sensitivities for the actuarial<br />

assumptions. The amendments will not have any major<br />

effects on <strong>ERGO</strong>. The extended disclosures in the notes<br />

need to be implemented.<br />

The amendments to IAS 32 (rev. 12/2011), Financial<br />

Instruments: Presentation – Offsetting Financial Assets<br />

and Financial Liabilities, and IFRS 7 (rev. 12/2011), Financial<br />

Instruments: Disclosures – Offsetting Financial Assets and<br />

Financial Liabilities, clarify some issues in relation to the<br />

admissibility of offsetting financial assets and financial<br />

liabilities. They also require additional disclosures in the<br />

notes to the financial statements. These additional disclosures<br />

comprise gross and net amounts related to offsetting<br />

as well as amounts for existing rights to offset that<br />

do not satisfy the offsetting criteria. The new disclosures<br />

are mandatory for annual periods beginning on or after<br />

1 January 2013 and the clarifications for annual periods<br />

beginning on or after 1 January 2014. We are currently<br />

proceeding on the assumption that these changes will<br />

have no practical significance for <strong>ERGO</strong>.<br />

IFRIC Interpretation 20 (10/2011), Stripping Costs in the<br />

Production Phase of a Surface Mine, clarifies when production<br />

stripping should lead to the recognition of an asset<br />

and how that asset should be measured, both initially and<br />

in subsequent periods. This interpretation has no practical<br />

relevance for <strong>ERGO</strong>.<br />

Non-current assets and disposal groups classified as<br />

“held for sale” and sold in the reporting period<br />

Non-current assets and disposal groups classified as “held<br />

for sale” are recognised at the lower of carrying amount or<br />

fair value less sales cost and shown separately on the consolidated<br />

balance sheet.<br />

In the fourth quarter of 2011 we sold, with economic<br />

impact in March <strong>2012</strong>, an investment property used by a<br />

third party with a carrying value of € 11,1 million. The sales<br />

price was € 51.9 million.<br />

We sold interests in fully consolidated subsidiaries during<br />

the <strong>2012</strong> financial year. For further details concerning<br />

these transactions, please refer to the Notes on the scope<br />

of consolidation on page 55.<br />

Assets<br />

Intangible assets<br />

Goodwill resulting from the first-time consolidation of<br />

subsidiaries is tested for impairment at least annually,<br />

in accordance with IAS 36. We additionally carry out adhoc<br />

impairment tests if there are indications of impairment.<br />

For impairment testing, the goodwill is allocated to<br />

the cash-generating units or groups of cash-generating<br />

units expected to derive benefit from the synergies of the<br />

business combination. To ascertain whether there is any<br />

impairment, the carrying amount (including allocated<br />

goodwill) of a cash-generating unit or a group of cashgenerating<br />

units is compared with that unit’s or group’s<br />

recoverable amount. The recoverable amount is the greater<br />

of the fair value less costs to sell and the value in use. If<br />

this recoverable amount is lower than the carrying amount,<br />

a write-down is made on the goodwill. If the amount of<br />

the impairment of a cash-generating unit or group of cashgenerating<br />

units is greater than the carrying amount of the<br />

goodwill allocated, the difference is generally allocated pro<br />

rata between the other relevant assets of the unit or group<br />

of units on the basis of their carrying amounts. However,<br />

the carrying amount may not be reduced below the highest<br />

of fair value less costs to sell, the value in use, and zero.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements63<br />

Principles of presentation and consolidation<br />

The other intangible assets mainly comprise acquired<br />

insurance portfolios, acquired and self-developed software,<br />

and acquired sales networks and client bases.<br />

Acquired insurance portfolios are recognised at their<br />

present value on acquisition (PVFP – present value of<br />

future profits). This is determined as the present value of<br />

expected profits from the portfolio acquired, without consideration<br />

of new business and tax effects. The acquired<br />

insurance portfolios are amortised in accordance with<br />

the realisation of the profits from the insurance portfolios<br />

underlying the PVFP calculation. They are regularly<br />

tested for impairment in accordance with IFRS 4 (liability<br />

adequacy test); cf. notes on liabilities item C: Gross technical<br />

provisions. Write-downs are recognised under operating<br />

expenses.<br />

Self-developed and other software, acquired sales networks,<br />

client bases and brand names are carried at cost.<br />

Self-developed and other software is amortised on a<br />

straightline basis at a rate of 20–33% over its useful life –<br />

three to five years – or in exceptional circumstances at a<br />

rate of 10% over a period of up to ten years. The useful<br />

lives and depreciation rates of the acquired sales networks<br />

and client bases are 2–17 years or 6–50%, and those of the<br />

brand names 1–30 years or 3–100%; the items in question<br />

are amortised consistently in accordance with the straightline<br />

method. Write-downs or write-ups are made if<br />

required. Write-downs and write-ups are distributed in<br />

the consolidated income statement between investment<br />

expenses, expenses for claims and benefits and operating<br />

expenses. If it is not possible to allocate the write-downs<br />

and write-ups to the functional areas, they are shown<br />

under other non-operating expenses or income.<br />

Investments<br />

Land and buildings shown under investments comprise<br />

property used by third parties and are carried at cost.<br />

Maintenance expenses are recognised as an expense.<br />

Structural measures equivalent to 5% or more of the<br />

historical cost of a building are generally assessed with<br />

regard to whether they have to be capitalised. Buildings are<br />

depreciated on a straight-line basis in accordance with the<br />

component approach, depending on the weighted useful<br />

life for their specific building class. The underlying useful<br />

lives mainly range between 40 and 55 years. If the recoverable<br />

amount of land and buildings falls below their carrying<br />

amount, the carrying amount is written down to the<br />

recoverable amount. Impairment losses are recognised as<br />

investment expense in the consolidated income statement,<br />

and reversals of impairment losses as investment income.<br />

Investments in affiliated companies that we do not consolidate<br />

because they are not material are generally carried<br />

at their fair values. If the investments are quoted on a<br />

stock exchange, we use the share prices at the balance<br />

sheet date; for unquoted investments, the fair value is<br />

measured using the discounted earnings or net asset value<br />

method. Unrealised gains or losses are recognised directly<br />

in other reserves after deduction of deferred taxes and<br />

amounts apportionable to policyholders of life and health<br />

insurers on realisation (provision for deferred premium<br />

refunds).<br />

Investments in associates are valued by the equity method<br />

at the <strong>Group</strong>’s proportionate share of their net assets.<br />

The associate’s earnings attributable to the <strong>Group</strong> are<br />

included in the investment result. As a rule, the equity and<br />

annual result from the most recent individual or consolidated<br />

financial statements of the associate are used; in<br />

the case of the annual financial statements of significant<br />

associates, appropriate adjustments are made to conform<br />

them to <strong>ERGO</strong>’s accounting policies, in accordance with<br />

IAS 28.27; exceptional transactions of material importance<br />

for a true and fair picture of the associate’s financial<br />

position are recognised in the same financial year. Investments<br />

in associates that are not material for assessing


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements64<br />

Principles of presentation and consolidation<br />

the <strong>Group</strong>’s financial position are generally accounted for<br />

at fair value. To determine the fair value, we use the share<br />

prices at the balance sheet date if the investments are<br />

quoted on a stock exchange; for unquoted investments,<br />

the fair value is measured using the discounted earnings<br />

or net asset value method. Changes in the fair value are<br />

recognised in “other reserves” under unrealised gains and<br />

losses after taking into account deferred taxes and those<br />

amounts at life and health insurers which, when realised,<br />

are due to policyholders (provision for deferred premium<br />

refunds).<br />

Loans are non-derivative financial assets with fixed or determinable<br />

payments that are not quoted in an active market.<br />

They are measured at amortised cost in accordance with<br />

the effective interest method. Write-downs for impairments<br />

are made in cases where the repayment of a loan<br />

can no longer be expected.<br />

Fixed-interest securities held to maturity are measured at<br />

amortised cost in accordance with the effective interest<br />

method.<br />

Fixed-interest or non-fixed-interest securities available<br />

for sale that are not designated as at fair value through<br />

profit or loss or recognised under loans are accounted for<br />

at fair value, with resulting changes in value recognised in<br />

equity with no effect on profit or loss. If no quoted prices<br />

in an active market are available, fair values are based<br />

on recognised valuation methods in line with the present<br />

value principle. Unrealised gains or losses are calculated<br />

taking into account interest accrued and, after deduction<br />

of deferred taxes and the amounts apportionable to<br />

policyholders by the life and health insurers on realisation<br />

(provision for deferred premium refunds), are recognised<br />

directly in equity under “other reserves”.<br />

Securities at fair value through profit or loss comprise<br />

securities held for trading and securities designated as at<br />

fair value through profit or loss. Securities held for trading<br />

are all fixed-interest and non-fixed-interest securities that<br />

we have acquired for trading purposes to earn short-term<br />

profits from price changes and differences. In addition,<br />

they include all derivative financial instruments with<br />

positive fair values which we have acquired to manage and<br />

hedge risks but which do not meet the requirements of<br />

IAS 39 for hedge accounting, and the positive fair values of<br />

insurance derivatives and of derivative components separated<br />

from the underlying insurance contract. Securities<br />

designated as at fair value through profit or loss comprise<br />

structured securities. This designation may only be made<br />

at the time of acquisition; reallocation to this category in<br />

later periods is not possible.<br />

Securities at fair value through profit or loss are accounted<br />

for at fair value at the balance sheet date. If no quoted<br />

prices in an active market are available, fair values particularly<br />

with derivatives) are based on recognised valuation<br />

methods. <strong>ERGO</strong> uses a range of valuation models for this<br />

purpose, details of which may be obtained from the following<br />

table below.<br />

All unrealised gains and losses from such valuation are<br />

included in the investment result.<br />

Other investments comprise deposits with banks, deposits<br />

retained on assumed reinsurance business and investments<br />

in renewable energies. Deposits with banks are<br />

measured at amortised cost in line with the effective interest<br />

method. Deposits retained are recorded at face value.<br />

Investments in renewable energies are generally recorded<br />

at amortised cost; the items in question are amortised on<br />

a straight-line basis with at least 5% over the useful life of<br />

20 years at the most


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements65<br />

Principles of presentation and consolidation<br />

Valuation models<br />

Derivatives Pricing method Parameters Pricing model<br />

Equity and index risks<br />

Stock options traded on<br />

the stock exchange<br />

Quoted price – –<br />

OTC stock options Theoretical price Listing of underlying shares,<br />

effective volatilities, money-market<br />

interest rate, dividend yield<br />

Equity forwards Theoretical price Money-market interest rate,<br />

share price, dividend yield<br />

Equity / index futures Quoted price − −<br />

Interest-rate risks<br />

Interest-rate swaps Theoretical price Swap curve, money-market<br />

interest-rate curve<br />

Swaptions / interestrate<br />

guarantee<br />

Theoretical price<br />

At-the-money volatility matrix<br />

and skew, swap curve, moneymarket<br />

interest-rate curve<br />

Interest-rate currency swaps Theoretical price Swap curve, money-market<br />

interest-rate curve,<br />

currency spot rates<br />

Interest-rate futures Quoted price − −<br />

Inflation swaps Theoretical price Zero-coupon inflation swap rates,<br />

money-market interest-rate curve,<br />

swap curve<br />

Bond futures Quoted price − −<br />

Quoted options on bond futures Quoted price − −<br />

Currency risks<br />

Currency options Theoretical price At-the-money volatility, currency<br />

spot rates, money-market interestrate<br />

curve<br />

Currency forwards Theoretical price Currency spot rates,<br />

money-market interest-rate curve<br />

Other transactions<br />

Insurance derivatives<br />

(excluding variable annuities)<br />

Insurance derivatives<br />

(variable annuities)<br />

Theoretical price<br />

Theoretical price<br />

Market values of the cat bonds,<br />

interest-rate curve<br />

Biometric and lapse rates,<br />

volatilities,<br />

interest-rate curve,<br />

currency spot rates<br />

Credit default swaps Theoretical price Credit spreads,<br />

recovery rates,<br />

interest-rate curve<br />

Total return swaps on<br />

commodities<br />

Black-Scholes (European); Cox,<br />

Ross and Rubinstein (American),<br />

Monte Carlo simulation<br />

Present-value method<br />

Present-value method<br />

Black-76<br />

Present-value method<br />

Present-value method<br />

Garman-Kohlhagen<br />

Present-value method<br />

Present-value method<br />

Present-value method<br />

Present-value method<br />

ISDA CDS Standard Model<br />

Theoretical price Listing of underlying index Index ratio calculation<br />

Commodity options Theoretical price Listing of underlying shares,<br />

effective volatilities,<br />

money-market interest rate<br />

Black-Scholes (European); Cox,<br />

Ross and Rubinstein (American)


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements66<br />

Principles of presentation and consolidation<br />

Repurchase agreements and securities lending<br />

Under repurchase agreements we, as the lender, acquire<br />

securities with the obligation to sell them back to the<br />

borrower at a later date. As the risks and rewards from the<br />

securities remain with the borrower, they are not posted<br />

as such in our accounts but are shown as a receivable<br />

from the borrower under “other investments, deposits<br />

with banks”. Interest income from these transactions is<br />

recognised in the investment result.<br />

Securities that we lend by way of securities lending continue<br />

to be recognised in our balance sheet, as the main risks<br />

and rewards remain with <strong>ERGO</strong>; securities that we have<br />

borrowed are accounted for by the lender. Interest income<br />

from these transactions is recognised in the investment<br />

result.<br />

Recognition of financial instruments<br />

Financial assets are accounted for at the settlement date.<br />

Determining fair values<br />

IAS 39 defines the fair value of a financial instrument<br />

as the amount for which a financial asset could be<br />

exchanged, or a financial liability settled, between knowledge<br />

able, willing parties in an arm’s length transaction.<br />

All financial instruments recognised at fair value are allocated<br />

to one of the valuation hierarchy levels of IFRS 7.<br />

This valuation hierarchy provides for three levels. The initial<br />

basis for the allocation is the economic investment class.<br />

Only if this does not result in an appropriate allocation do<br />

we deviate from such an approach in individual cases.<br />

The allocation reflects which of the fair values derive from<br />

transactions in the market and where valuation is based on<br />

models because market transactions are lacking.<br />

In the case of Level 1, valuation is based on unadjusted<br />

quoted prices in active markets for identical financial<br />

assets which <strong>ERGO</strong> can refer to at the balance sheet date.<br />

A market is deemed active if transactions take place with<br />

sufficient frequency and in sufficient quantity for price<br />

information to be available on an ongoing basis. Since a<br />

quoted price in an active market is the most reliable indicator<br />

of fair value, this should always be used if available.<br />

The financial instruments we have allocated to this level<br />

mainly comprise equities, investment funds (except property<br />

funds) and fixed-interest securities (bearer bonds) for<br />

which either a stock market price is available or prices are<br />

provided by a price quoter on the basis of actual market<br />

transactions. We have also allocated derivatives traded on<br />

the stock market to Level 1.<br />

Assets allocated to Level 2 are valued using models based<br />

on observable market data. For this, we use inputs directly<br />

or indirectly observable in the market, other than quoted<br />

prices. If the financial instrument concerned has a fixed<br />

contract period, the inputs used for valuation must be<br />

observable for the whole of this period. The financial<br />

instruments we have allocated to this level mainly comprise<br />

borrowers’ note loans, covered bonds, subordinated<br />

securities and derivatives not traded on the stock market.<br />

For assets allocated to Level 3, we use valuation techniques<br />

not based on inputs observable in the market. This<br />

is only permissible insofar as no observable market data<br />

are available. The inputs used reflect <strong>ERGO</strong>’s assumptions<br />

regarding the factors which market players would consider<br />

in their pricing. We use the best available information for<br />

this, including internal company data. The financial instruments<br />

allocated to this level of the fair value hierarchy<br />

largely comprise investments in private equity, in renewable<br />

energy (RENT) as well as in real-estate funds, certain<br />

credit structures, and investments in affiliated companies<br />

and associates measured at fair value. We also allocate<br />

insurance derivatives and derivative components that are<br />

separated from the host insurance contract to Level 3.<br />

Owing to their leverage effect, changes in individual inputs<br />

may significantly affect the fair value shown for instruments<br />

measured under Level 3. If we make such adjustments in<br />

measuring fair value in the individual case, we explain the<br />

resultant effects.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements67<br />

Principles of presentation and consolidation<br />

Net investment result<br />

The net investment result comprises regular income,<br />

income from write-ups, gains and losses on the disposal<br />

of investments, other income, write-downs of investments,<br />

management expenses, interest charges and other<br />

expenses. Regular income and expenses from investments<br />

not measured at fair value through profit or loss are calculated<br />

in accordance with the effective interest method, i. e.<br />

any premiums or discounts are deducted from or added<br />

to the acquisition costs, with impact on profit or loss, until<br />

maturity.<br />

Impairment<br />

At each balance sheet date, we assess whether there is<br />

any substantial objective evidence of impairment in a<br />

financial asset or group of financial assets. Impairments<br />

in value are recognised as an expense in the income<br />

statement. IAS 39.59 contains a list of factors providing<br />

evidence of impairment of such financial assets. In<br />

addition, IAS 39.61 states that for equity investments, a<br />

significant or prolonged decline in the fair value of the<br />

investment below its acquisition cost is objective evidence<br />

of impairment. These rules are given more concrete form<br />

by means of internal guidelines. For equities quoted on<br />

the stock exchange, we assume a significant decline in fair<br />

value if the market value at the review date is at least 20%<br />

below the average purchase price or has been lower than<br />

this amount for at least six months. In the case of fixedinterest<br />

securities and loans, the main basis for establishing<br />

impairment is an indication of substantial financial<br />

difficulty on the part of the issuer, the current market<br />

situation or media reports on the issuer.<br />

We determine acquisition cost on the basis of the average<br />

purchase price. In the case of an impairment, a writedown<br />

is made to the fair value at the balance sheet date,<br />

i. e. generally the publicly quoted market price. If there is<br />

a further fall in the fair value of equity investments that<br />

have already been written down once, a further writedown<br />

recognised in the income statement is made again<br />

immediately. Such impairments recognised in profit or<br />

loss may not be reversed through profit or loss. If, in a<br />

subsequent period, the reasons for the impairment of<br />

fixed-interest securities or loans cease to apply, the impairment<br />

is reversed, with impact on the income statement.<br />

The resultant carrying amount may not exceed the original<br />

amortised cost.<br />

In impairment tests of our financial assets (with the<br />

exception of equity investments), we generally first assess<br />

whether objective evidence of impairment exists for items<br />

that are individually significant. If this is not the case,<br />

as well as in cases of individually insignificant items, the<br />

impairment test is carried out collectively on the basis<br />

of groups of similar financial assets. Assets that are individually<br />

assessed for impairment are not included in the<br />

collective assessment. The amount of the probable loss is<br />

measured as the difference between the amortised cost of<br />

the asset or group of assets and the present value of estimated<br />

future cash flows. The impairment thus determined<br />

is recognised as an expense. We generally deduct impairments<br />

directly from the items concerned on the assets<br />

side without using a value adjustment account. If, in a<br />

subsequent period, the reasons for the impairment cease<br />

to apply, the impairment is reversed, with impact on the<br />

income statement. The resultant carrying amount may not<br />

exceed the original amortised cost.<br />

Investments for the benefit of life insurance policyholders<br />

who bear the investment risk<br />

These are investments for policyholders under unit-linked<br />

life insurances. They are measured at fair value. Unrealised<br />

gains or losses from changes in fair value are included in<br />

the investment result. These are matched by corresponding<br />

changes in the technical provisions (equity and liabilities<br />

item D: Gross technical provisions for life insurance policies<br />

where the investment risk is borne by the policyholders),<br />

which are included in the technical result. The change in<br />

technical provisions also includes changes from additional<br />

premium components. Recognising these investments at<br />

fair value, with impact on profit or loss, avoids valuation<br />

mismatches that would otherwise occur due to different<br />

measurement of the corresponding provisions.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements68<br />

Principles of presentation and consolidation<br />

Ceded share of technical provisions<br />

The share of technical provisions for business ceded by us<br />

is determined from the respective technical provisions in<br />

accordance with the terms of the reinsurance agreements;<br />

cf. the notes on equity and liabilities item C: Gross technical<br />

provisions. Appropriate allowance is made for the credit<br />

risk.<br />

Receivables<br />

Current tax receivables and other receivables are accounted<br />

for at nominal value. Adjustments are undertaken where<br />

there is an indication of substantial impairments; see Notes<br />

on assets, Item B: Investments – Impairment.<br />

Current tax receivables comprise current taxes on income<br />

of the individual companies, based on their respective<br />

national taxation. Other tax receivables are shown under<br />

“other receivables”.<br />

Cash at banks, cheques and cash in hand<br />

Cash and cheques are accounted for at face value.<br />

Deferred acquisition costs<br />

Deferred acquisition costs comprise commissions and<br />

other variable costs directly connected with acquisition or<br />

renewal of insurance contracts. In life business and longterm<br />

health insurance, acquisition costs are capitalised<br />

and amortised over the duration of the contracts. This is<br />

done either proportionally to the premium income (FAS 60)<br />

or proportionally to the respective contracts’ expected<br />

gross profit margins calculated for the relevant year of the<br />

contract term (FAS 97, 120). The allocation of individual<br />

contracts to the FASs concerned is shown in the notes on<br />

equity and liabilities item C: Gross technical provisions.<br />

In determining the amount of amortisation, we take into<br />

account an actuarial interest rate and changes resulting<br />

from the disposal or withdrawal of contracts from the portfolio.<br />

In property-casualty business and short-term health<br />

insurance, the deferred acquisition costs are amortised on<br />

a straight-line basis over the average term of the policies,<br />

from one to five years. Deferred acquisition costs are regularly<br />

tested for impairment using a liability adequacy test<br />

as per IFRS 4; cf. Notes on equity and liabilities item C:<br />

Gross technical provisions.<br />

Deferred tax assets<br />

Under IAS 12, deferred tax assets must be recognised in<br />

cases where asset items have to be valued lower, or liability<br />

items higher, in the consolidated balance sheet than<br />

in the tax accounts of the <strong>Group</strong> company concerned and<br />

these differences will be eliminated at a later date with a<br />

corresponding effect on taxable income (temporary differences).<br />

Also included are tax assets deriving from tax<br />

loss carry-forwards. We take into account the tax rates of<br />

the countries concerned and the consolidated company’s<br />

respective tax situation; in some cases, for purposes of<br />

simplification, we use uniform tax rates for individual circumstances<br />

or subsidiaries. Changes in tax rates and tax<br />

legislation that have already been adopted by the government<br />

at the balance sheet date are taken into account.<br />

Deferred tax assets are recognised if a realisation is<br />

probable.<br />

Other assets<br />

Other assets are generally carried at amortised cost. The<br />

owner-occupied property recognised under other assets<br />

is accounted for as outlined under the Notes on assets,<br />

item B: Investments – Land and buildings. Plant and equipment<br />

is amortised mainly on a straight-line basis, the<br />

underlying useful lives ranging between 1 and 50 years.<br />

Impairment losses, and impairment losses reversed, in the<br />

<strong>Group</strong>’s owner-occupied property and plant and equipment<br />

are distributed between the underwriting functional areas.<br />

Equity and liabilities<br />

Equity<br />

The item “issued capital and capital reserve” contains the<br />

amounts that <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> equity holders<br />

have paid in on shares. The capital reserve is reduced<br />

by the externally generated costs directly connected<br />

with equity capital measures, after taking tax effects into<br />

account.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements69<br />

Principles of presentation and consolidation<br />

Under retained earnings, we show the profits which<br />

consolidated companies have earned and retained since<br />

becoming part of the <strong>Group</strong> and income and expenses<br />

resulting from changes in the consolidated group. In<br />

addition, the adjustment amount resulting from changes<br />

in accounting policies for earlier periods not included in the<br />

consolidated financial statements is recorded in the opening<br />

balance of the retained earnings for the earliest prior<br />

period reported.<br />

Other reserves contain unrealised gains and losses resulting<br />

from the recognition of other securities available for<br />

sale at fair value and from investments in non-consolidated<br />

affiliated companies and in associates that we do<br />

not value at equity. These reserves also include unrealised<br />

gains and losses from the valuation of associates at equity,<br />

differences resulting from the currency translation of<br />

foreign subsidiaries’ figures, and the valuation result from<br />

the hedging of cash flows. Write-ups of equity investments<br />

available for sale are also recognised in this equity item.<br />

Non-controlling interests are accounted for in the balance<br />

sheet as part of equity. These are the shares of third<br />

parties in the equity of subsidiaries that are not wholly<br />

owned directly or indirectly by <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />

<strong>AG</strong>. Direct minority interests in special funds and in partnerships<br />

are recognised under “other liabilities”. The portion<br />

of the result attributable to non-controlling interests<br />

is shown in the consolidated result.<br />

Subordinated liabilities<br />

Subordinated liabilities are liabilities which, in the event of<br />

liquidation or insolvency, are only satisfied after the claims<br />

of other creditors. They are measured at amortised cost in<br />

accordance with the effective interest method.<br />

Gross technical provisions<br />

The technical provisions are shown as gross figures in the<br />

balance sheet, i. e. before deduction of the ceded share;<br />

cf. the explanatory remarks on assets item D: Reinsurers’<br />

share in technical provisions. The ceded share is calculated<br />

and accounted for on the basis of the individual reinsurance<br />

agreements. Acquisition costs for insurance contracts<br />

are capitalised and amortised over the terms of the contracts;<br />

cf. Notes on assets item G: Deferred acquisition costs. The<br />

measurement of technical provisions is based on US GAAP<br />

FAS 60, FAS 97 and FAS 120.<br />

Unearned premiums<br />

Unearned premiums are accrued premiums already written<br />

for future risk periods. These premiums are calculated<br />

separately for each insurance policy pro rata temporis. The<br />

posting of unearned premiums is restricted to short-term<br />

underwriting business. This concerns both property insurance<br />

and parts of accident and health insurance.<br />

Provision for future policy benefits<br />

The provision for future policy benefits in long-term underwriting<br />

business is posted for the actuarially calculated<br />

value of obligations arising from policyholders’ guaranteed<br />

entitlements. As well as life insurance, this concerns portions<br />

of health and personal accident insurance, insofar as<br />

the business is conducted as life insurance. Measurement<br />

is usually based on the prospective method by determining<br />

the difference between the present values of future<br />

benefits and future premiums. The actuarial biometric<br />

assumptions used for their calculation include, in particular,<br />

assumptions relating to mortality, disablement and<br />

morbidity, as well as assumptions regarding interest-rate<br />

development, lapses and costs. These are estimated on a<br />

realistic basis at the time the insurance contracts are concluded,<br />

and they include adequate provision for adverse<br />

deviation to make allowance for the risks of change, error<br />

and random fluctuations. Biometric accounting principles<br />

based on the tables prepared by the German Association<br />

of Actuaries (Deutschen Aktuarvereinigung e. V.) are used<br />

for German life insurance business. For other insurance<br />

business, it is mainly tables from the respective national<br />

actuary associations which are used. Life insurance is discounted<br />

using a technical interest rate which is limited to<br />

the respective maximum technical interest rate approved<br />

by the regulatory body. In health insurance, discount rates<br />

are chosen that reflect the best estimate of expected<br />

investment income, less a safety margin.<br />

The actuarial assumptions are adjusted if this is shown<br />

to be necessary by a liability adequacy test in accordance<br />

with IFRS 4.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements70<br />

Principles of presentation and consolidation<br />

The measurement of the provisions for future policy<br />

benefits depends on the type of contract, being based<br />

either on FAS 60 (life insurance without performancerelated<br />

participation in surplus, health insurance), on<br />

FAS 97 (life insurance on the universal life model and unitlinked<br />

life insurance) or on FAS 120 (life insurance with<br />

performance-related participation in surplus).<br />

For contracts in accordance with FAS 60, the provision<br />

for future policy benefits is calculated from the present<br />

value of estimated future policy benefits (including claims<br />

adjustment expenses) less the present value of future net<br />

level premiums. Net level premium is that part of the gross<br />

premium that is needed to finance future policy benefits.<br />

Life insurance contracts with limited premium payment are<br />

generally valued in accordance with FAS 97.<br />

For all other contracts as per FAS 97, an account is kept<br />

to which net level premiums and interest earnings are<br />

credited and from which risk premiums and administration<br />

expenses are debited, not all credits and debits being contractually<br />

fixed at the time the contracts are concluded.<br />

The provision for future policy benefits for life insurance<br />

where policyholders bear the investment risk themselves<br />

(unit-linked life insurance) is shown separately under<br />

Equity and liabilities, Item D: Gross technical provisions for<br />

life insurance policies where the investment risk is borne by<br />

the policyholders.<br />

In the case of contracts as per FAS 120, the provision for<br />

future policy benefits comprises the net level premium<br />

reserve and liabilities for terminal dividends. The net level<br />

premium reserve is calculated from the present value of<br />

guaranteed policy benefits (including acquired bonuses but<br />

excluding claims adjustment expenses) less the present<br />

value of future net level premiums. The net level premium<br />

is the net premium less the portion of the premium envisaged<br />

for covering claims adjustment expenses. The actuarial<br />

assumptions are generally the same as those used for<br />

premium calculation. The provision for terminal dividends<br />

is built up proportionally with a fixed share of the expected<br />

gross profit margins. The same method is used for this as<br />

for determining the amortisation of the deferred acquisition<br />

costs.<br />

Here the same technical interest rate and biometric calculation<br />

principles are employed which are used as the basis<br />

to calculate tariff premiums or surrender values. Additionally,<br />

a reserve is set up to cover administration expenses<br />

for non-contributory periods. The calculation principles<br />

of tariffs are regularly verified by the regulatory authorities<br />

or actuarial associations and include safety margins<br />

which take into account risks caused by change, error or<br />

random fluctuations. To the extent that safety margins in<br />

the biometric calculation principles have been used up in<br />

full, there may be a need to set up additional provisions<br />

or to conduct an unscheduled amortisation of deferred<br />

acquisition costs. This kind of adjustment is carried out in<br />

accordance with the IFRS 4 adequacy test if the adequacy<br />

of technical provisions can no longer be guaranteed when<br />

taking all calculation principles into account. A possible<br />

deficit is recognised in the income statement. The adequacy<br />

of the provision for future policy benefits is assessed<br />

on a regular basis using current, realistic estimates on the<br />

calculation principles, the proportionate amount of the<br />

investment return as well as future surplus-sharing for<br />

contracts which include this aspect.<br />

The biometric calculation principles used for life insurance<br />

policies are considered adequate. The actuaries in charge<br />

consider the mortality tables used to be adequate and to<br />

contain a sufficient safety margin for policies with mortality<br />

risk. Should, however, the trend towards a sustained<br />

improvement in life expectancy continue, a transfer of<br />

additional sums to the provision for future policy benefits<br />

cannot be ruled out in future.<br />

The accrual of the provision for terminal bonuses is carried<br />

out as scheduled over the term of the contracts by means<br />

of annual transfers and interest. For life insurance policies<br />

recorded in the balance sheet in accordance with FAS 97<br />

and FAS 120, transfers are based on expectations for<br />

future income which have already been used for capitalising<br />

deferred acquisition costs and on the income already<br />

realised in the past. Assumptions applied here are checked<br />

regularly and adjusted where necessary. The provision<br />

for terminal bonuses is recalculated following a necessary<br />

adjustment to the actuarial calculation principles.<br />

This normally leads to a change in the amount which is<br />

transferred. The revaluation of the provision for terminal<br />

bonuses is carried out within the provision for premium<br />

refunds without affecting profit or loss. It is for this reason<br />

that fluctuations do not have any effect on the consolidated<br />

result.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements71<br />

Principles of presentation and consolidation<br />

As far as contracts of a primarily investment nature<br />

are concerned (e. g. unit-linked life policies and AltZerG<br />

products with prospective entitlement in accordance with<br />

the German law on the Certification of Old-age Provision<br />

Agreements), assessment for the provision for future<br />

policy benefits is based on FAS 97. The provision for future<br />

policy benefits is made up from additions to the amounts<br />

invested, the performance of underlying investments and<br />

withdrawals in line with contracts plus provision for terminal<br />

bonuses and provision for “unearned parts of premiums”<br />

for these products.<br />

The main reasons for using FAS 60 in health insurance are<br />

the absence of causality in the generation and utilisation<br />

of surpluses and the usually lifelong term of health insurance<br />

policies calculated in the same manner as for life insurance<br />

policies.<br />

The provision shown is calculated as the difference<br />

between the present value of future insurance benefits,<br />

including claims adjustment expenses and the present<br />

value of future premiums. Here the share of the gross<br />

premium is taken into account which is required to finance<br />

future insurance benefits including the costs of claims<br />

settle ments (net level premium). The provision is calculated<br />

on current actuarial calculation bases. These include<br />

adequate safety margins in either direction.<br />

The provision which is based on Section 12 a, para. 2 of the<br />

German law on the Supervision of Insurance Companies<br />

(V<strong>AG</strong>), is not part of the provision for future policy benefits,<br />

but rather recorded in the provision for premium refunds.<br />

Provision for outstanding claims<br />

Provisions for outstanding claims are for payment obligations<br />

arising from insurance contracts where the size of the<br />

claim or the timing of the payment is still uncertain. Part<br />

of the provisions is for known claims for which individually<br />

calculated provisions are posted. Another part is for<br />

expenses for claims whose occurrence is not yet known<br />

(e. g. because they have not been reported yet or have not<br />

yet manifested themselves). A third class of provisions<br />

covers claims which are known but whose extent has<br />

turned out to be greater than originally foreseen. All these<br />

provisions include expenses for internal and external loss<br />

adjustment costs. Provisions for outstanding claims are<br />

based on estimates: the actual payments may be higher or<br />

lower. The amounts posted are the realistically estimated<br />

future amounts to be paid; they are calculated on the basis<br />

of past experience and assumptions about future developments<br />

(e. g. social, economic or technological factors).<br />

As regards industrial, property and transport business,<br />

provisions are set up for individual claims. In these lines of<br />

business, provisions for as yet unreported claims are based<br />

on past experience.<br />

Provisions for reinsurance business generally follows<br />

statements made by the ceding insurers. Provisions for<br />

outstanding claims are largely not discounted with the<br />

exception of some provisions concerning occupational disability,<br />

liability and annuities in workers’ compensation and<br />

other property-casualty lines of business. When determining<br />

provisions for outstanding claims, <strong>ERGO</strong> uses a range<br />

of actuarial projection methods, which comprise the chain<br />

ladder method and the Bornhuetter-Ferguson method.<br />

When applying the statistical method, we consider major<br />

losses separately. The standard actuarial methods used<br />

are applied to both the run-off triangles of payments<br />

as well as to the run-off triangles of the claims reported,<br />

meaning that we get a range of estimates for the final<br />

claims. A realistic estimated value is determined for the<br />

final claim within this range.<br />

Provisions for premium refunds<br />

Apart from non-performance-related premium refunds,<br />

this item contains in particular performance-related<br />

premium refunds for life, health and personal accident<br />

insurance. In health insurance, the non-performancerelated<br />

premium refunds also comprise sums which must<br />

be set up in accordance with Section 12 a of the German<br />

Insurance Supervision Act (V<strong>AG</strong>). According to national regulations,<br />

the provision only has to be set up for the German<br />

insurance business. Insofar as the provision for premium<br />

refunds has been set up, a valuation is generally conducted<br />

retrospectively based on regulations imposed by the regulatory<br />

authorities or as a result of provisions governing the<br />

individual contract. For those life insurance and pension<br />

fund companies which are subject to supervision by the<br />

Federal Financial Supervisory Authority (BaFin), the supervisory<br />

regulations of the German Insurance Supervision Act<br />

and the regulation pertaining to minimum appropriation<br />

must be observed.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements72<br />

Principles of presentation and consolidation<br />

In addition, provisions are set up for deferred premium<br />

refunds for the policyholders’ shares in the differences in<br />

valuation between IFRS and local accounting principles<br />

based on the expected future proportions on profit participation.<br />

For unrealised gains and losses from investments<br />

available for sale, which are recognised directly at equity,<br />

provisions for deferred premium refunds are set up without<br />

having an effect on the income statement; otherwise<br />

changes to this provision are charged against the income<br />

statement. To calculate the provision for deferred premium<br />

refunds for the amount stemming from the differences<br />

in valuation, proportions are used of between 50% and<br />

92.5% after tax. We have raised the assumption as to what<br />

degree policyholders will participate in bonuses in German<br />

life insurance in the future. The proportions for calculating<br />

the allocation to the provision for deferred premium<br />

refunds have been adjusted accordingly.<br />

When terminal bonuses are determined, they are reclassified<br />

from the provision for premium refunds to the provision<br />

for future policy benefits without affecting profit or<br />

loss. Here the funds reserved for terminal bonuses and<br />

available funds in the provision for performance-related<br />

premium refunds are used. If the provision for terminal<br />

bonuses exceeds these amounts, parts of the provision for<br />

deferred premium refunds are reclassified as well.<br />

All technical provisions are regularly subjected to a liability<br />

adequacy test in accordance with IFRS 4. If current experience<br />

shows that the provisions posted on the basis of the<br />

original assumptions less the related deferred acquisition<br />

costs and the present value of the related premiums<br />

are inadequate to cover the expected future benefits, we<br />

adjust the relevant technical provisions with recognition<br />

in the income statement and disclose those under impairment<br />

losses/unscheduled changes in the Notes to the<br />

consolidated financial statements; see [2] Other intangible<br />

assets, [10] Deferred acquisition costs and [16] Provision for<br />

future policy benefits. The adequacy of unearned premiums<br />

and of the provision for outstanding claims is checked<br />

for the current realistically estimated future amounts to<br />

be paid. The adequacy of the provision for future policy<br />

benefits is assessed using current, realistic estimates on<br />

the calculation principles, the proportionate amount of the<br />

investment return as well as (for policies with profit participation)<br />

the future surplus-sharing.<br />

Gross technical provisions for life insurance policies<br />

where the investment risk is borne by the policyholders<br />

This item comprises provisions for future policy benefits<br />

in life insurance where policyholders bear the investment<br />

risk themselves (unit-linked life insurance). The value of<br />

the provision for future policy benefits essentially corresponds<br />

to the market value of the relevant investments<br />

shown under Assets, Item C: Investments for the benefit of<br />

life insurance policyholders who bear the investment risk.<br />

Besides this, under FAS 97 and in certain circumstances,<br />

additional premium components may have to be included;<br />

please refer to Notes on Equity and liabilities, Item C: Gross<br />

technical provisions. Changes in this provision are fully<br />

recog nised in the technical result. Insofar as these changes<br />

derive from unrealised gains and losses from alterations<br />

in the fair values of the related investments, they are<br />

matched by opposite changes of the same amount in<br />

the investment result. Recognising these investments at<br />

fair value, with impact on profit or loss, avoids valuation<br />

mismatches that would otherwise occur due to different<br />

measurement of corresponding provisions.<br />

Other provisions<br />

This item includes inter alia the provision for post-employment<br />

benefits. The companies within <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> generally give commitments to their staff in the<br />

form of defined contribution plans or defined benefit plans.<br />

The type and amount of the pension obligations are determined<br />

by the conditions of the respective pension plan.<br />

In general, they are based on the staff member’s length<br />

of service and salary. Under defined contribution plans,<br />

the companies pay fixed contributions to an insurer or a<br />

pension fund. This fully covers the company’s obligations.<br />

Under defined benefit plans, the staff member is promised<br />

a particular level of retirement benefit either by the companies<br />

or by a pension fund. The company’s contributions<br />

needed to finance this are not fixed in advance. Where<br />

assets of a legally independent entity (e. g. a fund) are<br />

matched against pension obligations, which may only be<br />

used to cover the pension promise and the access of any<br />

creditors is denied (plan assets), these pension obligations<br />

are recognised after these assets have been deducted.<br />

Where the fair value of the assets exceeds the related outsourced<br />

pension obligations, this repayment claim must be<br />

shown under “other receivables”.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated
Financial Statements73<br />

Principles of presentation and consolidation<br />

Pension obligations are recognised in accordance with<br />

IAS 19, using the projected unit credit method and based<br />

on actuarial studies. The calculation includes not only<br />

the pension entitlements and current pensions known<br />

on the balance sheet date but also their expected future<br />

development.<br />

The interest rate at which the pension obligations are discounted<br />

is based on the yields for long-term high-quality<br />

bonds (e. g. commercial or government bonds). Actuarial<br />

gains or losses from pension obligations and plan assets<br />

result from the deviation of actual risk experience from<br />

estimated risk experience. They are recognised directly in<br />

equity, without impact on profit or loss.<br />

The other provisions included in this item are established<br />

in the amount of the probable requirement. Such amounts<br />

are not discounted if the interest-rate effect is insignificant.<br />

Liabilities<br />

Liabilities comprise deposits retained on ceded business,<br />

current tax liabilities and other liabilities. Financial liabilities<br />

are generally recognised at amortised cost. Derivatives<br />

(financial derivatives, insurance derivatives and derivative<br />

components which have been separated from the host<br />

insurance contract) are recognised at fair value. Details on<br />

the calculation of the fair value are provided under Notes<br />

on assets, Item B: Investments.<br />

Current tax liabilities comprise current taxes on income<br />

of the individual companies, based on their respective<br />

national taxation. Other tax liabilities are shown under<br />

“other liabilities”.<br />

Tax liabilities for current taxes are posted – without discounting<br />

– in accordance with the probable tax payments<br />

for the year under review or previous years. Deferred tax<br />

obligations are shown under Equity and liabilities, Item G:<br />

Deferred tax liabilities.<br />

Direct minority interests in special funds are measured at<br />

fair value.<br />

Deferred tax liabilities<br />

Under IAS 12, deferred tax liabilities must be recognised<br />

if asset items have to be valued higher, or liabilities items<br />

lower, in the consolidated balance sheet than in the tax<br />

accounts of the reporting company and these differences<br />

will be eliminated at a later date with a corresponding<br />

impact on taxable income (temporary differences), see<br />

Notes on assets, Item H: Deferred tax assets.<br />

Foreign currency translation<br />

The currency used by <strong>ERGO</strong> Insurance <strong>Group</strong> in its reports<br />

is the euro (€). The balance sheets of foreign subsidiaries<br />

whose national currency is not the euro are translated in<br />

accordance with the functional currency principle using<br />

the year-end exchange rates, and their income statements<br />

using average quarterly exchange rates. Any exchange<br />

differences arising in the process are recognised in equity<br />

(reserve for currency translation adjustment).<br />

By contrast, currency translation differences are largely<br />

recognised in the income statement of our subsidiaries’<br />

individual financial statements. This involves the translation<br />

of foreign currency items into the respective functional<br />

currency in accordance with IAS 21. An excess of<br />

assets over liabilities in a particular currency results on<br />

balance in a gain if that currency appreciates and in a loss<br />

if it falls in value. The reverse applies if cover is insufficient.<br />

The objective of our asset-liability management is to economically<br />

minimise excess or insufficient cover in foreign<br />

currencies within the <strong>Group</strong>. Insofar as this is done across<br />

<strong>Group</strong> companies with different functional currencies, it<br />

produces economically non-existent fluctuations in the<br />

consolidated result. Where exchange gains or losses occur<br />

in the translation of foreign-currency transactions into the<br />

national currencies of the consolidated companies, they<br />

are accounted for under “other non-operating income” and<br />

“other non-operating expenses” respectively.<br />

Beyond this, the impact of changes in exchange rates is<br />

reflected in period-to-period comparisons of all items in<br />

the income statement.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

74<br />

Consolidated Financial Statements<br />

Notes to the consolidated balance sheet – assets<br />

[1] Goodwill<br />

Major items included here are the goodwill of <strong>ERGO</strong><br />

Previdenza, Milan, from the acquisition in the 2000 financial<br />

year. Goodwill positions which amount to more than<br />

€ 30 million of the total <strong>Group</strong> goodwill are considered to be<br />

significant in line with IAS 36.134 and IAS 36.135.<br />

Allocation of goodwill to cash-generating units<br />

For impairment tests, goodwill is allocated to those cashgenerating<br />

units that derive benefits from the synergies<br />

from the respective business combination. At the same<br />

time, the unit to which the goodwill has been allocated is<br />

the lowest level at which goodwill is monitored for internal<br />

management purposes. We have allocated the goodwill<br />

amounts to legal entities or groups of legal entities.<br />

Our goodwill at 31 December <strong>2012</strong> was allocated to a<br />

cash-generating unit.<br />

Development during the financial year <strong>2012</strong><br />

€ million<br />

Year of acquisition 2000<br />

Cash-generating units or group of cash-generating units<br />

<strong>ERGO</strong><br />

Previdenza<br />

<strong>2012</strong><br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Other Total Total<br />

Gross carrying amount at 31 December previous year 43.1 573.8 616.9 666.8<br />

Accumulated impairment losses at 31 December previous year 10.0 401.3 411.3 389.9<br />

Carrying amount at 31 December previous year 33.1 172.5 205.6 276.9<br />

Currency translation differences − 0.1 0.1 − 0.4<br />

Additions − − − −<br />

Disposals − − − 49.5<br />

Impairment losses − − − 21.4<br />

Carrying amount at 31 December financial year 33.1 172.6 205.7 205.6<br />

Accumulated impairment losses at 31 December financial year 10.0 369.2 379.2 411.3<br />

Gross carrying amount at 31 December financial year 43.1 541.8 584.9 616.9


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements75<br />

Notes to the consolidated balance sheet – assets<br />

The impairment tests of goodwill positions classified as<br />

significant were carried out under the following assumptions:<br />

The recoverable amount of <strong>ERGO</strong> Previdenza, Milan, was<br />

derived on the basis of the market-consistent embedded<br />

value, which is usual in personal lines insurance business.<br />

The capital market parameters and volatilities applied are<br />

based on the cut-off date on 31 December 2011 and were<br />

adapted for changed capital market data in the meantime.<br />

There were also no indications for the recognition of impairment<br />

losses. Sensitivity analyses were carried out on the<br />

assumed technical risks, costs, capital market parameters<br />

and volatilities. The results thereby obtained were always<br />

above the book value of the cash-generating unit.<br />

For the impairment tests on the remaining goodwill<br />

positions the following assumptions were made:<br />

• The recoverable amount was derived on the basis of the<br />

value-in-use method or the market-consistent embedded<br />

value concept.<br />

• The Capital Asset Pricing Model (CAPM) is used to calculate<br />

the discount interest rate. It is calculated from<br />

a risk-free base rate plus a risk premium, taking into<br />

account a beta factor specific to the business. To derive<br />

the capital cost components (risk loading, capital<br />

structure), a peer group of international insurers is used<br />

in accordance with IAS 36. The risk-free base rate as<br />

well as the beta factor are taken from market data. For<br />

periods beyond the detailed cash flow planning growth<br />

rates of between 0.5% and 1.5% were used.<br />

The calculation is carried out before tax. A reconciliation<br />

with the capital costs of the <strong>ERGO</strong> Insurance <strong>Group</strong> is not<br />

possible. Other goodwill figures totalling € 172.6 million<br />

(172.5 m) were allocated to several cash-generating units<br />

or groups of units.<br />

The goodwill impairment tests in the <strong>2012</strong> financial year<br />

showed no recognition of impairment losses (2011: € 21.4 m).<br />

• The discount rate employed to calculate the valuein-use<br />

figure was calculated as cost of capital and<br />

amounts to between 7.2% and 13.2%, depending on<br />

the respective cash-generating unit.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements76<br />

Notes to the consolidated balance sheet – assets<br />

[2] Other intangible assets<br />

[2a]<br />

Development during<br />

the financial year<br />

Acquired<br />

insurance<br />

portfolios<br />

Self-<br />

developed<br />

Software<br />

Other<br />

Acquired<br />

brand<br />

names<br />

Acquired<br />

client<br />

bases<br />

Acquired<br />

licences/<br />

patents<br />

distribution<br />

networks/<br />

Selfdeveloped<br />

Other<br />

Other<br />

€ million € million € million € million € million € million € million € million € million<br />

Gross carrying amount<br />

at 31 December<br />

previous year 586.4 299.9 479.1 48.7 194.4 3.4 0.2 44.7 1,656.7<br />

Accumulated amortisation<br />

and accumulated<br />

impairment losses at<br />

31 December<br />

previous year 391.7 247.7 365.8 33.0 53.1 2.1 0.2 11.5 1,105.0<br />

Carrying amount<br />

at 31 December<br />

previous year 194.7 52.2 113.3 15.8 141.3 1.2 − 33.2 551.7<br />

Currency translation<br />

differences − − 2.4 − − − 0.1 0.7 3.2<br />

Change in<br />

consolidated group − − 1.4 − 1.2 − − − − − 1.0 − 3.6<br />

Additions 1.1 0.9 76.2 0.3 − − − 8.1 86.7<br />

Disposals − − 0.7 6.8 1.7 − − − 0.1 3.9 11.5<br />

Reclassification − 1.2 − 1.1 − − − − − 4.4 − 4.3<br />

Amortisation 37.8 6.7 42.0 1.4 11.5 0.4 − 2.9 102.7<br />

Impairment losses − − 0.1 12.9 − − − − 13.0<br />

Write-ups 12.8 − − − − − − − 12.8<br />

Carrying amount<br />

at 31 December<br />

financial year 170.7 47.1 140.7 0.1 129.8 0.8 − 29.7 519.0<br />

Accumulated amortisation<br />

and accumulated<br />

impairment losses at<br />

31 December<br />

financial year 416.8 252.3 402.8 45.8 61.1 2.6 0.1 18.1 1,199.6<br />

Gross carrying amount<br />

at 31 December<br />

financial year 587.5 299.4 543.5 45.9 191.0 3.4 0.1 47.8 1,718.6<br />

Total<br />

Acquired insurance portfolios comprise amortised book<br />

values of € 143.1 million (161.0 m) which stem from the<br />

acquisition of Bank Austria Creditanstalt Versicherung <strong>AG</strong>.<br />

Other intangible assets include rights equivalent to real<br />

property amounting to € 6.9 million (10.4 m). Additions<br />

mainly represent acquired software which, among other<br />

things, include the extension of portfolio management<br />

systems.<br />

Restrictions on disposals and pledges as security account<br />

for € – million (4.4 m). Commitments to acquire other<br />

intangible assets amount to € 1.0 million (1.7 m). Costs<br />

of € 0.1 million (15.8 m) for research and development<br />

incurred in connection with software projects were not<br />

capitalised but recognised as expenses.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements77<br />

Notes to the consolidated balance sheet – assets<br />

[2b]<br />

Development during<br />

the previous year<br />

Acquired<br />

insurance<br />

portfolios<br />

Self-<br />

developed<br />

Software<br />

Other<br />

Acquired<br />

brand<br />

names<br />

Acquired<br />

client<br />

bases<br />

Acquired<br />

licences/<br />

patents<br />

distribution<br />

networks/<br />

Selfdeveloped<br />

Other<br />

Other<br />

€ million € million € million € million € million € million € million € million € million<br />

Gross carrying amount<br />

at 31 December 2010 639.1 287.5 470.5 51.0 249.6 2.4 − 34.0 1,734.2<br />

Accumulated amortisation<br />

and accumulated<br />

impairment losses at<br />

31 December 2010 400.1 241.8 355.6 29.2 79.6 1.7 − 4.0 1,111.9<br />

Carrying amount at<br />

31 December 2010 239.0 45.8 115.0 21.9 170.0 0.7 − 29.9 622.3<br />

Currency translation<br />

differences − − − 3.6 − 0.4 − 0.8 − − − 0.3 − 5.1<br />

Change in<br />

consolidated group − 10.5 − 1.1 − 3.1 − − 0.1 − − 1.2 − 13.6<br />

Additions − 15.9 75.9 1.8 − 1.0 − 7.5 102.2<br />

Disposals − 1.7 21.3 − − 0.1 − 0.6 23.7<br />

Reclassification − 0.1 − 0.6 − − − − 0.1 − 0.4<br />

Amortisation 46.7 3.3 43.8 6.0 20.0 0.4 − 3.7 123.9<br />

Impairment losses 1.4 3.4 5.1 1.5 7.9 − − 1.0 20.3<br />

Write-ups 14.2 − − − − − − − 14.2<br />

Carrying amount at<br />

31 December 2011 194.7 52.2 113.3 15.8 141.3 1.2 − 33.2 551.7<br />

Accumulated amortisation<br />

and accumulated<br />

impairment losses at<br />

31 December 2011 391.7 247.7 365.8 33.0 53.1 2.1 0.2 11.5 1,105.0<br />

Gross carrying amount<br />

at 31 December 2011 586.4 299.9 479.1 48.7 194.4 3.4 0.2 44.7 1,656.7<br />

Total


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements78<br />

Notes to the consolidated balance sheet – assets<br />

[3] Land and buildings, including buildings on third-party land<br />

Development during the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gross carrying amount at 31 December previous year 3,181.5 3,529.3<br />

Accumulated depreciation and impairment losses at 31 December previous year 834.3 810.4<br />

Carrying amount at 31 December previous year 2,347.1 2,718.9<br />

Currency translation differences 0.7 − 8.1<br />

Change in consolidated group − − 268.6<br />

Additions 22.1 34.0<br />

Disposals 33.8 36.9<br />

Write-ups 11.7 3.3<br />

Depreciation 50.8 56.9<br />

Impairment losses 38.8 44.7<br />

Reclassification 12.6 6.0<br />

Carrying amount at 31 December financial year 2,270.8 2,347.1<br />

Accumulated depreciation and impairment losses at 31 December financial year 890.4 834.3<br />

Gross carrying amount at 31 December financial year 3,161.2 3,181.5<br />

Fair value as at 31 December financial year 3,051.4 3,151.6<br />

Restrictions on disposals and pledges as security exist<br />

for land and buildings totalling € 723.4 million (742.2 m).<br />

Capitalised expenditure on buildings under construction<br />

stood at € 1.6 million (8.3 m) on the balance sheet cutoff<br />

date; contractual commitments to acquire property<br />

stood at € 20.3 million (7.6 m).<br />

Buildings are depreciated on a straight-line basis over 40<br />

to 55 years. Impairment losses and write-ups are generally<br />

caused by adjustments to market value. The valuation is<br />

performed for each site individually at the cut-off date,<br />

except where valuation units are formed. Valuations are<br />

mainly conducted by in-house appraisers or, in some<br />

instances, by external experts. They are largely based on<br />

ascertaining the sustainability of income and expenditure<br />

flows while taking into account the development of the<br />

market situation where the respective property is located.<br />

The fair value is calculated for each individual property by<br />

discounting future net payments at the time of valuation.<br />

Interest rates are applied according to the type of property<br />

involved: residential property 3.0% to 5.5%, commercial<br />

property 4.0% to 8.0% and retail property from 4.0% to<br />

8.25%.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements79<br />

Notes to the consolidated balance sheet – assets<br />

[4] Investments in affiliated companies and associates<br />

The fair value of interests in associated companies, which<br />

are generally valued at equity, is € 762.7 million (776.0 m)<br />

at the balance sheet date. The fair value of interests in<br />

associated companies which are valued at equity includes<br />

interests amounting to € 69.0 million (62.2 m) for which<br />

publicly quoted market prices are available. In the financial<br />

year losses of € 4.3 million (11.4 m) incurred by associated<br />

companies were not recognised. Losses caused by associated<br />

companies but not recorded amount to a total of<br />

€ 30.1 million (25.8 m).<br />

The assets of all associated companies total € 5,427.0 million<br />

(5,722.2 m), the liabilities € 4,155.5 million (4,411.3 m),<br />

the annual results € − 20.1 million (7.1 m) and the turnover<br />

€ 1,441.1 million (715.5 m). For associated companies not<br />

valued at equity, the assets total € 87.1 million (91.5 m),<br />

liabilities € 61.2 million (64.6 m), annual results € 0.1 million<br />

(− 1.1 m), and turnover € 116.2 million (111.1 m).<br />

The full list of all shareholdings can be found in the “List of<br />

shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code”.<br />

Breakdown of investments in affiliated companies and associates <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Affiliated companies<br />

Accounted for at fair value 76.1 120.7<br />

Associates<br />

Accounted for using the equity method 441.9 410.6<br />

Accounted for at fair value 10.2 12.3<br />

452.1 422.9<br />

Total 528.2 543.6<br />

[5] Loans<br />

[5a]<br />

Breakdown of loans Carrying amounts Fair values<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Mortgage loans 4,427.0 4,408.0 5,059.7 4,852.4<br />

Loans and advance payments on insurance policies 598.1 601.0 598.1 601.0<br />

Other loans 49,348.2 48,205.6 57,531.3 51,384.8<br />

Total 54,373.3 53,214.6 63,189.1 56,838.2<br />

Other loans comprise mainly pfandbriefs, government<br />

bonds, and promissory notes by banks.<br />

The fair value of loans is determined by recognised methods<br />

of valuation in line with the present value principle and<br />

taking into account observed market parameters


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements80<br />

Notes to the consolidated balance sheet – assets<br />

[5b]<br />

Rating categories<br />

Carrying amounts<br />

Other securities<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

AAA 21,950.6 23,954.6<br />

AA 20,556.2 17,250.6<br />

A 4,109.7 4,690.6<br />

BBB 1,750.4 804.3<br />

BB and less 544.3 170.8<br />

No rating 437.1 1,334.7<br />

Total 49,348.2 48,205.6<br />

The rating categories are based on those of the leading<br />

international rating agencies. In deviation from the purely<br />

economic view, the carrying amount of the loans represents<br />

the maximum exposure to credit risk at the balance<br />

sheet date, in accordance with IFRS 7. Virtually no credit<br />

risk exists in respect of the mortgage loans or the loans<br />

and advance payments on insurance policies.<br />

[5c]<br />

Maturity structure<br />

Carrying amounts<br />

Fair values<br />

Loans<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Contractual period to maturity<br />

Up to one year 1,248.9 2,009.5 1,267.0 2,021.4<br />

Over one year and up to two years 1,984.7 1,358.1 2,089.5 1,395.9<br />

Over two years and up to three years 2,979.3 2,118.0 3,214.5 2,217.7<br />

Over three years and up to four years 2,014.9 3,013.8 2,202.9 3,221.7<br />

Over four years and up to five years 2,549.3 2,193.2 2,797.4 2,322.3<br />

Over five years and up to ten years 13,019.0 13,428.1 15,231.3 14,255.9<br />

Over ten years 30,577.2 29,093.9 36,386.5 31,403.3<br />

Total 54,373.3 53,214.6 63,189.1 56,838.2<br />

[6] Other securities<br />

[6a]<br />

Other securities –<br />

Carrying amounts<br />

Unrealised<br />

Fair values<br />

held to maturity<br />

gains / losses<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Government bonds − − − − − −<br />

Debt securities of banks 7.3 13.4 0.2 0.1 7.5 13.5<br />

Total 7.3 13.4 0.2 0.1 7.5 13.5


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements81<br />

Notes to the consolidated balance sheet – assets<br />

[6b]<br />

Allocation of investments measured at fair value<br />

to levels of the fair value hierarchy<br />

Other securities, available for sale<br />

Level 1<br />

€ million<br />

Level 2<br />

€ million<br />

Level 3<br />

€ million<br />

<strong>2012</strong><br />

Total<br />

€ million<br />

Fixed-interest securities 42,681.1 11,885.8 812.5 55,379.4<br />

Non-fixed-interest securities 2,478.3 52.2 1,290.4 3,820.9<br />

Investments in affiliated companies and associates<br />

45,159.4 11,938.0 2,102.9 59,200.3<br />

Affiliated companies measured at fair value − − 76.1 76.1<br />

Associates measured at fair value − − 10.2 10.2<br />

Other securities at fair value through profit or loss<br />

− − 86.3 86.3<br />

Held for trading (including derivatives) 1 42.4 1,199.7 1.0 1,243.1<br />

Designated as at fair value through profit or loss − 168.9 − 168.9<br />

42.4 1,368.6 1.0 1,412.0<br />

Investments for the benefit of life insurance<br />

policyholders who bear the investment risk 5,957.0 − − 5,957.0<br />

Total 51,158.7 13,306.6 2,190.2 66,655.5<br />

Breakdown in % 77 20 3 100<br />

1 Including hedging derivatives.<br />

Reconciliation for investments<br />

allocated to Level 3<br />

Other securities –<br />

available for sale<br />

Fixedinterest<br />

Non-fixedinterest<br />

Affiliated<br />

companies<br />

recognised<br />

at fair<br />

value<br />

Investments<br />

Other securities – at fair<br />

value through profit or loss<br />

Associates 1 Held for Designated as at<br />

trading<br />

(including<br />

derivatives) 2<br />

fair value through<br />

profit or loss<br />

Total<br />

€ million € million € million € million € million € million € million<br />

Carrying amount at<br />

31 December 2011 140.6 1,066.3 120.7 12.3 − − 1,339.9<br />

Gains and losses<br />

Gains (losses) recognised<br />

in the income statement − 2.7 − 16.3 − 4.9 − 2.4 − − − 26.3<br />

Gains (losses)<br />

recognised in equity 13.7 23.5 2.1 0.5 − − 39.8<br />

11.0 7.2 − 2.8 − 1.9 − − 13.5<br />

Acquisitions 285.0 263.1 2.5 0.7 − − 551.3<br />

Disposals − 144.9 − 106.0 − 42.0 − 1.1 − 0.1 − − 294.1<br />

Transfer to/out of Level 3 521.0 58.3 − 2.3 − 0.7 − 577.6<br />

Changes in the market<br />

value of derivatives − 0.3 1.5 − 0.1 0.4 − 1.8<br />

Carrying amount at<br />

31 December <strong>2012</strong> 812.5 1,290.4 76.1 10.2 1.0 − 2,190.2<br />

Gains (losses) recognised in the<br />

income statement that are attributable<br />

to investments shown at the<br />

end of the financial year − 11.4 − 7.3 − − 18.8<br />

1 Recognised at fair value.<br />

2 Including hedging derivatives.<br />

In the financial year we reclassified a further part of the<br />

residual mortgage-backed securities (RMBS) in our portfolio<br />

from level 3 to level 2. Increased liquidity meant that we<br />

were able to revert to using only observable market data<br />

for these products. At the same time, some collaterialized<br />

loan obligations (CLO) and commercial mortgage-backed<br />

securities (CMBS) were reclassified from level 2 to level 3,<br />

since we also took into consideration parameters for their<br />

valuation which were not observable on the market due to<br />

a lack of liquidity.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements82<br />

Notes to the consolidated balance sheet – assets<br />

Allocation of investments measured at fair value<br />

to levels of the fair value hierarchy<br />

Other securities, available for sale<br />

Level 1<br />

€ million<br />

Level 2<br />

€ million<br />

Level 3<br />

€ million<br />

2011<br />

Total<br />

€ million<br />

Fixed-interest securities 37,558.1 13,229.9 140.6 50,928.6<br />

Non-fixed-interest securities 1,439.8 155.2 1,066.3 2,661.4<br />

Investments in affiliated companies and associates<br />

38,997.9 13,385.1 1,206.9 53,589.9<br />

Affiliated companies measured at fair value − − 120.7 120.7<br />

Associates measured at fair value − − 12.3 12.3<br />

Other securities at fair value through profit or loss<br />

− − 133.0 133.0<br />

Held for trading (including derivatives) 1 147.1 802.1 − 949.2<br />

Designated as at fair value through profit or loss − 164.5 − 164.5<br />

147.1 966.6 − 1,113.7<br />

Investments for the benefit of life insurance<br />

policyholders who bear the investment risk 5,092.0 − − 5,092.0<br />

Total 44,237.0 14,351.7 1,339.9 59,928.6<br />

Breakdown in % 74 24 2 100<br />

1 Including hedging derivatives.<br />

Reconciliation for investments<br />

allocated to Level 3<br />

Other securities –<br />

available for sale<br />

Fixedinterest<br />

Non-fixedinterest<br />

Affiliated<br />

companies<br />

recognised<br />

at fair<br />

value<br />

Investments<br />

Other securities – at fair<br />

value through profit or loss<br />

Associates 1 Held for Designated as at<br />

trading<br />

(including<br />

derivatives) 2<br />

fair value through<br />

profit or loss<br />

Total<br />

€ million € million € million € million € million € million € million<br />

Carrying amount at<br />

31 December 2010 188.5 441.9 113.6 12.9 − − 756.8<br />

Gains and losses<br />

Gains (losses) recognised<br />

in the income statement 5.2 − 5.1 − 23.0 − 0.1 − − − 23.0<br />

Gains (losses)<br />

recognised in equity − 5.4 30.3 5.9 0.2 − − 31.0<br />

− 0.2 25.2 − 17.1 0.1 − − 8.0<br />

Acquisitions 95.8 203.1 58.0 0.1 − − 357.0<br />

Disposals − 91.9 − 47.6 − 35.8 − 0.8 − − − 176.0<br />

Transfer to/out of Level 3 − 51.6 443.8 1.9 − − − 394.1<br />

Changes in the market<br />

value of derivatives − − − − − − −<br />

Carrying amount at<br />

31 December 2011 140.6 1,066.3 120.7 12.3 − − 1,339.9<br />

Gains (losses) recognised in the<br />

income statement that are attributable<br />

to investments shown at the<br />

end of the financial year 3.5 − 10.8 − − 7.3<br />

1 Recognised at fair value.<br />

2 Including hedging derivatives.<br />

Trading assets allocated to level 3 are exclusively made<br />

up of derivatives with the appropriate level allocation.<br />

The increase in capital investments allocated to level 3 is<br />

largely the result of the reclassification of CMBS.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements83<br />

Notes to the consolidated balance sheet – assets<br />

[6c]<br />

Other securities –<br />

Carrying amounts<br />

Unrealised<br />

Fair values<br />

available for sale<br />

gains/losses<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Fixed-interest securities<br />

Government bonds<br />

Germany 4,648.3 5,467.6 668.7 518.7 5,317.0 5,986.3<br />

Rest of EU 12,500.0 13,183.5 972.8 − 649.5 13,472.8 12,534.0<br />

USA 538.5 83.7 7.8 1.8 546.3 85.5<br />

Other 1,222.7 1,085.7 98.2 − 5.9 1,321.0 1,079.8<br />

18,909.6 19,820.5 1,747.5 − 134.9 20,657.1 19,685.6<br />

Corporate debt securities 24,681.7 23,429.8 2,328.9 730.2 27,010.7 24,160.1<br />

Other 6,982.5 6,745.8 729.1 337.1 7,711.7 7,082.9<br />

50,573.9 49,996.1 4,805.5 932.4 55,379.4 50,928.6<br />

Non-fixed-interest securities<br />

Shares 1,376.4 691.9 160.6 68.1 1,537.0 760.0<br />

Investment funds<br />

Equity funds 285.4 273.8 30.2 11.1 315.6 284.9<br />

Bond funds 599.4 407.8 35.0 − 1.1 634.4 406.7<br />

Real estate funds 477.4 481.7 15.8 10.0 493.3 491.7<br />

1,362.3 1,163.4 81.0 20.0 1,443.3 1,183.4<br />

Other 776.7 670.9 63.9 47.1 840.6 718.0<br />

3,515.4 2,526.2 305.5 135.2 3,820.9 2,661.4<br />

Total 54,089.2 52,522.3 5,111.0 1,067.6 59,200.3 53,589.9<br />

Quoted securities account for 4.0% (2.6%) of the given<br />

balance sheet value.<br />

About two thirds of the debt instruments issued by companies<br />

are pfandbriefs, bank bonds or issues by development<br />

banks and comparable institutions. The remaining portfolio<br />

comprises debt instruments of German local and regional<br />

authorities, with each single risk representing less than<br />

2.0%, issues by companies outside the banking sector and<br />

asset-backed securities/mortgage-backed securities which<br />

have above-average ratings.<br />

A sum of € 1,049.5 million (224.2 m) from unrealised gains/<br />

losses totalling € 5,111.0 million (1,067.6 m) is contained<br />

in equity (other reserves) after deductions were made<br />

for expenditure on deferred premium refunds, deferred<br />

taxes and non-controlling interests as well as effects of<br />

consolidation.<br />

Restrictions on disposals and pledges as security account<br />

for € 188.5 million (102.2 m).<br />

€ 1,272,2 million (1,198.1 m) of securities shown are loaned<br />

to third parties. These securities continue to be recognised<br />

in our balance sheet, as the major opportunities and risks<br />

associated with them remain with the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong>.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements84<br />

Notes to the consolidated balance sheet – assets<br />

[6d]<br />

Other securities – at fair value through profit or loss <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Held for trading<br />

Fixed-interest securities 58.4 59.3<br />

Non-fixed-interest securities 0.2 2.3<br />

58.6 61.6<br />

Derivatives 1,124.6 842.2<br />

Designated as at fair value through profit or loss<br />

Fixed-interest securities 167.0 160.4<br />

Non-fixed-interest securities 2.0 4.1<br />

168.9 164.5<br />

Total 1,352.1 1,068.2<br />

To ascertain the fair values of derivatives, listed prices, option<br />

price models and valuations by external sources were taken<br />

into account. There are no securities lent to third parties.<br />

[6e]<br />

Maturity structure<br />

Carrying amounts<br />

Fair values<br />

Other securities – held to maturity<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Contractual period to maturity<br />

Up to one year 2.9 6.1 2.9 6.1<br />

Over one year and up to two years 4.2 2.9 4.3 2.9<br />

Over two years and up to three years 0.2 4.2 0.2 4.2<br />

Over three years and up to four years − 0.2 − 0.2<br />

Over four years and up to five years − − − −<br />

Over five years and up to ten years − − − −<br />

Over ten years − − − −<br />

Total 7.3 13.4 7.5 13.5<br />

[6f]<br />

Maturity structure<br />

Carrying amounts<br />

Fair values<br />

Other securities – available for sale; fixed-interest securities<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Contractual period to maturity<br />

Up to one year 5,130.7 4,592.3 4,483.8 4,635.5<br />

Over one year and up to two years 3,971.4 4,533.4 4,100.3 4,610.0<br />

Over two years and up to three years 4,111.7 4,249.2 4,460.2 4,405.6<br />

Over three years and up to four years 4,675.0 4,131.4 4,958.9 4,198.3<br />

Over four years and up to five years 4,515.9 3,964.9 4,854.8 4,096.1<br />

Over five years and up to ten years 15,643.2 16,629.1 17,477.5 16,890.6<br />

Over ten years 12,525.8 11,895.8 15,043.9 12,092.4<br />

Total 50,573.9 49,996.1 55,379.4 50,928.6


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements85<br />

Notes to the consolidated balance sheet – assets<br />

[6g]<br />

Rating categories<br />

Carrying amounts<br />

Other securities – held to maturity<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

AAA − −<br />

AA − 0.5<br />

A 7.0 12.5<br />

BBB − −<br />

BB and less − −<br />

No rating 0.3 0.3<br />

Total 7.3 13.4<br />

The rating categories are based on those of the leading<br />

international rating agencies. In deviation from the purely<br />

[6h]<br />

economic view, the carrying amount of the securities<br />

represents the maximum exposure to credit risk at the<br />

balance sheet date, in accordance with IFRS 7.<br />

Rating categories<br />

Fair values<br />

Other securities – available for sale; fixed-interest securities<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

AAA 23,872.8 26,895.5<br />

AA 13,112.8 9,778.0<br />

A 8,842.7 7,835.9<br />

BBB 8,389.1 4,555.2<br />

BB and less 1,034.6 1,739.6<br />

No rating 127.4 124.5<br />

Total 55,379.4 50,928.6<br />

The rating categories are based on those of the leading<br />

international rating agencies. In deviation from the purely<br />

[6i]<br />

economic view, the carrying amount of the securities<br />

represents the maximum exposure to credit risk at the<br />

balance sheet date, in accordance with IFRS 7.<br />

Rating categories<br />

Fair values<br />

Other securities – at fair value through profit or loss; fixed-interest securities<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

AAA 33.8 37.4<br />

AA 52.0 79.7<br />

A 94.3 60.4<br />

BBB 45.3 31.6<br />

BB and less − −<br />

No rating − 10.5<br />

Total 225.3 219.7<br />

The rating categories are based on those of the leading<br />

international rating agencies. In deviation from the purely<br />

economic view, the carrying amount of the securities<br />

represents the maximum exposure to credit risk at the<br />

balance sheet date, in accordance with IFRS 7.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements86<br />

Notes to the consolidated balance sheet – assets<br />

[6j]<br />

Disposal proceeds<br />

Other securities – available for sale<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Fixed-interest securities 17,512.6 12,716.2<br />

Non-fixed-interest securities<br />

Quoted 2,065.5 2,827.9<br />

Unquoted 119.7 84.7<br />

2,185.2 2,912.6<br />

Total 19,697.8 15,628.8<br />

[6k]<br />

Realised gains and losses<br />

Other securities – available for sale<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gains on disposal<br />

Fixed-interest securities 381.0 429.0<br />

Non-fixed-interest securities 145.3 177.1<br />

526.3 606.1<br />

Losses on disposal<br />

Fixed-interest securities 465.1 195.1<br />

Non-fixed-interest securities 64.2 166.8<br />

529.3 361.8<br />

Total − 3.0 244.3<br />

[6l] Derivatives<br />

Derivatives are financial instruments, the fair value of<br />

which is derived from one or more underlying assets.<br />

Derivatives are used to hedge against currency, interestrate<br />

and market risks. This is done at the individual <strong>Group</strong><br />

company level within the framework of individual supervisory<br />

regulations and additional internal company directives.<br />

The risk of default is virtually non-existent in the case<br />

of products traded on the stock exchange.<br />

Over-the-counter derivatives, on the other hand, harbour<br />

a theoretical risk in the amount of the replacement costs.<br />

Consequently, only top-quality counterparties are chosen<br />

by the <strong>ERGO</strong> Insurance <strong>Group</strong> for these transactions.<br />

For derivatives as at 31 December <strong>2012</strong>, <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> has received collateral in the form of securities with<br />

a minimum rating of AA which may be sold or passed on<br />

as security. The fair value of this collateral is € 621.6 million<br />

(260.9 m).<br />

Disclosure of derivatives by balance sheet item<br />

Fair value<br />

Positive<br />

Negative<br />

Qualifying for hedge<br />

accounting<br />

No<br />

Balance sheet item <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Investments, other<br />

securities, held for trading 1,124.6 842.2<br />

Yes Other assets 59.8 45.4<br />

No<br />

Yes<br />

Liabilities,<br />

other liabilities − 74.0 − 117.9<br />

Total 1,110.5 769.7


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements87<br />

Notes to the consolidated balance sheet – assets<br />

[6m]<br />

Derivatives – open items<br />

The table below shows the fair values and related par<br />

values of all our open items, broken down into risk types.<br />

Positive and negative fair values have been set off against<br />

each other. At € 1,110.5 million (769.7 m), open items<br />

accounted for 0.8% (0.6%) of the balance sheet total on<br />

31 December <strong>2012</strong>.<br />

Interest rate risks associated with life insurance are<br />

hedged using swaptions and total return swaps. These<br />

options for obtaining a fixed interest rate are shown in<br />

the category “interest-rate risks/over-the-counter” At the<br />

reporting date, the fair value of the said derivatives was<br />

€ 427.2 million (537.4 m), while the underlying nominal<br />

amount was € 2,841 million (5,039.8 m). The investment<br />

result from derivatives includes income stemming from<br />

fluctuations in the value of these items amounting to<br />

€ 124.8 million (355.0 m).<br />

Cash flow hedges<br />

Cash flow hedges play a role in countering fluctuations<br />

that may be caused, for example, by variable interest payments.<br />

At <strong>ERGO</strong> Insurance <strong>Group</strong>, cash flow hedges are<br />

largely used to hedge against interest-rate risks. We mainly<br />

use interest-rate swaps for this. Changes to the fair value<br />

of the hedging instrument are recognised directly in equity<br />

for this purpose. Only when the actual cash inflow or outflow<br />

takes place, caused by the hedged circumstance, is<br />

the relevant equity item reversed with recognition in the<br />

income statement.<br />

The change to the fair value of the hedging instrument<br />

assignable to the ineffective portion of the hedging is negligible<br />

on the reporting date. The equity item from cash<br />

flow hedges was € 5.2 million (4.7 m) on the reporting date.<br />

The net fair value of derivatives falling into this category on<br />

the reporting date stood at € 46.8 million (39.1 m).<br />

Although the derivatives basically serve to hedge risks<br />

economically at <strong>ERGO</strong> Insurance <strong>Group</strong>, only a portion of<br />

€ 46.8 million (39.1 m) meets the strict requirements of<br />

IAS 39 for hedge accounting.<br />

IAS 39 distinguishes between fair value hedges, cash flow<br />

hedges and the hedging of a net investment in a foreign<br />

business. For <strong>ERGO</strong> Insurance <strong>Group</strong>, only cash flow hedges<br />

are currently relevant.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements88<br />

Notes to the consolidated balance sheet – assets<br />

Derivatives – open positions Periods to maturity in years Total<br />

< 1 1−2 2−3 3−4 4−5 > 5 <strong>2012</strong> 2011<br />

€ million € million € million € million € million € million € million € million<br />

Interest-rate risks<br />

Traded on the stock exchange<br />

Fair values − 1.3 − − − − − − 1.3 − 4.0<br />

Notional principal amounts 739.4 − − − − − 739.4 602.5<br />

Over-the-counter<br />

Fair values 65.6 107.3 74.9 68.7 45.4 652.5 1,014.4 825.1<br />

Notional principal amounts 524.8 2,087.8 793.8 548.8 440.0 5,541.4 9,936.5 10,016.8<br />

Total<br />

Fair values 64.3 107.3 74.9 68.7 45.4 652.5 1,013.1 821.1<br />

Notional principal amounts 1,264.2 2,087.8 793.8 548.8 440.0 5,541.4 10,675.9 10,619.3<br />

Currency risks<br />

Traded on the stock exchange<br />

Fair values − − − − − − − − 0.1<br />

Notional principal amounts 21.5 − − − − − 21.5 20.0<br />

Over-the-counter<br />

Fair values 49.6 − − − − − 2.8 46.8 − 63.7<br />

Notional principal amounts 3,645.9 − − − − 218.5 3,864.4 2,884.5<br />

Total<br />

Fair values 49.6 − − − − − 2.8 46.8 − 63.8<br />

Notional principal amounts 3,667.4 − − − − 218.5 3,885.9 2,904.5<br />

Equity and index risks<br />

Traded on the stock exchange<br />

Fair values 34.2 − − − − − 34.2 − 0.3<br />

Notional principal amounts 1,174.9 − − − − − 1,174.9 320.9<br />

Over-the-counter<br />

Fair values − 0.6 15.7 0.3 − − 16.6 13.6<br />

Notional principal amounts 58.4 48.2 63.0 3.1 − − 172.7 157.5<br />

Total<br />

Fair values 34.2 0.6 15.7 0.3 − − 50.8 13.3<br />

Notional principal amounts 1,233.3 48.2 63.0 3.1 − − 1,347.6 478.3<br />

Credit risks<br />

Over-the-counter<br />

Fair values − − − − − 1.2 − − 1.2 − 2.2<br />

Notional principal amounts 6.1 − − − 49.0 − 55.1 71.9<br />

Commodity risks<br />

Over-the-counter<br />

Fair values − − − − − − − 0.6<br />

Notional principal amounts 14.4 − − − − − 14.4 14.6<br />

Insurance risks<br />

Over-the-counter<br />

Fair values − − − − − 1.0 1.0 0.7<br />

Notional principal amounts − − − − − 6.7 6.7 6.9<br />

Other Risks<br />

Over-the-counter<br />

Fair values − − − − − − − − 0.1<br />

Notional principal amounts − − − − − − − 1.6<br />

Total<br />

Fair values 148.1 107.9 90.6 69.1 44.2 650.6 1,110.5 769.7<br />

Notional principal amounts 6,185.3 2,135.9 856.7 551.9 489.0 5,766.7 15,985.6 14,097.1


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements89<br />

Notes to the consolidated balance sheet – assets<br />

[6n]<br />

The following table shows the period until maturity and<br />

amount of cash flows hedged at the balance sheet date.<br />

Notional principal amounts of hedged transactions <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Contractual period to maturity<br />

Up to one year – −<br />

Over one year and up to two years 25.0 −<br />

Over two years and up to three years – 25.0<br />

Over three years and up to four years 25.0 −<br />

Over four years and up to five years 25.0 25.0<br />

Over five years 314.0 339.0<br />

Total 389.0 389.0<br />

[7] Other investments<br />

Other investments mainly comprise deposits retained on<br />

assumed reinsurance business at € 152.8 million (171.0 m)<br />

and deposits with banks totalling € 1,520.9 million (1,255.2 m).<br />

The latter includes € 119.4 million (104.3 m) from repurchase<br />

agreements that have been booked by us as the<br />

lender.<br />

By contrast to the purely economic view, the book value<br />

of these other financial assets represents the maximum<br />

credit exposure at the balance sheet date, in accordance<br />

with IFRS 7.<br />

Since deposits with banks predominantly have a term of<br />

less than one year, the fair values are largely the same as<br />

the book values. Restrictions on disposals and pledges as<br />

security exist for deposits with banks totalling € 6.6 million<br />

(27.3 m).<br />

[8] Reinsurers’ share in technical provisions<br />

Reinsurers’ share in technical provisions <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Unearned premiums 122.0 143.1<br />

Provision for future policy benefits 3,627.9 3,586.7<br />

Provision for outstanding claims 638.1 859.4<br />

Other technical provisions 172.5 186.6<br />

Total 4,560.6 4,775.7


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements90<br />

Notes to the consolidated balance sheet – assets<br />

[9] Other receivables<br />

[9a]<br />

Receivables from insurance representatives account for<br />

€ 407.4 million (464.9 m) of amounts receivable from<br />

direct insurance business. Receivables include amounts<br />

of € 265.4 million (377.7 m) which result from contracts<br />

without significant risk transfer. These contracts are not<br />

subject to IFRS 4. By contrast to the purely economic<br />

view, the carrying amount of the receivables represents<br />

the maximum exposure to credit risk at the cut-off date,<br />

in accordance with IFRS 7. As other receivables generally<br />

have a term of less than one year, the fair values largely<br />

correspond to the carrying amounts.<br />

Other receivables <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Interest and rent 2,010.1 2,029.3<br />

Amounts receivable on direct business 1,042.7 1,051.7<br />

Amounts receivable from contracts without significant risk transfer 265.4 377.7<br />

Profit-unrelated tax receivables 121.2 117.6<br />

Accounts receivable on reinsurance business 125.9 109.9<br />

Miscellaneous receivables 856.7 646.0<br />

Total 4,422.0 4,332.2<br />

[9b]<br />

Maturity structure of other receivables<br />

Carrying amounts<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Contractual period to maturity<br />

Up to one year 4,254.8 4,140.9<br />

Over one and up to two years 35.4 31.1<br />

Over two years and up to three years 30.0 37.5<br />

Over three years and up to four years 29.5 28.6<br />

Over four years and up to five years 35.2 29.8<br />

Over five years and up to ten years 0.6 29.4<br />

Over ten years 36.5 34.9<br />

Total 4,422.0 4,332.2


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements91<br />

Notes to the consolidated balance sheet – assets<br />

[10] Deferred acquisition costs<br />

Deferred acquisition costs (gross) <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 6,413.7 6,522.9<br />

Currency translation differences 21.8 − 25.4<br />

Newly deferred acquisition costs 966.8 1,001.6<br />

Amortisation − 847.0 − 803.9<br />

Impairment losses − 172.6 − 248.8<br />

Change in consolidated group/other effects − 19.7 − 32.7<br />

Carrying amount at 31 December financial year 6,362.9 6,413.7<br />

Scheduled changes include amortisation as well as scheduled<br />

return on interest. Non-scheduled changes comprise writeups<br />

and write-downs resulting from changes made to the<br />

assumptions on which calculations are based and which<br />

need to be readjusted.<br />

Assumptions concerning the long-term interest level had to<br />

be revised in the financial year to take account of the longterm<br />

regular interest return on investments. The current<br />

lower interest margin and the revision of other assumptions<br />

led to impairment losses of deferred acquisition costs.<br />

[11] Deferred tax assets<br />

The deferred tax assets and liabilities recognised in the<br />

consolidated balance sheet concern the following balance<br />

sheet items:<br />

[11a]<br />

Causes of origin Assets Liabilities<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Assets<br />

Intangible assets 15.0 8.2 77.4 89.8<br />

Investments 806.1 1,197.5 1,299.0 1,183.6<br />

Deferred acquisition costs 1.8 1.6 546.7 572.3<br />

Other assets 569.2 513.6 445.5 392.5<br />

Total Assets 1,392.1 1,720.9 2,368.6 2,238.2<br />

Equity and liabilities<br />

Technical provisions (net) 405.1 458.5 369.7 442.4<br />

Other accrued liabilities 404.8 170.8 76.8 86.8<br />

Other liabilities 106.3 91.7 6.7 15.6<br />

Total equity and liabilities 916.2 721.0 453.2 544.8<br />

Off balance sheet<br />

Loss carry-forwards and tax credits 92.6 64.2 − −<br />

Total 2,401.0 2,506.1 2,821.8 2,783.0<br />

Of the change of € − 144.0 million (155.4 m) in net deferred<br />

tax liabilities, € 75.6 million (195.8 m) was recognised in<br />

earnings and € − 219.6 million (− 40.4 m) without impact on<br />

profit or loss.<br />

No deferred taxes were recorded for temporary differences<br />

of € 113.8 million (104.8 m) in conjunction with shares in<br />

subsidiaries and associated companies – so-called outside<br />

basis differences.<br />

Deferred taxes on loss carry-forwards were recognised<br />

as assets to the extent that the tax result planning led<br />

with sufficient certainty to an expected use. We have<br />

broken down the existing deferred tax assets on loss carryforwards<br />

in the following table.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements92<br />

Notes to the consolidated balance sheet – assets<br />

[11b]<br />

Development of deferred tax assets for<br />

loss carry-forwards and tax credits<br />

31 December<br />

previous<br />

Subsequent additions<br />

and reduc­<br />

Additions<br />

due to new<br />

Set off<br />

against<br />

31 December<br />

financial year<br />

year tions due to<br />

changes in valuation<br />

allowances<br />

losses income/<br />

Deconsolidation<br />

€ million € million € million € million € million<br />

Deferred tax assets for<br />

Corporation tax loss carry-forwards 58.0 3.7 25.3 − 6.9 80.1<br />

Trade tax loss carry-forwards 6.2 6.3 1.8 − 1.8 12.5<br />

Loss carry-forwards from capital losses − − − − −<br />

Tax credits − − − − −<br />

Total 64.2 10.0 27.1 − 8.7 92.6<br />

[11c]<br />

Tax loss carry-forwards<br />

and tax credits<br />

Corporation tax loss carry-forwards<br />

For which<br />

deferred tax<br />

assets are<br />

recognised<br />

For which<br />

deferred tax<br />

assets are not<br />

recognised<br />

<strong>2012</strong> 2011<br />

Total<br />

For which<br />

deferred tax<br />

assets are<br />

recognised<br />

For which<br />

deferred tax<br />

assets are not<br />

recognised<br />

Total<br />

€ million € million € million € million € million € million<br />

Expiring in up to three years 29.7 118.0 147.7 13.1 67.2 80.3<br />

Expiring in over three years<br />

and up to ten years 103.8 23.7 127.5 112.5 66.4 178.9<br />

Expiring in over ten years − 5.7 5.7 − 2.7 2.7<br />

Not expiring 205.6 201.2 406.8 130.6 252.2 382.8<br />

Trade tax loss carry-forwards<br />

339.1 348.6 687.7 256.2 388.5 644.7<br />

Not expiring 79.7 131.8 211.5 39.5 168.1 207.6<br />

Loss carry-forwards<br />

from capital losses<br />

Expiring in up to three years − − − − − −<br />

Expiring in over three years<br />

and up to ten years − − − − − −<br />

Expiring in over ten years − − − − − −<br />

Not expiring − − − − − −<br />

Tax credits<br />

Expiring in up to three years − − − − − −<br />

Expiring in over three years<br />

and up to ten years − − − − − −<br />

Expiring in over ten years − − − − − −<br />

Not expiring − − − − − −<br />

Total 418.8 480.4 899.2 295.7 556.6 852.3


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements93<br />

Notes to the consolidated balance sheet – assets<br />

[12] Other assets<br />

[12a]<br />

Breakdown <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Tangible assets 1,672.3 1,674.5<br />

Assets from insurance contracts 392.7 436.5<br />

Other 171.9 212.6<br />

Total 2,237.0 2,323.5<br />

[12b]<br />

Tangible assets –<br />

development during the financial year<br />

Owner-<br />

occupied<br />

property<br />

<strong>2012</strong><br />

€ million<br />

Operating<br />

and office<br />

equipment<br />

<strong>2012</strong><br />

€ million<br />

Other<br />

<strong>2012</strong><br />

€ million<br />

Total<br />

<strong>2012</strong><br />

€ million<br />

Gross carrying amount at 31 December previous year 2,084.7 564.8 6.0 2,655.6<br />

Accumulated depreciation and accumulated impairment<br />

losses at 31 December previous year 610.2 365.6 5.3 981.2<br />

Carrying amount at 31 December previous year 1,474.6 199.2 0.7 1,674.5<br />

Currency translation differences 3.8 1.6 − 5.4<br />

Change in consolidated group − − 1.2 − − 1.2<br />

Additions 39.2 61.9 0.3 101.4<br />

Disposals 4.6 5.9 − 10.5<br />

Write-ups 22.4 − − 22.4<br />

Depreciation 40.7 68.1 0.4 109.2<br />

Impairment losses 2.0 − − 2.0<br />

Reclassification − 8.3 − − − 8.3<br />

Carrying amount at 31 December financial year 1,484.3 187.4 0.6 1,672.3<br />

Accumulated depreciation and accumulated impairment<br />

losses at 31 December financial year 625.0 364.9 5.5 995.4<br />

Gross carrying amount at 31 December financial year 2,109.3 552.3 6.1 2,667.8


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements94<br />

Notes to the consolidated balance sheet – assets<br />

Development in 2011<br />

Owner-<br />

occupied<br />

property<br />

2011<br />

€ million<br />

Operating<br />

and office<br />

equipment<br />

2011<br />

€ million<br />

Other<br />

2011<br />

€ million<br />

Total<br />

2011<br />

€ million<br />

Gross carrying amount at 31 December 2010 2,083.9 553.6 6.1 2,643.6<br />

Accumulated depreciation and accumulated<br />

impairment losses at 31 December 2010 577.8 350.1 5.1 932.9<br />

Carrying amount at 31 December 2010 1,506.1 203.5 1.0 1,710.6<br />

Currency translation differences − 6.0 − 1.8 − − 7.7<br />

Change in consolidated group − 21.5 − 11.3 − − 32.9<br />

Additions 49.2 93.5 0.3 142.9<br />

Disposals 5.5 6.7 − 12.1<br />

Write-ups 0.4 − − 0.4<br />

Depreciation 36.3 77.5 0.6 114.3<br />

Impairment losses 5.8 1.5 − 7.3<br />

Reclassification − 6.0 1.0 − − 5.1<br />

Carrying amount at 31 December 2011 1,474.6 199.2 0.7 1,674.5<br />

Accumulated depreciation and accumulated<br />

impairment losses at 31 December 2011 610.2 365.6 5.3 981.2<br />

Gross carrying amount at 31 December 2011 2,084.7 564.8 6.0 2,655.6<br />

The fair value of land and buildings amounts to<br />

€ 1,571.4 million (1,566.7 m).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

95<br />

Consolidated Financial Statements<br />

Notes to the consolidated balance<br />

sheet – equity and liabilities<br />

[13] Equity<br />

[13a] Issued capital and capital reserve<br />

On the balance sheet date the Company’s issued share<br />

capital was € 196,279,504.20, and was broken down into<br />

75,492,117 individual bearer no-par-value shares.<br />

The authorised capital which allowed the Board of Management<br />

to raise the share capital with the consent of the<br />

Supervisory Board during the period ending on 8 May <strong>2012</strong><br />

in one or more steps by a total of up to € 97.5 million through<br />

the issue of up to € 37.5 million in new bearer no-par-value<br />

shares (authorised capital) has lapsed.<br />

No convertible bonds or bonds with warrants were issued<br />

up until 8 May <strong>2012</strong>. Consequently, the contingent capital<br />

of € 97.5 million earmarked for these convertible bonds or<br />

bonds with warrants can no longer be used.<br />

[13c] Claims equalisation reserves<br />

Retained earnings include € 319.6 million (352.2 m) in<br />

claims equalisation reserves. These reserves are set up<br />

in line with national legal provisions in order to compensate<br />

for fluctuations in claims in future years. Under IFRS<br />

accounting, they are included in equity.<br />

[13d] Other reserves<br />

Other reserves contain € 12.8 million (12.9 m) in unrealised<br />

gains and losses from the valuation at equity of associated<br />

companies and € 1,123.6 million (304.7 m) unrealised gains<br />

and losses from mainly other securities available for sale<br />

as well as interests in unconsolidated affiliates.<br />

[13b] Retained earnings<br />

Retained earnings can be broken down into the statutory<br />

reserve of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> of € 0.5 million<br />

and other retained earnings of the <strong>Group</strong> whose development<br />

and composition are detailed in the overview on<br />

pages 52 f.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements96<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[13e]<br />

Unrealised gains and losses on investments and hedging <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Non-consolidated affiliated companies and associates not accounted for using the equity method 77.8 82.8<br />

Associates accounted for using the equity method 23.1 23.1<br />

Hedging 46.6 35.4<br />

Other securities – available for sale<br />

Fixed-interest 4,805.5 932.4<br />

Non-fixed-interest 305.5 135.2<br />

5,111.0 1,067.6<br />

Less:<br />

Provision for deferred premium refunds recognised in equity 3,708.7 856.5<br />

Deferred taxes recognised in equity 432.4 60.3<br />

Non-controlling interests 18.7 10.8<br />

Consolidation and currency translation effects − 42.9 − 40.9<br />

Total 1,141.6 322.2<br />

[13f]<br />

Tax effects in the income and expenses<br />

recognised directly in equity<br />

<strong>2012</strong> 2011<br />

Before tax Tax After tax Before tax Tax After tax<br />

€ million € million € million € million € million € million<br />

Currency translation 34.2 − 34.2 − 43.6 − − 43.6<br />

Unrealised gains and losses on investments 1,200.7 372.2 828.5 − 3.9 1.9 − 5.8<br />

Change resulting from valuation at equity − 0.7 − − 0.7 − − −<br />

Change resulting from hedging 0.3 − 0.1 0.4 10.0 3.1 6.9<br />

Actuarial gains and losses on<br />

defined benefit plans − 506.9 − 158.8 − 348.1 44.8 13.3 31.5<br />

Other changes 5.6 − 5.6 − 8.4 − − 8.4<br />

Income and expenses recognised<br />

directly in equity 733.3 213.4 519.9 − 1.1 18.3 − 19.4


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements97<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[13g]<br />

Non-controlling interests <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Unrealised gains and losses on investments 18.7 10.8<br />

Share in consolidated result 13.3 15.3<br />

Other equity 115.0 142.9<br />

Total 146.9 168.9<br />

In the <strong>2012</strong> financial year, we acquired an additional 25.4%<br />

of the shares in <strong>ERGO</strong> Versicherung Aktiengesellschaft,<br />

Vienna (previously VICTORIA-VOLKSBANKEN Ver sicherungs<br />

aktien gesellschaft, Vienna).<br />

[14] Subordinated liabilities<br />

Subordinated liabilities include subordinated loans from<br />

Munich Re on the one hand.<br />

On the cut-off date the fair value of subordinated liabilities<br />

came to € 1,225.7 million (971.9 m).<br />

The item also comprises bearer bonds of Bank Austria<br />

Creditanstalt Versicherung <strong>AG</strong> (BA-CA Versicherung) on<br />

paid-in supplementary capital on the other.<br />

[15] Unearned premiums<br />

[15a]<br />

Unearned premiums <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gross 1,869.9 1,833.8<br />

Reinsurers’ share 122.0 143.1<br />

Net 1,747.9 1,690.7<br />

[15b]<br />

Development of unearned premiums (gross) <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 1,833.8 1,883.9<br />

Currency translation effects 76.2 − 108.4<br />

Change in consolidated group − 90.0 − 125.1<br />

Addition / disposal portfolio − −<br />

Premiums written 17,091.3 18,518.7<br />

Earned premiums 17,041.4 18,335.3<br />

Status at 31 December financial year 1,869.9 1,833.8


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements98<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[16] Provision for future policy benefits<br />

[16a]<br />

Provision for future policy benefits <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gross 95,544.2 94,012.3<br />

Reinsurers’ share 3,627.9 3,586.7<br />

Net 91,916.3 90,425.6<br />

In <strong>2012</strong> the German Federal Court of Justice ruled on a<br />

number of issues of major importance concerning the termination<br />

of life insurance contracts. Important aspects of<br />

its ruling relate to the calculation of acquisition costs and<br />

surrender values. As a result of this ruling, the provision for<br />

future policy benefits has been raised in the German life<br />

insurance sector.<br />

[16b]<br />

Gross provision for future policy benefits according to actuarial interest rates <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Actuarial interest rate ≤ 2.5% 9,375.7 7,330.0<br />

Actuarial interest rate > 2.5% and ≤ 3% 15,696.3 17,775.2<br />

Actuarial interest rate > 3% and ≤ 3.5% 29,229.0 27,136.3<br />

Actuarial interest rate > 3.5% and ≤ 4% 16,575.1 16,571.9<br />

Actuarial interest rate > 4% 20,553.8 20,784.7<br />

Without actuarial interest rate 4,114.2 4,414.2<br />

Total 95,544.2 94,012.3<br />

[16c]<br />

Development of gross provision for future policy benefits <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 94,012.3 93,617.5<br />

Currency translation differences 10.6 − 16.6<br />

Changes<br />

Scheduled 1,069.4 758.2<br />

Unscheduled − −<br />

In consolidated group − 15.9 − 1,034.1<br />

Other 467.8 687.3<br />

Status at 31 December financial year 95,544.2 94,012.3<br />

The change of € 452.6 million (472.1 m) shown under ‘Other’<br />

represents savings contributions for capitalisation products.<br />

The scheduled changes in the provision for future<br />

policy benefits includes changes resulting from the prospective<br />

calculation due to premium payments, claims<br />

and the unwinding of discounting in the financial year.<br />

In the context of determining the net level premium of a<br />

foreign subsidiary on a non-performance-related basis, the<br />

planned change to the provisions for future policy benefits<br />

for the previous year was adjusted by € 104.1 million and is<br />

now shown under ‘Other’ as savings contributions for capitalisation<br />

products. (For more information, see the section<br />

‘Changes in accounting policies’ on pages 58 f.).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements99<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[17] Provision for outstanding claims<br />

[17a]<br />

Provision for outstanding claims <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gross 8,049.4 7,561.8<br />

Reinsurers’ share 638.1 859.4<br />

Net 7,411.3 6,702.4<br />

The gross provision for outstanding claims comprises level<br />

premium reserve for pensions from health, motor, accident<br />

and liability insurance amounting to € 414.1 million (373.2 m).<br />

These were calculated based on actuarial principles with<br />

a discount rate of up to 4.0%.<br />

[17b]<br />

Development in the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 6,702.4 6,766.1<br />

Claims expenses (including expenses for claims settlement)<br />

Financial year 13,417.0 14,958.8<br />

Previous years − 315.8 − 326.7<br />

Total 13,101.1 14,632.1<br />

Thereof: payments (including payment for claims settlement)<br />

Financial year 10,419.9 11,747.8<br />

Previous years 1,991.4 2,576.3<br />

Total 12,411.3 14,324.1<br />

Other changes 41.6 − 56.3<br />

Change in consolidated group − 22.5 − 315.4<br />

Status at 31 December financial year 7,411.3 6,702.4<br />

[17c]<br />

Expected payments from the provisions for outstanding claims<br />

in property-casualty business<br />

<strong>2012</strong><br />

%<br />

2011<br />

%<br />

Up to one year 37.8 41.0<br />

Over one year and up to five years 37.1 35.8<br />

Over five years and up to ten years 14.1 12.8<br />

Over ten years and up to fifteen years 6.3 5.5<br />

Over fifteen years 4.7 4.9<br />

Total 100.0 100.0<br />

When ascertaining the expected payout dates concerning<br />

the provision for outstanding claims, it should be mentioned<br />

that these are of course associated with a considerable<br />

degree of uncertainty.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements100<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[17d] Net run-off results for business posted in line with property-casualty insurance<br />

Claims payments for the individual accident years (per calender year, net)<br />

€ million Accident year<br />

Calender year ≤ 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 <strong>2012</strong> Total<br />

2002 1,467.0 − − − − − − − − − − −<br />

2003 787.6 987.0 − − − − − − − − − −<br />

2004 376.0 493.3 1,033.9 − − − − − − − − −<br />

2005 256.9 198.2 516.5 1,065.2 − − − − − − − −<br />

2006 189.8 80.5 169.2 553.6 1,053.4 − − − − − − −<br />

2007 138.9 43.0 80.4 176.1 567.0 1,214.7 − − − − − −<br />

2008 110.4 40.3 49.7 88.1 183.4 623.5 1,335.3 − − − − −<br />

2009 99.7 23.5 34.4 48.2 90.3 181.1 670.9 1,443.9 − − − −<br />

2010 72.9 19.2 21.3 35.6 50.1 97.4 201.1 717.3 1,588.4 − − −<br />

2011 70.7 11.4 18.0 28.0 38.1 58.3 108.1 222.9 788.1 1,593.3 − −<br />

<strong>2012</strong> − 96.4 − 26.3 − 2.9 3.2 − 11.2 7.8 39.1 81.4 193.0 769.9 1,586.5 2,544.2<br />

Claims reserve for the individual accident years at the respective reporting dates (net)<br />

€ million Accident year<br />

<strong>Report</strong>ing date ≤ 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 <strong>2012</strong> Total<br />

31 Dec 2002 2,548.4 − − − − − − − − − − −<br />

31 Dec 2003 1,727.9 1,062.8 − − − − − − − − − −<br />

31 Dec 2004 1,294.1 597.1 1,157.9 − − − − − − − − −<br />

31 Dec 2005 1,127.1 319.3 527.2 1,243.1 − − − − − − − −<br />

31 Dec 2006 914.8 249.6 359.4 582.3 1,259.3 − − − − − − −<br />

31 Dec 2007 847.1 193.4 273.1 366.1 565.3 1,319.6 − − − − − −<br />

31 Dec 2008 659.0 185.7 211.0 266.4 357.7 586.7 1,452.9 − − − − −<br />

31 Dec 2009 568.8 123.0 173.1 227.9 261.2 374.5 648.5 1,549.8 − − − −<br />

31 Dec 2010 481.3 104.0 138.8 169.8 214.4 282.7 418.2 677.7 1,637.3 − − −<br />

31 Dec 2011 403.4 76.1 133.0 133.9 157.8 226.0 314.3 434.5 738.8 1,698.8 − −<br />

31 Dec <strong>2012</strong> 495.0 118.7 123.9 132.5 168.6 218.1 297.4 383.1 552.0 787.5 1,694.7 4,971.5<br />

Ultimate loss for the individual accident years at the respective reporting dates (net)<br />

€ million Accident year<br />

<strong>Report</strong>ing date ≤ 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 <strong>2012</strong> Total<br />

31 Dec 2002 4,015.4 − − − − − − − − − − −<br />

31 Dec 2003 3,982.6 2,049.8 − − − − − − − − − −<br />

31 Dec 2004 3,924.8 2,077.5 2,191.8 − − − − − − − − −<br />

31 Dec 2005 4,014.7 1,997.9 2,077.5 2,308.3 − − − − − − − −<br />

31 Dec 2006 3,992.1 2,008.7 2,079.0 2,201.1 2,312.7 − − − − − − −<br />

31 Dec 2007 4,063.3 1,995.5 2,073.1 2,161.0 2,185.7 2,534.3 − − − − − −<br />

31 Dec 2008 3,985.6 2,028.0 2,060.6 2,149.3 2,161.5 2,424.9 2,788.2 − − − − −<br />

31 Dec 2009 3,995.1 1,988.8 2,057.1 2,159.1 2,155.3 2,393.9 2,654.7 2,993.7 − − − −<br />

31 Dec 2010 3,980.5 1,989.0 2,044.1 2,136.6 2,158.5 2,399.4 2,625.6 2,839.0 3,225.7 − − −<br />

31 Dec 2011 3,973.3 1,972.6 2,056.3 2,128.7 2,140.1 2,401.1 2,629.8 2,818.7 3,115.3 3,292.1 − −<br />

31 Dec <strong>2012</strong> 3,968.6 1,988.9 2,044.2 2,130.5 2,139.6 2,401.0 2,652.0 2,848.6 3,121.5 3,150.8 3,281.2 29,726.9<br />

Currencyadjusted<br />

net<br />

run-off result 46.8 60.9 147.6 177.8 173.1 133.3 136.2 145.1 104.3 141.3 n. a. 1,266.3<br />

Change<br />

2011 to <strong>2012</strong> 4.7 − 16.3 12.1 − 1.8 0.4 0.1 − 22.2 − 30.0 − 6.2 141.3 n. a. 82.1


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements101<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

The values in the run-off triangles cover virtually 100% of<br />

our <strong>Group</strong>’s portfolio of property-casualty business. The<br />

final amount in any one year of occurrence comprises all<br />

payments made for that year up to the reporting date,<br />

plus the claims reserve at the reporting date. If all losses<br />

incurred were known on the balance sheet date, the ultimate<br />

loss status for the year in question would remain<br />

the same. The run-off triangles are based on figures<br />

adjusted for exchange rate effects. To this end, all figures<br />

are translated from the respective local currency into the<br />

<strong>Group</strong> currency (euro), consistently using the exchange<br />

rates applicable at the end of the year under review (i. e.<br />

at 31 December <strong>2012</strong>). This also ensures that neutral net<br />

run-off results in the original currency (i. e. where the ultimate<br />

loss originally estimated for the year of occurrence<br />

and current loss estimate concur) do not lead to currencyrelated<br />

run-off effects when expressed in the <strong>Group</strong><br />

currency.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements102<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[18] Provision for premium refunds and policyholders’ dividends<br />

[18a]<br />

Provision for premium refunds and policyholders’ dividends <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gross 13,602.9 9,853.9<br />

Reinsurers’ share 66.8 67.5<br />

Net 13,536.2 9,786.4<br />

[18b]<br />

Gross provision for premium refunds and policyholders’ dividends <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Provision for premium refunds (based on national regulations) 6,399.8 5,707.8<br />

Provision for deferred premium refunds<br />

Recognised directly in equity 3,671.2 856.0<br />

Recognised in profit or loss 3,532.0 3,290.1<br />

7,203.2 4,146.1<br />

Total 13,602.9 9,853.9<br />

[18c]<br />

Development during the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Provision for premium refunds (based on national regulations)<br />

Status at 31 December previous year 5,707.8 5,188.1<br />

Change in provision 692.0 519.7<br />

Status at 31 December financial year 6,399.8 5,707.8<br />

Provision for deferred premium refunds<br />

Status at 31 December previous year 4,146.1 4,014.8<br />

Change in consolidated group − 1.3<br />

Changes resulting from unrealised gains and losses on investments (recognised directly in equity) 2,815.2 236.6<br />

Changes resulting from other revaluations (recognised in profit or loss) 241.8 − 104.0<br />

Status at 31 December financial year 7,203.2 4,146.1<br />

Total provision for premium refunds<br />

Gross 13,602.9 9,853.9<br />

Reinsurers’ share 66.8 67.5<br />

Net 13,536.2 9,786.4<br />

[18d]<br />

The surplus allocation from direct bonuses in life insurance<br />

business amounts to € 198.9 million (257.4 m). It is granted<br />

in addition to the performance-related premium refund.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements103<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[19] Other technical provisions<br />

Other technical provisions <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Gross 95.5 119.0<br />

Reinsurers’ share 105.8 119.1<br />

Net − 10.3 − 0.1<br />

[20] Gross technical provisions for life insurance policies where the investment risk is borne by policyholders<br />

Development during the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 5,371.9 5,209.8<br />

Change in consolidated group − 110.0 − 79.6<br />

Currency translation differences 13.8 − 17.3<br />

Savings premiums 760.4 797.5<br />

Unrealised gains/losses on fund assets 598.6 − 258.8<br />

Withdrawal for expenses and risk 78.5 73.5<br />

Withdrawal for benefits 406.6 309.2<br />

Other 107.6 103.0<br />

Status at 31 December financial year 6,257.2 5,371.9<br />

These provisions are valued retrospectively. The withdrawal<br />

from premiums for technical risks and the provision for<br />

future policy benefits are conducted on the basis of cautious<br />

assumptions concerning anticipated mortality and disability.<br />

Here, as with the provision for future policy benefits<br />

for non-unit-linked life insurance, the underlying calculation<br />

is based on best estimates with adequate provision for<br />

safety margins. The provisions are directly covered by the<br />

investments for the benefit of life insurance policyholders<br />

who bear the investment risk. Marginal amounts in relation<br />

to these investments arise as a result of including unearned<br />

revenue liability in these provisions.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements104<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[21] Provisions for pensions and similar benefits<br />

[21a]<br />

For the majority of staff employed with the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong>, <strong>Group</strong> companies have either undertaken retirement<br />

provision directly or by means of payments made to<br />

private institutions. The nature and extent of pension sums<br />

are geared towards the respective terms of the pension<br />

scheme in question (pension terms, specific contractual<br />

promises, etc.), and are generally based on the length of<br />

service and salary of the person concerned. A distinction<br />

is made between defined contribution and defined benefit<br />

pension schemes. As far as defined contribution plans are<br />

concerned, member companies within the <strong>Group</strong> pay premiums<br />

to insurers on a voluntary basis as a result of terms<br />

in a contract. After paying the premiums, the companies<br />

do not have any further benefit obligations. Regular premium<br />

payments amounting to € 26.9 million (27.1 m) were<br />

expenses incurred during the current year.<br />

Expenditure on premiums payable to state-run schemes<br />

amounted to € 96.0 million in the financial year. Defined<br />

benefit plans are financed within the <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> by means of provisions for pension fund liabilities,<br />

which consist of both current pensions as well as entitlements<br />

to pensions payable in the future. Provisions for<br />

pension fund liabilities are calculated throughout the<br />

<strong>Group</strong> using the projected unit credit method in line with<br />

IAS 19 (revised in 2004). This involves calculating future<br />

obligations using actuarial methods with a realistic estimate<br />

of relevant variables. Pension benefits anticipated on<br />

the basis of dynamic parameters at the beginning of the<br />

actual retirement period are spread over the employee’s<br />

entire period of active employment.<br />

Change in the present value of defined benefit obligations under defined benefit plans <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 1,337.4 1,314.2<br />

Currency translation differences 1.8 2.1<br />

Change in consolidated group − − 2.7<br />

Current service cost 36.9 39.7<br />

Interest cost 64.8 60.2<br />

Actuarial gains / losses 556.2 − 42.9<br />

Paid pension benefits − 46.4 − 42.0<br />

Past service cost 11.2 9.5<br />

Other − 3.1 − 0.7<br />

Status at 31 December financial year 1,958.8 1,337.4<br />

[21b]<br />

Change in the plan assets for defined benefit plans in the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 146.6 133.4<br />

Currency translation differences 1.4 1.6<br />

Change in consolidated group − − 3.7<br />

Expected return 7.3 6.5<br />

Actuarial gains / losses 8.3 4.8<br />

Capital transfer to plan assets 21.7 11.9<br />

Paid pension benefits − 3.6 − 4.2<br />

Other − 3.5 − 3.7<br />

Status at 31 December financial year 178.2 146.6<br />

The defined benefit pension schemes also include benefits<br />

for medical care. The present value of earned rights for<br />

these benefits was € 152.9 million (95.4 m) on the cut-off<br />

date.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements105<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[21c]<br />

Change in the reimbursement rights for defined benefit plans in the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 91.8 77.3<br />

Currency translation differences − −<br />

Change in consolidated group − −<br />

Expected return 4.7 3.4<br />

Actuarial gains / losses 9.7 − 0.3<br />

Capital transfer 11.5 11.6<br />

Paid pension benefits − 3.0 − 1.5<br />

Other − 13.6 1.3<br />

Status at 31 December financial year 101.1 91.8<br />

Insurance claims stem from reinsurance which has been<br />

taken out to cover the pension obligations.<br />

[21d]<br />

Funded status of the defined benefit plans <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Unfunded obligations<br />

Present value 1,729.1 1,169.3<br />

Past service cost not yet recognised − −<br />

Other 0.1 0.1<br />

Net balance sheet liability 1,729.2 1,169.4<br />

Wholly / partly funded obligations<br />

Present value 229.7 168.1<br />

Fair value of plan assets − 178.2 − 146.6<br />

Past service cost not yet recognised − −<br />

Other receivables − −<br />

Other − −<br />

Net balance sheet liability 51.5 21.5<br />

Total net balance sheet liability 1,780.7 1,190.9<br />

[21e]<br />

Change in the provision for defined benefit plans in the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 1,190.9 1,182.5<br />

Currency translation differences 0.6 0.5<br />

Change in consolidated group − − 0.6<br />

Expenses 100.9 101.6<br />

Paid pension benefits − 39.8 − 36.3<br />

Capital transfer to plan assets − 21.7 − 11.9<br />

Transfer to other receivables − −<br />

Actuarial gains / losses recognised in equity 546.3 − 48.4<br />

Other 3.5 3.5<br />

Status at 31 December financial year 1,780.7 1,190.9


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements106<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[21f]<br />

Breakdown of expenses booked in the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Current service cost 36.9 39.7<br />

Interest cost 64.8 60.2<br />

Less<br />

Expected return on plan assets − 7.3 − 6.5<br />

Expected return on reimbursements − 4.7 − 3.4<br />

Amortisation of past service cost 11.2 9.5<br />

Other − 2.1<br />

Total 100.9 101.6<br />

The actual return on plan assets amounts to € 15.7 million<br />

(11.4 m), and the actual return on reimbursements<br />

to € 14.4 million (3.1 m). The expenses are shown mainly<br />

under ‘Operating expenses’ and ‘Expenses for claims and<br />

benefits’ in the consolidated income statement.<br />

Actuarial gains/losses included in the income and expenses<br />

for the financial year amount to € 539.3 million (− 46.7 m)<br />

and € 692.7 million (153.4 m) cumulative, taking currency<br />

fluctuations and other changes into account.<br />

[21g]<br />

Breakdown of plan assets to cover pension obligations <strong>2012</strong><br />

%<br />

2011<br />

%<br />

Non-fixed-interest securities 17.2 15.8<br />

Fixed-interest securities and loans 69.5 73.6<br />

Real estate 0.5 0.6<br />

Other 12.8 10.0<br />

Total 100.0 100.0<br />

[21h]<br />

The consolidated companies used the following assumptions<br />

(weighted average values) in order to calculate their<br />

pension obligations:<br />

Assumptions <strong>2012</strong><br />

%<br />

2011<br />

%<br />

Discount rate 3.0 5.0<br />

Expected rate of return on fund assets 3.9 4.9<br />

Expected rate of return on reimbursements 3.0 5.0<br />

Future increases in entitlement / salary 2.3 2.4<br />

Future pension increases 1.9 1.9<br />

Medical cost trend rate 2.8 2.5


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements107<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[21i]<br />

The expected rate of return on plan assets is determined<br />

on the basis of anticipated long-term capital yields. A one<br />

percent change in costs for medical care would have the<br />

following impact on the amount of pension commitments<br />

and pension expenditure:<br />

Increase by<br />

one percentage point<br />

Reduction by<br />

one percentage point<br />

€ million € million<br />

Present value of defined benefit obligations 34.2 − 26.2<br />

Pension expenses 2.4 − 1.8<br />

Capital transfers to plan assets amounting to € 1.3 million<br />

(1.2 m) are expected for the <strong>2012</strong> financial year.<br />

[21j]<br />

Other figures for the current financial year<br />

and previous years<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

2010<br />

€ million<br />

2009<br />

€ million<br />

2008<br />

€ million<br />

Present value of defined benefit obligations<br />

(excluding medical-care benefits) 1,805.9 1,242.0 1,224.2 1,117.1 883.3<br />

Plan assets 178.2 146.6 133.4 114.4 95.7<br />

Not covered by plan assets 1,627.7 1,095.4 1,090.8 1,002.7 787.6<br />

Experience adjustments arising<br />

on the plan liabilities 1.3 − 4.1 − 2.5 14.1 2.0<br />

Experience adjustments arising on the plan assets − 0.2 − 0.2 − 0.2 0.1 0.1<br />

[22] Other provisions<br />

[22a]<br />

Other provisions <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Provision for<br />

Earned commission 196.0 171.5<br />

Outstanding invoices 110.8 109.7<br />

Early-retirement benefits / semi-retirement 101.9 141.1<br />

Impending losses 70.5 53.0<br />

Other in-house staff and field representatives’ remuneration 57.8 48.6<br />

Holiday and overtime pay 44.9 39.5<br />

Anniversary benefits 44.8 39.4<br />

Bonuses 36.2 34.0<br />

Sales contests 17.2 20.8<br />

Miscellaneous 829.0 649.1<br />

Total 1,509.2 1,306.7<br />

The provisions for early retirement and semi-retirement<br />

and for anniversary benefits are mainly long-term, whereas<br />

the provisions for commissions, outstanding invoices, holiday<br />

and overtime pay and miscellaneous are essentially<br />

short-term.<br />

Other provisions include amounts totalling € 219.1 million<br />

(243.7 m) for restructuring measures as part of the<br />

“Continuous Improvement in Competitiveness” project and<br />

€ 258.1 million (–) for the restructuring of our sales forces in<br />

Germany.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements108<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[22b]<br />

Other provisions – development during the financial year <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Status at 31 December previous year 1,306.7 1,363.4<br />

Currency translation differences 7.4 − 7.9<br />

Change in consolidated group − 0.5 − 16.1<br />

Consumption 1,172.1 1,031.1<br />

Release 73.2 113.2<br />

Discounting effects 5.4 4.3<br />

Additions 1,435.5 1,107.2<br />

Other changes 0.2 −<br />

Status at 31 December financial year 1,509.2 1,306.7<br />

[23] Other liabilities<br />

[23a]<br />

Other liabilities <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Deposits retained on ceded business 4,101.3 4,179.3<br />

Accounts payable on direct insurance business 3,569.0 3,715.2<br />

Amounts due to banks 282.9 320.8<br />

Profit-unrelated tax liabilities 191.1 162.3<br />

Accounts payable on reinsurance business 85.9 84.5<br />

Interest and rents 53.3 57.1<br />

Accruals and deferred income 11.0 12.5<br />

In connection with social security 6.6 7.6<br />

Miscellaneous other liabilities 1,061.3 1,138.4<br />

Total 9,362.3 9,677.6<br />

Liabilities resulting from direct insurance business mainly<br />

take the form of liabilities vis-à-vis policyholders resulting<br />

from accumulated surplus-sharing, premium deposits<br />

and contracts without a significant risk transfer. Deposits<br />

retained on ceded business serve as collateral for technical<br />

provisions covering business ceded to reinsurers and retrocessionaires,<br />

and therefore do not lead to any cash flows.<br />

Changes to deposits retained on ceded business generally<br />

result from changes in the relevant technical provisions<br />

covering ceded business.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements109<br />

Notes to the consolidated balance sheet – equity and liabilities<br />

[23b]<br />

The table below shows the contractual maturities on<br />

liabilities. As liabilities from direct insurance business are<br />

directly linked to the underlying insurance business, the<br />

resulting liquidity risk can only be explained together with<br />

the corresponding insurance contracts. Deposits retained<br />

on ceded business do not have a fixed maturity date,<br />

their release is generally dependent on the run-off of the<br />

corresponding provisions. Consequently, both items are<br />

not taken into account in the table below.<br />

Other liabilities<br />

Maturity structure<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Contractual period to maturity<br />

Up to one year 1,335.6 1,422.8<br />

Over one year and up to two years 6.7 12.7<br />

Over two years and up to three years 1.6 30.9<br />

Over three years and up to four years 30.7 6.9<br />

Over four years and up to five years 1.2 4.3<br />

Over five years and up to ten years 279.7 213.8<br />

Over ten years 36.4 91.8<br />

Total 1,692.0 1,783.2<br />

[23c]<br />

Allocation of other liabilities measured at fair value<br />

to levels of the fair value hierarchy<br />

Level 1 Level 2 Level 3<br />

€ million € million € million<br />

<strong>2012</strong> 2011<br />

Total Level 1<br />

€ million € million<br />

Level 2 Level 3<br />

€ million € million<br />

Total<br />

€ million<br />

Other liabilities – derivatives 6.7 67.2 − 74.0 9.7 108.3 − 117.9<br />

Only derivatives with a negative market value are currently<br />

valued at fair value under ‘Other liabilities’.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

110<br />

Consolidated Financial Statements<br />

Notes to the consolidated income statement<br />

[24] Premiums<br />

[24a]<br />

Premiums <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Total premiums 18,561.5 20,269.5<br />

Gross premiums written 17,091.3 18,518.7<br />

Change in unearned premiums (− = expense) − 49.9 − 183.5<br />

Gross earned premiums 17,041.4 18,335.3<br />

Ceded premiums written 1,011.7 1,018.9<br />

Change in unearned premiums (reinsurers’ share) (− = income) − 9.4 − 15.0<br />

Ceded premiums 1,002.2 1,004.0<br />

Net earned premiums 16,039.1 17,331.3<br />

In accordance with international accounting principles the<br />

premiums from the gross provision for premium refunds<br />

and policyholders’ dividends are not stated as premiums<br />

but reduced in the change in the provision for future<br />

policy benefits. In German life insurance these amount<br />

to € 62.0 million (76.0 m) and in German health insurance<br />

to € 245.1 million (320.9 m). As regards premiums for life<br />

insurance products where the investment risk is borne by<br />

the policyholder, only those parts of the premiums used to<br />

cover the risks and costs are recorded as the premium.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements111<br />

Notes to the consolidated income statement<br />

[24b]<br />

Gross premiums written<br />

by business areas and lines of business<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Life Germany 3,930.1 4,165.0<br />

Health 4,932.5 5,974.5<br />

Property-casualty Germany 3,137.8 3,087.3<br />

Thereof:<br />

Motor 625.8 623.1<br />

Personal accident 700.2 711.3<br />

Fire and property 558.1 538.0<br />

Liability 505.2 488.1<br />

Transport and aviation 143.5 124.9<br />

Legal expenses 419.3 421.1<br />

Other 185.7 180.8<br />

Direct insurance 956.9 924.3<br />

Thereof:<br />

Life 482.2 497.9<br />

Health 360.7 312.8<br />

Motor 15.6 16.1<br />

Personal accident 37.5 37.2<br />

Other 61.0 60.4<br />

Travel insurance 460.1 485.3<br />

International 3,673.9 3,882.4<br />

Thereof:<br />

Life 1,355.9 1,454.5<br />

Property-casualty 2,318.0 2,427.9<br />

Thereof:<br />

Motor 1,027.3 1,090.9<br />

Legal expenses 625.7 587.2<br />

Other 665.0 749.8<br />

Total 17,091.3 18,518.7<br />

[24c]<br />

Gross premiums written<br />

by countries<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Germany 13,161.0 13,284.6<br />

Poland 1,008.6 1,011.4<br />

Austria 552.0 572.0<br />

Belgium 445.7 844.7<br />

Italy 406.3 497.7<br />

Turkey 301.6 306.3<br />

Great Britain 226.1 209.6<br />

The Netherlands 209.5 208.9<br />

Other 780.5 1,583.5<br />

Total 17,091.3 18,518.7


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements112<br />

Notes to the consolidated income statement<br />

[25] Income from technical interest<br />

The income statement for the <strong>Group</strong> splits the operational<br />

result into the technical and non-technical result, where<br />

the former is allocated an interest component in the<br />

form of a technical interest income. On the one hand, this<br />

interest income results from financial investments which<br />

cover technical provisions. Deposits retained on ceded<br />

business are also used as a reference value for income from<br />

technical interest. Thus the portion of investment income<br />

corresponding to deposit interest expenditure is included<br />

as a component of technical interest and reallocated to the<br />

technical result.<br />

Depending on the type of insurance business and the associated<br />

legal requirements, technical interest income should<br />

be interpreted in different ways in terms of coverage of<br />

technical provisions:<br />

In German life insurance the income from technical<br />

interest comprises gains and losses from unit-linked life<br />

insurance plus the guaranteed interest return and the<br />

profit participation calculated on the basis of non-technical<br />

sources of income. For life insurance business outside<br />

Germany, income from technical interest corresponds to<br />

the risk-free interest return on technical provisions at the<br />

relevant national long-term interest rate, gains and losses<br />

from unit-linked life insurance and the profit participation,<br />

insofar as contracts exist to this effect.<br />

In the health segment, income from technical interest<br />

corresponds to the allocation of interest to the ageing<br />

reserve (technical interest rate) and the allocation to the<br />

provision for premium refunds. This is based on the allocation<br />

of interest to the provision for non-performancerelated<br />

premium refunds, the investment result exceeding<br />

the technical interest rate and on policyholders’ participation<br />

in the other non-technical result components.<br />

In property-casualty insurance we take into account the<br />

fact that provisions created in earlier years were covered<br />

by investments with higher interest rates than are available<br />

on the market today. Consequently, technical interest<br />

income corresponds to the risk-free interest on our<br />

discounted technical provisions at the respective historic<br />

interest rate taking account of the relevant term and currency.<br />

For balance sheet provisions in excess of the discounted<br />

provisions, short-term interest rates are applied.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements113<br />

Notes to the consolidated income statement<br />

[26] Net expenses for claims and benefits<br />

Net expenses for claims and benefits <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Claims and benefits paid 13,542.9 14,999.8<br />

Change in provision for outstanding claims 475.8 336.0<br />

Change in provision for future policy benefits and other provisions 1,428.1 430.2<br />

Expenses for premium refunds and policyholders’ bonuses 1,919.0 1,418.6<br />

Other technical result (− = income) 190.3 184.6<br />

Gross expenses for claims and benefits 17,556.0 17,369.2<br />

Claims and benefits paid 1,131.6 675.7<br />

Change in provision for outstanding claims − 214.1 28.0<br />

Change in provision for future policy benefits and other provisions 39.9 100.4<br />

Expenses for premium refunds and policyholders’ bonuses 3.1 7.5<br />

Other technical result (− = expenses) − 149.0 − 145.5<br />

Reinsurers’ share of expenses for claims and benefits 811.5 666.1<br />

Claims and benefits paid 12,411.3 14,324.1<br />

Change in provision for outstanding claims 689.9 308.0<br />

Change in provision for future policy benefits and other provisions 1,388.1 329.8<br />

Expenses for premium refunds and policyholders’ bonuses 1,915.9 1,411.0<br />

Other technical result (− = income) 339.3 330.1<br />

Net expenses for claims and benefits 16,744.4 16,703.1<br />

[27] Net operating expenses<br />

Net operating expenses <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Acquisition costs 2,597.6 2,819.1<br />

Administrative expenses 1,122.5 1,157.5<br />

Deferred acquisition costs 60.4 55.5<br />

Amortisation of PVFP 19.8 26.5<br />

Gross operating expenses 3,800.2 4,058.6<br />

Reinsurers’ share of acquisition costs 3.3 4.1<br />

Reinsurers’ share of deferred acquisition costs 24.9 − 7.7<br />

Commission received on ceded business 259.6 248.5<br />

Reinsurers’ share of operating expenses 287.8 244.9<br />

Net operating expenses 3,512.3 3,813.6


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements114<br />

Notes to the consolidated income statement<br />

[28] Investment income and expenses (before deduction of technical interest)<br />

Investment income and expenses<br />

<strong>2012</strong><br />

€ million<br />

Regular income<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

Write-ups<br />

2011<br />

€ million<br />

Land and buildings, including buildings on third-party land 198.7 216.2 11.7 3.3<br />

Investments in affiliated companies 6.3 7.3 − −<br />

Investments in associates 77.0 36.2 3.0 −<br />

Loans 2,241.2 2,169.7 1.8 −<br />

Other securities<br />

Held to maturity 0.5 1.1 − −<br />

Available for sale<br />

Non-fixed-interest 153.6 186.6 − 6.3<br />

Fixed-interest 2,031.4 2,289.1 19.0 37.8<br />

At fair value through profit or loss<br />

Held for trading<br />

2,185.0 2,475.7 19.0 44.1<br />

Non-fixed-interest − 0.2 − −<br />

Fixed-interest 0.6 1.1 9.6 10.4<br />

Derivatives 68.5 86.3 453.9 856.0<br />

Designated as at fair value through profit or loss<br />

69.1 87.5 463.5 866.4<br />

Non-fixed-interest − − − −<br />

Fixed-interest 5.5 5.5 19.0 −<br />

5.5 5.5 19.0 −<br />

Total at fair value through profit or loss 74.6 93.0 482.5 866.4<br />

Total other securities 2,260.1 2,569.8 501.5 910.5<br />

Deposits retained on assumed reinsurance, and other investments 30.0 42.8 − −<br />

Subtotal 4,813.4 5,042.1 518.0 913.8<br />

Investments for the benefit of life insurance<br />

policyholders who bear the investment risk − − − −<br />

Expenses for the management of investments, other expenses − − − −<br />

Total 4,813.4 5,042.1 518.0 913.8<br />

In the <strong>2012</strong> financial year we sold our shares in the fully<br />

consolidated subsidiary <strong>ERGO</strong> Daum Direct General<br />

Insurance Co. Ltd., Seoul. For further details on this<br />

transaction, please refer to the Notes on consolidated<br />

group on pages 55 et seq.<br />

The gains from the disposal of shares in associated companies<br />

essentially contain a retrospective purchase price<br />

adjustment of € 10.2 million from the sale of international<br />

health insurance companies to Munich Health Holding<br />

Aktien gesellschaft, Munich, in 2011.<br />

Expenditure on the administration of investments includes<br />

interest expenditure of € 5.8 million (45.8 m), administration<br />

expenses for financial investments of € 200.3 million<br />

(200.9 m) and expenses for repair and maintenance of<br />

property of € 33.4 million (26.3 m).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements115<br />

Notes to the consolidated income statement<br />

Income Expenses Other<br />

Investment<br />

Gains on disposal Write-downs Losses on disposal<br />

income/expenses<br />

result<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

61.6 54.2 88.7 103.3 − 0.2 − − 183.2 170.4<br />

14.7 497.7 32.2 19.0 0.7 54.2 − 7.3 − 4.1 − 19.3 427.7<br />

0.6 21.9 15.9 6.6 − 4.6 − − 64.7 46.9<br />

131.5 100.8 8.1 58.2 63.5 10.8 − − 2,302.9 2,201.5<br />

− − − − − − − − 0.5 1.1<br />

145.3 177.1 64.6 259.3 64.2 166.8 − − 170.0 − 56.0<br />

381.0 429.0 6.3 1,142.6 465.1 195.1 − − 1,960.0 1,418.2<br />

526.3 606.1 70.9 1,401.9 529.3 361.8 − − 2,130.1 1,362.2<br />

− 0.1 − − − − − − − 0.2<br />

− − 0.1 0.8 − − − − 10.1 10.6<br />

101.8 295.8 189.3 364.5 208.0 421.6 − − 226.9 452.0<br />

101.8 295.9 189.4 365.3 208.0 421.6 − − 237.0 462.8<br />

− − − − 0.1 2.6 − − − 0.1 − 2.6<br />

0.3 4.9 2.4 − 0.4 17.6 − − 21.9 − 7.2<br />

0.3 4.9 2.4 − 0.4 20.2 − − 21.9 − 9.8<br />

102.2 300.8 191.9 365.3 208.5 441.8 − − 258.9 453.1<br />

628.4 906.9 262.8 1,767.2 737.8 803.6 − − 2,389.5 1,816.4<br />

− − 1.4 0.1 − − − − 28.6 42.6<br />

836.9 1,581.5 409.3 1,954.4 802.0 873.4 − 7.3 − 4.1 4,949.6 4,705.5<br />

− − − − − − 602.8 − 262.9 602.8 − 262.9<br />

− − − − − − − 290.8 − 326.6 − 290.8 − 326.6<br />

836.9 1,581.5 409.3 1,954.4 802.0 873.4 304.7 − 593.6 5,261.7 4,116.0


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements116<br />

Notes to the consolidated income statement<br />

[29] Other operating result<br />

Other operating result <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Income from services rendered and from broking funds and insurance policies 172.9 201.4<br />

Income from owner-occupied property 43.8 24.6<br />

Interest from other than investments 27.0 50.7<br />

Income from releases from other non-technical provisions 56.2 59.2<br />

Miscellaneous 52.6 23.7<br />

Other operating income 352.4 359.6<br />

Expenses for services rendered and for broking funds and insurance policies 138.6 140.1<br />

Expenses for owner-occupied property 14.0 33.0<br />

Interest charges and similar expenses 95.9 107.5<br />

Other write-downs 26.6 37.0<br />

Allocation to other non-technical provisions 15.8 11.8<br />

Miscellaneous 154.5 154.6<br />

Other operating expenses 445.5 484.0<br />

Total − 93.1 − 124.4<br />

[30] Other non-operating result<br />

Other non-operating result <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Foreign currency exchange gains 731.9 616.8<br />

Miscellaneous 99.1 103.8<br />

Other non-operating income 831.0 720.6<br />

Foreign currency exchange losses 775.2 630.4<br />

Miscellaneous 559.0 405.4<br />

Other non-operating expenses 1,334.3 1,035.8<br />

Total − 503.3 − 315.2<br />

Other non-operating expenses (‘Miscellaneous’) include<br />

amounts earmarked for restructuring measures in respect<br />

of our sales forces in Germany totalling € 258.1 million (−).<br />

[31] Impairment losses of goodwill<br />

In accordance with IFRS 3, there is no longer a scheduled<br />

amortisation of goodwill stated in the balance sheet. An<br />

impairment test was carried out at the balance sheet date.<br />

Impairment losses of goodwill from capital consolidation<br />

were not necessary in the <strong>2012</strong> financial year (2011:<br />

€ 21.4 m).<br />

[32] Finance costs<br />

Finance costs include all expenditure spent on interest<br />

and other expenses which are directly related to strategic<br />

debt, i. e. debt without an original and direct link to<br />

operative insurance business. Costs totalling € 81.8 million<br />

(65.8 m) stem primarily from liabilities of <strong>ERGO</strong><br />

<strong>Versicherungsgruppe</strong> <strong>AG</strong> due to Munich Re companies.<br />

The loans serve to strengthen the liquidity basis and to<br />

finance strategic assets.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements117<br />

Notes to the consolidated income statement<br />

[33] Taxes on income<br />

[33a]<br />

Current tax and the change in deferred tax together make<br />

up the ‘Taxes on income’ item in the consolidated income<br />

statement. Apart from current tax expenditure there was<br />

income from deferred tax which resulted from changes in<br />

deferred tax items due to revaluations.<br />

Taxes on income <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Current tax for financial year 179.9 331.4<br />

Current tax for other periods − 27.7 − 81.1<br />

Deferred tax resulting from the occurrence or reversal of temporary differences − 43.8 − 211.5<br />

Deferred tax resulting from the occurrence or utilisation of loss carry-forwards and write-downs − 24.9 2.7<br />

Valuation allowances for other deferred taxes − −<br />

Deferred tax for other periods − 7.0 13.0<br />

Total 76.6 54.5<br />

[33b]<br />

The <strong>Group</strong> tax rate corresponds to the average fiscal<br />

charges for all domestic <strong>Group</strong> companies. This amount<br />

is made up of German corporate tax amounting to 15%<br />

(15%) plus a 5.5% (5.5%) solidarity surcharge.<br />

Together with the domestic trade tax the uniform <strong>Group</strong><br />

tax rate is thus 32% (32%). Based on a net operating result<br />

after finance costs, the following table shows the reconciliation<br />

between the expected taxes on income and the<br />

taxes on income actually shown:<br />

Reconciliation to effective tax expenses <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Result before taxes on income (after other tax) 365.9 403.9<br />

x <strong>Group</strong> tax rate 32% (32%)<br />

= Expected taxes on income 117.1 129.3<br />

Tax effect of:<br />

+ Non-deductible expenses 56.5 36.3<br />

− Tax-free income − 59.7 − 58.3<br />

+ Tax rate differences − 2.1 − 13.6<br />

+ Tax for prior years − 34.7 − 68.1<br />

+ Amortisation of goodwill or PVFP − 12.3<br />

+ Miscellaneous − 0.6 16.6<br />

= Taxes on income shown 76.6 54.5


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

118<br />

Consolidated Financial Statements<br />

Disclosures on risks from insurance<br />

contracts and financial instruments<br />

<strong>ERGO</strong>’s reporting is based on various legal regulations<br />

governing risks it is exposed to as a result of its business<br />

operations:<br />

IFRS 4 prescribes disclosures on the type and extent of risks<br />

from insurance contracts. Under IFRS 7, analogous disclosures<br />

on risks from financial instruments are required.<br />

Besides this, Section 315, para. 2, item 2 of the German<br />

Commercial Code prescribes disclosures in the management<br />

report on risk management objectives and methods,<br />

hedging and risks in connection with financial instruments.<br />

These requirements are specified in more detail in the<br />

German Accounting Standard No. 15 (DRS 15) for management<br />

reports, as well as DRS 5 and DRS 5–20 for risk reporting<br />

and risk reporting at insurance companies.<br />

Risk reporting concerns not only accounting but also the<br />

activities of <strong>ERGO</strong>’s integrated risk management (IRM). To<br />

take both perspectives into account, information on risks is<br />

provided in the Risk report within the management report,<br />

in the disclosures on risks from insurance contracts and<br />

financial instruments as well as in the disclosures on financial<br />

instruments in the Notes to the financial statements.<br />

The disclosures in the Risk report largely adopt a purely<br />

economic view. This report provides a detailed account<br />

of the organisation of risk management and of <strong>ERGO</strong>’s<br />

risk strategy, and briefly outlines the main risks we are<br />

exposed to.<br />

The Notes to the financial statements deal in detail with<br />

the various risks from insurance contracts and describe<br />

uncertainties in measuring them. In accordance with the<br />

requirements of IFRS 4, the effects of a change in the<br />

assumptions underlying the measurement of insurance<br />

contracts and in the market environment are also quantified.<br />

For risks from financial instruments, IFRS 7 stipulates<br />

that the disclosures must comprise information on maximum<br />

credit risk exposure, the remaining terms, the rating,<br />

and a sensitivity analysis regarding the market risk. This<br />

information is also relevant for assessing the risk.<br />

To obtain a complete overview of the risks to which <strong>ERGO</strong><br />

is exposed, the reader needs to refer to both the risk report<br />

and the disclosures on risks from insurance contracts and<br />

financial instruments in the Notes to the financial statements,<br />

along with further information on individual items.<br />

Where necessary, we refer to the relevant information in<br />

the risk report or in the Notes.<br />

[34a] Risks from life and health insurance business<br />

Of primary importance for insurance contracts in life<br />

and health insurance are biometric risks, interest-rate<br />

risks and lapse risks. The measurement of technical<br />

provisions and deferred acquisition costs is based on<br />

biometric calculation tables, i. e. on assumptions with<br />

regard to mortality, disable ment and morbidity, and on<br />

the respective contract- or tariff-specific discount rates<br />

and actuarial interest rates. Besides this, measurement<br />

includes assumptions regarding the lapse rate and profit<br />

participation. In addition, other market risks from unitlinked<br />

policies and risks from embedded derivatives, as<br />

well as the liquidity risk, have to be taken into account.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements119<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Biometric risks<br />

Our portfolios’ risk of exposure to biometric risks depends<br />

on the type of insurance contracts:<br />

Product category Features Significant risks<br />

Life insurance<br />

Term life insurance<br />

Annuity insurance<br />

Occupational disability and<br />

disablement insurance<br />

Health insurance<br />

Long-term contracts with death benefit<br />

In most cases with a lump-sum payment on<br />

termination<br />

Actuarial assumptions fixed when contract<br />

is concluded, premium adjustments not<br />

possible<br />

In most cases guaranteed lifelong<br />

annuity payment<br />

Actuarial assumptions mainly fixed<br />

when contract is concluded, premium<br />

adjustments not possible<br />

Long-term policies with a guaranteed<br />

limited annuity in the event of disablement<br />

Actuarial assumptions fixed when contract<br />

is concluded<br />

Largely long-term contracts guaranteeing<br />

assumption of costs for medical treatment;<br />

provisions are established for covering<br />

increased costs on ageing<br />

Variable actuarial assumptions; premium<br />

adjustment possible if there are sustained<br />

changes in the cost structure<br />

Mortality (short-term): increase in claims<br />

expenditure due to exceptional one-off<br />

circumstances (e. g. pandemics)<br />

Mortality (long-term): increase in claims<br />

expenditure due to sustained rise in<br />

mortality in the portfolio<br />

Longevity: increase in expected expenditure<br />

for annuities due to sustained rise in life<br />

expectancy in the portfolio<br />

Disablement: increased expenditure due to<br />

rise in the number of cases of disablement in<br />

the portfolio and a reduction in the average<br />

age at which the insured event occurs.<br />

Longevity: increased expenditure due to rise<br />

in the average duration of annuity period<br />

Morbidity: increase in medical costs that<br />

cannot be absorbed through premium<br />

adjustments<br />

Increase in claims expenditure due to<br />

exceptional, one-off events (e. g. pandemics)<br />

Lapse risk: Deviation of actual lapse behaviour<br />

compared with actuarial assumptions<br />

The biometric assumptions we use for measuring insurance<br />

contracts in our portfolio are regularly reviewed on<br />

the basis of updated portfolio information. This includes<br />

considering country-specific reviews by supervisory authorities<br />

or associations of actuaries.<br />

We also take account of market standards when checking<br />

the adequacy of biometric actuarial assumptions and the<br />

trend assumptions included in them. This may result in a<br />

change in the safety margin allowed for in the actuarial<br />

assumptions. The amount of the technical provisions or<br />

the deferred acquisition costs is not directly affected as<br />

long as safety margins have been included. In the view of<br />

the appointed actuaries, the biometric actuarial assumptions<br />

we use are deemed sufficient. However, in long-term<br />

health insurance, we are proceeding on the assumption<br />

that there will be further advances in medical treatment,<br />

potentially giving rise to higher costs. It is generally<br />

possible to modify the actuarial assumptions for this business<br />

by means of a premium adjustment to reflect the<br />

changes.<br />

For short-term health insurance, on the other hand, the<br />

main risk is a sudden increase in expenses due to exceptional<br />

one-off events.<br />

Interventions by legislators or courts in the distribution<br />

of risks and rewards underlying the contracts concluded<br />

between the parties to insurance may mask or aggravate<br />

the biometric risks described, making it necessary to adjust<br />

the provision.<br />

We measure sensitivity to changes to biometric assumptions<br />

in life insurance and for long-term contracts in<br />

health insurance using an embedded value analysis (see<br />

page 123).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements120<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Interest-rate risks<br />

A distinction must be made between risks of changes in<br />

interest rates on the one hand and interest-rate guarantee<br />

risks on the other. Risks of changes in interest rates would<br />

result from the discounting of the provision for future<br />

policy benefits and of parts of the provision for outstanding<br />

claims. In accordance with accounting valuation rules, the<br />

discount rate is fixed at contract commencement and will<br />

generally not be adjusted during the term of the contract.<br />

To this extent, the accounting valuation of these technical<br />

provisions does not depend directly on the level of market<br />

interest rates.<br />

Economically, however, an interest-rate risk derives in principle<br />

from the need to earn a return on investment covering<br />

the provision that is commensurate with the discount<br />

rate used in measuring the provision.<br />

In life insurance, an implied or explicit guaranteed interest<br />

rate is normally granted over the whole duration, based<br />

on a fixed interest rate applying at the time the contract is<br />

concluded. The discount rate used to calculate the provision<br />

for future policy benefits is identical with this interest rate<br />

for the majority of contracts in our portfolios. An appropriate<br />

minimum return needs to be earned in the long term<br />

from the investment result (possibly also with assistance<br />

from the technical result) for contractually guaranteed<br />

benefits. In health insurance, a discount rate is used for<br />

calculating the provision for future policy benefits, too; but<br />

for long-term business, this rate can generally be altered<br />

by way of premium adjustment. For short-term business,<br />

there is no direct interest-rate risk.<br />

The discount rates relevant for the portfolio which relate to<br />

provisions for future policy benefits and provisions for outstanding<br />

claims are shown in tables [16b] and [17a] of the<br />

Notes to the consolidated financial statements.<br />

Moreover, in German health insurance, the valid discount<br />

rate is also used to calculate the provision for premium<br />

surcharge provisions and for the provision for the reduced<br />

premiums in later years which, according to the German<br />

Commercial Code, form part of the provision for future<br />

policy benefits and which are to be shown under the provision<br />

for premium refunds under IFRS. In principle, however,<br />

the discount rate can be changed whenever there is an<br />

adjustment made to premiums within the allowed range of<br />

0–3.5%.<br />

Provisions that are not covered by retained deposits are<br />

covered by investments. In the case of a discrepancy<br />

between the durations of these investments and the<br />

liabilities (“duration mismatch”), the main risk lies in the<br />

fact that if interest rates fall markedly over the remaining<br />

settlement period of the liabilities, the return on the<br />

re invested assets may be lower than the discount rates<br />

and thus necessitate further expenses. But a complete<br />

duration matching of liabilities with fixed-interest investments<br />

of identical maturities would not be expedient,<br />

because if interest rates rise significantly, policyholders<br />

might make increasing use of their surrender rights, resulting<br />

in a liquidity requirement for premature payouts.<br />

We measure sensitivity to this interest-rate risk using an<br />

embedded value analysis (see pages 123 f.).<br />

Lapse risks<br />

In reinsurance, a lapse risk derives primarily from the indirect<br />

transfer of lapse risks from cedants. As a rule, both<br />

this risk and the financial risk from extraordinary termination<br />

of reinsurance contracts are largely ruled out through<br />

appropriate contract design.<br />

In life insurance, the reported technical provision in the<br />

case of contracts with a surrender option is generally at<br />

least as high as the relevant surrender value. Expected<br />

surrenders are taken into account in the amortisation of<br />

deferred acquisition costs in life insurance. The policyholder’s<br />

right in some contracts to maintain the contract<br />

with a waiver of premium and an adjustment of the<br />

guaranteed benefits constitutes a partial lapse and is<br />

taken into account in the calculations analogously. The<br />

lump-sum option right for a deferred annuity gives the<br />

policyholder the option to have the annuity paid out in a<br />

lump sum on a given date. There is a potential risk here if,<br />

following a level of interest which is significantly above the


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements121<br />

Disclosures on risks from insurance contracts and financial instruments<br />

level used to calculate the annuity, an unexpectedly large<br />

number of policyholders exercise their lump-sum option.<br />

However, there is no direct interest or market sensitivity<br />

as the exercising of the option is influenced decisively<br />

by individual factors concerning the policyholder because<br />

there is an insurance component involved. Contractual<br />

aspects are also relevant, as the lump-sum option is sometimes<br />

excluded or severely limited, such as with company<br />

pensions or with state-subsidised products. The adequacy<br />

test for underwritten liabilities in accordance with IFRS 4<br />

explicitly takes this policyholders’ option into consideration.<br />

Based on the relevant legal parameters, reserves<br />

for health insurance business are calculated considering<br />

amounts payable due to transfer of policies. The underlying<br />

assumptions are regularly checked.<br />

The sensitivity towards a change in the lapse probability<br />

in life insurance as well as for long-term health insurance<br />

contracts are measured as part of an embedded value<br />

analysis (see page 123).<br />

Other market risks and embedded derivatives<br />

Risks to be considered are – besides the interest-rate<br />

guarantee, which we analyse in the modelling of the<br />

interest-rate risk – are particularly risks from unit-linked life<br />

insurance. Other embedded derivatives are economically<br />

insignificant.<br />

For unit-linked insurance contracts in our portfolios, investments<br />

are held for the benefit of life insurance policyholders<br />

who bear the investment risk, meaning that there is no<br />

direct market risk. Appropriate product design ensures that<br />

the necessary premium portions for payment of a guaranteed<br />

minimum benefit on occurrence of death are based<br />

on the current fund assets. In addition, unit-linked insurance<br />

policies may contain a guaranteed gross premium<br />

which is assured by an issuer in certain cases. As a result,<br />

our market risk is reduced accordingly, although there is<br />

a bad debt risk. In order to reduce this risk, we make high<br />

demands of the creditworthiness of the issuer.<br />

Liquidity risks<br />

For <strong>ERGO</strong>, there could be a liquidity risk if the cash outflow<br />

for insurance claims payments and the costs related to the<br />

business were to exceed the cash inflow from premiums<br />

and investments. For our mainly long-term business, we<br />

therefore analyse the expected future balance from cash<br />

inflows due to premium payments and outflows for payment<br />

of insurance claims and benefits plus costs.<br />

As regards business in force on the balance sheet date, this<br />

results in the future expected technical payment balances<br />

shown in the table on the next page according to duration<br />

bands. As only the technical payment flows are considered,<br />

inflows from investment income and investments<br />

that become free are not included in the quantification.<br />

Taking into account the inflows from investments, whose<br />

cash flows are largely aligned with those of the liabilities<br />

through our asset-liability management, items in the<br />

future expectations are positive throughout, so that the<br />

liquidity risk of these insurance contracts is minimised<br />

accordingly.<br />

With these numerical estimates, it should be borne in mind<br />

that these forward-looking data may involve considerable<br />

uncertainty.<br />

Further information on the liquidity risk is provided in the<br />

risk report on page 37.<br />

Claims risk<br />

The claims risk occurs when benefits have to be paid out<br />

of a previously determined premium. Here the scope of<br />

benefits has been agreed beforehand, but the risk lies<br />

in not knowing how medical expenses and benefits will<br />

develop in the future. The promise of benefits plays an<br />

important role in this aspect. In future, we also expect that<br />

medical possibilities will improve still further with more<br />

applications and, hence, higher costs. Consequently, the<br />

relationship of calculated costs to the benefits required is<br />

constantly monitored. Premiums will be adjusted for those<br />

tariffs where the required benefits deviate from calculated


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements122<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Life insurance – Expected future technical cash flow (gross) 1 <strong>2012</strong> 2011<br />

€ million 2 € million 2<br />

Up to one year − 3,298 − 2,713<br />

Over one year and up to five years − 15,600 − 14,564<br />

Over five years and up to ten years − 18,258 − 17,790<br />

Over ten years and up to twenty years − 29,385 − 27,821<br />

Over twenty years − 37,614 − 35,985<br />

1 Premiums less guaranteed benefits and costs (excl. unit-linked products).<br />

2 After eliminating internal <strong>Group</strong> transactions across all segments.<br />

Health insurance – Expected future technical cash flow (gross) <strong>2012</strong> 2011<br />

€ million 1 € million 1<br />

Up to one year 702 874<br />

Over one year and up to five years 950 2,000<br />

Over five years and up to ten years − 1,477 − 112<br />

Over ten years and up to twenty years − 11,458 − 11,008<br />

Over twenty years − 51,865 − 77,702<br />

1 After eliminating internal <strong>Group</strong> transactions across all segments.<br />

2 The decline of the estimate from 2011 to <strong>2012</strong> results from an adjustment of the underlying assumptions.<br />

benefits on a permanent basis. Actuarial assumptions used<br />

are deemed to be adequate by the appointed actuaries<br />

and the fiduciaries in cases inspected by the latter. These<br />

measures severely limit the risk resulting from expenses for<br />

claims and benefits. The risk of particularly high individual<br />

claims and a dramatic rise in the number of claims as a<br />

result of a pandemic are constrained by means of a special<br />

reinsurance concept.<br />

Risk minimisation measures<br />

The product design itself also ensures a substantial reduction<br />

in risk. For the most part, prudent actuarial assumptions<br />

are used in fixing the guaranteed benefits, in addition<br />

to which policyholders are granted a performance-related<br />

profit participation. Given the relevant margins in the<br />

actuarial assumptions, it is also possible to fulfil future<br />

guaranteed obligations without adjusting the provisions<br />

in the case of moderate changes in assumptions. Of great<br />

significance for risk-balancing in the case of adverse developments<br />

are parts of the provision for premium refunds<br />

based on national regulations, parts of the provision for<br />

deferred premium refunds resulting from other revaluations,<br />

and unrealised gains and losses on investments<br />

taken as a basis for posting the provision for deferred<br />

premium refunds.<br />

In health insurance, there is the additional possibility of<br />

adjusting premiums for most long-term contracts. If it is<br />

foreseeable that the assumptions behind the calculation<br />

are permanently inadequate to cover expenses for claims<br />

or the actual mortalities deviate significantly from the<br />

calculated ones, premiums can be raised accordingly, thus<br />

closely limiting the financial and balance sheet effects of<br />

cost increases in healthcare and permanent changes in<br />

morbidity.<br />

For information on our risk management processes, see<br />

also pages 31 f. in the risk report.<br />

Impact on equity and the consolidated income<br />

statement<br />

In the liability adequacy test pursuant to IFRS 4, technical<br />

provisions and deferred acquisition costs are regularly<br />

tested to ensure they are appropriate. An adjustment is<br />

made if such tests show that, as a whole, the amounts<br />

calculated using the previous assumptions for biometric<br />

actuarial rates, for discounting provisions and for lapses<br />

are no longer sufficient. The possibilities of adjusting the<br />

surplus are taken into account. In health insurance, the<br />

technical interest rate can be adjusted if it is necessary to<br />

alter the assumed technical interest rate within the framework<br />

of a premium adjustment.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements123<br />

Disclosures on risks from insurance contracts and financial instruments<br />

If an adjustment is required, we record any deficit as an<br />

expense in the consolidated income statement.<br />

Quantitative impact of changes in assumptions on longterm<br />

insurance business<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong> measures the sensitivity of its<br />

long-term insurance business in life and health insurance<br />

using an economic valuation on the basis of the CFO’s<br />

Forum’s Market-Consistent Embedded Value Principles<br />

and Guidance (see page 12). This covers more than 97%<br />

(94%) of long-term insurance business. Compared to<br />

incorporating the entire insurance portfolio, the difference<br />

is negligible.<br />

The sensitivities given below measure the impact of<br />

changes in the calculation bases and capital market<br />

parameters on the calculated economic value of our<br />

business. They take account of our risk minimisation<br />

measures and tax effects.<br />

<strong>ERGO</strong> continues to adhere to the strict rules of marketconsistent<br />

evaluation as at the end of the year.<br />

Embedded value sensitivities 1 <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Embedded value on the balance sheet date 2,728 875<br />

Change in the event of a sustained increase in interest rates by 100 BP 2,298 2,369<br />

Change in the event of a sustained decrease in interest rates by 100 BP − 3,769 − 4,009<br />

Change in the event of a 10% decrease in the value of equities and real estate − 176 − 210<br />

Changes in the event of an increase in mortality by 5% in the case of contracts mainly covering the mortality risk − 42 − 48<br />

Changes in the event of an decrease in mortality by 5% in the case of contracts mainly covering the longevity risk − 180 − 186<br />

Change in the event of an increase in morbidity by 5% − 73 − 85<br />

Change in the event of an increase in the lapse rate by 10% 140 112<br />

1 Premiums less guaranteed benefits and costs (excl. unit-linked products).<br />

[34b] Risks arising from property-casualty insurance<br />

business<br />

Of particular importance for these insurance contracts<br />

is the estimation risk with regard to the amount of the<br />

expected claims expenditure for future claims from current<br />

insurance contracts (premium risk) as well as for<br />

claims already incurred (reserve risk). In estimating claims<br />

expenditure, we also take cost increases into account.<br />

There is an interest-rate risk for parts of the portfolio.<br />

Besides this, the liquidity risk has to be taken into account.<br />

The basis for measuring the risk assumed is an estimate of<br />

the claims frequency to be expected for a contract or portfolio<br />

of contracts. In addition, an estimation of the claims<br />

amount is necessary, from which a mathematical distribution<br />

of the expected losses is derived. The result of these<br />

two steps is an estimation of the expected overall claims<br />

in a portfolio. A third element comprises the expected cash<br />

flows to settle claims incurred, a process which frequently<br />

extends over several years.<br />

Premium risks<br />

The degree of exposure to estimation risks differs according<br />

to class of business. On the basis of the loss ratios and<br />

combined ratios of past years, conclusions can be drawn<br />

about the historical volatilities in the different classes of<br />

business and about possible interdependencies. The differences<br />

in volatility are equally due to fluctuations in the<br />

amount of claims and fluctuations in the respective market<br />

price level for the cover granted.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements124<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Premiums, claims and expenses according to lines of business <strong>2012</strong> 2011 2010 2009<br />

Gross premiums € million<br />

Motor 1,669 1,730 1,724 1,534<br />

Thereof motor liability 936 942 910 808<br />

Thereof other motor 733 788 814 726<br />

Accident 838 875 902 888<br />

Fire and property 776 827 773 736<br />

Liability 584 560 532 516<br />

Transport and aviation 187 167 154 127<br />

Other 801 754 735 693<br />

Legal expenses 1,045 1,009 968 942<br />

Total 5,899 5,922 5,787 5,436<br />

Claims ratio % (net)<br />

Motor 79.6 87.2 88.2 83.2<br />

Thereof motor liability 85.1 89.6 90.6 84.7<br />

Thereof other motor 72.1 84.2 85.2 81.3<br />

Accident 41.0 39.9 35.3 33.1<br />

Fire and property 66.4 63.3 68.6 55.4<br />

Liability 62.5 56.8 46.1 55.0<br />

Transport and aviation 58.1 40.1 64.8 67.1<br />

Other 51.9 51.8 52.3 53.0<br />

Legal expenses 55.5 55.0 55.2 57.7<br />

Total 62.2 62.9 62.5 59.8<br />

Combined Ratio % (net)<br />

Motor 105.1 113.2 113.9 108.0<br />

Thereof motor liability 110.3 115.5 115.5 109.6<br />

Thereof other motor 98.1 110.3 112.1 106.0<br />

Accident 78.5 77.0 72.2 68.5<br />

Fire and property 103.8 100.3 104.7 90.7<br />

Liability 95.5 90.8 78.9 86.5<br />

Transport and aviation 99.1 87.8 94.4 93.1<br />

Other 95.4 95.9 96.0 97.0<br />

Legal expenses 97.2 97.5 96.8 97.8<br />

Total 97.2 98.3 97.0 93.5<br />

The estimation of technological, social and demographic<br />

parameters plays an important part in assessing and pricing<br />

risks assumed in all classes of business.<br />

Beyond this, in liability insurance and sections of motor<br />

insurance, the development of economic and legal<br />

parameters is significant. In the lines of business where<br />

there is a high degree of sensitivity regarding the underlying<br />

assumptions about natural catastrophes, we include<br />

expected trends in our considerations when assessing the<br />

risks.<br />

We are convinced that we have calculated our premiums<br />

to include a sufficient margin for risk. The containment<br />

of risk is guaranteed through our targeted underwriting<br />

policy, strict underwriting guidelines and guidelines for the<br />

degree of authority and competency. The systematic controlling<br />

of the portfolios and regular recalculation of premiums<br />

ensure that premium income and claims payments<br />

remain in an appropriate balance.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements125<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Reserve risks<br />

Interest-rate risks<br />

The provision for outstanding claims is subject to the risk<br />

that actual claims settlements may be less than or exceed<br />

the amount reserved (reserve risk). Particular attention<br />

is given to those situations where the funds dedicated to<br />

future claims payments may be inadequate.<br />

The measurement of the provision for outstanding claims<br />

is based on an analysis of the historical loss development<br />

data for the different classes of business. We use a range<br />

of well-established actuarial methods to analyse and value<br />

this data which embed various pricing, coverage, benefit<br />

and inflation levels. In doing so, we draw on the specialist<br />

knowledge present in our claims and underwriting<br />

departments and take all foreseeable future trends into<br />

account. As part of our regular results monitoring process,<br />

we keep a close eye on trends to ensure that the assumptions<br />

underlying the measurement of the provisions always<br />

reflect the latest developments. Consequently, in the<br />

course of reserve run-off, it may be necessary to revise the<br />

original estimates of the claims expenditure required and<br />

to adjust the provisions accordingly.<br />

Actuarial claims requirements can deviate from the<br />

expected claims requirements for future insurance risks<br />

from insurance business that has already been underwritten.<br />

A check is made during an IFRS 4 adequacy test<br />

to find out whether the expected loss requirement, including<br />

costs, is more than expected earned premiums plus<br />

the proportionate amount of investment income. If this<br />

is the case, additional reserves will be set up. Appropriate<br />

reserves are set up based on experience from past years.<br />

There have not been any major fluctuations in the past in<br />

either the claims ratio or run-off results.<br />

The development of our claims reserves and the corresponding<br />

run-off results are shown under [17] Provision for<br />

outstanding claims.<br />

Economically, an interest-rate risk derives in principle from<br />

the need to earn a return on the investment covering the<br />

provision that is commensurate with the discount rate<br />

used in measuring the provision. In balance sheet terms,<br />

the interest-rate risk affects only those parts of the technical<br />

provisions that are discounted. In our case, this risk lies<br />

predominantly with the provisions for personal accident<br />

insurance with premium refunds and annuities.<br />

However, as only around 10.2% of the actuarial and claims<br />

reserves to be considered in this respect are discounted,<br />

this risk can be deemed small. If investment income failed<br />

to cover the expenses arising from discounting, this would<br />

result in losses not included in the calculations. In such<br />

cases, a reserve adjustment may be necessary. Conversely,<br />

if the investment income were higher, this would result in<br />

unforeseen gains.<br />

Liquidity risks<br />

Such risks could result for <strong>ERGO</strong> if the cash outflow for<br />

insurance claims payments and the costs related to the<br />

business were to exceed the cash inflow from premiums<br />

and investments. In property-casualty insurance, a distinction<br />

must be made between payments for claims for which<br />

reserves were posted in previous years and immediate<br />

payments, i. e. payments for claims incurred in the current<br />

financial year. If claims reserves are posted, the liquidity<br />

risk can be minimised through our asset-liability management,<br />

in which investments are geared to the character<br />

of the liabilities. The proportion of immediate claims payments<br />

constitutes only a fraction of the total payments<br />

to be made and is, in our experience, stable over time.<br />

Consequently, the liquidity risks in respect of these payments<br />

can also be minimised by means of asset-liability<br />

management.<br />

The following table shows that in the past calendar years<br />

the liquidity situation has always been positive.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements126<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Cash flows and liquid funds (gross)<br />

<strong>2012</strong><br />

in individual calendar years 1 € million<br />

2011<br />

€ million<br />

2010<br />

€ million<br />

2009<br />

€ million<br />

2008<br />

€ million<br />

Premiums received 5,899 5,922 5,787 5,436 5,041<br />

Claims payments for financial year 1,776 1,828 1,871 1,686 1,430<br />

Claims payments for previous years 1,638 1,605 1,423 1,319 1,267<br />

Costs 2,037 2,039 1,965 1,799 1,601<br />

Liquid funds 448 450 529 632 743<br />

1 After eliminating internal <strong>Group</strong> transactions across all segments.<br />

For more information on the liquidity risk, see page 37 of<br />

the risk report.<br />

Impact of changes in technical assumptions on equity<br />

and the consolidated income statement<br />

As part of the monitoring of our portfolio, we check<br />

whether original assumptions need to be adjusted. By<br />

means of the IFRS 4 liability adequacy test, we review<br />

expected claims expenditure in the light of updated<br />

assumptions, taking into account our risk minimisation<br />

measures. If this test shows that an adjustment to<br />

technical provisions is required, the amount is recognised<br />

in the consolidated income statement.<br />

Risk minimisation measures<br />

With an underwriting policy geared to systematic<br />

diversification, i. e. the greatest possible mix and spread<br />

of individual risks, we substantially reduce the volatility<br />

for our insurance portfolio as a whole.<br />

As a result of the strong focus on business with private<br />

customers, there are, on the one hand, very few risks concerning<br />

future cash flows and, on the other, low exposure<br />

to large and very large losses. High single losses and large<br />

indemnity amounts associated with them, as well as the<br />

effect of cumulative events, are effectively contained<br />

regarding their effect on the income statement by our<br />

reinsurance programmes, meaning that their negative<br />

impact can be planned in the sense of profit-oriented company<br />

management. We make use of risk-based reinsurance<br />

solutions to achieve this goal. As regards ceded insurance,<br />

we pursue the objective of reducing the volatility of net<br />

results. This means that less equity is required for operational<br />

purposes and, at the same time, the results can be<br />

planned more accurately. To calculate our reinsurance<br />

needs, we regularly analyse the gross and net exposure of<br />

our insurance portfolios with a special focus on cumulative<br />

risks. From this analysis, we derive areas of action for steering<br />

our reinsurance programme.<br />

Due to the special significance of insurance against<br />

natural disasters and our companies’ exposure to those<br />

hazards, our portfolios are evaluated on a regular basis<br />

using recognised actuarial methods. The results of these<br />

analyses form the basis for the type and degree of protection<br />

programmes against natural disasters. The respective net<br />

retentions are financially viable sums for the companies.<br />

The portfolios of private customer lines of business are very<br />

homogeneous. Nevertheless, in the context of internal risk<br />

modelling, major, cumulative and basic losses are modelled<br />

and the effect of the current reinsurance structure tested<br />

on them. The normal (Pareto and generalised Pareto)<br />

dis tribution is then used as an assumption for claims<br />

amounts for major and cumulative losses. This internal risk<br />

model is used in addition to gauging reinsurance requirements<br />

and is part of the internal risk management process.<br />

As a result of the very different amounts regarding the<br />

insured values, commercial and industrial lines of business<br />

are characterised by heterogeneity of the portfolios.<br />

In the course of internal risk modelling, major, cumulative<br />

and basic losses are therefore assessed on a highly individual<br />

basis, and, accordingly, the impact of the respective<br />

current and highly individual reinsurance structure is<br />

permanently tested on them and adjusted where required.<br />

Where necessary, high individual risks are diversified using<br />

co-insurance or by taking out facultative reinsurance<br />

solutions.<br />

In addition, we create provisions for fluctuations in the<br />

pattern of results where required by national insurance<br />

supervisory authorities’ regulations and accounting principles.<br />

However, this is not shown in our IFRS consolidated<br />

financial statements.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements127<br />

Disclosures on risks from insurance contracts and financial instruments<br />

[34c] Credit risks from ceded reinsurance business<br />

The credit risk is also of relevance in connection with ceded<br />

business.<br />

For provisions ceded to reinsurers, the creditworthiness of<br />

our reinsurers is outlined in the table below.<br />

Here, 96% is directly collateralised through deposits. A<br />

credit risk can be ignored for this portion. Information on<br />

risks arising from defaults on receivables from insurance<br />

business can be found in the risk report on page 34.<br />

Technical provisions ceded to reinsurers according to rating <strong>2012</strong><br />

%<br />

2011<br />

%<br />

AAA 4 3<br />

AA 80 62<br />

A 15 13<br />

BBB and less − −<br />

No rating available 2 22<br />

[34d] Market risk from financing instruments – sensitivity analysis<br />

The sensitivity analysis shows the effect of capital market<br />

events on the value of investments and the corresponding<br />

impact on the consolidated income statement. Sensitivities<br />

of investments to share prices, interest rates and exchange<br />

rates are analysed independently of one another, i. e.<br />

ceteris paribus, with the change in market value being<br />

determined under selected capital market scenarios, as<br />

follows:<br />

The analysis of equities and equity derivatives is based on<br />

a market value of ± 10%, ± 30% of the delta-weighted exposure.<br />

Investment interests and alternative types of investments<br />

(private equity, hedge funds and commodities)<br />

are analysed together with shares. For interest-sensitive<br />

instruments, on the other hand, the change in market<br />

value resulting from a global change in interest rates of<br />

+ 100 BP, ± 50 BP and − 25 BP is determined using duration<br />

and convexity. The reaction of interest-rate derivatives to<br />

the change in market value of the underlying investments<br />

is taken into account using the delta of the derivative.<br />

Changes in exchange rates affect both interest-sensitive<br />

and equity-sensitive instruments as well as shareholdings.<br />

The sensitivity of instruments in foreign currencies is<br />

established by multiplying the euro market value by the<br />

hypothetical currency fluctuation of ± 10%.<br />

does not take into account the effects resulting from<br />

policy holders’ participation in surplus in dividends in<br />

insurance of the people. The impact on the results and<br />

equity shown below would be substantially reduced if<br />

these effects were considered. It is also assumed that<br />

changes in the capital markets occur instantaneously,<br />

preventing our limit systems and active countermeasures<br />

from taking effect. The analysis considers around 99% of<br />

<strong>ERGO</strong>’s investments.<br />

Market risk – share prices<br />

A rise in share prices does not generally have any effect<br />

on the income statement, but on the equity. Write-downs<br />

on hedging instruments following a rise in the share price<br />

are recorded in the income statement. By contrast, a<br />

drop in share prices leads to the changes of value being<br />

reflected in the income statement. Write-downs on shares<br />

are undertaken which are partly offset by the write-ups<br />

on hedging instruments also recorded in the income<br />

statement.<br />

The non-linear effects of equity options or other asymmetrical<br />

strategies are not taken into account in this presentation<br />

owing to the delta-weighted approach selected.<br />

The effects of events on the capital markets listed below<br />

do not take account of tax or the provision for premium<br />

refunds (gross amounts stated). This means the analysis


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements128<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Change in market value of<br />

Impact on Impact on Impact on Impact on<br />

investments sensitive to share prices<br />

profit or loss 1 equity 1<br />

profit or loss 1<br />

equity 1<br />

Change in share price<br />

<strong>2012</strong><br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

2011<br />

€ million<br />

Increase of 30% − 129 590 − 123 352<br />

Increase of 10% − 53 197 − 41 117<br />

Decrease of 10% − 54 − 88 − 42 − 35<br />

Decrease of 30% − 255 − 169 − 158 − 69<br />

Market values on 31 December 2,674 1,876<br />

1 Gross before tax and policyholder participation in surplus.<br />

Market risk – interest rates<br />

The change in the market price of investments sensitive<br />

to interest rates is calculated using a parallel shift of the<br />

interest-rate curve and a revaluation of the fixed-interest<br />

securities and interest-rate derivatives on the basis of their<br />

duration and convexity. Cash positions and other derivatives<br />

are not included in the calculation. Major strategic<br />

interest-rate derivatives are receiver swaps and swaptions.<br />

Bonds futures are used for tactical controlling.<br />

In terms of their market value, the fixed-interest investments<br />

of the <strong>ERGO</strong> Insurance <strong>Group</strong> react to interest-rate<br />

fluctuations in a way similar to a level-coupon bond with<br />

a residual term of about eight years. As part of the investments<br />

are valued at amortised cost, the effects shown<br />

nevertheless deviate from this.<br />

The impact on the consolidated income statement is<br />

small compared with the impact on equity, as most of<br />

the changes in the value of fixed-interest investments are<br />

accounted for in equity, with no effect on profit or loss.<br />

Also, around 50% of the investments considered in this<br />

analysis are measured at amortised cost, so that changes<br />

in market value have no effect on the financial statements.<br />

Economically speaking, the impact of the fixed-interest<br />

investments on equity is paralleled by a change in the economic<br />

value of the liabilities. Therefore our asset-liability<br />

management steers the investments in such a way that<br />

the effects of interest-rate changes on the value of the<br />

investments and on the economic value of the liabilities<br />

largely cancel each other out. This offsetting does not have<br />

an impact on the balance sheet, however, since significant<br />

portions of the liabilities are not valued on the basis of the<br />

current interest-rate curves.<br />

Change in market value of investments<br />

Impact on Impact on Impact on Impact on<br />

sensitive to interest rates<br />

profit or loss 1 equity 1 profit or loss 1 equity 1<br />

Change in interest rate<br />

<strong>2012</strong><br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

2011<br />

€ million<br />

Increase of 100 BP − 338 − 3,158 − 352 − 2,710<br />

Increase of 50 BP − 188 − 1,633 − 201 − 1,397<br />

Decrease of 25 BP 108 856 119 730<br />

Decrease of 50 BP 224 1,739 251 1,480<br />

Market values on 31 December 122,377 110,487<br />

1 Gross before tax and policyholder participation in surplus.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements129<br />

Disclosures on risks from insurance contracts and financial instruments<br />

Market risk – exchange rates<br />

A little less than half of foreign currency exposures taken<br />

into account come from British pounds and roughly a third<br />

from investments quoted in US dollars. The low sensitivity<br />

towards changes in the exchange rate is due to extensive<br />

currency hedging. In this analysis, a 10% rise in the currency<br />

rate is to be understood as a 10% appreciation in the foreign<br />

currency compared to the euro.<br />

Change in market value of investments<br />

Impact on Impact on Impact on Impact on<br />

sensitive to exchange rates<br />

profit or loss 1 equity 1 profit or loss 1 equity 1<br />

Change in exchange rates<br />

<strong>2012</strong><br />

€ million<br />

<strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

2011<br />

€ million<br />

Increase of 10 % 173 19 154 18<br />

Decrease of 10 % − 173 − 19 − 154 − 18<br />

Market values on 31 December 5,219 3,868<br />

1 Gross before tax and policyholder participation in surplus.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

130<br />

Consolidated Financial Statements<br />

Other information<br />

[35] Personnel expenses<br />

Personnel expenses <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Wages and salaries 1,419.1 1,506.4<br />

Social security contributions and employee assistance 299.6 299.8<br />

Expenses for employees’ pensions 100.9 99.0<br />

Total 1,819.5 1,905.2<br />

[36] Long-term incentive plan<br />

In each of the years 2002 to 2009, <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />

<strong>AG</strong> and some subsidiaries initiated long-term<br />

incentive schemes for members of the Board and for<br />

selected managing directors. This remuneration component<br />

with a long-term motivational effect is aimed at a<br />

sustainable rise in the share price of Munich Re. Those<br />

entitled received a defined number of share appreciation<br />

rights which can only be exercised if a waiting period of<br />

two years has expired, the Munich Re share price has risen<br />

by at least 20% since the scheme began, and the Euro<br />

Stoxx 50 index has been surpassed at least twice for three<br />

months each time in the seven years of the scheme. The<br />

gross amount that can be obtained from exercising the<br />

share appreciation rights is limited to a rise of no more<br />

than 150% of the initial share price. Appreciation rights<br />

could so far only be exercised under the schemes initiated<br />

in 2003 to 2006 and in 2009. The tables below show the<br />

long-term incentive schemes which had not expired at the<br />

beginning of the reporting period.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements131<br />

Other information<br />

Incentive plan 2009 2008 2007 2006 2005<br />

Plan commencement 1 July 2009 1 July 2008 1 July 2007 1 July 2006 1 July 2005<br />

Plan end 30 June 2016 30 June 2015 30 June 2014 30 June 2013 30 June <strong>2012</strong><br />

Initial share price 97.57 € 121.84 € 134.07 € 108.87 € 88.10 €<br />

Intrinsic value <strong>2012</strong> for one right 36.83 € 12.56 € 0.33 € 25.53 € 46.30 €<br />

Fair value <strong>2012</strong> for one right 36.83 € 12.99 € 7.06 € 25.53 € −<br />

Number of rights on 31 December 2004 − − − − −<br />

Exercisable at year-end − − − − −<br />

Additions − − − − 158,648<br />

Exercised − − − − −<br />

Forfeited − − − − −<br />

Number of rights on 31 December 2005 − − − − 158,648<br />

Exercisable at year-end − − − − −<br />

Additions − − − 130,667 −<br />

Exercised − − − − −<br />

Forfeited − − − − 3,072<br />

Number of rights on 31 December 2006 − − − 130,667 155,576<br />

Exercisable at year-end − − − − −<br />

Additions − − 94,115 − −<br />

Exercised − − − − 30,486<br />

Forfeited − − 10,422 6,849 −<br />

Number of rights on 31 December 2007 − − 83,693 123,818 125,090<br />

Exercisable at year-end − − − − 125,090<br />

Additions − 132,306 − − −<br />

Exercised − − − − 16,983<br />

Forfeited − − − − −<br />

Number of rights on 31 December 2008 − 132,306 83,693 123,818 108,107<br />

Exercisable at year-end − − − 123,818 108,107<br />

Additions 118,979 5,707 3,605 5,868 −<br />

Exercised − − − − 13,304<br />

Forfeited − − − − −<br />

Number of rights on 31 December 2009 118,979 138,013 87,298 129,686 94,803<br />

Exercisable at year-end − − 87,298 129,686 94,803<br />

Additions − − − − −<br />

Exercised − − − − 43,953<br />

Forfeited − − − − −<br />

Number of rights on 31 December 2010 118,979 138,013 87,298 129,686 50,850<br />

Exercisable at year-end − 138,013 87,298 129,686 50,850<br />

Additions − − − − −<br />

Exercised − − − − 26,957<br />

Forfeited − − − − −<br />

Number of rights on 31 December 2011 118,979 138,013 87,298 129,686 23,893<br />

Exercisable at year-end 118,979 138,013 87,298 129,686 23,893<br />

Additions − − − − −<br />

Exercised 109,813 − − 121,603 23,893<br />

Forfeited − − − − −<br />

Number of rights on 31 December <strong>2012</strong> 9,166 138,013 87,298 8,083 −<br />

Exercisable at year-end 9,166 138,013 87,298 8,083 −


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements132<br />

Other information<br />

[37] Cash flow statementent<br />

For a comment on the cash flow statement, reference<br />

is made to the management report, pages 25 f.<br />

[38] Total remuneration of the Supervisory Board and the Board of Management<br />

Expenditure for the Supervisory Board totalled € 0.7 million<br />

(0.8 m).<br />

Total remuneration for the Board of Management’s members<br />

for their activities on behalf of the holding company<br />

and <strong>Group</strong> companies amounted to € 8.3 million (8.2 m).<br />

Former members of the Board of Management and their<br />

surviving dependants received € 4.4 million (5.1 m) in total;<br />

a provision of € 48.1 million (41.2 m) has been set aside<br />

for current and future pension payments to this group of<br />

people.<br />

An overview of the members of the Company’s Supervisory<br />

Board and Board of Management are on pages 14 and<br />

15. This is part of the Notes to the consolidated financial<br />

statements.<br />

[39] <strong>Group</strong> affiliation<br />

As at 31 December <strong>2012</strong>, Münchener Rückversicherungs-<br />

Gesellschaft <strong>AG</strong>, Munich, controls directly and via its<br />

subsidiary P.A.N. GmbH & Co. KG, Grünwald, 100% of the<br />

issued share capital of <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>,<br />

Düsseldorf. <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong>, Düsseldorf,<br />

has prepared these consolidated financial statements<br />

as at 31 December <strong>2012</strong> according to International<br />

Financial <strong>Report</strong>ing Standards and is also included in<br />

the consolidated financial statements of Münchener<br />

Rückversicherungs-Gesellschaft <strong>AG</strong>, Munich. The consolidated<br />

financial statements are accessible on the website<br />

of the company register. They are also available from the<br />

companies upon request.<br />

[40] Auditor’s fees<br />

Auditor’s fees were paid for services rendered by the<br />

<strong>Group</strong> auditors KPMG Bayerische Treuhandgesellschaft <strong>AG</strong><br />

Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft,<br />

Munich, and affiliated companies in the meaning<br />

of Section 271 para. 2 of the German Commercial Code,<br />

to the parent company and consolidated subsidiaries in<br />

accordance with the following table:<br />

The affiliated companies of KPMG Bayerische Treuhandgesellschaft<br />

<strong>AG</strong> are the following: KPMG Germany,<br />

KPMG Spain, KPMG Switzerland, KPMG LLP (UK),<br />

KPMG Belgium, KPMG Netherlands, KPMG Luxembourg,<br />

KPMG Turkey, KPMG Russia, KPMG Georgia, KPMG Ukraine,<br />

KPMG Armenia, KPMG Kazakhstan, KPMG Kyrgyzstan,<br />

KPMG Norway, KPMG Kuwait, KPMG Jordan and<br />

KPMG Saudi-Arabia.<br />

Auditor’s fees <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

Audits of financial statements 4.3 1 4.3<br />

Other assurance and appraisal services 1.2 1 1.4<br />

Tax consultancy services 0.1 0.2<br />

Other services 1.2 0.6<br />

Total 6.8 6.6<br />

1 Thereof fees totalling € 4.6 million for KPMG Bayerische Treuhandgesellschaft <strong>AG</strong> Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements133<br />

Other information<br />

[41] Related parties<br />

<strong>ERGO</strong> Insurance <strong>Group</strong> maintains various reinsurance<br />

relationships with the Münchener Rückversicherungs-<br />

Gesellschaft <strong>AG</strong>, Munich, as well as with some of its<br />

reinsurance subsidiaries.<br />

In the year under review, premiums totalling € 597.2 million<br />

(639.5 m), i.e. 59.0% (62.8%) of total reinsurance premiums,<br />

were reinsured with them. In the reporting year<br />

a total of € 422.4 million (358.1 m) in claims expenditure<br />

came from these reinsurers.<br />

These companies’ share in deposits retained on ceded<br />

business is € 2,221.6 million (2,325.3 m). The share in receivables<br />

on reinsurance business accounts for € 52.0 million<br />

(55.9 m), and € 18.2 million (2.1 m) in accounts payable.<br />

Reinsurance relationships with Münchener Rückversicherungs-Gesellschaft<br />

<strong>AG</strong>, Munich, were reorganised<br />

in the reporting year. The agreed transfer price was<br />

€ 472.5 million.<br />

Besides the subordinated liabilities due to the Munich Re<br />

<strong>Group</strong> at the balance sheet date, there are further loan<br />

liabilities due to subsidiary companies of Münchener<br />

Rückversicherungs-Gesellschaft <strong>AG</strong> in Munich. <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />

<strong>AG</strong> has been lent € 30.0 million(180.0 m)<br />

by Itus Verwaltungs <strong>AG</strong>, Grünwald, and € 65.0 million<br />

(65.0 m) by Proserpina Vermögensverwaltungsgesellschaft<br />

mbH, Munich.<br />

In the context of an outsourcing contract, <strong>ERGO</strong> Insurance<br />

<strong>Group</strong> has transferred its portfolio management and<br />

administration of financial investments to ME<strong>AG</strong> MUNICH<br />

<strong>ERGO</strong> AssetManagement GmbH. The outsourcing agreement<br />

covers the administration of land and buildings,<br />

of all domestic and foreign marketable securities and of<br />

loans. In addition, ME<strong>AG</strong> MUNICH <strong>ERGO</strong> AssetManagement<br />

GmbH is assuming remits in property construction auditing.<br />

ME<strong>AG</strong> MUNICH <strong>ERGO</strong> AssetManagement GmbH is an<br />

associated company of <strong>ERGO</strong> Insurance <strong>Group</strong>. Remuneration<br />

of € 11.1 million (8.2 m) for services rendered and for<br />

insurance brokerage is attributable to ME<strong>AG</strong> companies.<br />

Expenses for services rendered and for insurance brokerage<br />

amounted to € 14.1 million (12.7 m).<br />

A retrospective purchase price adjustment from the sale of<br />

international health insurance companies to Munich Health<br />

Holding Aktiengesellschaft, Munich, in 2011 led to gains on<br />

the disposal of shares in affiliated companies amounting<br />

to € 10.2 million.<br />

No major reportable transactions between corporate<br />

bodies and the <strong>ERGO</strong> Insurance <strong>Group</strong> took place.<br />

[42] Contingent liabilities and other financial commitments<br />

The details below regarding contingent liabilities and other<br />

financial commitments refer to items in terms of IAS 37<br />

and Sections 251 and 285 no. 3 of the German Commercial<br />

Code (HGB) which go beyond the disclosure requirements<br />

under IAS 37. Under these provisions, financial commitments<br />

only need to be revealed where the likelihood of an<br />

outflow of funds is not minimal. It is not expected that the<br />

following disclosed contingent liabilities and secondary<br />

liabilities will be utilised.<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong> issued a letter of comfort<br />

amounting to € 4.3 million (4.3 m) for a non-affiliated<br />

company.<br />

In addition, guarantees of € 18.5 million (20.0 m) and<br />

DKK260.3 million (245.8 m) were given for non-affiliated<br />

companies. Guarantees to other companies amounted<br />

to € 10.3 million (10.3 m) and DKK16.0 million (20.0 m).<br />

Contingent repayment obligations to other companies<br />

stood at € 1.1 million (16.0 m).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements134<br />

Other information<br />

Assurances and guarantees resulting from the disposal of<br />

Capital Square Pte. Ltd. expired on schedule in July <strong>2012</strong>.<br />

<strong>ERGO</strong> Versicherung <strong>AG</strong> is member of several insurance<br />

pools, which means that if any other pool member became<br />

insolvent, it would be called upon to meet the policy claims<br />

against that member on a pro rata basis in accordance<br />

with its stake in the pool.<br />

As a result of their stakes in the Protektor Lebens versicherungs-<strong>AG</strong>,<br />

Berlin, <strong>ERGO</strong> Lebensversicherung <strong>AG</strong>,<br />

Hamburg, Victoria Lebensversicherung <strong>AG</strong>, Düsseldorf,<br />

<strong>ERGO</strong> Direkt Lebensversicherung <strong>AG</strong>, Fürth, Vorsorge<br />

Lebens versicherung <strong>AG</strong>, Düsseldorf, and Neckermann<br />

Lebens ver sicherung <strong>AG</strong>, Fürth, are required – in the event<br />

of a German life insurer becoming insolvent – to meet<br />

the latter’s policy claims on a pro rata basis according<br />

to the stake held. As in the previous year, <strong>ERGO</strong><br />

Insurance <strong>Group</strong> thus has a 10.76% stake in Protektor<br />

Lebensversicherungs-<strong>AG</strong>.<br />

Under Sections 124 et seq. of the German Insurance<br />

Supervision Act (V<strong>AG</strong>), German life and health insurers<br />

are obliged to become members of a protection fund. The<br />

protection fund is entitled to claim – in addition to the<br />

regular fees – extraordinary fees of 1‰ in the case of life<br />

insurers or 2‰ in the case of health insurers of net technical<br />

provisions. In addition, the Company has pledged to<br />

provide funding to the protection fund or, alternatively, to<br />

Protektor Lebensversicherungs-<strong>AG</strong> in case the protection<br />

fund’s financial resources should be insufficient. This obligation<br />

amounts to 1% of net technical provisions, taking<br />

into account the amounts already paid to the protection<br />

fund. This means that the <strong>ERGO</strong> Insurance <strong>Group</strong> may be<br />

required to pay € 525.5 million (531.2 m).<br />

[43] Investment and other financial liabilities<br />

Commitments of <strong>Group</strong> companies to non-affiliated companies<br />

stemming from work and service contracts came to<br />

€ 122.7 million (144.9 m) at the end of <strong>2012</strong>. Further, investment<br />

obligations (including additional payment obligations)<br />

to non-affiliated companies stood at € 479.1 million<br />

(581.5 m). These include INR1,329.0 million, or the equivalent<br />

of € 18.4 million, from a company start-up agreement<br />

in India. Moreover, investment obligations (including additional<br />

payment obligations) to associated companies stood<br />

at € 215.6 million (145.3 m). These include CNY700.0 million,<br />

or € 85.2 million, from the setting-up of a company in<br />

China. Credit facilities committed to non-affiliated companies<br />

totalled € 1.0 million (500.4 m).<br />

The aforementioned figures represent non-discounted<br />

nominal amounts.<br />

<strong>ERGO</strong> Versicherung <strong>AG</strong> and <strong>ERGO</strong> Direkt Versicherung <strong>AG</strong>,<br />

Fürth, have pledged contributions to an organisation set up<br />

to assist traffic accident victims (Verkehrsopferhilfe e.V.);<br />

each member company’s contribution is calculated on<br />

the basis of its share of the total membership’s premium<br />

income from direct motor third-party liability insurance<br />

in the calendar year before last (“direct” meaning: net of<br />

reinsurance accepted).


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements135<br />

Other information<br />

[44] Leasing<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong> as lessee<br />

At the balance sheet date, future minimum lease payments<br />

under non-cancellable operating leases totalled<br />

€ 215.8 million (248.6 m). Payments from operating<br />

leases concern in particular rents for offices and business<br />

premises of the <strong>Group</strong>. At € 0.5 million (0.6 m) on the<br />

balance sheet date, the sum of liabilities from financial<br />

leases only accounts for a subordinate amount.<br />

The <strong>ERGO</strong> Insurance <strong>Group</strong> as lessor<br />

Operating leases mainly involve leased property. The total<br />

of future minimum lease payments under non- cancellable<br />

leases at the balance sheet date was € 572.9 million<br />

(578.3 m). The total of contingent rental payments recorded<br />

in the financial year as income was € 0.4 million (0.7 m).<br />

Maturity of leasing relationships <strong>2012</strong><br />

€ million<br />

2011<br />

€ million<br />

<strong>ERGO</strong> as lessee<br />

Not later than one year 46.7 52.1<br />

Later than one year and not later than five years 100.1 133.7<br />

Later than five years 69.0 62.8<br />

Total 215.8 248.6<br />

<strong>ERGO</strong> as lessor<br />

Not later than one year 111.3 113.0<br />

Later than one year and not later than five years 311.3 283.4<br />

Later than five years 150.4 181.9<br />

Total 572.9 578.3<br />

[45] Liabilities secured by liens<br />

<strong>Group</strong> real estate holdings are encumbered by mortgages,<br />

land charges and annuity charges to a total value of<br />

€ 19.7 million (20.1 m).<br />

[46] Number of employees<br />

Employees (year-end) <strong>2012</strong> 2011<br />

In-house employees 24,166 25,352<br />

Salaried sales force 5,602 5,959<br />

Total 29,768 31,311<br />

The number of staff employed by the <strong>Group</strong> at year-end<br />

totalled 19,191 (19,731) in Germany and 10,577 (11,580) in<br />

other countries.<br />

[47] Events after the balance sheet date<br />

No events have occurred since the balance sheet date<br />

which require separate disclosure.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

136<br />

Consolidated Financial Statements<br />

List of shareholdings as at 31 December<br />

<strong>2012</strong> in accordance with Section 313 para. 2<br />

of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

Consolidated affiliated companies Germany<br />

AEVG 2004 GmbH, Frankfurt a 0.00%<br />

aktiva Vermittlung von Versicherungen und Finanz-Dienstleistungen GmbH, Cologne 100.00%<br />

ALICE GmbH, Düsseldorf 100.00%<br />

almeda GmbH, Munich 1, 8 100.00%<br />

almeda Versicherungs-Aktiengesellschaft, Munich 1, 8 100.00%<br />

avanturo GmbH, Düsseldorf 100.00%<br />

CAPITAL PLAZA Holding GmbH & Co. Singapore KG, Düsseldorf 100.00%<br />

D. A. S. Deutscher Automobil Schutz Allgemeine Rechtsschutz-Versicherungs-Aktiengesellschaft, Munich 2, 8 100.00%<br />

DKV Deutsche Krankenversicherung Aktiengesellschaft, Cologne 1, 8 100.00%<br />

DKV Pflegedienste & Residenzen GmbH, Cologne 100.00%<br />

<strong>ERGO</strong> Direkt Krankenversicherung <strong>AG</strong>, Fürth 1 100.00%<br />

<strong>ERGO</strong> Direkt Lebensversicherung <strong>AG</strong>, Fürth 1 100.00%<br />

<strong>ERGO</strong> Direkt Versicherung <strong>AG</strong>, Fürth 1 100.00%<br />

<strong>ERGO</strong> Elfte Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Eurosolar GmbH & Co. KG, Nuremberg 100.00%<br />

<strong>ERGO</strong> Grundstücksverwaltung GbR, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 14.Victoria & Co. KG, Kreien 9 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 5.Hamburg-Mannheimer & Co.KG, Kreien 9 100.00%<br />

<strong>ERGO</strong> International Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />

<strong>ERGO</strong> International Services GmbH, Düsseldorf 1 100.00%<br />

<strong>ERGO</strong> Lebensversicherung Aktiengesellschaft, Hamburg 1, 8 100.00%<br />

<strong>ERGO</strong> Neunte Beteiligungsgesellschaft mbH, Düsseldorf 1 100.00%<br />

<strong>ERGO</strong> Pensionsfonds Aktiengesellschaft, Düsseldorf 3, 8 100.00%<br />

<strong>ERGO</strong> Pensionskasse <strong>AG</strong>, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Private Capital Gesundheit GmbH & Co. KG, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Private Capital Leben GmbH & Co. KG, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Private Equity Gesundheit GmbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Private Equity Komposit GmbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Private Equity Leben GmbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Versicherung Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />

<strong>ERGO</strong> Zweite Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />

EUROPÄISCHE Reiseversicherung Aktiengesellschaft, Munich 1, 8 100.00%<br />

FAIRANCE GmbH, Düsseldorf 1 100.00%<br />

Flexitel Telefonservice GmbH, Berlin 100.00%<br />

Hamburg-Mannheimer Pensionskasse <strong>AG</strong>, Hamburg 100.00%<br />

HMV GFKL Beteiligungs GmbH, Düsseldorf 100.00%<br />

IDEENKAPITAL Financial Engineering GmbH, Düsseldorf 100.00%<br />

IDEENKAPITAL Financial Service GmbH, Düsseldorf 100.00%<br />

IDEENKAPITAL GmbH, Düsseldorf 100.00%<br />

IDEENKAPITAL Media Finance GmbH, Düsseldorf 50.10%<br />

IDEENKAPITAL Metropolen Europa GmbH & Co. KG, Düsseldorf 72.35%<br />

iii, Munich 100.00%<br />

IK Einkauf Objekt Eins GmbH & Co. KG, Düsseldorf 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements137<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

IK Einkauf Objektmanagement GmbH, Düsseldorf 100.00%<br />

IK Einkaufsmärkte Deutschland GmbH & Co. KG, Düsseldorf 52.04%<br />

IK Premium Fonds GmbH & Co. KG, Düsseldorf 100.00%<br />

IK Premium Fonds zwei GmbH & Co. KG, Düsseldorf 100.00%<br />

IRIS Capital Fund II German Investors GmbH & Co. KG, Düsseldorf 85.71%<br />

IT<strong>ERGO</strong> Informationstechnologie GmbH, Düsseldorf 1, 8 100.00%<br />

K & P Pflegezentrum IMMAC Uelzen Renditefonds GmbH & Co. KG, Düsseldorf 84.84%<br />

LEGIAL <strong>AG</strong>, Munich 100.00%<br />

Longial GmbH, Düsseldorf 100.00%<br />

ME<strong>AG</strong> Anglo Celtic Fund, Munich 100.00%<br />

ME<strong>AG</strong> BLN 2, Munich 100.00%<br />

ME<strong>AG</strong> EDL CurryGov, Munich 100.00%<br />

ME<strong>AG</strong> EDL EuroValue, Munich 100.00%<br />

ME<strong>AG</strong> EDS <strong>AG</strong>IL, Munich 100.00%<br />

ME<strong>AG</strong> Euro 1, Munich 100.00%<br />

ME<strong>AG</strong> Euro 2, Munich 100.00%<br />

ME<strong>AG</strong> Eurostar (Spezialfonds), Munich 100.00%<br />

ME<strong>AG</strong> German Prime Opportunities (GPO), Munich 100.00%<br />

ME<strong>AG</strong> Gilagrent, Munich 100.00%<br />

ME<strong>AG</strong> Golf 1, Munich 100.00%<br />

ME<strong>AG</strong> HBG 1, Munich 100.00%<br />

ME<strong>AG</strong> HM Renten, Munich 100.00%<br />

ME<strong>AG</strong> HM Sach 1, Munich 100.00%<br />

ME<strong>AG</strong> HM Sach Rent 1, Munich 100.00%<br />

ME<strong>AG</strong> HM2000, Munich 100.00%<br />

ME<strong>AG</strong> HMR1, Munich 100.00%<br />

ME<strong>AG</strong> HMR2, Munich 100.00%<br />

ME<strong>AG</strong> IREN, Munich 100.00%<br />

ME<strong>AG</strong> Kapital 2, Munich 100.00%<br />

ME<strong>AG</strong> Kapital 5, Munich 100.00%<br />

ME<strong>AG</strong> Multi Sach 1, Munich 100.00%<br />

ME<strong>AG</strong> OptiMax, Munich 100.00%<br />

ME<strong>AG</strong> PK-NORD, Munich 100.00%<br />

ME<strong>AG</strong> PK-WEST, Munich 100.00%<br />

ME<strong>AG</strong> PREMIUM, Munich 100.00%<br />

ME<strong>AG</strong> RenditePlus, Munich 100.00%<br />

ME<strong>AG</strong> REVO, Munich 100.00%<br />

ME<strong>AG</strong> S<strong>AG</strong> 1, Munich 100.00%<br />

ME<strong>AG</strong> Sustainability, Munich 100.00%<br />

ME<strong>AG</strong> Vidas 4, Munich 100.00%<br />

ME<strong>AG</strong> Vidas Rent 3, Munich 100.00%<br />

ME<strong>AG</strong> Vigifonds, Munich 100.00%<br />

ME<strong>AG</strong> VLA, Munich 100.00%<br />

Merkur Grundstücks- und Beteiligungs-Gesellschaft mit beschränkter Haftung, Düsseldorf 2 100.00%<br />

Neckermann Lebensversicherung <strong>AG</strong>, Fürth 100.00%<br />

Neckermann Versicherung <strong>AG</strong>, Nuremberg 100.00%<br />

OIK Mediclin, Wiesbaden 66.67%<br />

Seminaris Hotel- und Kongreßstätten-Betriebsgesellschaft mbH, Lüneburg 100.00%<br />

VHDK Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />

VICTORIA Asien Immobilienbeteiligungs GmbH & Co. KG, Munich 100.00%<br />

Victoria Italy Property GmbH, Düsseldorf 100.00%<br />

Victoria Lebensversicherung Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />

Victoria US Property Investment GmbH, Düsseldorf 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements138<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

Victoria US Property Zwei GmbH, Düsseldorf 100.00%<br />

Victoria Vierte Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />

Victoria Vierter Bauabschnitt GmbH & Co. KG, Düsseldorf 100.00%<br />

Vorsorge Lebensversicherung Aktiengesellschaft, Düsseldorf 1, 8 100.00%<br />

welivit <strong>AG</strong>, Nuremberg 100.00%<br />

wse Solarpark Spanien 1 GmbH & Co. KG, Fürth 65.17%<br />

Consolidated affiliated companies International<br />

ADB <strong>ERGO</strong> Lietuva, Vilnius 100.00%<br />

Amicus Legal Ltd., Bristol 100.00%<br />

Bank Austria Creditanstalt Versicherung <strong>AG</strong>, Vienna 90.00%<br />

Bos Incasso B. V., Groningen 89.76%<br />

CJSIC “European Travel Insurance”, Moscow 100.00%<br />

Compagnie Européenne d`Assurances, Nanterre 100.00%<br />

Compania Europea de Seguros S. A., Madrid 100.00%<br />

D. A. S. Defensa del Automovilista y de Siniestros – Internacional, S. A. de Seguros y Reaseguros, Barcelona 100.00%<br />

D. A. S. HELLAS Allgemeine Rechtsschutz-Versicherungs-<strong>AG</strong>, Athens 100.00%<br />

D. A. S. Jogvédelmi Biztosíto Részvénytársaság, Budapest 100.00%<br />

D. A. S. Luxembourg Allgemeine Rechtsschutz-Versicherung S. A., Strassen 99.95%<br />

D. A. S. Oigusabikulude Kindlustuse AS, Tallinn 100.00%<br />

D. A. S. Österreichische Allgemeine Rechtsschutz-Versicherungs-Aktiengesellschaft, Vienna 99.98%<br />

D. A. S. poist'ovna právnej ochrany, a. s., Bratislava 100.00%<br />

D. A. S. pojišt'ovna právní ochrany, a. s., Prague 100.00%<br />

D. A. S. Société anonyme belge d'assurances de Protection Juridique, Brussels 99.98%<br />

D. A. S. Towarzystwo Ubezpieczen Ochrony Prawnej S. A., Warszawa 99.95%<br />

DAS Assistance Limited, Bristol 100.00%<br />

DAS Holding N. V., Amsterdam 51.00%<br />

DAS Legal Expenses Insurance Co., Ltd., Seoul 100.00%<br />

DAS Legal Expenses Insurance Company Limited, Bristol 100.00%<br />

DAS Legal Finance B. V., Amsterdam 100.00%<br />

DAS Legal Protection Insurance Company Ltd., Toronto 100.00%<br />

DAS LEGAL SERVICES LIMITED, Bristol 100.00%<br />

DAS Nederlandse Rechtsbijstand Verzekeringmaatschappij N. V., Amsterdam 100.00%<br />

DAS Rechtsschutz-Versicherungs-<strong>AG</strong>, Lucerne 100.00%<br />

DAS Services Limited, Bristol 100.00%<br />

DAS Support B. V., Amsterdam 100.00%<br />

DAS UK Holdings Limited, Bristol 100.00%<br />

DB Platinum IV SICAV (Subfonds Institutional Fixed Income, Inhaber-Anteile I2D), Luxembourg a 100.00%<br />

<strong>ERGO</strong> ASIGURARI DE VIATA SA, Bucharest 100.00%<br />

<strong>ERGO</strong> Assicurazioni S. p. A., Milan 100.00%<br />

<strong>ERGO</strong> Austria International <strong>AG</strong>, Vienna 100.00%<br />

<strong>ERGO</strong> Direkt Lebensversicherung <strong>AG</strong>, Schwechat 100.00%<br />

<strong>ERGO</strong> Élétbiztosító Zrt., Budapest 100.00%<br />

<strong>ERGO</strong> Emeklilik ve Hayat A. S., Istanbul 100.00%<br />

<strong>ERGO</strong> Eurosolar S. a. s. di welivit Solar Italia S. r. l., Bozen 100.00%<br />

<strong>ERGO</strong> Funds AS, Tallinn 100.00%<br />

<strong>ERGO</strong> General Insurance Company S. A., Athens 100.00%<br />

<strong>ERGO</strong> Grubu Holding A. Ş., Istanbul 100.00%<br />

<strong>ERGO</strong> Insurance N. V., Brussels 100.00%<br />

<strong>ERGO</strong> Invest SIA, Riga 100.00%<br />

<strong>ERGO</strong> Italia Business Solutions S. c. r. l., Milan 100.00%<br />

<strong>ERGO</strong> Italia Direct Network s. r. l., Milan 100.00%<br />

<strong>ERGO</strong> Italia S. p. A., Milan 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements139<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

<strong>ERGO</strong> Kindlustuse AS, Tallinn 100.00%<br />

<strong>ERGO</strong> Latvija Versicherung <strong>AG</strong> (<strong>ERGO</strong> Latvija Apdrosinasanas Akciju Sabiedriba), Riga 100.00%<br />

<strong>ERGO</strong> Life Insurance Company S. A., Salonika 100.00%<br />

<strong>ERGO</strong> Life Insurance SE, Vilnius 100.00%<br />

<strong>ERGO</strong> osiguranje d.d, Zagreb 100.00%<br />

<strong>ERGO</strong> Partners N. V., Brussels 100.00%<br />

<strong>ERGO</strong> pojišt´ovna, a. s., Prague 100.00%<br />

<strong>ERGO</strong> Previdenza S. p. A., Milan 100.00%<br />

<strong>ERGO</strong> RUSS Versicherung <strong>AG</strong>, St. Petersburg 100.00%<br />

<strong>ERGO</strong> Shisn, Moscow 100.00%<br />

<strong>ERGO</strong> SIGORTA A. S., Istanbul 100.00%<br />

<strong>ERGO</strong> Versicherung Aktiengesellschaft, Vienna 100.00%<br />

<strong>ERGO</strong> Zivljenjska zavarovalnica d. d., Ljubljana 100.00%<br />

<strong>ERGO</strong> životná poisťovňa, a. s., Bratislava 100.00%<br />

<strong>ERGO</strong> Zivotno osiguranje d.d, Zagreb 100.00%<br />

ERV Försäkringsaktiebolag (publ), Stockholm 100.00%<br />

ERV pojišt'ovna, a. s., Prague 90.00%<br />

Europaeiske Rejseforsikring A/S, Copenhagen 100.00%<br />

European International Holding A/S, Copenhagen 100.00%<br />

Everything Legal Ltd., Bristol 100.00%<br />

Geschlossene Aktiengesellschaft Europäische Reiseversicherung, Kiev 100.00%<br />

GF 65, Vienna 100.00%<br />

Habiriscos – Investimentos Imobiliarios e Turisticos, S. A., Lisbon 100.00%<br />

Ibero Property Portugal – Investimentos Imobiliarios S. A., Lisbon 100.00%<br />

Ibero Property Trust S. A., Madrid 100.00%<br />

IKFE Properties I <strong>AG</strong>, Zurich 63.55%<br />

Imofloresmira – Investimentos Imobiliarios S. A., Lisbon 100.00%<br />

InsuranceAssistance FLLC, Minsk 100.00%<br />

Joint Stock Insurance Company <strong>ERGO</strong>, Minsk 92.31%<br />

Kapdom-Invest GmbH, Moscow 100.00%<br />

Landelijke Associatie van Gerechtsdeurwaarders B. V., Groningen c 89.76%<br />

LAVG Associatie van Gerechtsdeurwaarders Zuid Holding B. V., Breda c 80.00%<br />

Marina Sp. z. o. o., Sopot 100.00%<br />

MTU Moje Towarzystwo Ubezpieczeniowe S. A., Sopot 100.00%<br />

Nightingale Legal Services Ltd., Bristol 100.00%<br />

Queensley Holdings Limited, Singapore a, d 100.00%<br />

Renaissance Hotel Realbesitz GmbH, Vienna 60.00%<br />

Sopocki Instytut Ubezpieczeń S. A., Sopot 100.00%<br />

Sopockie Towarzystwo Ubezpieczen Ergo Hestia Spolka Akcyjna, Sopot 100.00%<br />

Sopockie Towarzystwo Ubezpieczen na Zycie Ergo Hestia Spolka Akcyjna, Sopot 100.00%<br />

Union Beteiligungsholding GmbH, Vienna 100.00%<br />

Van Arkel Gerechtsdeurwaarders B. V., Leiden c 79.90%<br />

Victoria Investment Properties Two L. P., Atlanta 100.00%<br />

Victoria US Holdings, Inc., Wilmington, Delaware 100.00%<br />

VICTORIA-VOLKSBANKEN Eletbiztosító Zrt., Budapest 100.00%<br />

VICTORIA-VOLKSBANKEN Poist´ovna, a. s., Bratislava 100.00%<br />

VICTORIA-VOLKSBANKEN Biztosító Zrt., Budapest 100.00%<br />

Vorsorge Luxembourg Lebensversicherung S. A., Munsbach 100.00%<br />

Non-consolidated affiliated companies Germany<br />

ARTES Assekuranzservice GmbH, Düsseldorf 100.00%<br />

ArztPartner almeda <strong>AG</strong>, Munich 100.00%<br />

BioEnergie Elbe-Elster GmbH & Co. KG, Elsterwerda 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements140<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

BioEnergie Verwaltungs-GmbH, Elsterwerda 100.00%<br />

Blitz 01–807 GmbH, Munich 100.00%<br />

CAPITAL PLAZA Holding GmbH, Düsseldorf 100.00%<br />

CarePlus Gesellschaft für Versorgungsmanagement mbH, Cologne 100.00%<br />

Ciborum GmbH, Munich 100.00%<br />

DKV – Beta Vermögensverwaltungs GmbH, Cologne 100.00%<br />

DKV Gesundheits Service GmbH, Cologne 100.00%<br />

DKV Immobilienverwaltungs GmbH, Cologne 100.00%<br />

DKV Residenz am Tibusplatz gGmbH, Münster 100.00%<br />

DKV-Residenz in der Contrescarpe GmbH, Bremen 100.00%<br />

<strong>ERGO</strong> Alpha GmbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Gourmet GmbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 1. DKV & Co. KG, Kreien 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 15.Victoria & Co. KG, Kreien 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 4. DKV & Co. KG, Kreien 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 6.Hamburg-Mannheimer & Co. KG, Kreien 100.00%<br />

<strong>ERGO</strong> Immobilien-GmbH 7.Hamburg-Mannheimer & Co. KG, Kreien 100.00%<br />

<strong>ERGO</strong> Immobilien-Verwaltungs-GmbH, Kreien 100.00%<br />

<strong>ERGO</strong> Leben Asien Verwaltungs GmbH, Munich 100.00%<br />

<strong>ERGO</strong> Private Capital GmbH, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Private Capital Zweite GmbH & Co. KG, Düsseldorf 100.00%<br />

<strong>ERGO</strong> Specialty GmbH, Hamburg 100.00%<br />

<strong>ERGO</strong> Versicherungs- und Finanzierungs-Vermittlung GmbH, Hamburg 100.00%<br />

<strong>ERGO</strong> Zehnte Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />

EUREKA GmbH, Düsseldorf 100.00%<br />

European Assistance Holding GmbH, Munich 100.00%<br />

EVV Logistik Management GmbH, Düsseldorf 100.00%<br />

Exolvo GmbH, Hamburg 100.00%<br />

GBG Vogelsanger Straße GmbH, Cologne 94.00%<br />

Gebäude Service Gesellschaft Überseering 35 mbH, Hamburg 100.00%<br />

GEMEDA Gesellschaft für medizinische Datenerfassung und Auswertung<br />

sowie Serviceleistungen für freie Berufe mbH, Cologne 100.00%<br />

goDentis – Gesellschaft für Innovation in der Zahnheilkunde mbH, Cologne 100.00%<br />

goMedus Gesellschaft für Qualität in der Medizin mbH, Cologne 100.00%<br />

goMedus GmbH & Co. KG, Cologne 100.00%<br />

Hamburg-Mannheimer Rechtsschutz Schaden-Service GmbH, Hamburg 100.00%<br />

Horbach GmbH Versicherungsvermittlung und Finanzdienstleistungen, Düsseldorf 70.10%<br />

IDEENKAPITAL Anlagebetreuungs GmbH, Düsseldorf 4 100.00%<br />

Ideenkapital Client Service GmbH, Düsseldorf 4 100.00%<br />

Ideenkapital erste Investoren Service GmbH, Düsseldorf 100.00%<br />

Ideenkapital Fonds Treuhand GmbH, Düsseldorf 100.00%<br />

Ideenkapital Media Treuhand GmbH, Düsseldorf 100.00%<br />

IDEENKAPITAL Metropolen Europa Verwaltungsgesellschaft mbH, Düsseldorf 100.00%<br />

IDEENKAPITAL PRORENDITA EINS Treuhandgesellschaft mbH, Düsseldorf 100.00%<br />

IDEENKAPITAL Schiffsfonds Treuhand GmbH, Düsseldorf 100.00%<br />

Ideenkapital Treuhand GmbH, Düsseldorf 100.00%<br />

IDEENKAPITAL Treuhand US Real Estate eins GmbH, Düsseldorf 100.00%<br />

IK Einkauf Objektverwaltungsgesellschaft mbH, Düsseldorf 100.00%<br />

IK Einkaufsmärkte Deutschland Verwaltungsgesellschaft mbH, Düsseldorf 100.00%<br />

IK FE Fonds Management GmbH, Düsseldorf 100.00%<br />

IK FE Management GmbH, Düsseldorf 100.00%<br />

IK Komp GmbH, Düsseldorf 100.00%<br />

IK Objekt Bensheim GmbH, Düsseldorf 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements141<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

IK Objekt Frankfurt Theodor-Heuss-Allee GmbH, Düsseldorf 100.00%<br />

IK Pflegezentrum Uelzen Verwaltungs-GmbH, Düsseldorf 100.00%<br />

IK Property Eins Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />

IK Property Treuhand GmbH, Düsseldorf 100.00%<br />

IK US Portfolio Invest DREI Verwaltungs-GmbH, Düsseldorf 100.00%<br />

IK US Portfolio Invest Verwaltungs-GmbH, Düsseldorf 100.00%<br />

IK US Portfolio Invest ZWEI Verwaltungs-GmbH, Düsseldorf 100.00%<br />

InterAssistance Gesellschaft für Dienstleistungen mit beschränkter Haftung, Munich 100.00%<br />

Juventus Vermögensverwaltungs <strong>AG</strong>, Hamburg 100.00%<br />

K & P Objekt Hamburg Hamburger Straße GmbH, Düsseldorf 100.00%<br />

K & P Objekt Munich Hufelandstraße GmbH, Düsseldorf 100.00%<br />

KQV Solarpark Franken 1 GmbH & Co. KG, Fürth 100.00%<br />

Legal Net GmbH, Munich 100.00%<br />

m:editerran POWER FRANCE GmbH, Nuremberg 100.00%<br />

m:editerran POWER GmbH & Co. KG, Nuremberg 100.00%<br />

MAYFAIR Holding GmbH, Düsseldorf 100.00%<br />

Mediastream Consulting GmbH, Grünwald 100.00%<br />

Mediastream Dritte Film GmbH, Grünwald 100.00%<br />

Mediastream Film GmbH, Grünwald 100.00%<br />

Mediastream Vierte Medien GmbH, Grünwald 100.00%<br />

Mediastream Zweite Film GmbH, Grünwald 100.00%<br />

MedWell Gesundheits-<strong>AG</strong>, Cologne 100.00%<br />

miCura Pflegedienste Berlin GmbH, Berlin 100.00%<br />

miCura Pflegedienste Bremen GmbH, Bremen 100.00%<br />

miCura Pflegedienste Düsseldorf GmbH, Düsseldorf 100.00%<br />

miCura Pflegedienste GmbH, Cologne 100.00%<br />

miCura Pflegedienste Hamburg GmbH, Hamburg 100.00%<br />

miCura Pflegedienste Krefeld GmbH, Krefeld 100.00%<br />

miCura Pflegedienste Munich / Dachau GmbH, Dachau 51.00%<br />

miCura Pflegedienste Munich GmbH, Munich 100.00%<br />

miCura Pflegedienste Munich Ost GmbH, Munich 65.00%<br />

miCura Pflegedienste Münster GmbH, Münster 100.00%<br />

miCura Pflegedienste Nuremberg GmbH, Nuremberg 51.00%<br />

PLATINIA Verwaltungs-GmbH, Munich 100.00%<br />

PRORENDITA DREI Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />

PRORENDITA EINS Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />

PRORENDITA FÜNF Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />

PRORENDITA VIER Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />

PRORENDITA ZWEI Verwaltungsgesellschaft mbH, Hamburg 100.00%<br />

Quirinus <strong>AG</strong>, Düsseldorf 100.00%<br />

Schrömbgens & Stephan GmbH, Versicherungsmakler, Düsseldorf 100.00%<br />

Seldac 1. Kommunaler-Rendite-Fonds GmbH & Co. KG, Düsseldorf 100.00%<br />

Seldac 1. Verwaltungs-GmbH, Düsseldorf 100.00%<br />

Solarfonds Garmisch-Partenkirchen 2011 GmbH & Co. KG, Nuremberg 99.75%<br />

TAS Assekuranz Service GmbH, Frankfurt/Main 100.00%<br />

TAS Touristik Assekuranz Service International GmbH, Frankfurt/Main 5 100.00%<br />

TAS Touristik Assekuranzmakler und Service GmbH, Frankfurt/Main 5 100.00%<br />

Titus <strong>AG</strong>, Düsseldorf 100.00%<br />

Trusted Documents GmbH, Nuremberg 100.00%<br />

US PROPERTIES VA Verwaltungs-GmbH, Düsseldorf 100.00%<br />

Verwaltungsgesellschaft “PORT VICTORIA” GmbH, Hamburg 100.00%<br />

Victoria Erste Beteiligungsgesellschaft mbH, Düsseldorf 100.00%<br />

Victoria Immobilien-Fonds GmbH, Düsseldorf 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements142<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

VICTORIA US Beteiligungsgesellschaft mbH, Munich 100.00%<br />

Victoria Vierter Bauabschnitt Management GmbH, Düsseldorf 100.00%<br />

Viwis GmbH, Munich 6 100.00%<br />

Vorsorge Service GmbH, Düsseldorf 100.00%<br />

welivit New Energy GmbH, Fürth 100.00%<br />

welivit Solar España GmbH, Nuremberg 100.00%<br />

WNE Solarfonds Süddeutschland 2 GmbH & Co. KG, Nuremberg 100.00%<br />

Wohnungsgesellschaft Brela mbH, Hamburg 7 100.00%<br />

Non-consolidated affiliated companies International<br />

80e LIMITED, Bristol 100.00%<br />

Acalater 140014 S. L., Playa del Inglés 100.00%<br />

Aitesacho 5005 S. L., Playa del Inglés 100.00%<br />

Albulzaga 8008 S. L., Playa del Inglés 100.00%<br />

Aleama 150015 S. L., Madrid 100.00%<br />

Amicus Ltd., Bristol 100.00%<br />

Amladeza 7007 S. L., Playa del Inglés 100.00%<br />

Arridabra 130013 S. L., Madrid 100.00%<br />

B&D Acquisition B. V., Amsterdam 80.00%<br />

B&D Business Solutions B. V., Utrecht 100.00%<br />

Badozoc 1001 S. L., Madrid 100.00%<br />

Bank Austria Creditanstalt Versicherungsdienst GmbH, Vienna 100.00%<br />

Baqueda 7007 S. L., Madrid 100.00%<br />

Bobasbe 6006 S. L., Madrid 100.00%<br />

Botedazo 8008 S. L., Madrid 100.00%<br />

Bureau voor kredietinformaties Janssen B. V., s-Gravenhage 100.00%<br />

Bureau voor kredietinformaties Janssen Holding B. V., s-Gravenhage 100.00%<br />

Callopio 5005 S. L., Madrid 100.00%<br />

Camcichu 9009 S. L., Madrid 100.00%<br />

Caracuel Solar Catorce S. L., Madrid 100.00%<br />

Caracuel Solar Cinco S. L., Madrid 100.00%<br />

Caracuel Solar Cuatro S. L., Madrid 100.00%<br />

Caracuel Solar Dieciocho S. L., Madrid 100.00%<br />

Caracuel Solar Dieciseis S. L., Madrid 100.00%<br />

Caracuel Solar Diecisiete S. L., Madrid 100.00%<br />

Caracuel Solar Diez S. L., Madrid 100.00%<br />

Caracuel Solar Doce S. L., Madrid 100.00%<br />

Caracuel Solar Dos S. L., Madrid 100.00%<br />

Caracuel Solar Nueve S. L., Madrid 100.00%<br />

Caracuel Solar Ocho S. L., Madrid 100.00%<br />

Caracuel Solar Once S. L., Madrid 100.00%<br />

Caracuel Solar Quince S. L., Madrid 100.00%<br />

Caracuel Solar Seis S. L., Madrid 100.00%<br />

Caracuel Solar Siete S. L., Madrid 100.00%<br />

Caracuel Solar Trece S. L., Madrid 100.00%<br />

Caracuel Solar Tres S. L., Madrid 100.00%<br />

Caracuel Solar Uno S. L., Madrid 100.00%<br />

Chobocuga 150015 S. L., Playa del Inglés 100.00%<br />

Cotatrillo 100010 S. L., Madrid 100.00%<br />

DAS Consultancy & Detachering Rotterdam B. V., Rotterdam 75.02%<br />

DAS Financial Services B. V., Amsterdam 51.00%<br />

DAS Incasso Arnhem B. V., Arnheim 100.00%<br />

DAS Incasso Eindhoven B. V., s-Hertogenbosch 80.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements143<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

DAS Incasso Rotterdam B. V., Rotterdam 80.00%<br />

DAS Law Limited, Bristol 100.00%<br />

DAS Legal Protection Ireland Limited, Dublin 100.00%<br />

DAS Legal Protection Limited, Christchurch, New Zealand 100.00%<br />

DAS Legal Protection Limited, Vancouver 100.00%<br />

DAS Legal Protection Pty. Ltd., Sydney 100.00%<br />

DAS Lex Assistance, S. L., L´Hospitalet de Llobregat 100.00%<br />

De Wit Vissers Incasso Holding B. V., Breda 95.00%<br />

DRA Debt Recovery Agency B. V., s-Gravenhage 100.00%<br />

Economic Data Research B. V., Leidschendam 100.00%<br />

Economic Data Resources B. V., Leidschendam 100.00%<br />

EDR Acquisition B. V., Amsterdam 100.00%<br />

EDR Credit Services B. V., s-Gravenhage 100.00%<br />

<strong>ERGO</strong> Asia Management Pte. Ltd., Singapore 100.00%<br />

<strong>ERGO</strong> GmbH, Herisau 100.00%<br />

<strong>ERGO</strong> Insurance Service GmbH, Vienna 99.60%<br />

<strong>ERGO</strong> PORTFÖY YÖNETIMI A. S., Istanbul 100.00%<br />

<strong>ERGO</strong> Pro Sp. z o. o., Warsaw 100.00%<br />

<strong>ERGO</strong> Pro, spol. s r. o., Prague 100.00%<br />

ERIN Sigorta Aracilik Hizmetleri Limited Sirketi, Istanbul 100.00%<br />

ERV (China) Travel Service and Consulting Ltd., Beijing 100.00%<br />

ERV (India) Travel Service and Consulting Private Limited, Mumbai 100.00%<br />

ERV Seyahat Sigorta Aracilik Hizmetleri ve Danismanlik Ltd.Sti., Istanbul 99.00%<br />

Esoleme 120012 S. L., Playa del Inglés 100.00%<br />

Etics, s. r. o., Prague 100.00%<br />

Etoblete 160016 S. L., Madrid 100.00%<br />

Etogibon 100010 S. L., Playa del Inglés 100.00%<br />

Etolede 6006 S. L., Playa del Inglés 100.00%<br />

Euro Alarm Assistance Pragueue, Prague 100.00%<br />

Euro-Center (Cyprus) Ltd., Larnaca 100.00%<br />

Euro-Center (Thailand) Co. Ltd., Bangkok 100.00%<br />

Euro-Center Cape Town (Pty.) Ltd., Cape Town 100.00%<br />

Euro-Center China (HK) Co., Ltd., Beijing 100.00%<br />

Euro-Center Holding A/S, Copenhagen 83.33%<br />

Euro-Center Holding North Asia (HK) Pte. Ltd., Hong Kong 100.00%<br />

Euro-Center Ltda., Rio de Janeiro 100.00%<br />

Euro-Center USA, Inc., New York 100.00%<br />

Euro-Center Yerel Yardim, Istanbul 100.00%<br />

Euro-Center, S. A. (Spain), Palma de Mallorca 100.00%<br />

Europäische (UK) Ltd., London 100.00%<br />

First Legal Protection Limited, Bristol 100.00%<br />

Gamaponti 140014 S. L., Madrid 100.00%<br />

GRANCAN Sun-Line S. L., Madrid 100.00%<br />

Guanzu 2002 S. L., Madrid 100.00%<br />

Hamburg-Mannheimer ForsikringService A/S, Copenhagen 100.00%<br />

Health OÜ, Tallinn 100.00%<br />

Hestia Advanced Risk Solutions Sp. z. o. o., Sopot 100.00%<br />

Hestia Loss Control Sp. z o. o., Sopot 100.00%<br />

HMI S. r. l., Verona 100.00%<br />

Humanity B. V., s-Gravenhage 100.00%<br />

Ibero Property Guadalix S. A., Madrid 100.00%<br />

Kuik & Partners Credit Management BVBA, Brussels 98.90%<br />

Kuik & Partners Gerechtsdeurwaarders & Incassobureau B. V., Eindhoven 100.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements144<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

LAVG Zuid B. V., Breda 100.00%<br />

LawAssist Limited, Bristol 100.00%<br />

m:editerran Power S. a. s. di welivit Solar Italia S. r. l., Bozen 100.00%<br />

MESA ASISTENCIA, S. A., Madrid 99.90%<br />

Naretoblera 170017 S. L., Madrid 100.00%<br />

Nassau Incasso Services Den Haag B. V., s-Gravenhage 100.00%<br />

Nerruze 120012 S. L., Madrid 100.00%<br />

Nicamballo 1001 S. L., Playa del Inglés 100.00%<br />

Olbodeca 4004 S. L., Playa del Inglés 100.00%<br />

Oracuet 160016 S. L., Playa del Inglés 100.00%<br />

Oragulno 9009 S. L., Playa del Inglés 100.00%<br />

Oraunte 130013 S. L., Playa del Inglés 100.00%<br />

Orrazipo 110011 S. L., Madrid 100.00%<br />

Otusleme 3003 S. L., Playa del Inglés 100.00%<br />

ProContact Sp. z o. o., Gdansk 100.00%<br />

SAINT LEON ENERGIE S. A. R. L., Strasbourg 100.00%<br />

Sopockie Towarzystwo Doradcze Sp. z o. o., Sopot 100.00%<br />

Stichting Aandelen Beheer D. A. S. Holding, Amsterdam 100.00%<br />

Sydney Euro-Center Pty. Ltd., Sydney 100.00%<br />

Teginago 2002 S. L., Playa del Inglés 100.00%<br />

Tenoslema 110011 S. L., Playa del Inglés 100.00%<br />

TGR Biztosítás Többesügynöki Zrt., Budapest 100.00%<br />

Tillobesta 180018 S. L., Madrid 100.00%<br />

VB Victoria Zastupanje u Osiguranju d. o. o., Zagreb 74.90%<br />

VFG Vorsorge-Finanzierungsconsulting GmbH, Vienna 100.00%<br />

Victoria VIP II, Inc., Wilmington, Delaware 100.00%<br />

VV-Consulting Gesellschaft für Risikoanalyse, Vorsorgeberatung und Versicherungsvermittlung GmbH, Vienna 100.00%<br />

VV-Consulting Többesügynöki Kft., Budapest 100.00%<br />

welivit Solar Italia s. r. l., Bozen 100.00%<br />

Zacobu 110011 S. L., Madrid 100.00%<br />

Zacuba 6006 S. L., Madrid 100.00%<br />

Zacubacon 150015 S. L., Madrid 100.00%<br />

Zafacesbe 120012 S. L., Madrid 100.00%<br />

Zagacobi 180018 S. L., Playa del Inglés 100.00%<br />

Zapaceba 170017 S. L., Playa del Inglés 100.00%<br />

Zapacubi 8008 S. L., Madrid 100.00%<br />

Zarzucolumbu 100010 S. L., Madrid 100.00%<br />

Zetaza 4004 S. L., Madrid 100.00%<br />

Zicobucar 140014 S. L., Madrid 100.00%<br />

Zucaelo 130013 S. L., Madrid 100.00%<br />

Zucampobi 3003 S. L., Madrid 100.00%<br />

Zucarrobiso 2002 S. L., Madrid 100.00%<br />

Zucobaco 7007 S. L., Madrid 100.00%<br />

Zulazor 3003 S. L., Madrid 100.00%<br />

Zumbicobi 5005 S. L., Madrid 100.00%<br />

Zumcasba 1001 S. L., Madrid 100.00%<br />

Zuncabu 4004 S. L., Madrid 100.00%<br />

Zuncolubo 9009 S. L., Madrid 100.00%<br />

Associates valued at equity Germany<br />

Dovull SPV GmbH & Co. KG, Frankfurt/Main 20.06%<br />

HighTech Beteiligungen GmbH und Co. KG, Düsseldorf 23.10%<br />

KarstadtQuelle Finanz Service GmbH, Düsseldorf 50.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements145<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

MAYFAIR Holding GmbH & Co. Singapore KG, Düsseldorf e 71.43%<br />

MCAF Verwaltungs-GmbH & Co.KG, Düsseldorf 50.00%<br />

ME<strong>AG</strong> Cash Management GmbH, Munich 40.00%<br />

ME<strong>AG</strong> MUNICH <strong>ERGO</strong> AssetManagement GmbH, Munich 40.00%<br />

MEDICLIN Aktiengesellschaft, Offenburg 35.00%<br />

MEGA 4 GbR, Berlin 34.26%<br />

Rendite Partner Gesellschaft für Vermögensverwaltung mbH, Frankfurt/Main 33.33%<br />

RP Vilbeler Fondsgesellschaft mbH, Frankfurt/Main 40.00%<br />

Sana Kliniken <strong>AG</strong>, Munich 21.70%<br />

TERTIANUM Besitzgesellschaft Berlin Passauer Strasse 5− 7 mbH, Munich 25.00%<br />

TERTIANUM Besitzgesellschaft Konstanz Marktstätte 2− 6 und Sigismundstrasse 5− 9 mbH, Munich 25.00%<br />

TERTIANUM Besitzgesellschaft Munich Jahnstrasse 45 mbH, Munich 33.33%<br />

US PROPERTIES VA GmbH & Co. KG, Düsseldorf 46.09%<br />

U. S. Property Fund IV GmbH & Co. KG, Munich b 9.78%<br />

VV Immobilien GmbH & Co. United States KG, Munich 28.95%<br />

VV Immobilien GmbH & Co. US City KG, Munich 23.10%<br />

VV Immobilien Verwaltungs GmbH & Co. Zentraleuropa KG, Munich 20.41%<br />

WISMA ATRIA Holding GmbH & Co. Singapore KG, Düsseldorf e 65.00%<br />

Associates valued at equity International<br />

D. A. S. Difesa Automobilistica Sinistri, S. p. A. di Assicurazione, Verona 49.99%<br />

<strong>ERGO</strong> China Life Insurance Co., Ltd., Jinan, Shandong Province 50.00%<br />

Europai Utazasi Biztosito Rt., Budapest 26.00%<br />

Europäische Reiseversicherungs-Aktiengesellschaft, Vienna 25.01%<br />

Global Insurance Company, Ho Chi Minh City 25.00%<br />

HDFC <strong>ERGO</strong> General Insurance Company Ltd., Mumbai 26.00%<br />

Millennium Entertainment Partners II L. P., New York f 42.30%<br />

Millennium Entertainment Partners L. P., New York g 27.54%<br />

Millennium Partners LLC, New York h 20.30%<br />

Property Finance France S. A., Luxembourg 45.46%<br />

SAS Le Point du Jour, Paris 50.00%<br />

VICTORIA-VOLKSBANKEN Pensionskassen Aktiengesellschaft, Vienna 47.50%<br />

VICTORIA-VOLKSBANKEN Vorsorgekasse <strong>AG</strong>, Vienna 50.00%<br />

Other associated companies Germany<br />

“PORT ELISABETH” GmbH & Co. KG, Hamburg 31.97%<br />

“PORT LOUIS” GmbH & Co. KG, Hamburg 25.82%<br />

Assistance Partner GmbH & Co. KG, Munich 21.66%<br />

BF.direkt <strong>AG</strong>, Stuttgart 27.20%<br />

carexpert Kfz-Sachverständigen GmbH, Walluf 25.00%<br />

Fernkälte Geschäftsstadt Nord Gesellschaft bürgerlichen Rechts, Hamburg 39.34%<br />

Hannover Finanz-Umwelt Beteiligungsgesellschaft mbH, Hillerse 20.00%<br />

IK Objektgesellschaft Frankfurt Theodor-Heuss-Allee GmbH & Co. KG, Düsseldorf 47.40%<br />

K & P Objekt Hamburg Hamburger Straße Immobilienfonds GmbH & Co.KG, Düsseldorf 36.69%<br />

MCAF Management GmbH, Düsseldorf 50.00%<br />

Reisegarant, Vermittler von Insolvenzversicherungen mbH, Hamburg 24.00%<br />

Teko – Technisches Kontor für Versicherungen Gesellschaft mit beschränkter Haftung, Düsseldorf 30.00%<br />

TERTIANUM Seniorenresidenz Betriebsgesellschaft Munich mbH, Munich 33.33%<br />

TERTIANUM Seniorenresidenzen Betriebsgesellschaft mbH, Konstanz 25.00%<br />

Verwaltungsgesellschaft “PORT ELISABETH” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “Port Hedland” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT KELANG” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “Port Lincoln” mbH, Hamburg 50.00%


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

Consolidated Financial Statements146<br />

List of shareholdings as at 31 December <strong>2012</strong> in accordance with<br />

Section 313 para. 2 of the German Commercial Code (HGB)<br />

Company name and registered office Footnote Stake held<br />

Verwaltungsgesellschaft “PORT LOUIS” GmbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT MAUBERT” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT MELBOURNE” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT MENIER” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT MOODY” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT MORESBY” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT MOUTON” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT NELSON” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT RUSSEL” GmbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT SAID” GmbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT STANLEY” GmbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT STEWART” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “PORT UNION” mbH, Hamburg 50.00%<br />

Verwaltungsgesellschaft “Port Williams” mbH, Hamburg 50.00%<br />

VV Immobilien GmbH & Co. GB KG, Düsseldorf 40.92%<br />

WISMA ATRIA Holding GmbH, Düsseldorf 50.00%<br />

Other associated companies International<br />

POOL Sp. z o. o., Warsaw 33.75%<br />

Secundi CBVA, Brussels 33.00%<br />

Triple IP B. V., Amsterdam 50.00%<br />

Volksbanken-Versicherungsdienst GmbH, Vienna 25.23%<br />

Other shareholdings<br />

– – –<br />

a) Consolidation pursuant to SIC 12<br />

b) Significant influence pursuant to IAS 28.7<br />

Differing voting power:<br />

c) 49.00%<br />

d) 0.00%<br />

e) 50.00%<br />

f) 42.34%<br />

g) 42.36%<br />

h) 25.00%<br />

1 Domination and profit transfer agreement with <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

2 Domination and profit transfer agreement with <strong>ERGO</strong> Versicherung Aktiengesellschaft<br />

3 Domination agreement with <strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

4 Profit transfer agreement with IDEENKAPITAL GmbH<br />

5 Profit transfer agreement with EUROPÄISCHE Reiseversicherung Aktiengesellschaft<br />

6 Profit transfer agreement with D.A.S. Deutscher Automobil Schutz Allgemeine Rechtsschutz-Versicherungs-Aktiengesellschaft<br />

7 Profit transfer agreement with <strong>ERGO</strong> Versicherung Aktiengesellschaft<br />

8 This fully consolidated subsidiary make full or partial use of the exemption in accordance with Section 264 para. 3<br />

of the German Commercial Code for their own financial statements.<br />

9 This fully consolidated subsidiary with the legal form of a partnership as defined in Section 264a of the German Commercial Code make full or<br />

partial use of the exemption in accordance with Section 264b of the German Commercial Code for their own financial statements.


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

147<br />

Düsseldorf, 12 February 2013<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

Board of Management<br />

Dr. Torsten Oletzky<br />

Dr. Bettina Anders<br />

Dr. Daniel von Borries<br />

Christian Diedrich<br />

Dr. Christoph Jurecka<br />

Dr. Ulf Mainzer<br />

Dr. Jochen Messemer<br />

Dr. Clemens Muth<br />

Dr. Rolf Wiswesser


<strong>ERGO</strong> Insurance <strong>Group</strong><br />

<strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />

148<br />

Auditor’s report<br />

We have duly audited the consolidated financial statements<br />

comprising the consolidated balance sheet, the consolidated<br />

income statement, the statement of recognised<br />

income and expense, the <strong>Group</strong> statement of changes<br />

in equity, the consolidated cash flow statement and the<br />

notes to the consolidated financial statements, together<br />

with the <strong>Group</strong> management report prepared by <strong>ERGO</strong> <strong>Versicherungsgruppe</strong><br />

<strong>AG</strong> in Düsseldorf for the financial year<br />

from 1 January to 31 December <strong>2012</strong>. The responsibility for<br />

preparing consolidated financial statements in line with<br />

IFRS, as adopted by the EU, and the additional provisions<br />

stated in Section 315a, para. 1 of the German Commercial<br />

Code (HGB) lies with the Company’s Board of Management.<br />

Our task is to form, on the basis of our audit, an assessment<br />

of the consolidated financial statements.<br />

We conducted our audit of the consolidated annual financial<br />

statements in accordance with Section 317 of the<br />

German Commercial Code (HGB), paying due regard to the<br />

generally accepted German standards concerning accounting<br />

principles as set out by the Institute of Public Auditors<br />

in Germany (IDW). These standards require that we plan<br />

and perform the audit such that misstatements materially<br />

affecting the presentation of net assets, financial position<br />

and earnings situation in the consolidated financial statements<br />

in accordance with the applicable financial reporting<br />

framework are detected with reasonable assurance. When<br />

determining the audit procedures, the knowledge of the<br />

<strong>Group</strong>’s field of business, its economic and legal environment<br />

and expectations regarding possible mistakes have<br />

to be taken into account. During the audit the effectiveness<br />

of the accounting-related internal control systems as well<br />

as evidence supporting the disclosures in the consolidated<br />

financial statements and <strong>Group</strong> management report are<br />

judged primarily on the basis of spot checks. The audit<br />

comprises the assessment of the financial statements<br />

of the individual companies included in the consolidated<br />

financial statements, definition of consolidated group,<br />

accounting and consolidating principles used and significant<br />

estimates made by the Board of Management, as<br />

well as an evaluation of the overall presentation of the<br />

consolidated financial statements and <strong>Group</strong> management<br />

report. We believe the audit we have conducted provides a<br />

sufficiently secure basis for our professional opinion.<br />

We have no objections to raise following our audit.<br />

In our opinion, based on the results of our audit, the<br />

consolidated financial statements conform to IFRS, as<br />

adopted by the EU, and the additional provisions stated in<br />

Section 315a, para. 1 HGB, and give a fair and true view of<br />

the net assets, financial position and earnings situation of<br />

the <strong>Group</strong> in accordance with these provisions. The <strong>Group</strong><br />

management report is in keeping with the consolidated<br />

financial statements and provides an accurate overall<br />

picture of the <strong>Group</strong>’s situation and suitably portrays the<br />

opportunities and risks inherent in future developments.<br />

Munich, 5 March 2013<br />

KPMG Bayerische Treuhandgesellschaft<br />

Aktiengesellschaft<br />

Wirtschaftsprüfungsgesellschaft<br />

Steuerberatungsgesellschaft<br />

Martin Berger<br />

Chartered accountant<br />

Roland Hansen<br />

Chartered accountant


Detailed contact information of our companies can<br />

be found on our website<br />

www.ergo.com<br />

under Company/<strong>ERGO</strong> Germany and <strong>ERGO</strong> International.<br />

Print<br />

compensated<br />

Id-No. 1325898<br />

www.bvdm-online.de<br />

Published by:<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

Victoriaplatz 2<br />

40198 Düsseldorf<br />

Tel + 49 211 477− 0<br />

Fax + 49 211 477− 1500<br />

www.ergo.com<br />

This edition of the <strong>Group</strong> <strong>Annual</strong> <strong>Report</strong><br />

has been translated into English from the German original.<br />

Concept, content and design:<br />

<strong>ERGO</strong> <strong>Versicherungsgruppe</strong> <strong>AG</strong><br />

Photos: Robert Brembeck, Christoph Bünten<br />

Lithography:<br />

Vignold <strong>Group</strong> GmbH, Ratingen<br />

Printed: August Lönneker GmbH & Co. KG,<br />

Stadtoldendorf


50064953 | <strong>ERGO</strong>48

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!